data_2n1p_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n1p _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.8 tp . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.185 0.517 . . . . 0.0 109.746 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.7 96.45 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.848 -0.532 . . . . 0.0 109.764 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.98 -39.16 93.89 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.579 -0.701 . . . . 0.0 109.738 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.97 -38.38 95.41 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.6 t -62.29 -41.29 91.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.498 -1.001 . . . . 0.0 109.827 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.99 -42.01 98.4 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 28.5 mm -66.88 -35.56 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.472 -1.016 . . . . 0.0 109.697 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -64.32 -26.98 68.72 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.275 -0.89 . . . . 0.0 109.513 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.433 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.9 mm? -78.46 -24.49 45.96 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.373 -0.829 . . . . 0.0 108.878 178.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.573 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 1.4 tp -134.44 56.03 16.78 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.581 -0.699 . . . . 0.0 110.763 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.573 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 43.4 Cg_endo . . . . . 0 C--N 1.319 -1.021 0 C-N-CA 121.096 1.197 . . . . 0.0 111.408 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.427 HD21 ' HA ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.803 0 CA-C-O 121.307 0.575 . . . . 0.0 109.624 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.8 -37.96 86.32 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.792 -0.567 . . . . 0.0 110.334 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.07 -40.56 96.21 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.455 -0.778 . . . . 0.0 109.965 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.48 -38.65 90.97 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 77.2 t -61.07 -41.23 88.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.474 -1.015 . . . . 0.0 109.939 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.32 -43.51 98.3 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 34.1 mm -67.48 -35.72 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.382 -1.069 . . . . 0.0 109.663 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -63.72 -25.67 68.31 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.217 -0.927 . . . . 0.0 109.645 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.463 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.6 mm? -80.07 -25.71 39.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.354 -0.841 . . . . 0.0 108.988 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.593 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 4.1 tp -131.28 52.76 10.01 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.467 -0.771 . . . . 0.0 111.126 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.593 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 43.0 Cg_endo . . . . . 0 C--N 1.319 -1.024 0 C-N-CA 120.895 1.064 . . . . 0.0 110.895 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 tt . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 121.21 0.529 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.8 -35.64 81.26 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.742 -0.599 . . . . 0.0 109.965 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.62 -42.19 64.72 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.504 -0.748 . . . . 0.0 109.979 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.6 -52.26 31.18 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 73.2 t -63.93 -35.25 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.482 -1.011 . . . . 0.0 110.015 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.58 -47.86 89.09 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.6 mt -68.02 -34.79 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.433 -1.04 . . . . 0.0 109.789 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -64.32 -25.08 67.88 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.163 -0.96 . . . . 0.0 109.769 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.479 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.2 mm? -80.81 -26.48 37.07 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.378 -0.826 . . . . 0.0 108.919 178.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.593 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 4.7 tp -130.14 52.0 8.58 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.591 -0.693 . . . . 0.0 111.215 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.593 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.7 Cg_endo . . . . . 0 C--N 1.319 -0.977 0 O-C-N 123.095 1.05 . . . . 0.0 110.787 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.8 tp . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.174 0.511 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.7 -41.49 95.3 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.725 -0.609 . . . . 0.0 109.999 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.56 -39.25 93.06 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.486 -0.759 . . . . 0.0 109.912 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.88 -39.14 94.87 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.6 t -62.01 -40.34 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.453 -1.027 . . . . 0.0 109.832 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.62 -46.75 91.44 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 37.9 mm -66.56 -33.89 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.54 -0.977 . . . . 0.0 109.578 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -62.5 -25.16 67.86 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.357 -0.839 . . . . 0.0 109.813 178.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.484 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.5 OUTLIER -80.71 -25.62 37.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.51 -0.743 . . . . 0.0 109.095 178.54 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.62 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -130.29 51.08 6.87 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.544 -0.723 . . . . 0.0 111.192 179.544 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.62 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 43.4 Cg_endo . . . . . 0 C--N 1.318 -1.053 0 O-C-N 123.039 1.02 . . . . 0.0 110.651 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.0 tp . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.322 0.582 . . . . 0.0 109.627 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.41 -39.99 95.99 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.882 -0.511 . . . . 0.0 109.811 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.62 -40.18 96.16 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.563 -0.71 . . . . 0.0 109.875 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.56 -39.22 96.63 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 89.7 t -61.5 -42.11 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.452 -1.028 . . . . 0.0 109.813 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.464 ' HA2' HD11 ' A' ' 26' ' ' LEU . . . -63.06 -42.32 99.61 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 31.3 mm -67.18 -36.28 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.497 -1.002 . . . . 0.0 109.691 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -62.54 -26.63 68.66 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.198 -0.939 . . . . 0.0 109.609 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.464 HD11 ' HA2' ' A' ' 23' ' ' GLY . 12.8 mt -79.52 -22.21 44.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.438 -0.789 . . . . 0.0 109.146 178.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.589 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.6 tp -135.8 54.63 10.51 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.565 -0.709 . . . . 0.0 110.756 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.589 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.8 Cg_endo . . . . . 0 C--N 1.319 -1.024 0 O-C-N 123.264 1.139 . . . . 0.0 111.039 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.0 tp . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 121.224 0.535 . . . . 0.0 109.838 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.06 -39.94 83.62 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.842 -0.536 . . . . 0.0 110.298 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.35 -41.13 98.35 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.485 -0.76 . . . . 0.0 110.006 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.28 -40.39 96.58 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 71.9 t -62.89 -40.58 89.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.503 -0.998 . . . . 0.0 109.943 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.06 -42.17 99.72 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 36.0 mt -67.05 -36.96 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.458 -1.025 . . . . 0.0 109.782 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -64.8 -26.17 68.23 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.166 -0.959 . . . . 0.0 109.6 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.467 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.7 mm? -79.17 -25.69 42.78 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.34 -0.85 . . . . 0.0 108.858 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.568 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -131.49 55.33 17.97 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.602 -0.686 . . . . 0.0 110.962 179.556 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.568 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.2 Cg_endo . . . . . 0 C--N 1.318 -1.065 0 C-N-CA 120.891 1.061 . . . . 0.0 110.993 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.4 tt . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.378 0.608 . . . . 0.0 109.377 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.56 -35.1 78.38 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.879 -0.513 . . . . 0.0 109.803 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.7 -39.85 94.36 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.587 -0.695 . . . . 0.0 110.018 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.54 -42.28 95.75 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 64.2 t -65.05 -42.26 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.512 -0.993 . . . . 0.0 109.538 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.3 -46.93 89.39 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.0 mt -65.43 -32.14 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.445 -1.032 . . . . 0.0 109.872 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.432 ' O ' ' HG3' ' A' ' 28' ' ' PRO . 44.0 t80 -64.79 -28.09 69.34 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.983 -1.073 . . . . 0.0 109.565 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.439 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.8 OUTLIER -77.37 -25.79 51.28 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.037 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.516 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.1 OUTLIER -133.8 59.13 37.14 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.724 -0.61 . . . . 0.0 109.975 179.35 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.516 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.6 Cg_endo . . . . . 0 C--N 1.319 -1.011 0 C-N-CA 121.223 1.282 . . . . 0.0 111.535 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 121.237 0.542 . . . . 0.0 109.863 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.15 -41.78 98.61 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.839 -0.538 . . . . 0.0 109.979 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.01 -40.58 98.18 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.636 -0.665 . . . . 0.0 109.958 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.404 ' HA2' HD11 ' A' ' 24' ' ' ILE . . . -62.17 -38.87 96.88 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 88.5 t -64.73 -41.6 92.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.516 -0.99 . . . . 0.0 109.792 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.82 -41.49 99.18 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.404 HD11 ' HA2' ' A' ' 21' ' ' GLY . 38.4 mt -66.73 -34.9 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.427 -1.043 . . . . 0.0 109.593 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -63.88 -27.04 68.88 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.291 -0.88 . . . . 0.0 109.606 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.97 -21.7 46.72 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.455 -0.778 . . . . 0.0 109.125 178.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.589 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 6.5 tp -136.25 54.07 8.91 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.619 -0.675 . . . . 0.0 110.757 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.589 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.4 Cg_endo . . . . . 0 C--N 1.318 -1.033 0 O-C-N 123.263 1.139 . . . . 0.0 111.435 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.36 0.6 . . . . 0.0 109.611 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.57 -37.8 85.71 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.632 -0.667 . . . . 0.0 109.774 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.02 -41.02 91.52 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.537 -0.727 . . . . 0.0 109.946 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.84 -37.37 94.21 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.3 t -61.71 -39.36 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.526 -0.984 . . . . 0.0 109.618 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.57 -49.16 66.2 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -65.08 -32.2 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.434 -1.039 . . . . 0.0 109.971 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -62.94 -27.0 69.08 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.148 -0.97 . . . . 0.0 109.631 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.466 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.8 OUTLIER -78.64 -26.54 45.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.41 -0.806 . . . . 0.0 108.927 178.238 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.556 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.7 OUTLIER -131.6 56.56 24.93 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.504 -0.747 . . . . 0.0 110.738 179.386 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.556 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.9 Cg_endo . . . . . 0 C--N 1.316 -1.14 0 C-N-CA 121.138 1.225 . . . . 0.0 111.129 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.0 tp . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.394 0.616 . . . . 0.0 109.649 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.78 -33.25 75.21 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.828 -0.545 . . . . 0.0 109.926 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.54 -43.09 67.06 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.481 -0.762 . . . . 0.0 110.135 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.48 -53.06 22.79 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 81.8 t -65.62 -36.83 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.435 -1.038 . . . . 0.0 110.132 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.07 -47.82 87.38 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.6 mm -65.46 -35.07 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.368 -1.078 . . . . 0.0 110.013 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -64.11 -28.48 69.8 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.996 -1.065 . . . . 0.0 109.718 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.481 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.7 OUTLIER -78.9 -25.54 43.81 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.341 -0.849 . . . . 0.0 108.882 178.253 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.574 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.2 OUTLIER -131.31 55.27 17.77 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.594 -0.691 . . . . 0.0 110.854 179.677 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.574 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.9 Cg_endo . . . . . 0 C--N 1.319 -1.007 0 C-N-CA 121.013 1.142 . . . . 0.0 110.95 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.15 0.5 . . . . 0.0 109.823 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.96 -39.67 82.4 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.765 -0.584 . . . . 0.0 109.995 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.86 -40.64 97.04 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.52 -0.738 . . . . 0.0 109.671 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.34 -37.09 94.29 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 76.4 t -61.83 -40.42 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.506 -0.997 . . . . 0.0 109.53 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.21 -45.15 95.92 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.2 mt -68.49 -32.36 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.377 -1.072 . . . . 0.0 109.657 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -61.41 -22.2 64.78 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.458 -0.776 . . . . 0.0 109.901 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.5 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.8 mm? -82.3 -25.05 34.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.399 -0.813 . . . . 0.0 109.487 178.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.618 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.6 OUTLIER -127.58 48.29 3.25 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.411 -0.806 . . . . 0.0 111.589 179.749 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.618 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 45.7 Cg_endo . . . . . 0 C--N 1.319 -0.976 0 O-C-N 122.862 0.928 . . . . 0.0 110.839 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.2 tt . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.322 0.582 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.49 -38.87 92.51 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.827 -0.546 . . . . 0.0 109.765 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.84 -40.23 96.09 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.6 -0.688 . . . . 0.0 109.724 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.77 -37.65 94.61 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.5 t -62.97 -41.64 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.45 -1.029 . . . . 0.0 109.805 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.67 -41.84 98.9 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.4 mm -67.17 -34.9 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.409 -1.054 . . . . 0.0 109.692 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -63.44 -26.75 68.88 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.255 -0.903 . . . . 0.0 109.637 178.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.446 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.8 OUTLIER -79.06 -24.9 43.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.412 -0.805 . . . . 0.0 109.022 178.226 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.582 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 5.7 tp -132.65 54.35 13.47 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.518 -0.739 . . . . 0.0 110.946 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.582 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.9 Cg_endo . . . . . 0 C--N 1.319 -1.018 0 C-N-CA 120.936 1.091 . . . . 0.0 111.162 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.219 0.533 . . . . 0.0 109.894 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.26 -40.7 95.06 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.72 -0.612 . . . . 0.0 109.773 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.64 -39.92 95.36 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.629 -0.669 . . . . 0.0 109.78 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.42 -37.58 93.96 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 87.7 t -61.62 -42.65 94.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.474 -1.016 . . . . 0.0 109.843 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.02 -41.83 99.79 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.421 HG22 HD12 ' A' ' 24' ' ' ILE . 30.3 mm -67.23 -36.57 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.455 -1.027 . . . . 0.0 109.761 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -63.08 -25.96 68.61 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.272 -0.893 . . . . 0.0 109.801 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.411 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 13.3 mt -81.44 -20.35 40.52 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.328 -0.858 . . . . 0.0 109.323 178.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.622 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 1.3 tp -135.99 51.86 5.82 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.412 -0.805 . . . . 0.0 110.902 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.622 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 44.7 Cg_endo . . . . . 0 C--N 1.32 -0.946 0 C-N-CA 121.113 1.209 . . . . 0.0 111.223 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.316 0.579 . . . . 0.0 109.747 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.14 -38.38 85.44 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.861 -0.524 . . . . 0.0 109.922 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.28 -43.11 98.86 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.531 -0.731 . . . . 0.0 109.928 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.57 -39.41 96.43 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.7 t -64.35 -37.2 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.62 -0.93 . . . . 0.0 109.714 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.438 ' HA2' HD12 ' A' ' 26' ' ' LEU . . . -60.15 -46.97 93.27 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.37 -34.16 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.521 -0.988 . . . . 0.0 109.65 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -63.23 -26.15 68.65 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.084 -1.01 . . . . 0.0 109.64 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.438 HD12 ' HA2' ' A' ' 23' ' ' GLY . 14.8 mt -78.82 -23.78 44.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.293 -0.88 . . . . 0.0 108.909 178.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.561 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -134.59 56.2 17.02 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.553 -0.717 . . . . 0.0 110.681 179.311 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.561 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 40.1 Cg_endo . . . . . 0 C--N 1.318 -1.055 0 O-C-N 123.235 1.124 . . . . 0.0 111.024 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.5 tt . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 121.174 0.512 . . . . 0.0 109.74 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.79 -40.51 97.54 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.755 -0.591 . . . . 0.0 109.67 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.51 -38.84 90.88 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.501 -0.75 . . . . 0.0 109.475 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.482 ' HA2' HD12 ' A' ' 24' ' ' ILE . . . -62.42 -36.41 93.09 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 87.4 t -62.76 -41.75 93.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.512 -0.993 . . . . 0.0 109.625 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.43 -42.0 99.67 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.482 HD12 ' HA2' ' A' ' 21' ' ' GLY . 22.3 mt -68.98 -32.18 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.545 -0.974 . . . . 0.0 109.555 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -63.46 -25.42 68.26 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.323 -0.86 . . . . 0.0 109.521 178.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.403 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.3 mp -78.61 -22.68 46.63 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.5 -0.75 . . . . 0.0 109.007 178.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.584 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 3.5 tp -135.28 53.98 9.9 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.603 -0.686 . . . . 0.0 110.78 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.584 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.6 Cg_endo . . . . . 0 C--N 1.318 -1.033 0 O-C-N 123.15 1.079 . . . . 0.0 110.86 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.065 0.459 . . . . 0.0 109.848 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.42 -45.6 93.03 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.648 -0.657 . . . . 0.0 109.5 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.73 -34.83 78.71 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.623 -0.673 . . . . 0.0 109.801 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.04 -40.12 95.04 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 77.3 t -60.04 -42.54 90.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.491 -1.005 . . . . 0.0 109.736 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.61 -45.26 93.45 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.9 mt -66.54 -35.26 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.491 -1.006 . . . . 0.0 109.736 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -63.43 -26.61 68.81 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.152 -0.968 . . . . 0.0 109.585 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.453 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.4 mm? -78.86 -26.51 44.04 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 178.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.556 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.0 tp -132.23 56.26 22.28 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.587 -0.696 . . . . 0.0 110.707 179.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.556 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.0 Cg_endo . . . . . 0 C--N 1.317 -1.093 0 O-C-N 123.323 1.17 . . . . 0.0 111.015 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 121.109 0.48 . . . . 0.0 109.848 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.54 -41.53 94.64 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.72 -0.612 . . . . 0.0 110.051 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.41 -38.24 89.36 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.55 -0.719 . . . . 0.0 109.827 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.6 -40.72 96.14 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 69.9 t -62.94 -38.14 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.504 -0.997 . . . . 0.0 109.895 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.33 -48.09 87.68 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.427 HG22 HD12 ' A' ' 24' ' ' ILE . 28.9 mm -71.48 -35.81 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.486 -1.008 . . . . 0.0 109.587 179.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -65.01 -26.62 68.36 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.266 -0.896 . . . . 0.0 109.629 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.401 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 10.7 mt -79.32 -21.23 46.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 0.0 109.046 178.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.574 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 3.0 tp -135.86 54.3 9.81 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.603 -0.685 . . . . 0.0 110.698 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.574 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 40.7 Cg_endo . . . . . 0 C--N 1.317 -1.092 0 O-C-N 123.103 1.054 . . . . 0.0 111.183 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.264 0.554 . . . . 0.0 109.724 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.97 -41.16 99.45 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.69 -0.631 . . . . 0.0 109.688 179.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.64 -39.03 93.31 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.541 -0.724 . . . . 0.0 109.66 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.52 -37.16 93.39 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 88.0 t -61.24 -41.02 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.408 -1.054 . . . . 0.0 109.576 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.71 -45.65 92.16 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.0 mt -68.14 -33.03 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.48 -1.012 . . . . 0.0 109.793 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -60.71 -23.46 64.91 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.304 -0.872 . . . . 0.0 109.821 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 12.3 mt -81.06 -17.4 50.26 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.328 -0.858 . . . . 0.0 109.638 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.624 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.4 tp -137.29 51.31 4.31 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.268 -0.895 . . . . 0.0 111.015 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.624 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 43.4 Cg_endo . . . . . 0 C--N 1.318 -1.03 0 O-C-N 123.16 1.084 . . . . 0.0 111.059 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.9 tt . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.307 0.575 . . . . 0.0 109.658 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.86 -39.02 93.22 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.755 -0.59 . . . . 0.0 109.97 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.97 -41.05 97.57 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.603 -0.686 . . . . 0.0 109.813 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.35 -38.09 95.37 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.5 t -63.2 -40.65 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.471 -1.017 . . . . 0.0 109.777 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.34 -41.41 98.16 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 29.9 mm -66.91 -36.36 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.382 -1.07 . . . . 0.0 109.697 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -64.58 -26.58 68.47 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.14 -0.975 . . . . 0.0 109.48 178.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.428 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.6 mm? -78.13 -24.76 47.26 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.406 -0.809 . . . . 0.0 108.872 177.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.56 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.3 tp -134.41 56.05 16.9 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.71 -0.619 . . . . 0.0 110.752 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.56 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.2 Cg_endo . . . . . 0 C--N 1.317 -1.126 0 C-N-CA 121.081 1.187 . . . . 0.0 111.139 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 121.313 0.577 . . . . 0.0 109.78 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.94 -36.94 75.71 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.79 -0.569 . . . . 0.0 109.92 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.44 -40.17 95.72 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.62 -0.675 . . . . 0.0 109.991 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.09 -45.21 88.74 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 179.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.3 t -65.52 -40.96 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.515 -0.991 . . . . 0.0 109.747 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.99 -48.83 80.84 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 23.8 mm -65.67 -34.97 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.406 -1.056 . . . . 0.0 109.71 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -62.29 -26.14 68.24 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.221 -0.925 . . . . 0.0 109.66 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.469 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 16.9 mt -79.58 -25.61 41.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.357 -0.84 . . . . 0.0 109.114 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.585 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 3.8 tp -131.52 53.54 11.88 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.453 -0.779 . . . . 0.0 110.921 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.585 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.5 Cg_endo . . . . . 0 C--N 1.319 -1.016 0 C-N-CA 120.96 1.107 . . . . 0.0 110.749 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.285 0.564 . . . . 0.0 109.811 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.68 -40.54 92.5 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.668 -0.645 . . . . 0.0 110.178 179.537 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.19 -42.05 99.28 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.522 -0.736 . . . . 0.0 109.695 179.374 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.404 ' HA2' HD11 ' A' ' 24' ' ' ILE . . . -62.38 -38.5 96.38 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.288 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 89.9 t -62.95 -41.41 92.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.535 -0.979 . . . . 0.0 109.841 179.5 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.96 -42.24 99.67 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.338 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.404 HD11 ' HA2' ' A' ' 21' ' ' GLY . 19.9 mt -67.67 -35.26 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.576 -0.955 . . . . 0.0 109.53 179.06 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 92.7 t80 -63.9 -22.46 66.93 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.354 -0.841 . . . . 0.0 110.006 178.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.499 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -83.77 -25.05 30.8 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.426 -0.796 . . . . 0.0 109.505 178.75 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.663 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.9 tp -125.65 44.75 1.22 Allowed Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.39 -0.819 . . . . 0.0 111.92 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.663 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 44.3 Cg_endo . . . . . 0 C--N 1.322 -0.831 0 O-C-N 122.868 0.931 . . . . 0.0 110.077 179.437 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.258 0.551 . . . . 0.0 109.56 . . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.09 -39.88 95.03 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.679 -0.638 . . . . 0.0 109.732 179.17 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.55 -38.66 91.97 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.519 -0.738 . . . . 0.0 109.712 179.151 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.38 -37.48 90.43 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 179.292 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 71.7 t -61.06 -39.21 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.307 -1.114 . . . . 0.0 109.534 179.242 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.0 -47.28 75.26 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.399 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 tp -68.0 -29.01 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.406 -1.055 . . . . 0.0 110.008 179.514 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -64.23 -21.63 66.65 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.288 -0.883 . . . . 0.0 109.81 178.703 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.435 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 12.6 mt -83.98 -21.3 31.78 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.323 -0.86 . . . . 0.0 109.685 178.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.66 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 5.5 tp -130.38 45.59 1.83 Allowed Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.322 -0.861 . . . . 0.0 111.668 179.772 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.66 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 47.1 Cg_endo . . . . . 0 C--N 1.322 -0.828 0 O-C-N 122.946 0.972 . . . . 0.0 110.239 179.434 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.7 tt . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 121.385 0.612 . . . . 0.0 109.632 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.73 -35.43 72.68 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.733 -0.605 . . . . 0.0 109.956 179.275 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.77 -39.19 87.76 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.524 -0.735 . . . . 0.0 110.231 179.696 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.4 -47.59 82.78 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.566 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 88.2 t -65.72 -39.76 85.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.586 -0.95 . . . . 0.0 109.7 179.324 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.78 -44.7 94.4 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.615 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 26.3 mt -65.17 -36.82 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.361 -1.082 . . . . 0.0 109.955 179.582 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -64.54 -26.27 68.35 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.137 -0.977 . . . . 0.0 109.599 178.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.462 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.4 mm? -78.32 -26.64 46.94 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.002 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.56 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 5.9 tp -131.74 55.81 20.46 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.549 -0.719 . . . . 0.0 110.874 179.579 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.56 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.9 Cg_endo . . . . . 0 C--N 1.318 -1.044 0 C-N-CA 121.038 1.158 . . . . 0.0 111.049 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.8 tt . . . . . 0 N--CA 1.494 1.766 0 CA-C-O 121.249 0.547 . . . . 0.0 109.58 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.6 -38.75 90.36 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.792 -0.568 . . . . 0.0 109.797 179.118 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.8 -38.44 91.09 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.528 -0.733 . . . . 0.0 109.851 179.224 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.42 -38.15 93.3 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.299 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.2 t -60.99 -44.17 97.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.473 -1.016 . . . . 0.0 109.677 179.403 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.415 ' HA2' HD13 ' A' ' 26' ' ' LEU . . . -63.91 -44.48 95.99 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.347 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 67.5 mt -65.93 -35.06 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.461 -1.023 . . . . 0.0 109.735 179.41 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -62.61 -26.76 68.78 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.215 -0.928 . . . . 0.0 109.524 178.744 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.415 HD13 ' HA2' ' A' ' 23' ' ' GLY . 6.1 mt -78.81 -23.6 45.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.385 -0.822 . . . . 0.0 108.98 178.206 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.567 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.5 tp -134.85 56.54 17.43 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.444 -0.785 . . . . 0.0 110.633 179.34 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.567 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.9 Cg_endo . . . . . 0 C--N 1.316 -1.133 0 C-N-CA 121.084 1.189 . . . . 0.0 111.202 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 121.119 0.485 . . . . 0.0 109.999 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.84 -41.73 96.41 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.703 -0.623 . . . . 0.0 110.015 179.392 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.29 95.07 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.532 -0.73 . . . . 0.0 109.686 179.21 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.28 -37.58 94.71 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.338 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 76.8 t -62.34 -41.8 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.416 -1.05 . . . . 0.0 109.724 179.415 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.75 -41.44 98.92 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.317 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 51.0 mt -66.59 -37.88 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.389 -1.065 . . . . 0.0 109.71 179.501 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -64.2 -26.19 68.4 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.182 -0.948 . . . . 0.0 109.646 178.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.445 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.5 mm? -79.08 -25.25 43.1 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.573 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 3.5 tp -133.05 55.04 15.1 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.662 -0.649 . . . . 0.0 110.863 179.678 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.573 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.2 Cg_endo . . . . . 0 C--N 1.319 -1.023 0 C-N-CA 120.963 1.109 . . . . 0.0 111.063 -179.932 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.5 tp . . . . . 0 N--CA 1.493 1.704 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.1 -39.69 95.43 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.865 -0.522 . . . . 0.0 109.652 179.112 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.06 -39.86 90.44 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.626 -0.671 . . . . 0.0 109.729 179.221 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.42 -40.12 98.5 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.417 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.7 t -63.24 -37.36 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.486 -1.008 . . . . 0.0 109.684 179.336 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.51 -46.94 92.48 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.371 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.7 mt -76.7 -27.68 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.381 -1.07 . . . . 0.0 109.812 179.204 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -60.94 -23.63 65.44 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.035 -1.041 . . . . 0.0 109.696 178.966 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.459 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.9 mm? -79.47 -24.37 42.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.256 -0.903 . . . . 0.0 109.177 178.476 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.581 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.5 tp -132.15 53.73 12.1 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.48 -0.762 . . . . 0.0 110.961 179.718 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.581 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.3 Cg_endo . . . . . 0 C--N 1.318 -1.065 0 C-N-CA 120.947 1.098 . . . . 0.0 111.005 -179.875 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.6 tt . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 121.342 0.592 . . . . 0.0 109.63 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.36 -37.84 86.23 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.747 -0.595 . . . . 0.0 109.894 179.327 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.89 -42.21 99.69 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.612 -0.68 . . . . 0.0 109.97 179.462 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.419 ' HA2' HD12 ' A' ' 24' ' ' ILE . . . -62.31 -38.87 96.95 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.441 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 91.2 t -64.2 -40.67 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.49 -1.006 . . . . 0.0 109.757 179.506 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.54 -42.04 99.01 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.51 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.419 HD12 ' HA2' ' A' ' 21' ' ' GLY . 24.2 mt -65.66 -36.67 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.423 -1.046 . . . . 0.0 109.821 179.527 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -64.93 -26.53 68.35 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.216 -0.927 . . . . 0.0 109.681 178.889 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.473 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.9 mm? -80.0 -24.76 40.64 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.367 -0.833 . . . . 0.0 108.99 178.29 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.588 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 1.2 tp -131.93 53.43 11.38 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.558 -0.714 . . . . 0.0 111.032 179.736 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.588 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 43.4 Cg_endo . . . . . 0 C--N 1.318 -1.035 0 C-N-CA 121.002 1.134 . . . . 0.0 111.144 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.5 tt . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 121.238 0.542 . . . . 0.0 109.65 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.67 -39.56 93.89 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.799 -0.563 . . . . 0.0 109.807 179.284 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.75 -39.95 95.75 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.635 -0.666 . . . . 0.0 109.897 179.391 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.55 -37.42 94.39 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.398 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 90.4 t -63.07 -41.35 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.53 -0.982 . . . . 0.0 109.685 179.471 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.31 -42.66 97.69 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.398 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.4 mt -66.36 -36.27 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.413 -1.051 . . . . 0.0 109.809 179.45 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -63.76 -27.59 69.3 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.32 -0.862 . . . . 0.0 109.8 179.085 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.454 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 3.8 mt -81.25 -21.65 39.3 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.425 -0.797 . . . . 0.0 109.16 178.306 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.624 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.1 OUTLIER -133.18 51.98 7.85 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.524 -0.735 . . . . 0.0 110.896 179.82 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.624 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 45.7 Cg_endo . . . . . 0 C--N 1.32 -0.936 0 C-N-CA 121.101 1.201 . . . . 0.0 111.329 -179.742 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.5 tp . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 121.425 0.631 . . . . 0.0 109.706 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.23 -35.42 77.91 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.819 -0.551 . . . . 0.0 109.943 179.198 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.94 -40.02 87.45 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.55 -0.719 . . . . 0.0 110.283 179.589 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.36 -46.64 90.02 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.577 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 76.5 t -66.06 -40.88 88.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.557 -0.966 . . . . 0.0 109.665 179.363 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.17 -47.14 88.13 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.59 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 35.2 mt -64.48 -33.72 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.435 -1.038 . . . . 0.0 109.885 179.542 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -63.65 -27.22 69.07 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.031 -1.043 . . . . 0.0 109.678 178.87 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.459 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.7 OUTLIER -79.14 -25.25 42.92 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.446 -0.784 . . . . 0.0 108.94 178.229 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.562 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.5 tp -132.95 56.63 23.09 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.539 -0.725 . . . . 0.0 110.714 179.498 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.562 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.5 Cg_endo . . . . . 0 C--N 1.318 -1.048 0 C-N-CA 121.143 1.229 . . . . 0.0 111.496 -179.837 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.1 tt . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 121.324 0.583 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.34 -37.92 89.19 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.851 -0.531 . . . . 0.0 109.704 179.207 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.5 -40.04 96.02 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.575 -0.703 . . . . 0.0 109.905 179.249 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.6 -36.98 93.81 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.384 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.5 t -63.81 -41.41 92.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.55 -0.97 . . . . 0.0 109.751 179.478 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.17 -41.45 98.37 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.372 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 29.8 mm -66.52 -34.86 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.467 -1.019 . . . . 0.0 109.779 179.293 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -63.49 -26.13 68.58 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.277 -0.889 . . . . 0.0 109.654 178.76 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.455 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.9 OUTLIER -79.84 -24.73 41.11 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.356 -0.84 . . . . 0.0 109.037 178.237 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.598 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 14.6 tp -132.13 53.21 10.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.499 -0.751 . . . . 0.0 110.97 179.583 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.598 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.2 Cg_endo . . . . . 0 C--N 1.32 -0.93 0 O-C-N 123.183 1.096 . . . . 0.0 111.005 179.893 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.6 tp . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.211 0.529 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.71 -42.63 97.6 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.76 -0.588 . . . . 0.0 109.964 179.511 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.87 -39.83 95.13 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.53 -0.731 . . . . 0.0 109.928 179.235 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.56 -39.35 93.88 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.506 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 78.8 t -60.89 -43.37 95.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.503 -0.998 . . . . 0.0 109.996 179.619 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.42 -43.92 98.37 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.496 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.7 mt -66.46 -37.08 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.46 -1.023 . . . . 0.0 109.753 179.446 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -62.45 -26.24 68.41 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.293 -0.879 . . . . 0.0 109.982 179.213 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.452 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 13.4 mt -81.61 -22.43 37.66 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.355 -0.841 . . . . 0.0 109.224 178.349 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.617 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.1 OUTLIER -132.5 51.75 7.73 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.581 -0.699 . . . . 0.0 110.812 179.731 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.617 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.9 Cg_endo . . . . . 0 C--N 1.32 -0.943 0 O-C-N 123.048 1.025 . . . . 0.0 110.822 -179.997 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.3 tp . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 121.24 0.543 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.47 -41.79 94.92 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.809 -0.557 . . . . 0.0 109.73 179.258 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.78 -40.99 92.53 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.539 -0.726 . . . . 0.0 109.815 179.121 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.425 ' HA2' HD13 ' A' ' 24' ' ' ILE . . . -61.63 -41.09 99.52 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 179.38 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.5 t -62.76 -40.03 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.568 -0.96 . . . . 0.0 109.801 179.418 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.469 ' HA2' HD13 ' A' ' 26' ' ' LEU . . . -59.69 -42.89 98.1 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.39 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.425 HD13 ' HA2' ' A' ' 21' ' ' GLY . 18.2 mt -68.61 -35.38 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.474 -1.015 . . . . 0.0 109.592 179.26 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -62.97 -27.03 69.12 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.204 -0.935 . . . . 0.0 109.613 178.824 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.469 HD13 ' HA2' ' A' ' 23' ' ' GLY . 13.5 mt -79.18 -18.27 53.36 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.379 -0.826 . . . . 0.0 109.314 178.359 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.588 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.9 tp -140.52 55.09 5.56 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.574 -0.704 . . . . 0.0 110.577 179.643 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.588 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.7 Cg_endo . . . . . 0 C--N 1.319 -1.021 0 C-N-CA 121.106 1.204 . . . . 0.0 111.377 -179.582 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.0 tp . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.263 0.554 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.87 -40.44 97.5 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.734 -0.604 . . . . 0.0 109.834 179.305 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.65 -37.39 87.17 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.629 -0.669 . . . . 0.0 109.884 179.311 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.98 -40.68 93.43 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.453 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.7 t -60.49 -42.24 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.505 -0.997 . . . . 0.0 109.802 179.496 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.41 ' HA2' HD11 ' A' ' 26' ' ' LEU . . . -64.21 -44.18 95.98 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.368 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.5 mt -65.22 -34.53 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.447 -1.031 . . . . 0.0 109.775 179.434 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -62.94 -27.23 69.24 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.148 -0.97 . . . . 0.0 109.497 178.754 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.41 HD11 ' HA2' ' A' ' 23' ' ' GLY . 6.1 mt -79.56 -17.7 53.37 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.428 -0.795 . . . . 0.0 109.353 178.303 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.598 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.7 tp -141.44 54.9 4.6 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.57 -0.706 . . . . 0.0 110.5 179.495 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.598 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.1 Cg_endo . . . . . 0 C--N 1.319 -0.999 0 C-N-CA 121.242 1.294 . . . . 0.0 111.249 -179.836 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.0 tp . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.347 0.594 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.63 -38.77 92.13 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.841 -0.537 . . . . 0.0 109.796 179.09 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.38 -38.67 91.85 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.587 -0.696 . . . . 0.0 110.054 179.398 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.69 -40.63 94.0 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.595 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 99.3 t -61.54 -42.15 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.458 -1.025 . . . . 0.0 109.828 179.577 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.97 -45.53 92.05 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.528 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.2 mt -65.77 -35.14 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.422 -1.046 . . . . 0.0 109.717 179.478 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -63.7 -25.91 68.42 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.315 -0.865 . . . . 0.0 109.498 178.75 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.456 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.3 mm? -79.05 -27.11 43.11 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.203 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.563 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 8.8 tp -131.16 55.46 19.03 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.576 -0.703 . . . . 0.0 110.849 179.518 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.563 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 39.9 Cg_endo . . . . . 0 C--N 1.318 -1.053 0 O-C-N 123.217 1.114 . . . . 0.0 110.561 179.647 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.7 tt . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.497 0.665 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.24 -35.06 78.78 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.849 -0.532 . . . . 0.0 110.376 179.613 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.36 -41.79 97.65 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.417 -0.802 . . . . 0.0 110.223 179.735 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.36 -46.92 66.48 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.632 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 77.9 t -64.61 -37.85 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.546 -0.973 . . . . 0.0 110.036 179.607 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.96 -46.97 92.99 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.704 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.3 mt -65.4 -35.14 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.384 -1.068 . . . . 0.0 109.925 179.605 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -64.99 -27.71 69.01 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.064 -1.022 . . . . 0.0 109.599 178.867 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.423 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.7 mm? -77.86 -25.34 48.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.321 -0.862 . . . . 0.0 108.689 178.016 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.539 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 5.6 tp -133.59 57.06 23.39 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.617 -0.677 . . . . 0.0 110.468 179.488 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 39.6 Cg_endo . . . . . 0 C--N 1.318 -1.076 0 C-N-CA 121.111 1.207 . . . . 0.0 111.212 -179.666 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.9 tp . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.16 0.505 . . . . 0.0 109.956 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.37 -46.26 89.16 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.814 -0.554 . . . . 0.0 109.823 179.352 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.93 -37.53 84.49 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.537 -0.727 . . . . 0.0 109.782 179.199 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.9 -39.01 96.96 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.469 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.1 t -60.35 -44.7 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.491 -1.005 . . . . 0.0 109.668 179.566 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.51 -41.93 99.74 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.411 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 31.1 mt -66.89 -35.35 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.449 -1.03 . . . . 0.0 109.801 179.469 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -62.49 -27.95 69.49 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.161 -0.962 . . . . 0.0 109.663 178.924 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.4 mt -80.6 -17.62 50.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.428 -0.795 . . . . 0.0 109.248 178.293 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.636 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -138.88 51.78 3.77 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.553 -0.717 . . . . 0.0 110.732 179.771 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.636 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 47.3 Cg_endo . . . . . 0 C--N 1.32 -0.936 0 C-N-CA 121.126 1.217 . . . . 0.0 111.145 -179.663 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.5 tt . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.362 0.601 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.59 -39.56 91.72 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.655 -0.653 . . . . 0.0 109.696 179.061 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.09 -39.55 94.3 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.627 -0.671 . . . . 0.0 109.974 179.304 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.98 -37.91 94.84 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.441 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.5 t -60.63 -43.29 94.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.512 -0.993 . . . . 0.0 109.76 179.621 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.414 ' HA2' HD11 ' A' ' 26' ' ' LEU . . . -64.11 -42.74 97.96 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.215 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 29.2 mm -68.03 -35.46 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.399 -1.06 . . . . 0.0 109.769 179.375 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -62.44 -25.91 68.22 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.259 -0.9 . . . . 0.0 109.571 178.845 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.437 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 8.4 mt -79.4 -24.41 42.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.311 -0.868 . . . . 0.0 108.9 178.27 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.572 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.8 tp -133.65 55.32 15.52 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.609 -0.682 . . . . 0.0 110.716 179.38 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.572 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.6 Cg_endo . . . . . 0 C--N 1.318 -1.032 0 C-N-CA 121.022 1.148 . . . . 0.0 110.994 179.904 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 121.294 0.569 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.94 -39.04 93.24 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.773 -0.579 . . . . 0.0 109.885 179.153 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.67 -41.75 98.15 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.554 -0.716 . . . . 0.0 109.763 179.255 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.441 ' HA2' HD12 ' A' ' 24' ' ' ILE . . . -62.16 -38.86 96.86 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.32 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 90.0 t -62.43 -43.2 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.552 -0.969 . . . . 0.0 109.797 179.433 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.462 ' HA2' HD12 ' A' ' 26' ' ' LEU . . . -62.43 -41.28 99.78 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.584 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.441 HD12 ' HA2' ' A' ' 21' ' ' GLY . 29.2 mt -66.64 -37.31 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.425 -1.044 . . . . 0.0 109.688 179.582 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -62.98 -26.68 68.96 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.216 -0.927 . . . . 0.0 109.666 178.948 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.462 HD12 ' HA2' ' A' ' 23' ' ' GLY . 11.7 mt -80.06 -17.31 53.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.371 -0.83 . . . . 0.0 109.429 178.373 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.609 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -140.26 53.5 4.3 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.539 -0.726 . . . . 0.0 110.648 179.561 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.609 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.7 Cg_endo . . . . . 0 C--N 1.318 -1.072 0 C-N-CA 121.03 1.153 . . . . 0.0 111.11 -179.689 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.8 tp . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 121.375 0.607 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.43 -37.86 89.0 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.808 -0.558 . . . . 0.0 109.945 179.285 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.38 -40.09 96.29 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.621 -0.675 . . . . 0.0 110.1 179.482 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.12 -42.19 94.6 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.624 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 73.2 t -62.32 -40.0 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.45 -1.03 . . . . 0.0 109.972 179.567 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.45 ' HA2' HD11 ' A' ' 26' ' ' LEU . . . -64.12 -44.74 95.3 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.567 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.3 mt -64.8 -35.58 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.358 -1.083 . . . . 0.0 109.784 179.543 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -63.69 -26.54 68.71 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.127 -0.983 . . . . 0.0 109.671 178.775 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.45 HD11 ' HA2' ' A' ' 23' ' ' GLY . 14.9 mt -79.18 -24.2 43.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.401 -0.812 . . . . 0.0 108.862 178.19 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.552 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.3 OUTLIER -133.72 56.31 19.6 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.579 -0.701 . . . . 0.0 110.558 179.411 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.552 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 40.3 Cg_endo . . . . . 0 C--N 1.318 -1.042 0 O-C-N 123.346 1.182 . . . . 0.0 111.143 -179.821 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 121.283 0.563 . . . . 0.0 109.604 . . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.14 -38.99 92.36 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.747 -0.596 . . . . 0.0 109.98 179.295 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.39 -43.22 95.13 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.587 -0.696 . . . . 0.0 109.758 179.359 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.12 -40.03 96.62 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.231 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.9 t -63.89 -37.8 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.529 -0.983 . . . . 0.0 109.71 179.244 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.441 ' HA2' HD11 ' A' ' 26' ' ' LEU . . . -60.06 -46.12 94.75 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.415 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.2 mp -67.18 -34.48 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.447 -1.031 . . . . 0.0 109.561 179.325 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -63.48 -25.99 68.52 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.15 -0.969 . . . . 0.0 109.575 178.842 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.441 HD11 ' HA2' ' A' ' 23' ' ' GLY . 13.6 mt -80.09 -19.43 47.44 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.353 -0.842 . . . . 0.0 109.266 178.273 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.595 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 10.9 tp -138.54 53.95 6.24 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.54 -0.725 . . . . 0.0 110.623 179.438 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.595 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 40.9 Cg_endo . . . . . 0 C--N 1.319 -1.003 0 O-C-N 123.232 1.122 . . . . 0.0 110.967 -179.975 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.4 tt . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 121.226 0.536 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.16 -38.04 84.79 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.791 -0.568 . . . . 0.0 109.682 179.088 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.65 -39.16 91.1 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.636 -0.665 . . . . 0.0 110.0 179.337 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.1 -39.74 97.46 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.43 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.3 t -62.22 -43.47 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.497 -1.002 . . . . 0.0 109.608 179.548 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.57 -44.39 92.89 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.411 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.4 mt -65.56 -35.02 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.455 -1.026 . . . . 0.0 109.721 179.411 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -64.1 -27.06 68.84 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.112 -0.992 . . . . 0.0 109.388 178.737 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.401 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.5 mm? -77.92 -24.88 48.15 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.097 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.543 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 3.4 tp -134.63 57.09 20.23 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.559 -0.713 . . . . 0.0 110.643 179.512 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.543 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.2 Cg_endo . . . . . 0 C--N 1.316 -1.137 0 O-C-N 123.225 1.118 . . . . 0.0 111.121 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 121.012 0.434 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.5 m -110.99 51.25 0.78 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.405 -0.81 . . . . 0.0 110.13 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.7 t 56.35 49.26 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 CA-C-O 121.471 0.653 . . . . 0.0 110.486 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.4 -36.02 15.71 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.244 -0.91 . . . . 0.0 110.176 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -113.74 31.24 6.66 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.791 -0.568 . . . . 0.0 110.011 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.52 45.91 1.39 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.537 -0.727 . . . . 0.0 110.165 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.2 mmm-85 -97.69 118.49 64.06 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.277 -0.889 . . . . 0.0 109.882 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -72.17 -84.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.238 0 O-C-N 123.908 1.478 . . . . 0.0 110.88 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -140.72 28.71 1.95 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.898 -1.126 . . . . 0.0 110.84 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 49.6 t90 -59.73 -45.31 92.57 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.378 -0.826 . . . . 0.0 109.836 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -86.64 -12.34 48.76 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.568 -0.708 . . . . 0.0 110.543 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -98.74 13.61 31.64 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.114 -0.991 . . . . 0.0 111.347 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -60.64 -51.35 69.77 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.279 -0.888 . . . . 0.0 109.945 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.8 t -61.16 -33.77 73.96 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.439 0.638 . . . . 0.0 109.469 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.01 -40.98 87.43 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.5 tt -64.44 -40.46 95.78 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.599 -0.688 . . . . 0.0 110.008 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.14 -32.02 72.57 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.481 0.658 . . . . 0.0 109.592 179.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.8 tp -74.95 -37.01 62.08 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.827 -0.546 . . . . 0.0 109.746 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.7 96.45 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.848 -0.532 . . . . 0.0 109.764 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.98 -39.16 93.89 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.579 -0.701 . . . . 0.0 109.738 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.97 -38.38 95.41 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.6 t -62.29 -41.29 91.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.498 -1.001 . . . . 0.0 109.827 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.99 -42.01 98.4 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 28.5 mm -66.88 -35.56 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.472 -1.016 . . . . 0.0 109.697 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -64.32 -26.98 68.72 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.275 -0.89 . . . . 0.0 109.513 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.433 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.9 mm? -78.46 -24.49 45.96 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.373 -0.829 . . . . 0.0 108.878 178.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.573 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 1.4 tp -134.44 56.03 16.78 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.581 -0.699 . . . . 0.0 110.763 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.573 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 43.4 Cg_endo -91.95 -19.75 0.71 Allowed 'Trans proline' 0 C--N 1.319 -1.021 0 C-N-CA 121.096 1.197 . . . . 0.0 111.408 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -103.59 -3.97 24.5 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.26 -0.9 . . . . 0.0 111.203 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.9 0 CA-C-O 117.88 -1.057 . . . . 0.0 110.243 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 72.7 t60 . . . . . 0 N--CA 1.495 1.808 0 CA-C-O 121.117 0.484 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.0 m -136.6 47.52 2.17 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.553 -0.717 . . . . 0.0 110.426 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.6 t -116.9 30.32 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.385 -0.822 . . . . 0.0 110.298 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.1 t -75.89 -20.87 57.69 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.118 -0.989 . . . . 0.0 110.968 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.41 31.32 3.76 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.421 -0.799 . . . . 0.0 110.533 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 51.72 37.38 20.08 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.463 -0.773 . . . . 0.0 110.913 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.2 mtm180 -116.6 86.96 19.57 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.414 -0.804 . . . . 0.0 109.694 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.69 137.91 20.78 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 123.846 1.445 . . . . 0.0 111.075 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.546 ' HA ' ' HB3' ' A' ' 12' ' ' TRP . 2.1 ttt-85 -145.39 -48.5 0.23 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.754 -0.591 . . . . 0.0 110.008 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -46.45 -47.47 19.13 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.701 -0.624 . . . . 0.0 110.443 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -95.71 -29.2 14.41 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.507 -0.745 . . . . 0.0 110.086 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.546 ' HB3' ' HA ' ' A' ' 9' ' ' ARG . 75.3 t-105 -59.28 -30.55 68.39 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.441 -0.787 . . . . 0.0 110.68 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -58.13 -37.39 74.5 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.641 -0.662 . . . . 0.0 109.743 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.4 t -66.2 -36.51 83.25 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.7 tt -66.94 -43.07 84.15 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 tt -64.74 -36.92 85.84 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.487 -0.758 . . . . 0.0 109.684 179.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.22 -32.26 73.78 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.618 0.723 . . . . 0.0 109.509 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.427 HD21 ' HA ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -84.78 -33.9 22.9 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.307 0.575 . . . . 0.0 109.624 179.025 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.8 -37.96 86.32 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.792 -0.567 . . . . 0.0 110.334 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.07 -40.56 96.21 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.455 -0.778 . . . . 0.0 109.965 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.48 -38.65 90.97 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 77.2 t -61.07 -41.23 88.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.474 -1.015 . . . . 0.0 109.939 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.32 -43.51 98.3 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 34.1 mm -67.48 -35.72 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.382 -1.069 . . . . 0.0 109.663 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -63.72 -25.67 68.31 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.217 -0.927 . . . . 0.0 109.645 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.463 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.6 mm? -80.07 -25.71 39.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.354 -0.841 . . . . 0.0 108.988 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.593 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 4.1 tp -131.28 52.76 10.01 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.467 -0.771 . . . . 0.0 111.126 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.593 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 43.0 Cg_endo -90.14 -20.88 1.02 Allowed 'Trans proline' 0 C--N 1.319 -1.024 0 C-N-CA 120.895 1.064 . . . . 0.0 110.895 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -80.99 -36.54 30.56 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.432 -0.792 . . . . 0.0 110.338 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.19 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.667 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 120.735 0.303 . . . . 0.0 110.27 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.441 ' O ' HG11 ' A' ' 3' ' ' VAL . 1.3 t 62.84 82.59 0.18 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.588 -0.695 . . . . 0.0 109.834 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.441 HG11 ' O ' ' A' ' 2' ' ' SER . 0.4 OUTLIER 60.63 19.45 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 CA-C-O 121.19 0.519 . . . . 0.0 111.008 -179.266 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.6 t -79.45 -38.39 34.74 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.989 -1.07 . . . . 0.0 110.423 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -153.39 26.02 0.52 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.62 -0.675 . . . . 0.0 111.137 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 46.8 48.11 14.97 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.444 -0.785 . . . . 0.0 110.679 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.611 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 6.5 mtt180 -76.32 -54.08 2.0 Allowed Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 121.497 -0.752 . . . . 0.0 110.99 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.611 ' HD3' ' HB2' ' A' ' 7' ' ' ARG . 53.9 Cg_endo -82.91 166.81 14.76 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 O-C-N 123.394 1.208 . . . . 0.0 110.616 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.6 ttm-85 63.48 7.73 3.16 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.826 -0.546 . . . . 0.0 111.924 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' HA ' ' CE3' ' A' ' 10' ' ' TRP . 6.1 t-105 -101.06 -47.64 4.69 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.973 -1.079 . . . . 0.0 109.73 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -78.06 -20.0 53.17 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.552 -0.717 . . . . 0.0 110.274 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 21.8 m95 -58.26 -28.3 64.81 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.358 -0.839 . . . . 0.0 110.832 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -60.72 -45.24 94.98 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.474 -0.766 . . . . 0.0 109.493 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.9 t -66.56 -36.37 82.48 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.07 -42.81 88.9 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 tt -61.14 -41.49 96.85 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.798 -0.564 . . . . 0.0 109.941 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 tt -60.69 -35.56 76.59 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.382 0.61 . . . . 0.0 109.6 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 tt -73.72 -34.54 64.84 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.21 0.529 . . . . 0.0 109.945 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.8 -35.64 81.26 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.742 -0.599 . . . . 0.0 109.965 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.62 -42.19 64.72 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.504 -0.748 . . . . 0.0 109.979 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.6 -52.26 31.18 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 73.2 t -63.93 -35.25 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.482 -1.011 . . . . 0.0 110.015 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.58 -47.86 89.09 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.6 mt -68.02 -34.79 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.433 -1.04 . . . . 0.0 109.789 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -64.32 -25.08 67.88 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.163 -0.96 . . . . 0.0 109.769 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.479 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.2 mm? -80.81 -26.48 37.07 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.378 -0.826 . . . . 0.0 108.919 178.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.593 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 4.7 tp -130.14 52.0 8.58 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.591 -0.693 . . . . 0.0 111.215 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.593 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.7 Cg_endo -89.03 -33.81 0.1 Allowed 'Trans proline' 0 C--N 1.319 -0.977 0 O-C-N 123.095 1.05 . . . . 0.0 110.787 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -109.14 5.59 24.08 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.398 -0.814 . . . . 0.0 110.691 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.8 mtp85 . . . . . 0 N--CA 1.496 1.838 0 O-C-N 121.218 -0.926 . . . . 0.0 110.436 179.845 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.5 m80 . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 121.031 0.443 . . . . 0.0 110.368 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.3 p -153.92 43.19 0.55 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.552 -0.717 . . . . 0.0 110.69 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.4 t -120.34 46.21 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.209 -0.932 . . . . 0.0 110.064 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.45 -41.29 20.01 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.188 -0.945 . . . . 0.0 110.347 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -140.0 28.93 2.09 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.78 -0.575 . . . . 0.0 110.388 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.411 ' O ' ' CB ' ' A' ' 7' ' ' ARG . . . 51.59 39.83 25.8 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.543 -0.723 . . . . 0.0 110.784 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.411 ' CB ' ' O ' ' A' ' 6' ' ' ALA . 1.6 ttp180 69.45 123.11 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.166 0 O-C-N 121.903 -0.498 . . . . 0.0 110.393 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.67 -28.28 21.06 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 O-C-N 123.64 1.337 . . . . 0.0 110.701 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.6 ttt85 -159.58 -162.26 1.01 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.505 -0.747 . . . . 0.0 109.373 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 52.41 32.97 12.1 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.399 -0.813 . . . . 0.0 110.431 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -174.01 -42.42 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.637 -0.664 . . . . 0.0 109.894 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 27.4 m95 -59.4 -19.72 49.3 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.672 -0.642 . . . . 0.0 111.697 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.04 -37.14 76.28 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.216 -0.928 . . . . 0.0 109.983 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 39.4 m -65.25 -36.7 84.92 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.34 -40.91 94.25 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.84 -39.58 94.55 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.609 -0.682 . . . . 0.0 109.719 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 tp -61.55 -33.42 73.81 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.488 0.661 . . . . 0.0 109.582 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.8 tp -75.03 -31.59 61.38 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.872 -0.517 . . . . 0.0 109.96 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.7 -41.49 95.3 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.725 -0.609 . . . . 0.0 109.999 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.56 -39.25 93.06 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.486 -0.759 . . . . 0.0 109.912 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.88 -39.14 94.87 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.6 t -62.01 -40.34 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.453 -1.027 . . . . 0.0 109.832 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.62 -46.75 91.44 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 37.9 mm -66.56 -33.89 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.54 -0.977 . . . . 0.0 109.578 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -62.5 -25.16 67.86 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.357 -0.839 . . . . 0.0 109.813 178.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.484 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.5 OUTLIER -80.71 -25.62 37.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.51 -0.743 . . . . 0.0 109.095 178.54 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.62 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -130.29 51.08 6.87 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.544 -0.723 . . . . 0.0 111.192 179.544 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.62 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 43.4 Cg_endo -90.17 -19.14 1.25 Allowed 'Trans proline' 0 C--N 1.318 -1.053 0 O-C-N 123.039 1.02 . . . . 0.0 110.651 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -84.96 -36.2 21.53 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.444 -0.785 . . . . 0.0 110.226 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.6 ttp85 . . . . . 0 N--CA 1.501 2.121 0 CA-C-O 118.088 -0.958 . . . . 0.0 110.824 179.854 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . 0.544 ' CD2' ' HB2' ' A' ' 5' ' ' HIS . 23.2 t-160 . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 121.12 0.486 . . . . 0.0 110.244 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.6 m -138.28 -96.57 0.18 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.6 -0.687 . . . . 0.0 109.88 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.4 m -125.33 8.57 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.271 -0.893 . . . . 0.0 110.789 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.2 t -95.96 -31.83 12.9 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.315 -0.866 . . . . 0.0 110.006 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.544 ' HB2' ' CD2' ' A' ' 1' ' ' HIS . 70.5 m-70 -103.17 10.03 38.01 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.703 -0.623 . . . . 0.0 110.687 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.41 16.45 19.89 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.268 -0.895 . . . . 0.0 110.729 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.7 tpm_? -154.85 68.19 5.49 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.243 -0.911 . . . . 0.0 109.967 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.47 ' HA ' ' CZ3' ' A' ' 10' ' ' TRP . 44.6 Cg_endo -73.01 -89.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.316 -1.152 0 O-C-N 123.838 1.441 . . . . 0.0 110.925 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.413 ' CG ' ' O ' ' A' ' 8' ' ' PRO . 24.5 ptt85 39.51 30.16 0.05 OUTLIER 'General case' 0 N--CA 1.509 2.521 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.47 ' CZ3' ' HA ' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -68.8 89.05 0.39 Allowed 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 177.139 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 60.56 26.92 16.59 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 -174.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 47.42 43.98 16.04 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.872 0.844 . . . . 0.0 110.138 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -69.35 -45.5 69.24 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.293 0.568 . . . . 0.0 109.524 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.4 t -65.2 -34.39 78.25 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 178.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 tt -66.24 -42.48 88.55 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.1 tt -63.82 -39.94 95.43 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.592 -0.693 . . . . 0.0 110.083 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 tt -62.01 -32.03 72.47 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.516 0.674 . . . . 0.0 109.465 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.0 tp -74.14 -37.91 63.9 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.322 0.582 . . . . 0.0 109.627 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.41 -39.99 95.99 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.882 -0.511 . . . . 0.0 109.811 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.62 -40.18 96.16 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.563 -0.71 . . . . 0.0 109.875 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.56 -39.22 96.63 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 89.7 t -61.5 -42.11 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.452 -1.028 . . . . 0.0 109.813 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.464 ' HA2' HD11 ' A' ' 26' ' ' LEU . . . -63.06 -42.32 99.61 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 31.3 mm -67.18 -36.28 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.497 -1.002 . . . . 0.0 109.691 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -62.54 -26.63 68.66 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.198 -0.939 . . . . 0.0 109.609 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.464 HD11 ' HA2' ' A' ' 23' ' ' GLY . 12.8 mt -79.52 -22.21 44.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.438 -0.789 . . . . 0.0 109.146 178.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.589 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.6 tp -135.8 54.63 10.51 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.565 -0.709 . . . . 0.0 110.756 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.589 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.8 Cg_endo -90.57 -21.63 0.79 Allowed 'Trans proline' 0 C--N 1.319 -1.024 0 O-C-N 123.264 1.139 . . . . 0.0 111.039 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -93.92 -37.29 11.78 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.347 -0.845 . . . . 0.0 110.191 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.123 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 52.0 m80 . . . . . 0 N--CA 1.496 1.837 0 CA-C-O 120.754 0.311 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.2 p 53.36 36.9 24.12 Favored 'General case' 0 N--CA 1.504 2.268 0 CA-C-O 121.128 0.489 . . . . 0.0 111.721 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.452 HG22 ' HG3' ' A' ' 8' ' ' PRO . 16.3 t -116.61 29.16 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 120.944 -1.097 . . . . 0.0 110.326 179.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.33 -38.48 90.26 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.059 -1.026 . . . . 0.0 110.136 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -112.85 33.87 4.76 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.856 -0.528 . . . . 0.0 109.985 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 51.72 43.23 30.09 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.635 -0.665 . . . . 0.0 110.932 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.546 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -63.36 -52.91 57.26 Favored Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 121.288 -0.882 . . . . 0.0 110.808 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.546 ' HD3' ' HB3' ' A' ' 7' ' ' ARG . 48.4 Cg_endo -74.36 -163.99 0.2 Allowed 'Trans proline' 0 N--CA 1.486 1.054 0 O-C-N 123.513 1.27 . . . . 0.0 110.233 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.452 ' HA ' ' HB2' ' A' ' 12' ' ' TRP . 4.7 mmt85 -95.61 19.63 10.83 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.151 -0.968 . . . . 0.0 111.09 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 7.7 t-105 -65.2 -49.02 71.36 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.239 -0.913 . . . . 0.0 109.981 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -91.37 11.35 24.05 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.498 -0.751 . . . . 0.0 110.558 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.452 ' HB2' ' HA ' ' A' ' 9' ' ' ARG . 18.1 m95 -105.43 14.77 28.22 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.163 -0.961 . . . . 0.0 110.752 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -62.17 -53.71 51.46 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.121 -0.987 . . . . 0.0 109.93 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.9 t -60.91 -33.22 72.8 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.393 0.616 . . . . 0.0 109.791 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -69.65 -40.56 76.4 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.761 -0.587 . . . . 0.0 109.444 178.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 tt -63.78 -40.02 95.65 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.587 -0.695 . . . . 0.0 109.91 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 tt -63.17 -29.74 71.03 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.406 0.622 . . . . 0.0 109.632 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.0 tp -79.7 -34.44 40.15 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.823 -0.548 . . . . 0.0 109.838 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.06 -39.94 83.62 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.842 -0.536 . . . . 0.0 110.298 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.35 -41.13 98.35 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.485 -0.76 . . . . 0.0 110.006 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.28 -40.39 96.58 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 71.9 t -62.89 -40.58 89.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.503 -0.998 . . . . 0.0 109.943 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.06 -42.17 99.72 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 36.0 mt -67.05 -36.96 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.458 -1.025 . . . . 0.0 109.782 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -64.8 -26.17 68.23 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.166 -0.959 . . . . 0.0 109.6 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.467 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.7 mm? -79.17 -25.69 42.78 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.34 -0.85 . . . . 0.0 108.858 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.568 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -131.49 55.33 17.97 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.602 -0.686 . . . . 0.0 110.962 179.556 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.568 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.2 Cg_endo -90.45 -21.96 0.79 Allowed 'Trans proline' 0 C--N 1.318 -1.065 0 C-N-CA 120.891 1.061 . . . . 0.0 110.993 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -92.35 -10.79 36.95 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.298 -0.876 . . . . 0.0 110.922 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 20.6 mtm-85 . . . . . 0 N--CA 1.502 2.145 0 O-C-N 121.463 -0.773 . . . . 0.0 110.675 -179.865 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 30.2 p80 . . . . . 0 N--CA 1.498 1.974 0 CA-C-O 120.96 0.41 . . . . 0.0 110.556 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 t -155.28 54.87 0.63 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.493 -0.755 . . . . 0.0 110.426 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.4 t 57.58 23.35 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 121.593 -0.692 . . . . 0.0 111.252 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.89 -37.4 13.59 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.886 -1.134 . . . . 0.0 110.059 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -118.17 13.82 13.85 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.74 -0.6 . . . . 0.0 110.845 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -107.35 46.4 0.94 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.303 -0.873 . . . . 0.0 110.488 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 56.62 83.31 0.23 Allowed Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.515 -0.741 . . . . 0.0 110.656 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -73.05 84.34 1.32 Allowed 'Trans proline' 0 C--N 1.314 -1.24 0 O-C-N 123.612 1.322 . . . . 0.0 110.79 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.463 ' HG3' ' CD1' ' A' ' 10' ' ' TRP . 1.3 ptm180 -154.58 -119.76 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.475 -0.766 . . . . 0.0 110.051 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.512 ' O ' ' CB ' ' A' ' 11' ' ' PHE . 27.6 p-90 32.44 88.89 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.766 0 CA-C-N 119.026 0.83 . . . . 0.0 112.064 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.512 ' CB ' ' O ' ' A' ' 10' ' ' TRP . 6.4 t80 78.89 -43.48 0.33 Allowed 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.656 -0.653 . . . . 0.0 111.14 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.401 ' HB3' ' O ' ' A' ' 9' ' ' ARG . 67.4 t-105 -57.49 -35.48 70.26 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.05 -1.031 . . . . 0.0 110.127 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -55.64 -35.07 65.53 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.757 -0.589 . . . . 0.0 109.707 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.0 m -64.55 -37.45 87.59 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.0 tt -65.01 -42.5 94.37 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 tt -64.93 -35.53 81.47 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.547 -0.721 . . . . 0.0 109.731 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.7 tp -62.92 -37.07 85.55 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.4 tt -65.76 -39.25 90.85 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.378 0.608 . . . . 0.0 109.377 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.56 -35.1 78.38 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.879 -0.513 . . . . 0.0 109.803 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.7 -39.85 94.36 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.587 -0.695 . . . . 0.0 110.018 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.54 -42.28 95.75 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 64.2 t -65.05 -42.26 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.512 -0.993 . . . . 0.0 109.538 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.3 -46.93 89.39 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.0 mt -65.43 -32.14 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.445 -1.032 . . . . 0.0 109.872 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.432 ' O ' ' HG3' ' A' ' 28' ' ' PRO . 44.0 t80 -64.79 -28.09 69.34 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.983 -1.073 . . . . 0.0 109.565 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.439 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.8 OUTLIER -77.37 -25.79 51.28 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.037 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.516 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.1 OUTLIER -133.8 59.13 37.14 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.724 -0.61 . . . . 0.0 109.975 179.35 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.516 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.6 Cg_endo -90.99 -19.55 0.91 Allowed 'Trans proline' 0 C--N 1.319 -1.011 0 C-N-CA 121.223 1.282 . . . . 0.0 111.535 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -58.1 -32.54 68.19 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.408 -0.807 . . . . 0.0 110.764 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.199 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.553 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.4 p 39.47 48.4 1.75 Allowed 'General case' 0 N--CA 1.506 2.329 0 CA-C-O 121.225 0.536 . . . . 0.0 111.592 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.0 p -120.27 19.72 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.28 -0.888 . . . . 0.0 110.729 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 45.4 t -65.97 -26.35 67.52 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.183 -0.948 . . . . 0.0 110.526 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 34.3 p-80 -129.78 15.77 5.85 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.739 -0.601 . . . . 0.0 110.705 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -111.49 32.61 5.26 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.461 -0.775 . . . . 0.0 110.965 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.0 ptt-85 -151.82 62.36 4.72 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 121.109 -0.994 . . . . 0.0 110.395 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -74.37 -174.79 1.94 Allowed 'Trans proline' 0 C--N 1.315 -1.209 0 O-C-N 123.735 1.387 . . . . 0.0 111.017 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -164.87 61.05 0.13 Allowed 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.809 0.814 . . . . 0.0 110.276 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -138.9 -58.17 0.61 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.76 -0.588 . . . . 0.0 110.079 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -79.47 -16.39 56.17 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.467 -0.771 . . . . 0.0 110.643 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 13.9 m95 -56.7 -31.26 64.3 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.419 -0.8 . . . . 0.0 111.267 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -63.59 -39.55 94.66 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.413 -0.804 . . . . 0.0 109.66 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.8 t -65.9 -35.78 81.57 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.3 tt -66.07 -41.61 90.51 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 tt -63.61 -37.91 89.12 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.686 -0.634 . . . . 0.0 109.923 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.0 tp -62.66 -33.81 75.8 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.599 0.714 . . . . 0.0 109.44 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.64 -36.57 60.16 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.237 0.542 . . . . 0.0 109.863 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.15 -41.78 98.61 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.839 -0.538 . . . . 0.0 109.979 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.01 -40.58 98.18 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.636 -0.665 . . . . 0.0 109.958 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.404 ' HA2' HD11 ' A' ' 24' ' ' ILE . . . -62.17 -38.87 96.88 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 88.5 t -64.73 -41.6 92.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.516 -0.99 . . . . 0.0 109.792 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.82 -41.49 99.18 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.404 HD11 ' HA2' ' A' ' 21' ' ' GLY . 38.4 mt -66.73 -34.9 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.427 -1.043 . . . . 0.0 109.593 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -63.88 -27.04 68.88 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.291 -0.88 . . . . 0.0 109.606 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.97 -21.7 46.72 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.455 -0.778 . . . . 0.0 109.125 178.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.589 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 6.5 tp -136.25 54.07 8.91 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.619 -0.675 . . . . 0.0 110.757 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.589 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.4 Cg_endo -89.86 -29.21 0.22 Allowed 'Trans proline' 0 C--N 1.318 -1.033 0 O-C-N 123.263 1.139 . . . . 0.0 111.435 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -84.53 -33.46 23.49 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.234 -0.916 . . . . 0.0 110.545 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.2 ttm180 . . . . . 0 N--CA 1.502 2.148 0 CA-C-O 118.091 -0.957 . . . . 0.0 111.124 179.785 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 12.3 m80 . . . . . 0 N--CA 1.494 1.768 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 86.7 p 39.58 44.26 1.18 Allowed 'General case' 0 N--CA 1.507 2.399 0 O-C-N 122.064 -0.398 . . . . 0.0 111.798 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.5 t 47.01 39.93 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.611 -0.681 . . . . 0.0 110.668 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.2 m -80.04 -73.09 0.37 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.152 -0.967 . . . . 0.0 110.065 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.406 ' CD2' ' HG3' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -151.91 -75.31 0.14 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.69 -0.631 . . . . 0.0 110.623 179.787 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 49.62 56.76 7.36 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.835 -0.54 . . . . 0.0 110.513 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.444 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 4.2 ttp180 -173.44 -57.84 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.073 0 O-C-N 121.512 -0.743 . . . . 0.0 110.823 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.444 ' HD3' ' HB3' ' A' ' 7' ' ' ARG . 43.3 Cg_endo -69.74 -169.96 0.36 Allowed 'Trans proline' 0 N--CA 1.492 1.407 0 O-C-N 123.549 1.289 . . . . 0.0 111.277 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.403 ' HA ' ' HB3' ' A' ' 12' ' ' TRP . 0.3 OUTLIER -62.68 -73.75 0.1 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.376 -0.828 . . . . 0.0 111.042 -179.201 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 74.4 t-105 52.53 -94.26 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.62 -0.675 . . . . 0.0 110.214 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -76.83 -32.06 57.32 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.026 -1.046 . . . . 0.0 109.667 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.403 ' HB3' ' HA ' ' A' ' 9' ' ' ARG . 68.5 t-105 -68.91 -17.19 63.93 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.564 -0.71 . . . . 0.0 110.484 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -63.77 -36.41 83.77 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.436 -0.79 . . . . 0.0 109.529 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.23 -40.5 94.15 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 tt -62.97 -41.55 99.57 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.9 tt -64.51 -42.08 96.03 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.713 -0.617 . . . . 0.0 109.957 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 tt -61.06 -32.57 72.2 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.545 0.688 . . . . 0.0 109.441 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.79 -39.45 80.15 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.36 0.6 . . . . 0.0 109.611 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.57 -37.8 85.71 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.632 -0.667 . . . . 0.0 109.774 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.02 -41.02 91.52 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.537 -0.727 . . . . 0.0 109.946 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.84 -37.37 94.21 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.3 t -61.71 -39.36 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.526 -0.984 . . . . 0.0 109.618 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.57 -49.16 66.2 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -65.08 -32.2 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.434 -1.039 . . . . 0.0 109.971 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -62.94 -27.0 69.08 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.148 -0.97 . . . . 0.0 109.631 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.466 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.8 OUTLIER -78.64 -26.54 45.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.41 -0.806 . . . . 0.0 108.927 178.238 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.556 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.7 OUTLIER -131.6 56.56 24.93 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.504 -0.747 . . . . 0.0 110.738 179.386 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.556 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.9 Cg_endo -91.79 -19.19 0.8 Allowed 'Trans proline' 0 C--N 1.316 -1.14 0 C-N-CA 121.138 1.225 . . . . 0.0 111.129 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -89.54 -0.67 57.67 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.311 -0.868 . . . . 0.0 111.24 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.802 0 O-C-N 121.021 -1.05 . . . . 0.0 110.237 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 29.8 m80 . . . . . 0 N--CA 1.496 1.826 0 CA-C-O 121.066 0.46 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.1 p -104.85 35.02 2.92 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.44 -0.787 . . . . 0.0 110.721 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.5 t 51.97 47.15 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.507 -0.746 . . . . 0.0 110.349 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 t -98.65 -15.85 19.26 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.256 -0.903 . . . . 0.0 110.773 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -98.22 37.89 1.39 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.384 -0.822 . . . . 0.0 110.342 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -151.24 41.61 0.73 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.454 -0.779 . . . . 0.0 110.19 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.496 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -165.89 -62.47 0.01 OUTLIER Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.363 -0.835 . . . . 0.0 110.515 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.496 ' CD ' ' CB ' ' A' ' 7' ' ' ARG . 46.8 Cg_endo -72.74 110.3 2.98 Favored 'Trans proline' 0 N--CA 1.485 1.02 0 O-C-N 123.445 1.234 . . . . 0.0 110.295 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.2 mmt85 -103.91 16.2 26.86 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.608 -0.682 . . . . 0.0 110.944 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 84.6 t90 -62.04 -45.48 93.37 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.228 -0.92 . . . . 0.0 110.15 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -69.6 -22.72 63.48 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.567 -0.708 . . . . 0.0 110.523 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -105.3 13.69 30.06 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.362 -0.836 . . . . 0.0 111.259 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -70.11 -51.3 32.69 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.178 -0.951 . . . . 0.0 109.683 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.2 p -64.03 -35.09 79.58 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.84 -41.94 86.59 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.1 tt -65.36 -38.04 88.85 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.611 -0.68 . . . . 0.0 109.559 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.0 tp -61.56 -35.43 77.77 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.501 0.667 . . . . 0.0 109.411 178.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.0 tp -71.92 -36.05 69.85 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.394 0.616 . . . . 0.0 109.649 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.78 -33.25 75.21 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.828 -0.545 . . . . 0.0 109.926 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.54 -43.09 67.06 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.481 -0.762 . . . . 0.0 110.135 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.48 -53.06 22.79 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 81.8 t -65.62 -36.83 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.435 -1.038 . . . . 0.0 110.132 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.07 -47.82 87.38 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.6 mm -65.46 -35.07 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.368 -1.078 . . . . 0.0 110.013 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -64.11 -28.48 69.8 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.996 -1.065 . . . . 0.0 109.718 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.481 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.7 OUTLIER -78.9 -25.54 43.81 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.341 -0.849 . . . . 0.0 108.882 178.253 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.574 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.2 OUTLIER -131.31 55.27 17.77 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.594 -0.691 . . . . 0.0 110.854 179.677 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.574 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.9 Cg_endo -91.21 -20.43 0.77 Allowed 'Trans proline' 0 C--N 1.319 -1.007 0 C-N-CA 121.013 1.142 . . . . 0.0 110.95 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -100.94 6.2 43.51 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.366 -0.834 . . . . 0.0 110.896 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.237 0 O-C-N 121.497 -0.752 . . . . 0.0 111.351 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 120.837 0.351 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 60.36 74.15 0.46 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.688 -0.632 . . . . 0.0 109.993 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.491 HG13 ' HD3' ' A' ' 8' ' ' PRO . 36.5 t 57.46 68.25 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 CA-C-O 121.605 0.717 . . . . 0.0 109.867 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.5 t -137.81 -63.58 0.57 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.376 -0.828 . . . . 0.0 110.623 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -115.7 34.27 5.03 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.586 -0.697 . . . . 0.0 110.646 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -176.7 48.7 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.561 -0.712 . . . . 0.0 110.078 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.443 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.9 OUTLIER -173.5 -57.32 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.097 0 O-C-N 121.269 -0.894 . . . . 0.0 111.429 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.491 ' HD3' HG13 ' A' ' 3' ' ' VAL . 44.3 Cg_endo -75.33 -84.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.487 1.099 0 O-C-N 123.37 1.195 . . . . 0.0 111.297 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.418 ' O ' ' C ' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -135.99 -61.88 0.69 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.083 -1.011 . . . . 0.0 110.293 -179.685 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.508 ' O ' ' CB ' ' A' ' 11' ' ' PHE . 6.1 m95 -39.97 136.61 1.09 Allowed 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.162 -0.961 . . . . 0.0 111.021 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.508 ' CB ' ' O ' ' A' ' 10' ' ' TRP . 2.6 t80 81.3 -10.25 1.21 Allowed 'General case' 0 N--CA 1.507 2.387 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.131 -179.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.503 ' CE3' ' N ' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -88.88 13.05 13.56 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.962 -1.086 . . . . 0.0 110.935 179.101 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.503 ' N ' ' CE3' ' A' ' 12' ' ' TRP . 2.5 t80 -73.24 -42.01 63.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.582 -0.699 . . . . 0.0 109.454 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.78 -33.19 75.41 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.9 tp -66.37 -40.3 89.64 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.6 tt -64.77 -39.08 93.02 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.688 -0.632 . . . . 0.0 109.342 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.18 -31.63 72.91 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.682 0.753 . . . . 0.0 109.048 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.76 -32.06 67.3 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.881 -0.512 . . . . 0.0 109.823 178.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.96 -39.67 82.4 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.765 -0.584 . . . . 0.0 109.995 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.86 -40.64 97.04 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.52 -0.738 . . . . 0.0 109.671 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.34 -37.09 94.29 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 76.4 t -61.83 -40.42 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.506 -0.997 . . . . 0.0 109.53 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.21 -45.15 95.92 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.2 mt -68.49 -32.36 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.377 -1.072 . . . . 0.0 109.657 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -61.41 -22.2 64.78 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.458 -0.776 . . . . 0.0 109.901 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.5 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.8 mm? -82.3 -25.05 34.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.399 -0.813 . . . . 0.0 109.487 178.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.618 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.6 OUTLIER -127.58 48.29 3.25 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.411 -0.806 . . . . 0.0 111.589 179.749 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.618 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 45.7 Cg_endo -90.42 -21.08 0.9 Allowed 'Trans proline' 0 C--N 1.319 -0.976 0 O-C-N 122.862 0.928 . . . . 0.0 110.839 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -100.32 -39.09 8.18 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.391 -0.818 . . . . 0.0 110.275 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 117.927 -1.035 . . . . 0.0 110.015 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 31.6 m80 . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 120.991 0.424 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.7 t -111.37 48.12 0.97 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.503 -0.748 . . . . 0.0 110.38 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.6 t -111.66 36.43 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.294 -0.879 . . . . 0.0 110.141 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.2 t -93.76 -34.36 13.24 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.198 -0.939 . . . . 0.0 110.406 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -96.3 13.4 27.75 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.744 -0.598 . . . . 0.0 111.067 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 52.62 71.92 0.44 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.282 -0.886 . . . . 0.0 110.262 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 12' ' ' TRP . 1.3 mmp_? -86.99 118.79 70.55 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.291 -0.88 . . . . 0.0 110.762 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -75.67 -27.61 8.81 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 123.896 1.472 . . . . 0.0 110.637 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.478 ' O ' ' HB2' ' A' ' 10' ' ' TRP . 7.0 mmt180 -141.99 -165.7 2.07 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.434 -0.791 . . . . 0.0 109.839 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.478 ' HB2' ' O ' ' A' ' 9' ' ' ARG . 16.4 m-90 62.49 -82.39 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.825 -0.547 . . . . 0.0 110.175 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.75 16.63 10.36 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.265 -0.897 . . . . 0.0 110.043 178.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.41 ' HB2' ' O ' ' A' ' 7' ' ' ARG . 67.9 t-105 -105.55 -21.09 13.28 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.335 -0.853 . . . . 0.0 111.097 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -61.74 -45.42 94.01 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.347 -0.846 . . . . 0.0 109.888 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.9 p -62.7 -33.36 74.92 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.94 -43.77 91.65 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.9 tt -63.72 -36.62 84.45 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.771 -0.58 . . . . 0.0 109.767 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.3 tp -64.65 -36.98 86.02 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.646 0.736 . . . . 0.0 109.157 178.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.2 tt -68.45 -37.12 79.93 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.322 0.582 . . . . 0.0 109.434 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.49 -38.87 92.51 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.827 -0.546 . . . . 0.0 109.765 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.84 -40.23 96.09 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.6 -0.688 . . . . 0.0 109.724 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.77 -37.65 94.61 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.5 t -62.97 -41.64 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.45 -1.029 . . . . 0.0 109.805 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.67 -41.84 98.9 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.4 mm -67.17 -34.9 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.409 -1.054 . . . . 0.0 109.692 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -63.44 -26.75 68.88 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.255 -0.903 . . . . 0.0 109.637 178.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.446 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.8 OUTLIER -79.06 -24.9 43.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.412 -0.805 . . . . 0.0 109.022 178.226 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.582 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 5.7 tp -132.65 54.35 13.47 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.518 -0.739 . . . . 0.0 110.946 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.582 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.9 Cg_endo -90.67 -22.43 0.67 Allowed 'Trans proline' 0 C--N 1.319 -1.018 0 C-N-CA 120.936 1.091 . . . . 0.0 111.162 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.75 -28.96 66.22 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.232 -0.917 . . . . 0.0 110.398 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? . . . . . 0 N--CA 1.505 2.307 0 CA-C-O 118.305 -0.855 . . . . 0.0 111.079 179.67 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.497 1.902 0 CA-C-O 121.095 0.474 . . . . 0.0 110.431 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.5 m -128.84 37.75 4.04 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.584 -0.698 . . . . 0.0 110.25 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.8 m -115.12 52.44 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.28 -0.887 . . . . 0.0 110.143 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.32 -28.33 47.32 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.44 -0.788 . . . . 0.0 110.749 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -95.9 42.1 1.09 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.483 -0.761 . . . . 0.0 110.386 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.35 31.89 1.52 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.27 -0.894 . . . . 0.0 110.605 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 48.9 mtt180 45.22 59.87 13.88 Favored Pre-proline 0 N--CA 1.503 2.2 0 O-C-N 121.726 -0.609 . . . . 0.0 111.178 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.43 -36.71 4.96 Favored 'Trans proline' 0 N--CA 1.488 1.19 0 O-C-N 123.719 1.379 . . . . 0.0 110.718 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.1 ptp85 -143.87 -150.16 0.3 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.485 -0.759 . . . . 0.0 109.678 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 9.6 t-105 68.19 -67.38 0.2 Allowed 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.755 -0.591 . . . . 0.0 110.39 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -84.23 -19.43 33.94 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.35 -0.844 . . . . 0.0 110.588 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.529 ' HA ' ' CE3' ' A' ' 12' ' ' TRP . 2.3 m95 -85.91 13.32 7.62 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.116 -0.99 . . . . 0.0 111.419 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -66.69 -46.72 74.69 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.986 -1.071 . . . . 0.0 109.711 179.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.0 p -61.35 -34.81 75.92 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.424 0.631 . . . . 0.0 109.437 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.9 tp -64.17 -42.0 96.9 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 tt -63.37 -39.97 95.99 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.692 -0.63 . . . . 0.0 109.749 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.36 -35.34 78.82 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.475 0.655 . . . . 0.0 109.435 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 tt -72.93 -36.1 67.16 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.219 0.533 . . . . 0.0 109.894 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.26 -40.7 95.06 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.72 -0.612 . . . . 0.0 109.773 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.64 -39.92 95.36 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.629 -0.669 . . . . 0.0 109.78 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.42 -37.58 93.96 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 87.7 t -61.62 -42.65 94.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.474 -1.016 . . . . 0.0 109.843 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.02 -41.83 99.79 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.421 HG22 HD12 ' A' ' 24' ' ' ILE . 30.3 mm -67.23 -36.57 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.455 -1.027 . . . . 0.0 109.761 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -63.08 -25.96 68.61 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.272 -0.893 . . . . 0.0 109.801 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.411 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 13.3 mt -81.44 -20.35 40.52 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.328 -0.858 . . . . 0.0 109.323 178.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.622 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 1.3 tp -135.99 51.86 5.82 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.412 -0.805 . . . . 0.0 110.902 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.622 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 44.7 Cg_endo -91.63 -19.61 0.78 Allowed 'Trans proline' 0 C--N 1.32 -0.946 0 C-N-CA 121.113 1.209 . . . . 0.0 111.223 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -71.57 -38.32 70.97 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.253 -0.905 . . . . 0.0 110.429 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.836 0 CA-C-O 118.353 -0.832 . . . . 0.0 110.562 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 43.0 m80 . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 120.995 0.426 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.5 p -110.49 49.87 0.83 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.574 -0.704 . . . . 0.0 110.018 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.425 HG11 ' HA ' ' A' ' 6' ' ' ALA . 15.7 t 56.27 57.33 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 121.649 -0.657 . . . . 0.0 110.516 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.1 t -68.62 -34.84 76.43 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.318 -0.864 . . . . 0.0 110.523 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -135.13 26.72 3.54 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.696 -0.627 . . . . 0.0 110.667 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.425 ' HA ' HG11 ' A' ' 3' ' ' VAL . . . 47.44 49.84 15.39 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.551 -0.718 . . . . 0.0 111.035 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.1 113.52 29.71 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.245 -0.909 . . . . 0.0 110.675 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -79.07 113.32 3.2 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.844 1.444 . . . . 0.0 110.667 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -140.31 -99.57 0.15 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.459 -0.776 . . . . 0.0 110.218 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 53.15 61.6 3.08 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -178.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 61.44 26.17 15.99 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 -175.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.7 m-90 45.22 44.32 8.73 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.816 0.817 . . . . 0.0 110.148 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -66.42 -47.48 73.09 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.6 t -63.21 -36.47 83.77 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.4 tt -68.04 -43.73 78.06 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.3 tt -62.81 -38.17 89.65 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.613 -0.679 . . . . 0.0 109.986 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.0 tt -61.64 -35.84 79.09 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.592 0.711 . . . . 0.0 109.322 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 tt -69.6 -37.22 76.81 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.316 0.579 . . . . 0.0 109.747 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.14 -38.38 85.44 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.861 -0.524 . . . . 0.0 109.922 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.28 -43.11 98.86 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.531 -0.731 . . . . 0.0 109.928 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.57 -39.41 96.43 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.7 t -64.35 -37.2 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.62 -0.93 . . . . 0.0 109.714 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.438 ' HA2' HD12 ' A' ' 26' ' ' LEU . . . -60.15 -46.97 93.27 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.37 -34.16 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.521 -0.988 . . . . 0.0 109.65 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -63.23 -26.15 68.65 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.084 -1.01 . . . . 0.0 109.64 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.438 HD12 ' HA2' ' A' ' 23' ' ' GLY . 14.8 mt -78.82 -23.78 44.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.293 -0.88 . . . . 0.0 108.909 178.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.561 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -134.59 56.2 17.02 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.553 -0.717 . . . . 0.0 110.681 179.311 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.561 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 40.1 Cg_endo -89.76 -22.52 0.87 Allowed 'Trans proline' 0 C--N 1.318 -1.055 0 O-C-N 123.235 1.124 . . . . 0.0 111.024 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -85.97 -33.83 21.02 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.272 -0.893 . . . . 0.0 110.235 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.106 0 CA-C-O 118.173 -0.918 . . . . 0.0 110.836 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 121.07 0.462 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.6 p -105.03 40.51 1.5 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.57 -0.706 . . . . 0.0 110.377 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.5 m 34.29 46.64 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.549 0 CA-C-O 121.37 0.605 . . . . 0.0 111.961 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.69 -21.23 17.72 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.536 -0.728 . . . . 0.0 110.775 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -120.36 29.51 7.43 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.401 -0.812 . . . . 0.0 110.74 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 63.11 86.74 0.11 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.569 -0.707 . . . . 0.0 110.277 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 10.0 ptt-85 -53.59 143.63 37.08 Favored Pre-proline 0 N--CA 1.5 2.073 0 O-C-N 121.689 -0.632 . . . . 0.0 110.582 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.431 ' HG2' ' HB3' ' A' ' 11' ' ' PHE . 48.0 Cg_endo -74.36 171.01 18.93 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 O-C-N 123.768 1.404 . . . . 0.0 110.919 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.7 mtp85 -108.88 -37.23 5.91 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.677 -0.639 . . . . 0.0 110.399 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 45.3 p-90 -61.71 -32.23 72.44 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.401 -0.812 . . . . 0.0 110.415 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.431 ' HB3' ' HG2' ' A' ' 8' ' ' PRO . 11.5 t80 -69.86 -42.75 73.12 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.376 -0.827 . . . . 0.0 109.766 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.466 ' HA ' ' CE3' ' A' ' 12' ' ' TRP . 3.9 m95 -67.82 -13.57 62.25 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.453 -0.779 . . . . 0.0 110.969 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -63.91 -34.51 78.13 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.329 -0.857 . . . . 0.0 109.439 178.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.8 t -63.57 -36.76 84.86 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.36 -42.95 87.31 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 tt -62.13 -39.88 94.07 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.656 -0.652 . . . . 0.0 110.042 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.4 tt -61.4 -35.52 77.74 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.492 0.663 . . . . 0.0 109.508 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.5 tt -70.39 -35.46 73.49 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.174 0.512 . . . . 0.0 109.74 179.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.79 -40.51 97.54 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.755 -0.591 . . . . 0.0 109.67 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.51 -38.84 90.88 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.501 -0.75 . . . . 0.0 109.475 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.482 ' HA2' HD12 ' A' ' 24' ' ' ILE . . . -62.42 -36.41 93.09 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 87.4 t -62.76 -41.75 93.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.512 -0.993 . . . . 0.0 109.625 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.43 -42.0 99.67 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.482 HD12 ' HA2' ' A' ' 21' ' ' GLY . 22.3 mt -68.98 -32.18 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.545 -0.974 . . . . 0.0 109.555 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -63.46 -25.42 68.26 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.323 -0.86 . . . . 0.0 109.521 178.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.403 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.3 mp -78.61 -22.68 46.63 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.5 -0.75 . . . . 0.0 109.007 178.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.584 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 3.5 tp -135.28 53.98 9.9 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.603 -0.686 . . . . 0.0 110.78 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.584 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.6 Cg_endo -89.39 -42.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.033 0 O-C-N 123.15 1.079 . . . . 0.0 110.86 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -79.89 -32.69 40.32 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.408 -0.807 . . . . 0.0 110.395 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.7 mtp180 . . . . . 0 N--CA 1.501 2.107 0 CA-C-O 118.506 -0.759 . . . . 0.0 110.85 179.907 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 29.4 t60 . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 120.952 0.406 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.3 t 53.61 66.96 1.08 Allowed 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 121.331 0.586 . . . . 0.0 110.679 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.447 ' O ' ' CB ' ' A' ' 4' ' ' SER . 0.9 OUTLIER -148.62 -83.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.35 -0.844 . . . . 0.0 110.358 179.838 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.447 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER 72.3 -14.0 0.58 Allowed 'General case' 0 N--CA 1.511 2.583 0 O-C-N 121.499 -0.751 . . . . 0.0 112.303 179.859 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.5 p-80 -105.34 5.85 32.2 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.2 -0.937 . . . . 0.0 110.959 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -101.42 45.44 0.97 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.471 -0.768 . . . . 0.0 110.221 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -114.99 150.46 44.23 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.42 -0.8 . . . . 0.0 109.937 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.551 ' HA ' ' HB3' ' A' ' 14' ' ' SER . 50.9 Cg_endo -76.64 56.09 5.05 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.754 1.397 . . . . 0.0 110.866 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.51 4.1 5.09 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.204 -0.935 . . . . 0.0 111.355 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.403 ' O ' ' HB2' ' A' ' 11' ' ' PHE . 73.7 t90 -63.11 93.0 0.06 Allowed 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 177.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.403 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 97.1 m-85 56.38 27.26 11.75 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 -175.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 18.5 m-90 44.66 38.65 2.86 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 122.057 0.932 . . . . 0.0 109.768 -178.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -79.35 -46.92 16.7 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.312 0.577 . . . . 0.0 109.611 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.551 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 6.5 t -63.6 -33.06 74.77 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -68.4 -41.94 79.76 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.3 tt -62.67 -40.8 98.23 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.665 -0.647 . . . . 0.0 109.941 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.2 tt -61.13 -33.46 73.43 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.402 0.62 . . . . 0.0 109.505 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.56 -34.08 67.24 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.879 -0.513 . . . . 0.0 109.848 178.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.42 -45.6 93.03 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.648 -0.657 . . . . 0.0 109.5 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.73 -34.83 78.71 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.623 -0.673 . . . . 0.0 109.801 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.04 -40.12 95.04 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 77.3 t -60.04 -42.54 90.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.491 -1.005 . . . . 0.0 109.736 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.61 -45.26 93.45 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.9 mt -66.54 -35.26 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.491 -1.006 . . . . 0.0 109.736 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -63.43 -26.61 68.81 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.152 -0.968 . . . . 0.0 109.585 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.453 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.4 mm? -78.86 -26.51 44.04 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 178.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.556 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.0 tp -132.23 56.26 22.28 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.587 -0.696 . . . . 0.0 110.707 179.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.556 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.0 Cg_endo -90.1 -20.24 1.12 Allowed 'Trans proline' 0 C--N 1.317 -1.093 0 O-C-N 123.323 1.17 . . . . 0.0 111.015 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -78.68 -32.28 47.01 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.419 -0.801 . . . . 0.0 110.302 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.059 0 CA-C-O 117.716 -1.135 . . . . 0.0 110.758 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . 0.455 ' HB3' HG23 ' A' ' 3' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 121.149 0.5 . . . . 0.0 110.335 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.9 p -109.55 48.51 0.88 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.439 -0.788 . . . . 0.0 110.439 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.455 HG23 ' HB3' ' A' ' 1' ' ' HIS . 20.0 m -123.16 30.9 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.347 -0.846 . . . . 0.0 110.623 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.1 m -120.3 -68.65 0.89 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.355 -0.841 . . . . 0.0 110.045 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 51.7 m80 -128.76 19.39 6.12 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.667 -0.646 . . . . 0.0 110.996 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 52.7 32.67 12.38 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.509 -0.744 . . . . 0.0 111.128 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -150.56 94.71 3.6 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.242 -0.911 . . . . 0.0 110.153 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.15 90.09 1.01 Allowed 'Trans proline' 0 C--N 1.313 -1.342 0 O-C-N 123.916 1.482 . . . . 0.0 110.408 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.35 -81.21 0.61 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.389 -0.819 . . . . 0.0 110.013 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 13.8 m95 47.4 -92.88 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.739 -0.6 . . . . 0.0 111.26 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -83.08 -26.82 30.71 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.158 -0.964 . . . . 0.0 110.816 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 17.9 m95 -71.0 -0.72 10.0 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.244 -0.91 . . . . 0.0 111.796 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -61.26 -40.2 93.2 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.043 -1.036 . . . . 0.0 110.142 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.4 p -65.21 -36.28 83.68 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.429 0.633 . . . . 0.0 109.481 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.1 tt -65.02 -41.61 95.16 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 178.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.75 -35.09 79.28 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.589 -0.694 . . . . 0.0 109.871 179.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.0 tp -67.26 -32.82 74.1 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.22 -30.82 65.28 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.109 0.48 . . . . 0.0 109.848 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.54 -41.53 94.64 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.72 -0.612 . . . . 0.0 110.051 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.41 -38.24 89.36 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.55 -0.719 . . . . 0.0 109.827 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.6 -40.72 96.14 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 69.9 t -62.94 -38.14 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.504 -0.997 . . . . 0.0 109.895 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.33 -48.09 87.68 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.427 HG22 HD12 ' A' ' 24' ' ' ILE . 28.9 mm -71.48 -35.81 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.486 -1.008 . . . . 0.0 109.587 179.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -65.01 -26.62 68.36 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.266 -0.896 . . . . 0.0 109.629 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.401 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 10.7 mt -79.32 -21.23 46.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 0.0 109.046 178.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.574 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 3.0 tp -135.86 54.3 9.81 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.603 -0.685 . . . . 0.0 110.698 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.574 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 40.7 Cg_endo -89.77 -24.98 0.55 Allowed 'Trans proline' 0 C--N 1.317 -1.092 0 O-C-N 123.103 1.054 . . . . 0.0 111.183 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -92.05 -14.87 28.64 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.276 -0.89 . . . . 0.0 110.696 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.501 2.08 0 CA-C-O 117.92 -1.038 . . . . 0.0 110.791 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 33.9 p80 . . . . . 0 N--CA 1.497 1.906 0 CA-C-O 120.956 0.408 . . . . 0.0 110.477 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.3 m 53.47 44.92 29.28 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.702 -0.624 . . . . 0.0 110.806 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.4 p -119.23 22.85 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.263 -0.898 . . . . 0.0 110.802 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.62 -13.87 16.36 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.263 -0.898 . . . . 0.0 111.276 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 24.2 m80 -100.57 41.29 1.18 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.271 -0.893 . . . . 0.0 110.874 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -128.8 22.04 5.86 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.18 -0.95 . . . . 0.0 110.808 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -144.68 150.45 46.96 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.235 -0.916 . . . . 0.0 110.112 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -72.48 -66.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.269 0 O-C-N 123.807 1.425 . . . . 0.0 111.102 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 19.3 mtp85 55.75 21.51 4.75 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.494 -0.754 . . . . 0.0 111.683 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 31.4 p-90 -99.38 -33.27 10.77 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.12 -0.988 . . . . 0.0 109.743 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -85.36 -13.81 48.34 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.466 -0.771 . . . . 0.0 109.929 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 30.8 m95 -104.27 7.68 35.93 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.211 -0.931 . . . . 0.0 111.306 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -69.27 -48.59 61.33 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.099 -1.0 . . . . 0.0 109.516 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.5 p -63.42 -33.63 75.97 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.58 -42.28 95.71 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.9 tt -63.66 -40.8 97.76 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.716 -0.615 . . . . 0.0 109.735 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 tt -62.31 -36.5 82.35 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.649 0.737 . . . . 0.0 109.336 178.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 tt -69.11 -36.59 77.69 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.264 0.554 . . . . 0.0 109.724 178.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.97 -41.16 99.45 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.69 -0.631 . . . . 0.0 109.688 179.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.64 -39.03 93.31 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.541 -0.724 . . . . 0.0 109.66 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.52 -37.16 93.39 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 88.0 t -61.24 -41.02 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.408 -1.054 . . . . 0.0 109.576 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.71 -45.65 92.16 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.0 mt -68.14 -33.03 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.48 -1.012 . . . . 0.0 109.793 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -60.71 -23.46 64.91 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.304 -0.872 . . . . 0.0 109.821 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 12.3 mt -81.06 -17.4 50.26 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.328 -0.858 . . . . 0.0 109.638 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.624 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.4 tp -137.29 51.31 4.31 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.268 -0.895 . . . . 0.0 111.015 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.624 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 43.4 Cg_endo -90.64 -21.0 0.85 Allowed 'Trans proline' 0 C--N 1.318 -1.03 0 O-C-N 123.16 1.084 . . . . 0.0 111.059 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -89.96 -37.75 14.13 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.355 -0.841 . . . . 0.0 110.433 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 . . . . . 0 N--CA 1.495 1.816 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.268 179.955 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 12.7 m80 . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 120.874 0.369 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.1 m 53.82 39.65 30.6 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.763 -0.586 . . . . 0.0 110.934 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.4 p -116.58 22.61 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.253 -0.905 . . . . 0.0 110.804 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.1 t -105.4 -12.28 16.09 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.278 -0.889 . . . . 0.0 111.044 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -90.95 34.06 0.93 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.274 -0.891 . . . . 0.0 110.92 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -128.01 23.34 6.12 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.177 -0.952 . . . . 0.0 110.928 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.531 ' HB3' ' HD2' ' A' ' 9' ' ' ARG . 11.2 mtt-85 -154.23 142.28 14.11 Favored Pre-proline 0 N--CA 1.498 1.949 0 O-C-N 121.28 -0.888 . . . . 0.0 110.371 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -74.17 82.02 1.89 Allowed 'Trans proline' 0 C--N 1.314 -1.262 0 O-C-N 123.7 1.368 . . . . 0.0 110.102 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.531 ' HD2' ' HB3' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -135.73 6.94 3.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.318 -0.864 . . . . 0.0 111.762 -179.188 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 77.3 t-105 -64.9 87.84 0.06 Allowed 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.403 ' N ' ' O ' ' A' ' 9' ' ' ARG . 0.2 OUTLIER 58.33 25.06 12.32 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -175.008 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 1.9 m-90 44.99 38.54 3.07 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.905 0.86 . . . . 0.0 109.555 -177.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -66.92 -58.15 5.55 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.828 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.5 m -59.94 -34.09 72.79 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.03 -44.35 89.41 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.2 tt -67.17 -38.48 85.51 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.652 -0.655 . . . . 0.0 109.41 178.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.8 -37.31 86.22 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.65 0.738 . . . . 0.0 109.189 178.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.9 tt -72.96 -35.93 67.02 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.307 0.575 . . . . 0.0 109.658 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.86 -39.02 93.22 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.755 -0.59 . . . . 0.0 109.97 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.97 -41.05 97.57 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.603 -0.686 . . . . 0.0 109.813 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.35 -38.09 95.37 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.5 t -63.2 -40.65 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.471 -1.017 . . . . 0.0 109.777 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.34 -41.41 98.16 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 29.9 mm -66.91 -36.36 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.382 -1.07 . . . . 0.0 109.697 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -64.58 -26.58 68.47 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.14 -0.975 . . . . 0.0 109.48 178.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.428 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.6 mm? -78.13 -24.76 47.26 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.406 -0.809 . . . . 0.0 108.872 177.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.56 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.3 tp -134.41 56.05 16.9 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.71 -0.619 . . . . 0.0 110.752 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.56 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.2 Cg_endo -90.85 -20.49 0.84 Allowed 'Trans proline' 0 C--N 1.317 -1.126 0 C-N-CA 121.081 1.187 . . . . 0.0 111.139 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -105.32 5.61 32.06 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.355 -0.841 . . . . 0.0 110.856 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.83 0 O-C-N 121.276 -0.89 . . . . 0.0 110.501 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 9.4 m80 . . . . . 0 N--CA 1.496 1.834 0 CA-C-O 120.766 0.317 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.2 t 51.74 45.79 27.59 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.684 -0.635 . . . . 0.0 110.965 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.2 t 54.29 31.53 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 121.56 -0.713 . . . . 0.0 110.771 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.3 t -110.41 -15.42 13.93 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.097 -1.002 . . . . 0.0 111.04 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.4 m80 -135.87 62.22 1.63 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.289 -0.882 . . . . 0.0 109.932 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -131.96 -82.88 0.5 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.507 -0.746 . . . . 0.0 110.425 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.97 88.96 6.2 Favored Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 121.466 -0.771 . . . . 0.0 110.085 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -69.59 -10.66 29.25 Favored 'Trans proline' 0 N--CA 1.491 1.366 0 O-C-N 123.65 1.342 . . . . 0.0 111.723 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.407 ' O ' ' N ' ' A' ' 11' ' ' PHE . 12.7 mtm-85 -72.59 -67.37 0.56 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.2 -0.938 . . . . 0.0 110.519 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER 56.79 -85.12 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.854 -0.528 . . . . 0.0 110.184 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.407 ' N ' ' O ' ' A' ' 9' ' ' ARG . 10.0 t80 -75.52 -18.34 59.83 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.14 -0.975 . . . . 0.0 110.321 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -84.8 17.65 2.72 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.307 -0.871 . . . . 0.0 111.118 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -68.46 -41.68 79.83 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.09 -1.006 . . . . 0.0 109.619 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.8 m -62.3 -36.79 83.22 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.463 0.649 . . . . 0.0 109.298 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 tt -63.65 -41.97 98.17 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.9 tt -62.78 -38.35 90.28 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.609 -0.682 . . . . 0.0 109.9 179.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.6 tt -62.14 -36.13 80.86 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.536 0.684 . . . . 0.0 109.43 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.85 -35.23 72.33 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.313 0.577 . . . . 0.0 109.78 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.94 -36.94 75.71 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.79 -0.569 . . . . 0.0 109.92 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.44 -40.17 95.72 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.62 -0.675 . . . . 0.0 109.991 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.09 -45.21 88.74 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 179.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.3 t -65.52 -40.96 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.515 -0.991 . . . . 0.0 109.747 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.99 -48.83 80.84 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 23.8 mm -65.67 -34.97 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.406 -1.056 . . . . 0.0 109.71 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -62.29 -26.14 68.24 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.221 -0.925 . . . . 0.0 109.66 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.469 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 16.9 mt -79.58 -25.61 41.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.357 -0.84 . . . . 0.0 109.114 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.585 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 3.8 tp -131.52 53.54 11.88 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.453 -0.779 . . . . 0.0 110.921 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.585 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.5 Cg_endo -90.2 -20.75 1.02 Allowed 'Trans proline' 0 C--N 1.319 -1.016 0 C-N-CA 120.96 1.107 . . . . 0.0 110.749 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.04 -38.43 8.17 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.377 -0.827 . . . . 0.0 110.03 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.4 mtt85 . . . . . 0 N--CA 1.497 1.878 0 CA-C-O 117.916 -1.04 . . . . 0.0 110.218 179.76 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 . . . . . 0 N--CA 1.497 1.9 0 CA-C-O 121.306 0.575 . . . . 0.0 110.377 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.3 52.65 0.91 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.315 -0.865 . . . . 0.0 110.274 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.6 t 53.19 55.05 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.585 -0.697 . . . . 0.0 110.625 179.759 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.7 t -86.72 -19.39 29.23 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.245 -0.91 . . . . 0.0 110.929 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -144.89 40.14 1.25 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.519 -0.738 . . . . 0.0 110.269 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.31 31.84 2.38 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.249 -0.907 . . . . 0.0 111.013 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.57 84.92 0.2 Allowed Pre-proline 0 N--CA 1.502 2.146 0 O-C-N 121.506 -0.746 . . . . 0.0 110.887 179.691 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.64 98.87 0.9 Allowed 'Trans proline' 0 C--N 1.314 -1.255 0 O-C-N 123.627 1.33 . . . . 0.0 110.542 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -62.17 -31.69 72.22 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.539 -0.726 . . . . 0.0 110.704 -179.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 27.6 m-90 -55.11 -40.15 70.17 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.664 -0.648 . . . . 0.0 110.416 179.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -98.82 -33.42 10.9 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.545 -0.722 . . . . 0.0 110.111 179.635 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 68.3 t-105 -64.57 -25.76 68.11 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.406 -0.809 . . . . 0.0 110.839 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -60.0 -43.25 95.32 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.506 -0.746 . . . . 0.0 109.625 179.391 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.1 t -63.15 -34.24 77.19 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.307 0.575 . . . . 0.0 109.539 179.052 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.2 tt -67.09 -42.27 84.9 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 tt -61.25 -40.31 93.59 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.65 -0.656 . . . . 0.0 109.885 179.276 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 tt -63.82 -32.0 73.37 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.609 0.719 . . . . 0.0 109.399 178.703 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.46 -32.81 58.63 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.285 0.564 . . . . 0.0 109.811 178.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.68 -40.54 92.5 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.668 -0.645 . . . . 0.0 110.178 179.537 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.19 -42.05 99.28 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.522 -0.736 . . . . 0.0 109.695 179.374 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.404 ' HA2' HD11 ' A' ' 24' ' ' ILE . . . -62.38 -38.5 96.38 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.288 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 89.9 t -62.95 -41.41 92.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.535 -0.979 . . . . 0.0 109.841 179.5 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.96 -42.24 99.67 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.338 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.404 HD11 ' HA2' ' A' ' 21' ' ' GLY . 19.9 mt -67.67 -35.26 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.576 -0.955 . . . . 0.0 109.53 179.06 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 92.7 t80 -63.9 -22.46 66.93 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.354 -0.841 . . . . 0.0 110.006 178.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.499 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -83.77 -25.05 30.8 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.426 -0.796 . . . . 0.0 109.505 178.75 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.663 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.9 tp -125.65 44.75 1.22 Allowed Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.39 -0.819 . . . . 0.0 111.92 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.663 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 44.3 Cg_endo -88.99 -46.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.322 -0.831 0 O-C-N 122.868 0.931 . . . . 0.0 110.077 179.437 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -109.11 7.69 25.72 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.622 -0.674 . . . . 0.0 110.524 179.152 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.7 mmt85 . . . . . 0 N--CA 1.502 2.14 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.697 -179.764 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 . . . . . 0 N--CA 1.495 1.783 0 CA-C-O 121.374 0.607 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.8 p -106.18 27.44 8.65 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.445 -0.784 . . . . 0.0 110.643 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.2 t 49.54 47.38 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 O-C-N 121.593 -0.692 . . . . 0.0 110.474 -179.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.7 t -85.33 -17.64 36.21 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.272 -0.893 . . . . 0.0 110.963 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -107.85 33.13 4.25 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.461 -0.775 . . . . 0.0 110.181 179.553 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -159.44 42.37 0.22 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.504 -0.748 . . . . 0.0 110.191 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.491 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -165.09 -61.47 0.01 OUTLIER Pre-proline 0 N--CA 1.498 1.949 0 O-C-N 121.465 -0.772 . . . . 0.0 110.369 -179.985 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 7' ' ' ARG . 47.7 Cg_endo -74.17 144.17 33.13 Favored 'Trans proline' 0 N--CA 1.484 0.94 0 O-C-N 123.436 1.23 . . . . 0.0 110.502 179.698 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.56 -142.46 0.37 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.618 -0.676 . . . . 0.0 110.242 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 1.4 m95 64.71 -82.82 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.422 -0.798 . . . . 0.0 110.422 -179.654 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -65.09 -33.18 75.41 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.119 -0.988 . . . . 0.0 109.836 179.39 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 49.3 t-105 -83.76 -21.51 32.18 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.384 -0.822 . . . . 0.0 110.089 179.129 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -62.26 -41.61 98.6 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.618 -0.676 . . . . 0.0 109.776 179.352 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.62 -35.62 81.59 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.78 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.9 tt -63.93 -40.91 97.53 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.743 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 tt -63.39 -41.91 98.77 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.372 0.606 . . . . 0.0 109.853 179.136 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 tt -63.12 -36.42 83.53 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.669 0.747 . . . . 0.0 109.008 178.559 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -67.82 -35.71 79.1 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.258 0.551 . . . . 0.0 109.56 178.709 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.09 -39.88 95.03 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.679 -0.638 . . . . 0.0 109.732 179.17 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.55 -38.66 91.97 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.519 -0.738 . . . . 0.0 109.712 179.151 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.38 -37.48 90.43 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 179.292 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 71.7 t -61.06 -39.21 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.307 -1.114 . . . . 0.0 109.534 179.242 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.0 -47.28 75.26 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.399 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 tp -68.0 -29.01 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.406 -1.055 . . . . 0.0 110.008 179.514 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -64.23 -21.63 66.65 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.288 -0.883 . . . . 0.0 109.81 178.703 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.435 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 12.6 mt -83.98 -21.3 31.78 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.323 -0.86 . . . . 0.0 109.685 178.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.66 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 5.5 tp -130.38 45.59 1.83 Allowed Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.322 -0.861 . . . . 0.0 111.668 179.772 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.66 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 47.1 Cg_endo -89.46 -45.84 0.03 OUTLIER 'Trans proline' 0 C--N 1.322 -0.828 0 O-C-N 122.946 0.972 . . . . 0.0 110.239 179.434 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -108.06 -37.05 6.16 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.659 -0.65 . . . . 0.0 109.936 179.551 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? . . . . . 0 N--CA 1.496 1.863 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.21 179.679 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.829 0 CA-C-O 120.924 0.392 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 t 67.42 89.59 0.1 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.606 -0.684 . . . . 0.0 110.224 -179.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.623 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 46.4 t -95.8 16.38 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.645 -0.659 . . . . 0.0 110.473 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.38 -26.58 66.53 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.182 -0.949 . . . . 0.0 110.282 179.304 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -105.5 35.55 2.82 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.692 -0.63 . . . . 0.0 110.028 179.444 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.529 ' HB1' ' HB2' ' A' ' 9' ' ' ARG . . . 56.74 66.54 1.16 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.713 -0.617 . . . . 0.0 110.335 -179.751 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.623 ' HB2' ' HA ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER -53.51 -52.04 70.47 Favored Pre-proline 0 N--CA 1.502 2.139 0 O-C-N 121.596 -0.69 . . . . 0.0 111.35 -179.779 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 7' ' ' ARG . 45.0 Cg_endo -70.83 -21.74 28.13 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 O-C-N 123.369 1.194 . . . . 0.0 111.006 179.884 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.529 ' HB2' ' HB1' ' A' ' 6' ' ' ALA . 18.3 mtt180 -91.73 -100.04 0.12 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.318 -0.864 . . . . 0.0 110.127 179.871 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 11.1 t90 51.38 63.71 2.13 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 -177.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 63.86 28.54 14.64 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 -175.371 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 3.0 m-90 47.01 45.39 15.59 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.805 0.812 . . . . 0.0 110.433 -178.51 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -79.72 -49.05 12.65 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.139 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.1 m -63.89 -35.36 80.41 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.459 0.647 . . . . 0.0 109.376 178.906 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -67.26 -41.34 85.74 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.668 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.6 tt -63.97 -39.34 93.92 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.53 -0.731 . . . . 0.0 109.881 179.092 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.4 tt -60.65 -36.82 79.63 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.536 0.684 . . . . 0.0 109.393 178.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.7 tt -70.52 -35.56 73.25 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.385 0.612 . . . . 0.0 109.632 178.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.73 -35.43 72.68 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.733 -0.605 . . . . 0.0 109.956 179.275 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.77 -39.19 87.76 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.524 -0.735 . . . . 0.0 110.231 179.696 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.4 -47.59 82.78 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.566 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 88.2 t -65.72 -39.76 85.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.586 -0.95 . . . . 0.0 109.7 179.324 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.78 -44.7 94.4 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.615 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 26.3 mt -65.17 -36.82 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.361 -1.082 . . . . 0.0 109.955 179.582 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -64.54 -26.27 68.35 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.137 -0.977 . . . . 0.0 109.599 178.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.462 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.4 mm? -78.32 -26.64 46.94 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.002 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.56 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 5.9 tp -131.74 55.81 20.46 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.549 -0.719 . . . . 0.0 110.874 179.579 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.56 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.9 Cg_endo -90.24 -21.72 0.87 Allowed 'Trans proline' 0 C--N 1.318 -1.044 0 C-N-CA 121.038 1.158 . . . . 0.0 111.049 -179.948 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 -68.11 -36.36 79.63 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.388 -0.82 . . . . 0.0 110.207 179.595 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.147 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.207 179.791 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 . . . . . 0 N--CA 1.496 1.828 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.73 27.32 6.46 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.444 -0.785 . . . . 0.0 110.894 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.4 t -117.93 50.85 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.153 -0.967 . . . . 0.0 109.93 179.539 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.2 t -83.94 -41.19 17.62 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.173 -0.954 . . . . 0.0 109.973 179.7 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -139.63 29.02 2.16 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.868 -0.52 . . . . 0.0 110.305 179.533 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 52.65 51.37 16.19 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.477 -0.764 . . . . 0.0 110.72 -179.921 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 38.8 mtt85 53.95 75.62 0.6 Allowed Pre-proline 0 N--CA 1.501 2.107 0 O-C-N 121.81 -0.556 . . . . 0.0 110.766 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.464 ' HG2' ' CE2' ' A' ' 10' ' ' TRP . 43.8 Cg_endo -71.0 148.27 56.7 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.753 1.396 . . . . 0.0 110.582 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 62.8 mtt85 -104.65 20.51 18.5 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.648 -0.657 . . . . 0.0 111.0 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.59 ' N ' ' CD1' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -40.8 -84.69 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.506 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.594 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -83.34 22.28 1.04 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.675 -1.265 . . . . 0.0 111.209 -179.547 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.435 ' CE3' ' HB3' ' A' ' 15' ' ' LEU . 26.0 t-105 -103.51 -23.02 13.54 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.126 -0.984 . . . . 0.0 110.36 179.527 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -56.27 -46.96 79.47 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.401 -0.812 . . . . 0.0 109.92 179.649 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.5 p -63.95 -37.98 89.4 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.369 0.605 . . . . 0.0 109.753 179.156 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.435 ' HB3' ' CE3' ' A' ' 12' ' ' TRP . 1.6 tp -67.25 -41.42 85.64 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.801 -0.562 . . . . 0.0 109.527 179.115 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.9 tt -63.47 -39.1 93.55 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.577 -0.702 . . . . 0.0 109.669 178.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.0 tt -62.11 -37.3 84.58 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.571 0.701 . . . . 0.0 109.435 178.768 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.8 tt -68.29 -36.55 79.53 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.249 0.547 . . . . 0.0 109.58 178.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.6 -38.75 90.36 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.792 -0.568 . . . . 0.0 109.797 179.118 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.8 -38.44 91.09 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.528 -0.733 . . . . 0.0 109.851 179.224 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.42 -38.15 93.3 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.299 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.2 t -60.99 -44.17 97.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.473 -1.016 . . . . 0.0 109.677 179.403 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.415 ' HA2' HD13 ' A' ' 26' ' ' LEU . . . -63.91 -44.48 95.99 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.347 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 67.5 mt -65.93 -35.06 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.461 -1.023 . . . . 0.0 109.735 179.41 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -62.61 -26.76 68.78 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.215 -0.928 . . . . 0.0 109.524 178.744 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.415 HD13 ' HA2' ' A' ' 23' ' ' GLY . 6.1 mt -78.81 -23.6 45.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.385 -0.822 . . . . 0.0 108.98 178.206 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.567 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.5 tp -134.85 56.54 17.43 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.444 -0.785 . . . . 0.0 110.633 179.34 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.567 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.9 Cg_endo -91.09 -21.33 0.69 Allowed 'Trans proline' 0 C--N 1.316 -1.133 0 C-N-CA 121.084 1.189 . . . . 0.0 111.202 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -97.92 6.15 48.07 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.292 -0.88 . . . . 0.0 110.658 179.594 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 118.142 -0.932 . . . . 0.0 110.196 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 . . . . . 0 N--CA 1.498 1.969 0 CA-C-O 120.966 0.413 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.5 p -130.3 32.43 4.47 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.254 -0.904 . . . . 0.0 110.726 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.6 t 50.59 48.01 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.463 -0.773 . . . . 0.0 110.347 179.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 t -90.08 -28.39 19.04 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.245 -0.909 . . . . 0.0 110.521 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -128.25 33.95 4.64 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.71 -0.619 . . . . 0.0 110.418 179.777 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -124.01 37.51 4.39 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.363 -0.836 . . . . 0.0 110.286 179.59 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.63 84.65 8.23 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.358 -0.839 . . . . 0.0 110.131 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.71 -23.04 26.91 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.58 1.305 . . . . 0.0 111.658 -179.552 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.509 ' HG2' ' HB2' ' A' ' 12' ' ' TRP . 4.0 ttt85 -100.6 18.67 18.61 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.242 -0.911 . . . . 0.0 111.396 -179.7 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 4.9 p-90 -73.37 -28.92 62.29 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.157 -0.964 . . . . 0.0 111.053 -179.856 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.92 19.39 19.49 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.253 -0.905 . . . . 0.0 110.475 179.556 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.509 ' HB2' ' HG2' ' A' ' 9' ' ' ARG . 57.0 m95 -105.02 10.86 33.93 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.218 -0.926 . . . . 0.0 110.652 179.615 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -73.43 -42.59 61.83 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.332 -0.855 . . . . 0.0 109.357 179.223 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.1 m -64.74 -35.1 79.96 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.691 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -63.73 -40.57 97.08 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.614 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.66 -40.12 96.04 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.369 0.604 . . . . 0.0 109.752 178.801 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.54 -34.84 76.24 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.469 0.652 . . . . 0.0 109.576 178.88 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.37 -32.62 62.82 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.119 0.485 . . . . 0.0 109.999 178.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.84 -41.73 96.41 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.703 -0.623 . . . . 0.0 110.015 179.392 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.29 95.07 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.532 -0.73 . . . . 0.0 109.686 179.21 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.28 -37.58 94.71 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.338 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 76.8 t -62.34 -41.8 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.416 -1.05 . . . . 0.0 109.724 179.415 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.75 -41.44 98.92 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.317 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 51.0 mt -66.59 -37.88 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.389 -1.065 . . . . 0.0 109.71 179.501 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -64.2 -26.19 68.4 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.182 -0.948 . . . . 0.0 109.646 178.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.445 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.5 mm? -79.08 -25.25 43.1 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.573 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 3.5 tp -133.05 55.04 15.1 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.662 -0.649 . . . . 0.0 110.863 179.678 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.573 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.2 Cg_endo -90.82 -20.8 0.82 Allowed 'Trans proline' 0 C--N 1.319 -1.023 0 C-N-CA 120.963 1.109 . . . . 0.0 111.063 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -76.45 -23.58 53.91 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.316 -0.865 . . . . 0.0 110.761 179.894 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 45.0 mtt-85 . . . . . 0 N--CA 1.496 1.864 0 CA-C-O 117.884 -1.055 . . . . 0.0 110.255 -179.912 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 5.0 m80 . . . . . 0 N--CA 1.495 1.793 0 CA-C-O 120.747 0.308 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.4 p 40.39 56.72 2.64 Favored 'General case' 0 N--CA 1.505 2.28 0 CA-C-O 121.314 0.578 . . . . 0.0 111.408 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.449 ' O ' ' CB ' ' A' ' 4' ' ' SER . 29.1 m -96.64 29.95 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 O-C-N 121.427 -0.796 . . . . 0.0 110.821 179.832 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.449 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 2.0 t 76.57 -49.21 0.57 Allowed 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.898 -0.502 . . . . 0.0 110.727 -179.697 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -95.29 30.17 2.29 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.764 -0.585 . . . . 0.0 110.493 179.48 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -100.8 26.09 7.23 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.385 -0.822 . . . . 0.0 110.686 179.775 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.507 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -75.45 -49.53 3.8 Favored Pre-proline 0 N--CA 1.498 1.931 0 O-C-N 121.126 -0.984 . . . . 0.0 110.66 179.53 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 7' ' ' ARG . 46.3 Cg_endo -73.63 -167.47 0.38 Allowed 'Trans proline' 0 N--CA 1.488 1.148 0 O-C-N 123.499 1.263 . . . . 0.0 110.438 179.788 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 64.71 31.68 11.74 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.507 -0.745 . . . . 0.0 110.54 -179.513 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -47.63 26.04 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.388 -0.82 . . . . 0.0 110.431 179.778 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -75.03 -28.36 60.42 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.479 -0.763 . . . . 0.0 110.708 -179.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -84.28 -0.03 50.83 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.198 -0.939 . . . . 0.0 111.422 -179.6 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -65.06 -40.31 94.53 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.177 -0.952 . . . . 0.0 110.036 179.374 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.7 m -64.16 -36.78 85.18 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.38 0.61 . . . . 0.0 109.403 178.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.3 tt -64.23 -42.37 96.57 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.858 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.9 tt -65.68 -37.44 86.5 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.637 -0.665 . . . . 0.0 109.838 179.136 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.8 tp -63.08 -36.06 82.32 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.573 0.702 . . . . 0.0 109.284 178.633 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.5 tp -69.04 -36.87 78.19 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.883 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.1 -39.69 95.43 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.865 -0.522 . . . . 0.0 109.652 179.112 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.06 -39.86 90.44 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.626 -0.671 . . . . 0.0 109.729 179.221 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.42 -40.12 98.5 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.417 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.7 t -63.24 -37.36 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.486 -1.008 . . . . 0.0 109.684 179.336 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.51 -46.94 92.48 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.371 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.7 mt -76.7 -27.68 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.381 -1.07 . . . . 0.0 109.812 179.204 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -60.94 -23.63 65.44 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.035 -1.041 . . . . 0.0 109.696 178.966 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.459 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.9 mm? -79.47 -24.37 42.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.256 -0.903 . . . . 0.0 109.177 178.476 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.581 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.5 tp -132.15 53.73 12.1 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.48 -0.762 . . . . 0.0 110.961 179.718 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.581 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.3 Cg_endo -89.67 -21.2 1.11 Allowed 'Trans proline' 0 C--N 1.318 -1.065 0 C-N-CA 120.947 1.098 . . . . 0.0 111.005 -179.875 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -75.13 -30.77 60.9 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.398 -0.814 . . . . 0.0 110.439 179.634 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 . . . . . 0 N--CA 1.503 2.192 0 CA-C-O 118.348 -0.834 . . . . 0.0 111.094 179.799 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 121.133 0.492 . . . . 0.0 110.416 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.2 m -125.02 27.97 6.55 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.484 -0.76 . . . . 0.0 110.821 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.9 p -126.05 19.3 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.241 -0.912 . . . . 0.0 110.75 179.675 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.9 t -82.65 -25.49 33.04 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.222 -0.924 . . . . 0.0 110.631 179.783 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 33.4 p80 -66.67 -20.86 66.08 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.656 -0.652 . . . . 0.0 110.951 179.672 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -96.42 45.74 1.06 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.348 -0.845 . . . . 0.0 109.884 179.699 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -121.78 81.04 41.14 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.383 -0.823 . . . . 0.0 110.238 -179.9 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.46 93.07 0.75 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.837 1.44 . . . . 0.0 110.008 179.772 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.4 mtm105 56.61 33.61 23.03 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 121.353 0.596 . . . . 0.0 110.474 -179.019 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 28.7 t-105 -66.29 140.43 58.12 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.515 -0.74 . . . . 0.0 110.332 179.861 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.7 t80 66.87 8.76 6.28 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.849 -0.532 . . . . 0.0 111.347 -179.695 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 22.1 m95 -120.69 2.24 10.61 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.017 -1.052 . . . . 0.0 110.848 179.681 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -69.77 -43.29 72.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.309 -0.869 . . . . 0.0 109.707 179.399 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.2 p -64.02 -34.77 78.77 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 178.658 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.9 tt -64.35 -42.99 95.95 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.468 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 tt -62.63 -38.76 91.52 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.664 -0.648 . . . . 0.0 109.886 179.114 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 tt -61.4 -37.48 83.57 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.553 0.692 . . . . 0.0 109.319 178.838 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.6 tt -70.13 -38.08 75.45 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.342 0.592 . . . . 0.0 109.63 178.917 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.36 -37.84 86.23 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.747 -0.595 . . . . 0.0 109.894 179.327 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.89 -42.21 99.69 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.612 -0.68 . . . . 0.0 109.97 179.462 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.419 ' HA2' HD12 ' A' ' 24' ' ' ILE . . . -62.31 -38.87 96.95 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.441 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 91.2 t -64.2 -40.67 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.49 -1.006 . . . . 0.0 109.757 179.506 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.54 -42.04 99.01 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.51 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.419 HD12 ' HA2' ' A' ' 21' ' ' GLY . 24.2 mt -65.66 -36.67 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.423 -1.046 . . . . 0.0 109.821 179.527 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -64.93 -26.53 68.35 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.216 -0.927 . . . . 0.0 109.681 178.889 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.473 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.9 mm? -80.0 -24.76 40.64 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.367 -0.833 . . . . 0.0 108.99 178.29 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.588 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 1.2 tp -131.93 53.43 11.38 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.558 -0.714 . . . . 0.0 111.032 179.736 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.588 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 43.4 Cg_endo -91.53 -18.93 0.88 Allowed 'Trans proline' 0 C--N 1.318 -1.035 0 C-N-CA 121.002 1.134 . . . . 0.0 111.144 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.33 7.05 46.0 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.322 -0.861 . . . . 0.0 111.234 -179.77 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 117.808 -1.091 . . . . 0.0 110.289 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 10.5 m80 . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 121.04 0.448 . . . . 0.0 110.412 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.9 p -150.92 50.2 0.85 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.503 -0.748 . . . . 0.0 110.334 -179.829 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.441 ' O ' ' CB ' ' A' ' 4' ' ' SER . 32.2 m 35.51 42.31 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.588 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.977 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 1.4 t 73.89 -30.51 0.21 Allowed 'General case' 0 N--CA 1.509 2.523 0 O-C-N 121.837 -0.539 . . . . 0.0 112.445 179.512 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -166.69 82.2 0.25 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.156 -0.965 . . . . 0.0 110.271 -179.747 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -104.02 37.23 2.11 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.656 -0.653 . . . . 0.0 110.508 179.886 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.9 ttp180 68.1 132.43 0.04 OUTLIER Pre-proline 0 N--CA 1.504 2.245 0 O-C-N 121.793 -0.567 . . . . 0.0 111.177 179.732 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.99 102.66 1.48 Allowed 'Trans proline' 0 C--N 1.314 -1.244 0 O-C-N 123.632 1.333 . . . . 0.0 110.798 -179.945 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.6 mtp85 -65.91 -24.07 66.76 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.478 -0.764 . . . . 0.0 110.82 179.91 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.472 ' O ' ' CB ' ' A' ' 11' ' ' PHE . 1.1 m-90 -53.36 152.01 5.01 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.599 -0.688 . . . . 0.0 110.176 179.768 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.472 ' CB ' ' O ' ' A' ' 10' ' ' TRP . 16.0 t80 77.58 -42.54 0.38 Allowed 'General case' 0 N--CA 1.508 2.475 0 O-C-N 122.069 -0.395 . . . . 0.0 110.554 -179.086 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 20.7 m95 -76.62 6.02 6.57 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.134 -0.979 . . . . 0.0 111.468 179.651 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -62.21 -39.44 92.77 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.018 -1.051 . . . . 0.0 110.08 179.626 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.5 t -62.98 -35.26 79.59 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.516 0.674 . . . . 0.0 109.425 178.882 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 tt -68.25 -41.9 80.48 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.907 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 tt -63.78 -38.72 92.15 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.675 -0.641 . . . . 0.0 110.019 179.43 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 tt -62.03 -34.13 75.64 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.488 0.661 . . . . 0.0 109.474 178.846 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.5 tt -70.91 -38.16 72.95 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.238 0.542 . . . . 0.0 109.65 178.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.67 -39.56 93.89 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.799 -0.563 . . . . 0.0 109.807 179.284 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.75 -39.95 95.75 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.635 -0.666 . . . . 0.0 109.897 179.391 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.55 -37.42 94.39 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.398 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 90.4 t -63.07 -41.35 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.53 -0.982 . . . . 0.0 109.685 179.471 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.31 -42.66 97.69 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.398 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.4 mt -66.36 -36.27 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.413 -1.051 . . . . 0.0 109.809 179.45 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -63.76 -27.59 69.3 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.32 -0.862 . . . . 0.0 109.8 179.085 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.454 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 3.8 mt -81.25 -21.65 39.3 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.425 -0.797 . . . . 0.0 109.16 178.306 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.624 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.1 OUTLIER -133.18 51.98 7.85 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.524 -0.735 . . . . 0.0 110.896 179.82 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.624 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 45.7 Cg_endo -92.89 -17.64 0.72 Allowed 'Trans proline' 0 C--N 1.32 -0.936 0 C-N-CA 121.101 1.201 . . . . 0.0 111.329 -179.742 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -68.54 -37.11 79.7 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.307 -0.87 . . . . 0.0 110.706 -179.493 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.7 mmt85 . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 117.851 -1.071 . . . . 0.0 110.281 -179.974 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.4 t60 . . . . . 0 N--CA 1.499 1.983 0 CA-C-O 120.737 0.303 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.7 p -113.2 45.68 1.35 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.06 -1.025 . . . . 0.0 110.15 179.903 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.9 t 58.74 17.87 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.688 -0.633 . . . . 0.0 111.114 -179.535 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.15 -16.65 14.22 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.005 -1.06 . . . . 0.0 110.613 179.438 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -102.83 39.68 1.5 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.518 -0.739 . . . . 0.0 109.993 179.568 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -105.02 1.7 28.85 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.4 -0.813 . . . . 0.0 111.244 -179.961 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.501 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -61.9 -50.03 82.99 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 121.29 -0.881 . . . . 0.0 110.321 179.504 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 7' ' ' ARG . 48.9 Cg_endo -75.26 -174.61 2.03 Favored 'Trans proline' 0 N--CA 1.485 0.975 0 O-C-N 123.503 1.265 . . . . 0.0 110.131 179.359 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 23.1 mtt180 -88.19 21.99 2.6 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.344 -0.848 . . . . 0.0 111.01 179.656 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -71.98 -67.42 0.54 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.065 -1.022 . . . . 0.0 109.948 179.838 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.48 -26.82 58.51 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.478 -0.764 . . . . 0.0 110.132 179.293 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 65.5 t-105 -79.69 -6.35 57.01 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.564 -0.71 . . . . 0.0 111.315 -179.911 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -53.63 -51.75 62.1 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.104 -0.997 . . . . 0.0 110.406 179.772 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.3 p -58.74 -36.16 73.88 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.296 0.569 . . . . 0.0 109.992 179.515 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.3 -45.56 69.27 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.834 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.52 -36.52 84.07 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.565 -0.709 . . . . 0.0 109.665 178.98 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.4 tt -62.74 -37.26 85.88 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.589 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.5 tp -68.61 -37.68 79.96 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.425 0.631 . . . . 0.0 109.706 178.86 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.23 -35.42 77.91 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.819 -0.551 . . . . 0.0 109.943 179.198 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.94 -40.02 87.45 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.55 -0.719 . . . . 0.0 110.283 179.589 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.36 -46.64 90.02 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.577 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 76.5 t -66.06 -40.88 88.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.557 -0.966 . . . . 0.0 109.665 179.363 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.17 -47.14 88.13 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.59 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 35.2 mt -64.48 -33.72 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.435 -1.038 . . . . 0.0 109.885 179.542 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -63.65 -27.22 69.07 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.031 -1.043 . . . . 0.0 109.678 178.87 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.459 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.7 OUTLIER -79.14 -25.25 42.92 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.446 -0.784 . . . . 0.0 108.94 178.229 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.562 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.5 tp -132.95 56.63 23.09 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.539 -0.725 . . . . 0.0 110.714 179.498 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.562 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.5 Cg_endo -91.92 -20.39 0.65 Allowed 'Trans proline' 0 C--N 1.318 -1.048 0 C-N-CA 121.143 1.229 . . . . 0.0 111.496 -179.837 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -78.05 -37.48 46.66 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.109 -0.994 . . . . 0.0 110.612 -179.979 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.914 0 O-C-N 121.336 -0.853 . . . . 0.0 110.747 179.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 . . . . . 0 N--CA 1.496 1.833 0 CA-C-O 120.934 0.397 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.23 53.53 1.55 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.463 -0.773 . . . . 0.0 110.496 -179.821 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.7 t 52.42 57.47 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.625 -0.672 . . . . 0.0 110.772 179.618 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.5 t -81.58 -15.62 54.18 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.13 -0.981 . . . . 0.0 111.166 179.771 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -104.04 18.8 21.29 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.24 -0.912 . . . . 0.0 110.65 179.734 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -163.79 60.56 0.16 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.179 -0.951 . . . . 0.0 109.883 179.826 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.455 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -58.69 -53.36 67.1 Favored Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 121.509 -0.744 . . . . 0.0 111.582 -179.604 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 7' ' ' ARG . 43.2 Cg_endo -70.46 -92.03 0.01 OUTLIER 'Trans proline' 0 N--CA 1.487 1.116 0 O-C-N 123.56 1.295 . . . . 0.0 110.453 -179.717 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.448 ' C ' ' O ' ' A' ' 8' ' ' PRO . 10.6 ttt-85 31.38 -105.84 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.641 -0.662 . . . . 0.0 111.84 179.775 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.482 ' O ' ' HB2' ' A' ' 11' ' ' PHE . 3.3 m95 49.55 66.31 1.16 Allowed 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 -177.969 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 94.8 m-85 62.51 31.25 17.1 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -175.618 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER 46.64 35.55 3.09 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.563 0.697 . . . . 0.0 110.463 -178.337 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -79.76 -52.02 8.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.606 -0.684 . . . . 0.0 109.3 179.205 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.9 m -60.65 -32.92 72.08 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.757 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.84 -41.02 83.6 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.8 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.1 tt -65.26 -39.45 92.65 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.566 -0.709 . . . . 0.0 109.953 179.225 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 tt -62.18 -35.33 78.49 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.511 0.672 . . . . 0.0 109.369 178.845 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.1 tt -69.2 -39.09 78.86 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.324 0.583 . . . . 0.0 109.5 178.778 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.34 -37.92 89.19 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.851 -0.531 . . . . 0.0 109.704 179.207 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.5 -40.04 96.02 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.575 -0.703 . . . . 0.0 109.905 179.249 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.6 -36.98 93.81 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.384 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.5 t -63.81 -41.41 92.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.55 -0.97 . . . . 0.0 109.751 179.478 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.17 -41.45 98.37 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.372 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 29.8 mm -66.52 -34.86 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.467 -1.019 . . . . 0.0 109.779 179.293 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -63.49 -26.13 68.58 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.277 -0.889 . . . . 0.0 109.654 178.76 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.455 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.9 OUTLIER -79.84 -24.73 41.11 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.356 -0.84 . . . . 0.0 109.037 178.237 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.598 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 14.6 tp -132.13 53.21 10.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.499 -0.751 . . . . 0.0 110.97 179.583 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.598 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.2 Cg_endo -90.23 -21.31 0.93 Allowed 'Trans proline' 0 C--N 1.32 -0.93 0 O-C-N 123.183 1.096 . . . . 0.0 111.005 179.893 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -82.85 -37.17 24.75 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.381 -0.824 . . . . 0.0 110.216 179.664 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.501 2.079 0 CA-C-O 118.069 -0.967 . . . . 0.0 111.024 179.93 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 . . . . . 0 N--CA 1.495 1.803 0 CA-C-O 121.028 0.442 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.7 39.7 3.57 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.507 -0.746 . . . . 0.0 110.451 179.862 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.4 t 52.6 52.82 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.628 -0.67 . . . . 0.0 110.609 179.852 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.8 t -90.04 -39.69 12.77 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.183 -0.948 . . . . 0.0 110.283 179.682 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.4 ' CD2' ' HA ' ' A' ' 8' ' ' PRO . 48.7 t60 -98.45 2.15 47.45 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.789 -0.569 . . . . 0.0 110.656 179.579 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 48.59 49.78 18.01 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.547 -0.721 . . . . 0.0 110.746 179.819 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpt85 68.38 121.81 0.03 OUTLIER Pre-proline 0 N--CA 1.503 2.177 0 O-C-N 121.945 -0.472 . . . . 0.0 110.644 -179.773 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.4 ' HA ' ' CD2' ' A' ' 5' ' ' HIS . 52.5 Cg_endo -74.0 -105.3 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.182 0 O-C-N 123.708 1.372 . . . . 0.0 110.863 -179.764 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.8 ptp85 -173.83 -163.67 0.18 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.813 -1.179 . . . . 0.0 109.829 -179.798 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER 66.26 125.34 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 CA-C-O 121.263 0.554 . . . . 0.0 110.547 -179.912 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 58.79 17.09 4.93 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.597 -0.689 . . . . 0.0 110.848 -179.298 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -123.46 -21.22 5.35 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.087 -1.008 . . . . 0.0 110.936 -179.944 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -61.5 -40.46 94.68 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.305 -0.872 . . . . 0.0 109.89 179.482 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.9 m -61.42 -36.08 79.34 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.378 0.609 . . . . 0.0 109.397 178.952 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.7 tt -67.01 -42.94 84.12 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.757 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.91 -40.48 97.72 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.693 -0.629 . . . . 0.0 109.937 179.216 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.8 tt -60.99 -36.59 79.86 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.637 0.732 . . . . 0.0 109.426 178.889 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.6 tp -72.6 -34.17 67.21 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.211 0.529 . . . . 0.0 109.903 178.984 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.71 -42.63 97.6 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.76 -0.588 . . . . 0.0 109.964 179.511 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.87 -39.83 95.13 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.53 -0.731 . . . . 0.0 109.928 179.235 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.56 -39.35 93.88 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.506 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 78.8 t -60.89 -43.37 95.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.503 -0.998 . . . . 0.0 109.996 179.619 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.42 -43.92 98.37 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.496 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.7 mt -66.46 -37.08 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.46 -1.023 . . . . 0.0 109.753 179.446 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -62.45 -26.24 68.41 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.293 -0.879 . . . . 0.0 109.982 179.213 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.452 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 13.4 mt -81.61 -22.43 37.66 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.355 -0.841 . . . . 0.0 109.224 178.349 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.617 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.1 OUTLIER -132.5 51.75 7.73 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.581 -0.699 . . . . 0.0 110.812 179.731 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.617 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.9 Cg_endo -91.11 -45.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.32 -0.943 0 O-C-N 123.048 1.025 . . . . 0.0 110.822 -179.997 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -107.74 -37.15 6.22 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.492 -0.755 . . . . 0.0 110.148 179.796 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.137 179.756 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.07 0.462 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.7 p -111.2 37.73 2.76 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.543 -0.723 . . . . 0.0 110.668 -179.837 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.3 t 52.84 39.68 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 O-C-N 121.539 -0.726 . . . . 0.0 110.899 179.833 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.7 t -104.03 -15.06 15.71 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.139 -0.976 . . . . 0.0 111.045 179.799 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -111.5 38.7 2.52 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.407 -0.808 . . . . 0.0 110.381 179.971 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -108.15 42.42 1.37 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.25 -0.906 . . . . 0.0 110.0 179.671 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.36 84.44 0.2 Allowed Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 121.733 -0.604 . . . . 0.0 110.566 -179.786 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.03 -170.26 0.68 Allowed 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.732 1.385 . . . . 0.0 110.498 179.849 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.631 ' HB3' ' HB2' ' A' ' 12' ' ' TRP . 12.7 ttt180 -140.9 167.4 22.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.143 -0.973 . . . . 0.0 110.433 179.712 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 40.6 m0 -61.73 -59.36 5.28 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.379 -0.825 . . . . 0.0 109.879 179.779 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -69.13 -18.07 63.91 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.445 -0.784 . . . . 0.0 109.981 178.828 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.631 ' HB2' ' HB3' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -54.82 -44.57 73.98 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.466 -0.772 . . . . 0.0 110.109 179.323 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -64.97 -35.8 82.36 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.67 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.7 m -66.75 -34.15 77.19 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.507 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.2 tt -65.63 -41.62 92.45 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.707 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 tt -66.87 -39.4 87.51 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.719 -0.613 . . . . 0.0 109.83 179.071 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.3 -33.61 75.9 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.496 0.665 . . . . 0.0 109.385 178.885 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.3 tp -72.42 -36.91 68.72 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.24 0.543 . . . . 0.0 109.61 178.902 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.47 -41.79 94.92 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.809 -0.557 . . . . 0.0 109.73 179.258 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.78 -40.99 92.53 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.539 -0.726 . . . . 0.0 109.815 179.121 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.425 ' HA2' HD13 ' A' ' 24' ' ' ILE . . . -61.63 -41.09 99.52 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 179.38 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.5 t -62.76 -40.03 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.568 -0.96 . . . . 0.0 109.801 179.418 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.469 ' HA2' HD13 ' A' ' 26' ' ' LEU . . . -59.69 -42.89 98.1 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.39 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.425 HD13 ' HA2' ' A' ' 21' ' ' GLY . 18.2 mt -68.61 -35.38 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.474 -1.015 . . . . 0.0 109.592 179.26 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -62.97 -27.03 69.12 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.204 -0.935 . . . . 0.0 109.613 178.824 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.469 HD13 ' HA2' ' A' ' 23' ' ' GLY . 13.5 mt -79.18 -18.27 53.36 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.379 -0.826 . . . . 0.0 109.314 178.359 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.588 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.9 tp -140.52 55.09 5.56 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.574 -0.704 . . . . 0.0 110.577 179.643 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.588 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.7 Cg_endo -91.18 -21.22 0.69 Allowed 'Trans proline' 0 C--N 1.319 -1.021 0 C-N-CA 121.106 1.204 . . . . 0.0 111.377 -179.582 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -98.71 -33.86 10.76 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.251 -0.906 . . . . 0.0 110.299 179.815 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.1 mtt180 . . . . . 0 N--CA 1.496 1.861 0 CA-C-O 117.916 -1.04 . . . . 0.0 110.284 179.842 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 30.1 p80 . . . . . 0 N--CA 1.497 1.894 0 CA-C-O 121.11 0.481 . . . . 0.0 110.528 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.4 p -166.93 78.42 0.2 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.495 -0.753 . . . . 0.0 110.359 -179.977 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.7 t -100.12 45.03 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.264 -0.897 . . . . 0.0 109.707 179.695 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.4 t -82.75 -34.22 27.21 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.265 -0.897 . . . . 0.0 110.377 179.959 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 47.7 m-70 -128.86 40.3 3.66 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.659 -0.651 . . . . 0.0 109.963 179.807 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -129.51 61.02 1.56 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.431 -0.793 . . . . 0.0 110.236 -179.953 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.28 72.67 19.51 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.361 -0.837 . . . . 0.0 110.079 179.735 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -76.37 78.89 3.12 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 O-C-N 123.715 1.376 . . . . 0.0 110.632 -179.768 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.5 ttp-105 60.37 28.88 18.53 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.621 -0.674 . . . . 0.0 110.659 -179.821 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -77.49 -40.09 44.13 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.256 -0.902 . . . . 0.0 110.116 179.816 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -77.86 -28.87 50.15 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.484 -0.76 . . . . 0.0 110.325 179.576 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 46.9 m95 -80.27 9.45 5.72 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.37 -0.831 . . . . 0.0 111.515 -179.654 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -61.1 -44.82 96.76 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.169 -0.957 . . . . 0.0 109.511 179.193 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 56.8 p -63.57 -36.34 83.49 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.679 0.752 . . . . 0.0 109.315 178.651 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.34 -41.59 89.37 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.943 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.2 tt -64.72 -37.69 88.45 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.533 -0.73 . . . . 0.0 109.85 179.081 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.01 -35.11 79.13 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.609 0.718 . . . . 0.0 109.291 178.74 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.0 tp -71.83 -37.78 70.26 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.263 0.554 . . . . 0.0 109.753 179.025 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.87 -40.44 97.5 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.734 -0.604 . . . . 0.0 109.834 179.305 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.65 -37.39 87.17 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.629 -0.669 . . . . 0.0 109.884 179.311 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.98 -40.68 93.43 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.453 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.7 t -60.49 -42.24 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.505 -0.997 . . . . 0.0 109.802 179.496 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.41 ' HA2' HD11 ' A' ' 26' ' ' LEU . . . -64.21 -44.18 95.98 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.368 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.5 mt -65.22 -34.53 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.447 -1.031 . . . . 0.0 109.775 179.434 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -62.94 -27.23 69.24 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.148 -0.97 . . . . 0.0 109.497 178.754 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.41 HD11 ' HA2' ' A' ' 23' ' ' GLY . 6.1 mt -79.56 -17.7 53.37 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.428 -0.795 . . . . 0.0 109.353 178.303 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.598 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.7 tp -141.44 54.9 4.6 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.57 -0.706 . . . . 0.0 110.5 179.495 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.598 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.1 Cg_endo -91.08 -20.8 0.75 Allowed 'Trans proline' 0 C--N 1.319 -0.999 0 C-N-CA 121.242 1.294 . . . . 0.0 111.249 -179.836 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -104.45 5.37 34.11 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.253 -0.905 . . . . 0.0 110.893 179.722 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.833 0 O-C-N 121.163 -0.961 . . . . 0.0 110.628 179.885 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 120.765 0.317 . . . . 0.0 110.223 . . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.0 m 55.99 41.25 30.02 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.554 -0.716 . . . . 0.0 110.81 -179.897 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.5 t 52.29 45.79 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.68 -0.638 . . . . 0.0 110.674 179.664 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.0 t -82.83 -21.13 34.55 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.238 -0.914 . . . . 0.0 110.908 179.961 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.7 m80 -126.11 57.12 1.4 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.402 -0.811 . . . . 0.0 110.136 -179.803 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -99.18 22.04 11.02 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.38 -0.825 . . . . 0.0 110.959 179.894 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.481 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -59.48 -51.54 80.53 Favored Pre-proline 0 N--CA 1.501 2.097 0 O-C-N 121.204 -0.935 . . . . 0.0 110.723 179.652 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 7' ' ' ARG . 48.8 Cg_endo -74.62 -14.39 22.13 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.528 1.278 . . . . 0.0 110.88 179.495 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.532 ' HB3' ' HB2' ' A' ' 13' ' ' PHE . 46.2 mmt-85 -89.7 -103.41 0.09 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.301 -0.874 . . . . 0.0 109.688 -179.928 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER 56.99 -82.09 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.501 -0.749 . . . . 0.0 111.283 179.519 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.401 ' N ' ' O ' ' A' ' 9' ' ' ARG . 90.7 m-85 -97.73 -34.17 11.01 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.122 -0.987 . . . . 0.0 109.496 179.535 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 72.7 t-105 -74.51 -11.71 60.29 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.585 -0.697 . . . . 0.0 110.511 179.267 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.532 ' HB2' ' HB3' ' A' ' 9' ' ' ARG . 56.1 t80 -59.38 -51.71 68.76 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.356 -0.84 . . . . 0.0 110.105 179.753 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.7 p -62.87 -37.54 87.28 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.022 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.13 -41.27 86.42 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.332 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.38 -39.03 91.75 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.025 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.5 tp -61.16 -38.54 86.81 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.596 0.712 . . . . 0.0 109.09 178.606 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.0 tp -67.83 -37.71 82.29 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.347 0.594 . . . . 0.0 109.453 178.779 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.63 -38.77 92.13 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.841 -0.537 . . . . 0.0 109.796 179.09 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.38 -38.67 91.85 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.587 -0.696 . . . . 0.0 110.054 179.398 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.69 -40.63 94.0 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.595 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 99.3 t -61.54 -42.15 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.458 -1.025 . . . . 0.0 109.828 179.577 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.97 -45.53 92.05 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.528 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.2 mt -65.77 -35.14 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.422 -1.046 . . . . 0.0 109.717 179.478 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -63.7 -25.91 68.42 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.315 -0.865 . . . . 0.0 109.498 178.75 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.456 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.3 mm? -79.05 -27.11 43.11 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.203 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.563 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 8.8 tp -131.16 55.46 19.03 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.576 -0.703 . . . . 0.0 110.849 179.518 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.563 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 39.9 Cg_endo -88.88 -22.45 1.1 Allowed 'Trans proline' 0 C--N 1.318 -1.053 0 O-C-N 123.217 1.114 . . . . 0.0 110.561 179.647 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -103.38 -14.07 16.41 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.37 -0.831 . . . . 0.0 110.188 178.997 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.049 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.964 -179.99 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 . . . . . 0 N--CA 1.497 1.911 0 CA-C-O 120.97 0.414 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.2 m -105.26 27.38 8.32 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.487 -0.758 . . . . 0.0 110.922 -179.871 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.2 t 53.09 58.51 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.358 -0.839 . . . . 0.0 110.515 179.701 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.86 -24.45 55.73 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.22 -0.925 . . . . 0.0 110.581 179.705 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.454 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 6.0 t-80 -119.17 32.41 6.13 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.646 -0.659 . . . . 0.0 109.977 179.615 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 58.84 32.54 22.32 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.71 -0.619 . . . . 0.0 110.961 -179.908 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 10.9 mtm180 51.62 72.14 1.3 Allowed Pre-proline 0 N--CA 1.502 2.138 0 O-C-N 121.538 -0.726 . . . . 0.0 110.884 179.695 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.454 ' HD3' ' HB3' ' A' ' 5' ' ' HIS . 51.6 Cg_endo -77.94 177.38 8.87 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.723 1.38 . . . . 0.0 110.593 179.853 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER 61.21 -78.1 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.216 0 O-C-N 122.029 -0.419 . . . . 0.0 111.347 179.662 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER 68.42 -68.09 0.18 Allowed 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.708 -0.62 . . . . 0.0 110.3 -179.529 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -97.09 -18.59 19.25 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.369 -0.832 . . . . 0.0 110.199 179.484 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -95.46 16.24 17.51 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.315 -0.866 . . . . 0.0 111.089 -179.934 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -64.61 -45.4 87.06 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.128 -0.982 . . . . 0.0 110.06 179.76 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.8 m -62.16 -37.43 85.19 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.435 0.636 . . . . 0.0 109.635 179.236 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 tt -65.88 -42.34 90.42 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.017 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.9 tt -63.53 -35.44 80.48 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.655 -0.653 . . . . 0.0 109.675 179.122 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.3 tp -63.55 -34.05 76.95 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.586 0.708 . . . . 0.0 109.304 178.525 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.7 tt -80.51 -38.63 29.41 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.497 0.665 . . . . 0.0 109.525 178.878 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.24 -35.06 78.78 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.849 -0.532 . . . . 0.0 110.376 179.613 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.36 -41.79 97.65 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.417 -0.802 . . . . 0.0 110.223 179.735 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.36 -46.92 66.48 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.632 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 77.9 t -64.61 -37.85 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.546 -0.973 . . . . 0.0 110.036 179.607 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.96 -46.97 92.99 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.704 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.3 mt -65.4 -35.14 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.384 -1.068 . . . . 0.0 109.925 179.605 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -64.99 -27.71 69.01 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.064 -1.022 . . . . 0.0 109.599 178.867 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.423 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.7 mm? -77.86 -25.34 48.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.321 -0.862 . . . . 0.0 108.689 178.016 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.539 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 5.6 tp -133.59 57.06 23.39 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.617 -0.677 . . . . 0.0 110.468 179.488 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 39.6 Cg_endo -89.89 -22.39 0.86 Allowed 'Trans proline' 0 C--N 1.318 -1.076 0 C-N-CA 121.111 1.207 . . . . 0.0 111.212 -179.666 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -67.23 -34.07 76.7 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.327 -0.858 . . . . 0.0 110.171 179.461 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.5 mtt180 . . . . . 0 N--CA 1.499 1.985 0 CA-C-O 118.743 -0.646 . . . . 0.0 110.563 179.966 . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 35.1 t60 . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 121.099 0.476 . . . . 0.0 110.351 . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.3 p -159.56 58.81 0.39 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.52 -0.737 . . . . 0.0 110.457 179.955 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.0 m -131.31 42.66 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.293 -0.88 . . . . 0.0 110.349 179.82 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.4 m -121.26 -85.79 0.66 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.421 -0.799 . . . . 0.0 110.282 179.957 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -132.12 42.36 3.14 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.364 -0.835 . . . . 0.0 110.193 179.804 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -118.09 56.86 0.85 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.474 -0.766 . . . . 0.0 109.934 179.88 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -73.67 132.13 81.25 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 121.425 -0.797 . . . . 0.0 110.437 -179.933 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -87.32 31.67 0.44 Allowed 'Trans proline' 0 C--N 1.315 -1.196 0 O-C-N 123.676 1.356 . . . . 0.0 111.37 179.907 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.8 mtt85 60.53 -177.45 0.1 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.486 -0.759 . . . . 0.0 110.789 -179.915 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 2.1 t90 69.44 134.33 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 121.226 0.536 . . . . 0.0 110.306 -179.419 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.8 t80 64.0 12.12 6.65 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.558 -0.714 . . . . 0.0 110.853 -179.232 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 41.2 m95 -126.5 13.49 7.58 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.269 -0.894 . . . . 0.0 110.433 179.646 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -69.12 -41.47 77.35 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.245 -0.91 . . . . 0.0 109.541 179.486 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.1 t -63.95 -34.09 77.19 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.427 0.632 . . . . 0.0 109.527 178.83 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 tt -69.38 -41.47 76.46 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.106 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 tt -66.81 -38.24 86.09 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.582 -0.698 . . . . 0.0 109.878 179.386 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.5 tp -62.78 -31.32 72.26 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.534 0.683 . . . . 0.0 109.518 178.814 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.9 tp -75.61 -35.2 60.59 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.16 0.505 . . . . 0.0 109.956 179.167 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.37 -46.26 89.16 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.814 -0.554 . . . . 0.0 109.823 179.352 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.93 -37.53 84.49 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.537 -0.727 . . . . 0.0 109.782 179.199 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.9 -39.01 96.96 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.469 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.1 t -60.35 -44.7 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.491 -1.005 . . . . 0.0 109.668 179.566 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.51 -41.93 99.74 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.411 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 31.1 mt -66.89 -35.35 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.449 -1.03 . . . . 0.0 109.801 179.469 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -62.49 -27.95 69.49 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.161 -0.962 . . . . 0.0 109.663 178.924 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.4 mt -80.6 -17.62 50.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.428 -0.795 . . . . 0.0 109.248 178.293 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.636 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -138.88 51.78 3.77 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.553 -0.717 . . . . 0.0 110.732 179.771 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.636 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 47.3 Cg_endo -92.86 -16.82 0.81 Allowed 'Trans proline' 0 C--N 1.32 -0.936 0 C-N-CA 121.126 1.217 . . . . 0.0 111.145 -179.663 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -69.02 -38.1 79.01 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.494 -0.754 . . . . 0.0 110.644 -179.47 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.6 mtt180 . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 117.866 -1.064 . . . . 0.0 110.201 179.956 . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 27.2 m80 . . . . . 0 N--CA 1.496 1.871 0 CA-C-O 121.062 0.458 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.9 m -116.66 52.86 0.91 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.478 -0.764 . . . . 0.0 110.157 179.905 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.1 t -110.49 50.1 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.409 -0.807 . . . . 0.0 110.021 -179.908 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.88 -29.02 19.96 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.253 -0.905 . . . . 0.0 110.559 179.651 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -127.68 44.16 2.98 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.541 -0.724 . . . . 0.0 110.19 179.779 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -95.8 42.24 1.09 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.371 -0.83 . . . . 0.0 110.412 179.781 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -83.35 154.47 66.25 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.328 -0.857 . . . . 0.0 110.372 179.92 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.0 92.21 0.72 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.999 1.526 . . . . 0.0 110.572 179.98 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.404 ' O ' ' HB2' ' A' ' 10' ' ' TRP . 8.3 ptt180 -148.26 158.57 44.16 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.51 -0.743 . . . . 0.0 110.226 179.951 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.404 ' HB2' ' O ' ' A' ' 9' ' ' ARG . 1.8 m-90 61.77 -78.48 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.322 0 O-C-N 122.006 -0.434 . . . . 0.0 110.89 -179.833 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -72.97 -8.37 55.36 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.294 -0.879 . . . . 0.0 111.19 179.911 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -74.6 -7.81 54.35 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.2 -0.937 . . . . 0.0 111.69 -179.883 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.92 -38.7 89.4 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.245 -0.909 . . . . 0.0 110.068 179.721 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.1 m -63.38 -38.72 92.23 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.44 0.638 . . . . 0.0 109.439 178.879 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 tt -63.26 -42.58 99.18 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.983 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 tt -65.27 -36.37 83.9 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.529 -0.732 . . . . 0.0 109.985 179.33 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.1 tp -64.28 -34.53 78.32 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.631 -0.668 . . . . 0.0 109.365 178.606 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.5 tt -67.79 -38.68 83.65 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.362 0.601 . . . . 0.0 109.527 178.866 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.59 -39.56 91.72 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.655 -0.653 . . . . 0.0 109.696 179.061 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.09 -39.55 94.3 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.627 -0.671 . . . . 0.0 109.974 179.304 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.98 -37.91 94.84 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.441 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.5 t -60.63 -43.29 94.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.512 -0.993 . . . . 0.0 109.76 179.621 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.414 ' HA2' HD11 ' A' ' 26' ' ' LEU . . . -64.11 -42.74 97.96 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.215 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 29.2 mm -68.03 -35.46 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.399 -1.06 . . . . 0.0 109.769 179.375 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -62.44 -25.91 68.22 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.259 -0.9 . . . . 0.0 109.571 178.845 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.437 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 8.4 mt -79.4 -24.41 42.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.311 -0.868 . . . . 0.0 108.9 178.27 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.572 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.8 tp -133.65 55.32 15.52 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.609 -0.682 . . . . 0.0 110.716 179.38 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.572 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.6 Cg_endo -90.54 -21.12 0.86 Allowed 'Trans proline' 0 C--N 1.318 -1.032 0 C-N-CA 121.022 1.148 . . . . 0.0 110.994 179.904 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -89.52 -36.8 15.17 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.304 -0.873 . . . . 0.0 110.07 179.608 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.211 179.758 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 121.038 0.447 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 57.3 m -113.99 46.61 1.3 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.548 -0.72 . . . . 0.0 110.344 179.883 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.4 t -105.38 47.42 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.378 -0.826 . . . . 0.0 109.814 179.824 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.89 -31.92 21.94 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.367 -0.833 . . . . 0.0 110.66 -179.928 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -123.99 24.81 8.14 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.747 -0.596 . . . . 0.0 110.585 179.897 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.4 50.38 0.87 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.203 -0.936 . . . . 0.0 109.896 179.525 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -143.78 129.16 9.79 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.429 -0.795 . . . . 0.0 110.264 -179.934 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.29 -45.03 0.67 Allowed 'Trans proline' 0 C--N 1.315 -1.203 0 O-C-N 123.876 1.461 . . . . 0.0 110.937 -179.893 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 57.73 24.71 10.98 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.555 -0.716 . . . . 0.0 111.34 -179.899 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.417 ' O ' ' HB2' ' A' ' 11' ' ' PHE . 71.7 t-105 -67.93 89.62 0.29 Allowed 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 177.229 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.417 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 96.6 m-85 57.77 29.0 16.74 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 -174.63 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER 48.44 37.59 9.16 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.505 0.669 . . . . 0.0 109.963 -178.133 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -67.09 -49.23 65.69 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.697 -0.627 . . . . 0.0 109.733 179.5 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 t -61.85 -34.38 75.88 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.316 0.579 . . . . 0.0 109.523 179.189 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.6 tt -67.07 -41.51 86.27 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.901 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.3 tt -63.53 -42.11 98.44 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.629 -0.669 . . . . 0.0 109.919 179.353 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 tt -61.41 -33.13 73.17 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.572 0.701 . . . . 0.0 109.372 178.724 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.05 -38.45 72.52 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.294 0.569 . . . . 0.0 109.515 178.898 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.94 -39.04 93.24 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.773 -0.579 . . . . 0.0 109.885 179.153 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.67 -41.75 98.15 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.554 -0.716 . . . . 0.0 109.763 179.255 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.441 ' HA2' HD12 ' A' ' 24' ' ' ILE . . . -62.16 -38.86 96.86 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.32 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 90.0 t -62.43 -43.2 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.552 -0.969 . . . . 0.0 109.797 179.433 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.462 ' HA2' HD12 ' A' ' 26' ' ' LEU . . . -62.43 -41.28 99.78 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.584 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.441 HD12 ' HA2' ' A' ' 21' ' ' GLY . 29.2 mt -66.64 -37.31 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.425 -1.044 . . . . 0.0 109.688 179.582 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -62.98 -26.68 68.96 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.216 -0.927 . . . . 0.0 109.666 178.948 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.462 HD12 ' HA2' ' A' ' 23' ' ' GLY . 11.7 mt -80.06 -17.31 53.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.371 -0.83 . . . . 0.0 109.429 178.373 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.609 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -140.26 53.5 4.3 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.539 -0.726 . . . . 0.0 110.648 179.561 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.609 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.7 Cg_endo -90.39 -21.77 0.83 Allowed 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 121.03 1.153 . . . . 0.0 111.11 -179.689 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.489 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 6.1 p-10 -89.39 -18.13 27.44 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.375 -0.828 . . . . 0.0 111.001 179.78 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.489 ' HG3' ' O ' ' A' ' 29' ' ' ASN . 2.5 ptm180 . . . . . 0 N--CA 1.509 2.489 0 CA-C-O 117.813 -1.089 . . . . 0.0 111.857 -179.76 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 121.086 0.47 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 t -109.6 50.01 0.81 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.504 -0.747 . . . . 0.0 110.223 179.785 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.8 t -114.49 29.68 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.389 -0.82 . . . . 0.0 109.929 179.618 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.0 m -112.11 -80.16 0.59 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.192 -0.942 . . . . 0.0 110.225 179.917 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -112.6 37.26 3.12 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.66 -0.65 . . . . 0.0 110.675 179.979 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -115.16 46.12 1.51 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.387 -0.821 . . . . 0.0 109.982 179.559 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.73 115.1 47.22 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 121.538 -0.726 . . . . 0.0 110.243 -179.801 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.66 84.12 1.65 Allowed 'Trans proline' 0 C--N 1.315 -1.209 0 O-C-N 123.822 1.433 . . . . 0.0 110.286 179.776 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.484 ' O ' ' HB2' ' A' ' 10' ' ' TRP . 1.0 OUTLIER -134.13 -161.45 1.15 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.398 -0.814 . . . . 0.0 110.095 -179.843 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.484 ' HB2' ' O ' ' A' ' 9' ' ' ARG . 14.4 m-90 64.27 -73.2 0.05 Allowed 'General case' 0 N--CA 1.506 2.346 0 O-C-N 122.003 -0.436 . . . . 0.0 110.417 -179.777 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -70.15 -22.82 62.94 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.28 -0.888 . . . . 0.0 110.203 178.959 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -98.07 17.66 17.91 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.279 -0.888 . . . . 0.0 111.169 -179.961 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -61.89 -45.9 91.72 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.145 -0.972 . . . . 0.0 109.933 179.586 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.3 t -59.91 -35.67 75.38 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.008 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.6 tt -66.17 -47.64 73.32 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.532 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.5 tt -65.76 -37.02 85.2 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.52 0.676 . . . . 0.0 109.211 178.566 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -61.52 -33.01 73.08 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.518 0.675 . . . . 0.0 109.407 178.611 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.8 tp -74.09 -39.53 63.36 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.375 0.607 . . . . 0.0 109.688 178.915 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.43 -37.86 89.0 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.808 -0.558 . . . . 0.0 109.945 179.285 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.38 -40.09 96.29 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.621 -0.675 . . . . 0.0 110.1 179.482 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.12 -42.19 94.6 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.624 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 73.2 t -62.32 -40.0 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.45 -1.03 . . . . 0.0 109.972 179.567 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.45 ' HA2' HD11 ' A' ' 26' ' ' LEU . . . -64.12 -44.74 95.3 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.567 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.3 mt -64.8 -35.58 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.358 -1.083 . . . . 0.0 109.784 179.543 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -63.69 -26.54 68.71 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.127 -0.983 . . . . 0.0 109.671 178.775 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.45 HD11 ' HA2' ' A' ' 23' ' ' GLY . 14.9 mt -79.18 -24.2 43.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.401 -0.812 . . . . 0.0 108.862 178.19 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.552 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.3 OUTLIER -133.72 56.31 19.6 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.579 -0.701 . . . . 0.0 110.558 179.411 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.552 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 40.3 Cg_endo -90.29 -21.49 0.89 Allowed 'Trans proline' 0 C--N 1.318 -1.042 0 O-C-N 123.346 1.182 . . . . 0.0 111.143 -179.821 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -79.68 -37.13 36.52 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.254 -0.904 . . . . 0.0 110.298 179.514 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.15 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.889 179.962 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 27.5 p80 . . . . . 0 N--CA 1.499 1.988 0 CA-C-O 120.728 0.299 . . . . 0.0 111.575 . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.3 p -117.21 22.91 12.19 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.276 -0.89 . . . . 0.0 110.706 179.971 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.2 m -129.45 59.22 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.175 -0.953 . . . . 0.0 109.99 -179.982 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.7 p -135.33 -90.55 0.31 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.458 -0.777 . . . . 0.0 110.427 -179.646 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -108.79 34.0 3.92 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.695 -0.628 . . . . 0.0 110.188 179.838 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -159.83 76.98 0.66 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.456 -0.777 . . . . 0.0 109.596 179.978 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.7 mpp_? -115.93 76.62 6.28 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.5 -0.75 . . . . 0.0 110.242 -179.577 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.2 -41.24 1.34 Allowed 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.65 1.342 . . . . 0.0 110.785 179.931 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.534 ' HA ' ' HB3' ' A' ' 12' ' ' TRP . 0.2 OUTLIER -116.46 -19.63 10.0 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.411 -0.806 . . . . 0.0 111.118 -179.744 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.406 ' HA ' ' CE3' ' A' ' 10' ' ' TRP . 5.7 t-105 -54.6 -56.3 20.43 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.274 -0.891 . . . . 0.0 110.474 -179.883 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -71.35 -35.21 71.08 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.323 -0.86 . . . . 0.0 109.605 179.161 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.534 ' HB3' ' HA ' ' A' ' 9' ' ' ARG . 35.3 t-105 -61.65 -23.45 66.08 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.699 -0.625 . . . . 0.0 110.633 179.358 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -59.76 -37.54 79.3 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.511 -0.743 . . . . 0.0 110.203 179.384 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 81.3 p -66.78 -33.15 74.98 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.581 -0.699 . . . . 0.0 109.492 179.047 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.5 tt -67.66 -41.48 83.72 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.49 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 tt -61.32 -41.06 96.38 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.656 -0.653 . . . . 0.0 109.781 179.078 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 tt -62.21 -37.33 84.91 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.543 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.79 -36.34 78.15 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.283 0.563 . . . . 0.0 109.604 178.843 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.14 -38.99 92.36 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.747 -0.596 . . . . 0.0 109.98 179.295 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.39 -43.22 95.13 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.587 -0.696 . . . . 0.0 109.758 179.359 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.12 -40.03 96.62 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.231 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.9 t -63.89 -37.8 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.529 -0.983 . . . . 0.0 109.71 179.244 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.441 ' HA2' HD11 ' A' ' 26' ' ' LEU . . . -60.06 -46.12 94.75 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.415 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.2 mp -67.18 -34.48 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.447 -1.031 . . . . 0.0 109.561 179.325 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -63.48 -25.99 68.52 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.15 -0.969 . . . . 0.0 109.575 178.842 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.441 HD11 ' HA2' ' A' ' 23' ' ' GLY . 13.6 mt -80.09 -19.43 47.44 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.353 -0.842 . . . . 0.0 109.266 178.273 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.595 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 10.9 tp -138.54 53.95 6.24 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.54 -0.725 . . . . 0.0 110.623 179.438 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.595 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 40.9 Cg_endo -89.6 -30.15 0.19 Allowed 'Trans proline' 0 C--N 1.319 -1.003 0 O-C-N 123.232 1.122 . . . . 0.0 110.967 -179.975 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -86.85 -14.86 40.87 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.271 -0.893 . . . . 0.0 110.745 179.468 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 26.2 mtt180 . . . . . 0 N--CA 1.5 2.06 0 O-C-N 121.646 -0.659 . . . . 0.0 110.285 -179.624 . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 4.9 m170 . . . . . 0 N--CA 1.497 1.882 0 CA-C-O 121.034 0.445 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.9 p -142.26 35.67 1.51 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.486 -0.759 . . . . 0.0 110.673 -179.955 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.5 t 49.82 43.16 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 121.497 -0.752 . . . . 0.0 110.196 -179.842 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.0 t -70.98 -32.85 69.81 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.276 -0.89 . . . . 0.0 110.656 -179.861 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.487 ' HB3' ' HG3' ' A' ' 8' ' ' PRO . 64.4 m170 -108.19 31.8 5.27 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.604 -0.685 . . . . 0.0 110.336 179.857 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 7' ' ' ARG . . . 55.48 56.89 5.82 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.608 -0.682 . . . . 0.0 110.653 -179.913 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER 30.11 69.56 0.64 Allowed Pre-proline 0 N--CA 1.509 2.507 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 179.796 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.487 ' HG3' ' HB3' ' A' ' 5' ' ' HIS . 52.4 Cg_endo -82.02 170.66 13.56 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.652 1.343 . . . . 0.0 110.926 -179.987 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.9 ptt-85 -110.1 -29.86 8.02 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.535 -0.728 . . . . 0.0 110.427 179.314 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 73.8 t-105 -63.18 -32.61 74.05 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.356 -0.84 . . . . 0.0 110.236 179.506 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -74.25 -23.43 59.14 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.456 -0.777 . . . . 0.0 110.637 179.609 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.416 ' HA ' ' CE3' ' A' ' 12' ' ' TRP . 0.0 OUTLIER -78.0 9.16 3.86 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.303 -0.873 . . . . 0.0 111.319 179.991 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -62.49 -32.18 73.04 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.038 -1.039 . . . . 0.0 109.919 179.532 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.31 -38.87 82.03 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.588 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 tt -63.27 -39.51 94.78 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.388 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.3 tt -64.42 -39.0 92.99 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.346 0.594 . . . . 0.0 109.791 178.984 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.2 tp -63.22 -34.99 78.84 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.51 0.671 . . . . 0.0 109.444 178.795 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.4 tt -68.81 -37.34 79.15 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.226 0.536 . . . . 0.0 109.688 178.89 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.16 -38.04 84.79 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.791 -0.568 . . . . 0.0 109.682 179.088 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.65 -39.16 91.1 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.636 -0.665 . . . . 0.0 110.0 179.337 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.1 -39.74 97.46 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.43 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.3 t -62.22 -43.47 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.497 -1.002 . . . . 0.0 109.608 179.548 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.57 -44.39 92.89 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.411 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.4 mt -65.56 -35.02 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.455 -1.026 . . . . 0.0 109.721 179.411 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -64.1 -27.06 68.84 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.112 -0.992 . . . . 0.0 109.388 178.737 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.401 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.5 mm? -77.92 -24.88 48.15 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.097 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.543 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 3.4 tp -134.63 57.09 20.23 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.559 -0.713 . . . . 0.0 110.643 179.512 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.543 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.2 Cg_endo -90.86 -20.61 0.83 Allowed 'Trans proline' 0 C--N 1.316 -1.137 0 O-C-N 123.225 1.118 . . . . 0.0 111.121 -179.927 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -93.31 -23.93 18.31 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.296 -0.878 . . . . 0.0 110.723 179.925 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 . . . . . 0 N--CA 1.497 1.918 0 CA-C-O 118.121 -0.942 . . . . 0.0 110.567 -179.8 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.539 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.8 tp . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.185 0.517 . . . . 0.0 109.746 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.7 96.45 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.848 -0.532 . . . . 0.0 109.764 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.98 -39.16 93.89 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.579 -0.701 . . . . 0.0 109.738 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.97 -38.38 95.41 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 18' ' ' LEU . 84.6 t -62.29 -41.29 91.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.498 -1.001 . . . . 0.0 109.827 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.99 -42.01 98.4 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 28.5 mm -66.88 -35.56 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.472 -1.016 . . . . 0.0 109.697 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -64.32 -26.98 68.72 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.275 -0.89 . . . . 0.0 109.513 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.483 ' HA ' HD13 ' A' ' 26' ' ' LEU . 1.9 mm? -78.46 -24.49 45.96 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.373 -0.829 . . . . 0.0 108.878 178.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.573 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 1.4 tp -134.44 56.03 16.78 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.581 -0.699 . . . . 0.0 110.763 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.573 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 43.4 Cg_endo . . . . . 0 C--N 1.319 -1.021 0 C-N-CA 121.096 1.197 . . . . 0.0 111.408 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.464 HD22 ' HA ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.803 0 CA-C-O 121.307 0.575 . . . . 0.0 109.624 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.8 -37.96 86.32 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.792 -0.567 . . . . 0.0 110.334 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.07 -40.56 96.21 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.455 -0.778 . . . . 0.0 109.965 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.48 -38.65 90.97 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 77.2 t -61.07 -41.23 88.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.474 -1.015 . . . . 0.0 109.939 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.32 -43.51 98.3 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 34.1 mm -67.48 -35.72 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.382 -1.069 . . . . 0.0 109.663 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -63.72 -25.67 68.31 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.217 -0.927 . . . . 0.0 109.645 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.494 ' HA ' HD13 ' A' ' 26' ' ' LEU . 1.6 mm? -80.07 -25.71 39.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.354 -0.841 . . . . 0.0 108.988 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.599 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 4.1 tp -131.28 52.76 10.01 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.467 -0.771 . . . . 0.0 111.126 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.599 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 43.0 Cg_endo . . . . . 0 C--N 1.319 -1.024 0 C-N-CA 120.895 1.064 . . . . 0.0 110.895 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 tt . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 121.21 0.529 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.8 -35.64 81.26 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.742 -0.599 . . . . 0.0 109.965 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.62 -42.19 64.72 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.504 -0.748 . . . . 0.0 109.979 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.6 -52.26 31.18 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 73.2 t -63.93 -35.25 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.482 -1.011 . . . . 0.0 110.015 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.58 -47.86 89.09 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.6 mt -68.02 -34.79 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.433 -1.04 . . . . 0.0 109.789 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -64.32 -25.08 67.88 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.163 -0.96 . . . . 0.0 109.769 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.511 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.2 mm? -80.81 -26.48 37.07 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.378 -0.826 . . . . 0.0 108.919 178.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.605 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 4.7 tp -130.14 52.0 8.58 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.591 -0.693 . . . . 0.0 111.215 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.605 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.7 Cg_endo . . . . . 0 C--N 1.319 -0.977 0 O-C-N 123.095 1.05 . . . . 0.0 110.787 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.8 tp . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.174 0.511 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.7 -41.49 95.3 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.725 -0.609 . . . . 0.0 109.999 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.56 -39.25 93.06 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.486 -0.759 . . . . 0.0 109.912 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.88 -39.14 94.87 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.6 t -62.01 -40.34 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.453 -1.027 . . . . 0.0 109.832 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.62 -46.75 91.44 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 37.9 mm -66.56 -33.89 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.54 -0.977 . . . . 0.0 109.578 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -62.5 -25.16 67.86 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.357 -0.839 . . . . 0.0 109.813 178.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.513 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.5 OUTLIER -80.71 -25.62 37.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.51 -0.743 . . . . 0.0 109.095 178.54 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.628 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -130.29 51.08 6.87 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.544 -0.723 . . . . 0.0 111.192 179.544 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.628 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 43.4 Cg_endo . . . . . 0 C--N 1.318 -1.053 0 O-C-N 123.039 1.02 . . . . 0.0 110.651 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.552 ' O ' HG23 ' A' ' 22' ' ' VAL . 9.0 tp . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.322 0.582 . . . . 0.0 109.627 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.41 -39.99 95.99 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.882 -0.511 . . . . 0.0 109.811 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.62 -40.18 96.16 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.563 -0.71 . . . . 0.0 109.875 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.56 -39.22 96.63 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 18' ' ' LEU . 89.7 t -61.5 -42.11 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.452 -1.028 . . . . 0.0 109.813 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.446 ' HA2' HD12 ' A' ' 26' ' ' LEU . . . -63.06 -42.32 99.61 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 31.3 mm -67.18 -36.28 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.497 -1.002 . . . . 0.0 109.691 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -62.54 -26.63 68.66 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.198 -0.939 . . . . 0.0 109.609 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.446 HD12 ' HA2' ' A' ' 23' ' ' GLY . 12.8 mt -79.52 -22.21 44.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.438 -0.789 . . . . 0.0 109.146 178.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.592 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.6 tp -135.8 54.63 10.51 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.565 -0.709 . . . . 0.0 110.756 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.592 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.8 Cg_endo . . . . . 0 C--N 1.319 -1.024 0 O-C-N 123.264 1.139 . . . . 0.0 111.039 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.0 tp . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 121.224 0.535 . . . . 0.0 109.838 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.06 -39.94 83.62 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.842 -0.536 . . . . 0.0 110.298 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.35 -41.13 98.35 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.485 -0.76 . . . . 0.0 110.006 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.28 -40.39 96.58 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 71.9 t -62.89 -40.58 89.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.503 -0.998 . . . . 0.0 109.943 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.06 -42.17 99.72 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 36.0 mt -67.05 -36.96 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.458 -1.025 . . . . 0.0 109.782 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -64.8 -26.17 68.23 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.166 -0.959 . . . . 0.0 109.6 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.488 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.7 mm? -79.17 -25.69 42.78 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.34 -0.85 . . . . 0.0 108.858 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.573 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -131.49 55.33 17.97 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.602 -0.686 . . . . 0.0 110.962 179.556 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.573 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.2 Cg_endo . . . . . 0 C--N 1.318 -1.065 0 C-N-CA 120.891 1.061 . . . . 0.0 110.993 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.4 tt . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.378 0.608 . . . . 0.0 109.377 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.56 -35.1 78.38 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.879 -0.513 . . . . 0.0 109.803 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.7 -39.85 94.36 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.587 -0.695 . . . . 0.0 110.018 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.54 -42.28 95.75 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 64.2 t -65.05 -42.26 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.512 -0.993 . . . . 0.0 109.538 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.3 -46.93 89.39 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.0 mt -65.43 -32.14 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.445 -1.032 . . . . 0.0 109.872 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.438 ' O ' ' HG3' ' A' ' 28' ' ' PRO . 44.0 t80 -64.79 -28.09 69.34 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.983 -1.073 . . . . 0.0 109.565 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.46 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.8 OUTLIER -77.37 -25.79 51.28 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.037 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.515 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.1 OUTLIER -133.8 59.13 37.14 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.724 -0.61 . . . . 0.0 109.975 179.35 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.6 Cg_endo . . . . . 0 C--N 1.319 -1.011 0 C-N-CA 121.223 1.282 . . . . 0.0 111.535 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.513 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 121.237 0.542 . . . . 0.0 109.863 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.15 -41.78 98.61 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.839 -0.538 . . . . 0.0 109.979 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.01 -40.58 98.18 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.636 -0.665 . . . . 0.0 109.958 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.17 -38.87 96.88 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 18' ' ' LEU . 88.5 t -64.73 -41.6 92.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.516 -0.99 . . . . 0.0 109.792 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.82 -41.49 99.18 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 38.4 mt -66.73 -34.9 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.427 -1.043 . . . . 0.0 109.593 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -63.88 -27.04 68.88 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.291 -0.88 . . . . 0.0 109.606 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.41 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.6 OUTLIER -78.97 -21.7 46.72 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.455 -0.778 . . . . 0.0 109.125 178.254 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.588 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 6.5 tp -136.25 54.07 8.91 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.619 -0.675 . . . . 0.0 110.757 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.588 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.4 Cg_endo . . . . . 0 C--N 1.318 -1.033 0 O-C-N 123.263 1.139 . . . . 0.0 111.435 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.547 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.36 0.6 . . . . 0.0 109.611 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.57 -37.8 85.71 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.632 -0.667 . . . . 0.0 109.774 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.02 -41.02 91.52 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.537 -0.727 . . . . 0.0 109.946 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.84 -37.37 94.21 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 18' ' ' LEU . 94.3 t -61.71 -39.36 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.526 -0.984 . . . . 0.0 109.618 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.57 -49.16 66.2 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -65.08 -32.2 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.434 -1.039 . . . . 0.0 109.971 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -62.94 -27.0 69.08 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.148 -0.97 . . . . 0.0 109.631 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.487 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.8 OUTLIER -78.64 -26.54 45.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.41 -0.806 . . . . 0.0 108.927 178.238 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.554 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.7 OUTLIER -131.6 56.56 24.93 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.504 -0.747 . . . . 0.0 110.738 179.386 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.554 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.9 Cg_endo . . . . . 0 C--N 1.316 -1.14 0 C-N-CA 121.138 1.225 . . . . 0.0 111.129 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.0 tp . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.394 0.616 . . . . 0.0 109.649 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.78 -33.25 75.21 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.828 -0.545 . . . . 0.0 109.926 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.54 -43.09 67.06 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.481 -0.762 . . . . 0.0 110.135 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.48 -53.06 22.79 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 81.8 t -65.62 -36.83 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.435 -1.038 . . . . 0.0 110.132 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.07 -47.82 87.38 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.6 mm -65.46 -35.07 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.368 -1.078 . . . . 0.0 110.013 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.403 ' O ' ' HG3' ' A' ' 28' ' ' PRO . 16.1 t80 -64.11 -28.48 69.8 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.996 -1.065 . . . . 0.0 109.718 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.503 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.7 OUTLIER -78.9 -25.54 43.81 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.341 -0.849 . . . . 0.0 108.882 178.253 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.573 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.2 OUTLIER -131.31 55.27 17.77 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.594 -0.691 . . . . 0.0 110.854 179.677 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.573 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.9 Cg_endo . . . . . 0 C--N 1.319 -1.007 0 C-N-CA 121.013 1.142 . . . . 0.0 110.95 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.551 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.15 0.5 . . . . 0.0 109.823 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.96 -39.67 82.4 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.765 -0.584 . . . . 0.0 109.995 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.86 -40.64 97.04 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.52 -0.738 . . . . 0.0 109.671 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.34 -37.09 94.29 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 18' ' ' LEU . 76.4 t -61.83 -40.42 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.506 -0.997 . . . . 0.0 109.53 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.21 -45.15 95.92 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.2 mt -68.49 -32.36 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.377 -1.072 . . . . 0.0 109.657 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -61.41 -22.2 64.78 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.458 -0.776 . . . . 0.0 109.901 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.534 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.8 mm? -82.3 -25.05 34.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.399 -0.813 . . . . 0.0 109.487 178.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.629 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.6 OUTLIER -127.58 48.29 3.25 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.411 -0.806 . . . . 0.0 111.589 179.749 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.629 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 45.7 Cg_endo . . . . . 0 C--N 1.319 -0.976 0 O-C-N 122.862 0.928 . . . . 0.0 110.839 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.538 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.2 tt . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.322 0.582 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.49 -38.87 92.51 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.827 -0.546 . . . . 0.0 109.765 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.84 -40.23 96.09 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.6 -0.688 . . . . 0.0 109.724 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.77 -37.65 94.61 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 18' ' ' LEU . 95.5 t -62.97 -41.64 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.45 -1.029 . . . . 0.0 109.805 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.67 -41.84 98.9 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.4 mm -67.17 -34.9 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.409 -1.054 . . . . 0.0 109.692 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -63.44 -26.75 68.88 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.255 -0.903 . . . . 0.0 109.637 178.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.471 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.8 OUTLIER -79.06 -24.9 43.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.412 -0.805 . . . . 0.0 109.022 178.226 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.586 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 5.7 tp -132.65 54.35 13.47 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.518 -0.739 . . . . 0.0 110.946 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.586 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.9 Cg_endo . . . . . 0 C--N 1.319 -1.018 0 C-N-CA 120.936 1.091 . . . . 0.0 111.162 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.57 ' O ' HG23 ' A' ' 22' ' ' VAL . 1.3 tt . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.219 0.533 . . . . 0.0 109.894 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.26 -40.7 95.06 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.72 -0.612 . . . . 0.0 109.773 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.64 -39.92 95.36 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.629 -0.669 . . . . 0.0 109.78 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.42 -37.58 93.96 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 18' ' ' LEU . 87.7 t -61.62 -42.65 94.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.474 -1.016 . . . . 0.0 109.843 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.02 -41.83 99.79 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 30.3 mm -67.23 -36.57 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.455 -1.027 . . . . 0.0 109.761 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -63.08 -25.96 68.61 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.272 -0.893 . . . . 0.0 109.801 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.438 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 13.3 mt -81.44 -20.35 40.52 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.328 -0.858 . . . . 0.0 109.323 178.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.627 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 1.3 tp -135.99 51.86 5.82 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.412 -0.805 . . . . 0.0 110.902 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.627 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 44.7 Cg_endo . . . . . 0 C--N 1.32 -0.946 0 C-N-CA 121.113 1.209 . . . . 0.0 111.223 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.496 ' O ' HG23 ' A' ' 22' ' ' VAL . 1.3 tt . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.316 0.579 . . . . 0.0 109.747 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.14 -38.38 85.44 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.861 -0.524 . . . . 0.0 109.922 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.28 -43.11 98.86 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.531 -0.731 . . . . 0.0 109.928 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.57 -39.41 96.43 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 18' ' ' LEU . 98.7 t -64.35 -37.2 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.62 -0.93 . . . . 0.0 109.714 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.421 ' HA2' HD12 ' A' ' 26' ' ' LEU . . . -60.15 -46.97 93.27 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.37 -34.16 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.521 -0.988 . . . . 0.0 109.65 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -63.23 -26.15 68.65 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.084 -1.01 . . . . 0.0 109.64 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.448 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 14.8 mt -78.82 -23.78 44.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.293 -0.88 . . . . 0.0 108.909 178.123 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.56 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -134.59 56.2 17.02 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.553 -0.717 . . . . 0.0 110.681 179.311 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.56 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 40.1 Cg_endo . . . . . 0 C--N 1.318 -1.055 0 O-C-N 123.235 1.124 . . . . 0.0 111.024 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.57 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.5 tt . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 121.174 0.512 . . . . 0.0 109.74 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.79 -40.51 97.54 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.755 -0.591 . . . . 0.0 109.67 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.51 -38.84 90.88 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.501 -0.75 . . . . 0.0 109.475 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.483 ' HA2' HD12 ' A' ' 24' ' ' ILE . . . -62.42 -36.41 93.09 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.177 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 18' ' ' LEU . 87.4 t -62.76 -41.75 93.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.512 -0.993 . . . . 0.0 109.625 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.43 -42.0 99.67 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.483 HD12 ' HA2' ' A' ' 21' ' ' GLY . 22.3 mt -68.98 -32.18 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.545 -0.974 . . . . 0.0 109.555 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -63.46 -25.42 68.26 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.323 -0.86 . . . . 0.0 109.521 178.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.431 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.3 mp -78.61 -22.68 46.63 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.5 -0.75 . . . . 0.0 109.007 178.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.589 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 3.5 tp -135.28 53.98 9.9 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.603 -0.686 . . . . 0.0 110.78 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.589 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.6 Cg_endo . . . . . 0 C--N 1.318 -1.033 0 O-C-N 123.15 1.079 . . . . 0.0 110.86 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.557 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.065 0.459 . . . . 0.0 109.848 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.42 -45.6 93.03 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.648 -0.657 . . . . 0.0 109.5 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.73 -34.83 78.71 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.623 -0.673 . . . . 0.0 109.801 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.04 -40.12 95.04 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 18' ' ' LEU . 77.3 t -60.04 -42.54 90.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.491 -1.005 . . . . 0.0 109.736 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.61 -45.26 93.45 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.9 mt -66.54 -35.26 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.491 -1.006 . . . . 0.0 109.736 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -63.43 -26.61 68.81 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.152 -0.968 . . . . 0.0 109.585 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.475 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.4 mm? -78.86 -26.51 44.04 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 178.034 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.559 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.0 tp -132.23 56.26 22.28 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.587 -0.696 . . . . 0.0 110.707 179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.559 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.0 Cg_endo . . . . . 0 C--N 1.317 -1.093 0 O-C-N 123.323 1.17 . . . . 0.0 111.015 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.41 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 121.109 0.48 . . . . 0.0 109.848 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.54 -41.53 94.64 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.72 -0.612 . . . . 0.0 110.051 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.41 -38.24 89.36 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.55 -0.719 . . . . 0.0 109.827 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.6 -40.72 96.14 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 18' ' ' LEU . 69.9 t -62.94 -38.14 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.504 -0.997 . . . . 0.0 109.895 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.33 -48.09 87.68 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 28.9 mm -71.48 -35.81 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.486 -1.008 . . . . 0.0 109.587 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -65.01 -26.62 68.36 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.266 -0.896 . . . . 0.0 109.629 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.426 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 10.7 mt -79.32 -21.23 46.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 0.0 109.046 178.201 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.574 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 3.0 tp -135.86 54.3 9.81 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.603 -0.685 . . . . 0.0 110.698 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.574 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 40.7 Cg_endo . . . . . 0 C--N 1.317 -1.092 0 O-C-N 123.103 1.054 . . . . 0.0 111.183 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.562 ' O ' HG23 ' A' ' 22' ' ' VAL . 1.3 tt . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.264 0.554 . . . . 0.0 109.724 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.97 -41.16 99.45 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.69 -0.631 . . . . 0.0 109.688 179.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.64 -39.03 93.31 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.541 -0.724 . . . . 0.0 109.66 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.52 -37.16 93.39 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 18' ' ' LEU . 88.0 t -61.24 -41.02 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.408 -1.054 . . . . 0.0 109.576 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.453 ' HA2' HD12 ' A' ' 26' ' ' LEU . . . -64.71 -45.65 92.16 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.0 mt -68.14 -33.03 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.48 -1.012 . . . . 0.0 109.793 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -60.71 -23.46 64.91 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.304 -0.872 . . . . 0.0 109.821 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.453 HD12 ' HA2' ' A' ' 23' ' ' GLY . 12.3 mt -81.06 -17.4 50.26 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.328 -0.858 . . . . 0.0 109.638 178.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.636 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.4 tp -137.29 51.31 4.31 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.268 -0.895 . . . . 0.0 111.015 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.636 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 43.4 Cg_endo . . . . . 0 C--N 1.318 -1.03 0 O-C-N 123.16 1.084 . . . . 0.0 111.059 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.523 ' O ' HG23 ' A' ' 22' ' ' VAL . 1.9 tt . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.307 0.575 . . . . 0.0 109.658 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.86 -39.02 93.22 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.755 -0.59 . . . . 0.0 109.97 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.97 -41.05 97.57 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.603 -0.686 . . . . 0.0 109.813 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.35 -38.09 95.37 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 18' ' ' LEU . 95.5 t -63.2 -40.65 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.471 -1.017 . . . . 0.0 109.777 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.34 -41.41 98.16 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 29.9 mm -66.91 -36.36 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.382 -1.07 . . . . 0.0 109.697 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -64.58 -26.58 68.47 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.14 -0.975 . . . . 0.0 109.48 178.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.451 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.6 mm? -78.13 -24.76 47.26 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.406 -0.809 . . . . 0.0 108.872 177.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.561 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.3 tp -134.41 56.05 16.9 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.71 -0.619 . . . . 0.0 110.752 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.561 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.2 Cg_endo . . . . . 0 C--N 1.317 -1.126 0 C-N-CA 121.081 1.187 . . . . 0.0 111.139 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 121.313 0.577 . . . . 0.0 109.78 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.94 -36.94 75.71 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.79 -0.569 . . . . 0.0 109.92 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.44 -40.17 95.72 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.62 -0.675 . . . . 0.0 109.991 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.09 -45.21 88.74 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 179.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.3 t -65.52 -40.96 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.515 -0.991 . . . . 0.0 109.747 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.99 -48.83 80.84 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 23.8 mm -65.67 -34.97 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.406 -1.056 . . . . 0.0 109.71 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -62.29 -26.14 68.24 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.221 -0.925 . . . . 0.0 109.66 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.495 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 16.9 mt -79.58 -25.61 41.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.357 -0.84 . . . . 0.0 109.114 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.591 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 3.8 tp -131.52 53.54 11.88 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.453 -0.779 . . . . 0.0 110.921 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.591 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.5 Cg_endo . . . . . 0 C--N 1.319 -1.016 0 C-N-CA 120.96 1.107 . . . . 0.0 110.749 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.474 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.285 0.564 . . . . 0.0 109.811 . . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.68 -40.54 92.5 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.668 -0.645 . . . . 0.0 110.178 179.537 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.19 -42.05 99.28 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.522 -0.736 . . . . 0.0 109.695 179.374 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.38 -38.5 96.38 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.288 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 18' ' ' LEU . 89.9 t -62.95 -41.41 92.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.535 -0.979 . . . . 0.0 109.841 179.5 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.96 -42.24 99.67 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.338 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.9 mt -67.67 -35.26 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.576 -0.955 . . . . 0.0 109.53 179.06 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 92.7 t80 -63.9 -22.46 66.93 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.354 -0.841 . . . . 0.0 110.006 178.916 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.538 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -83.77 -25.05 30.8 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.426 -0.796 . . . . 0.0 109.505 178.75 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.68 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.9 tp -125.65 44.75 1.22 Allowed Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.39 -0.819 . . . . 0.0 111.92 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.68 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 44.3 Cg_endo . . . . . 0 C--N 1.322 -0.831 0 O-C-N 122.868 0.931 . . . . 0.0 110.077 179.437 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.258 0.551 . . . . 0.0 109.56 . . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.09 -39.88 95.03 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.679 -0.638 . . . . 0.0 109.732 179.17 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.55 -38.66 91.97 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.519 -0.738 . . . . 0.0 109.712 179.151 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.38 -37.48 90.43 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 179.292 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 18' ' ' LEU . 71.7 t -61.06 -39.21 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.307 -1.114 . . . . 0.0 109.534 179.242 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.439 ' HA2' HD12 ' A' ' 26' ' ' LEU . . . -66.0 -47.28 75.26 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.399 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 tp -68.0 -29.01 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.406 -1.055 . . . . 0.0 110.008 179.514 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -64.23 -21.63 66.65 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.288 -0.883 . . . . 0.0 109.81 178.703 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.469 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 12.6 mt -83.98 -21.3 31.78 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.323 -0.86 . . . . 0.0 109.685 178.891 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.674 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 5.5 tp -130.38 45.59 1.83 Allowed Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.322 -0.861 . . . . 0.0 111.668 179.772 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.674 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 47.1 Cg_endo . . . . . 0 C--N 1.322 -0.828 0 O-C-N 122.946 0.972 . . . . 0.0 110.239 179.434 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.7 tt . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 121.385 0.612 . . . . 0.0 109.632 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.73 -35.43 72.68 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.733 -0.605 . . . . 0.0 109.956 179.275 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.77 -39.19 87.76 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.524 -0.735 . . . . 0.0 110.231 179.696 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.4 -47.59 82.78 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.566 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 88.2 t -65.72 -39.76 85.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.586 -0.95 . . . . 0.0 109.7 179.324 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.78 -44.7 94.4 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.615 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 26.3 mt -65.17 -36.82 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.361 -1.082 . . . . 0.0 109.955 179.582 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -64.54 -26.27 68.35 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.137 -0.977 . . . . 0.0 109.599 178.898 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.488 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.4 mm? -78.32 -26.64 46.94 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.002 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.565 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 5.9 tp -131.74 55.81 20.46 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.549 -0.719 . . . . 0.0 110.874 179.579 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.565 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.9 Cg_endo . . . . . 0 C--N 1.318 -1.044 0 C-N-CA 121.038 1.158 . . . . 0.0 111.049 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.543 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.8 tt . . . . . 0 N--CA 1.494 1.766 0 CA-C-O 121.249 0.547 . . . . 0.0 109.58 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.6 -38.75 90.36 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.792 -0.568 . . . . 0.0 109.797 179.118 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.8 -38.44 91.09 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.528 -0.733 . . . . 0.0 109.851 179.224 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.42 -38.15 93.3 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.299 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 18' ' ' LEU . 94.2 t -60.99 -44.17 97.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.473 -1.016 . . . . 0.0 109.677 179.403 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.91 -44.48 95.99 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.347 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 67.5 mt -65.93 -35.06 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.461 -1.023 . . . . 0.0 109.735 179.41 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -62.61 -26.76 68.78 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.215 -0.928 . . . . 0.0 109.524 178.744 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.438 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 6.1 mt -78.81 -23.6 45.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.385 -0.822 . . . . 0.0 108.98 178.206 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.571 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.5 tp -134.85 56.54 17.43 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.444 -0.785 . . . . 0.0 110.633 179.34 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.571 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.9 Cg_endo . . . . . 0 C--N 1.316 -1.133 0 C-N-CA 121.084 1.189 . . . . 0.0 111.202 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.602 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 121.119 0.485 . . . . 0.0 109.999 . . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.84 -41.73 96.41 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.703 -0.623 . . . . 0.0 110.015 179.392 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.29 95.07 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.532 -0.73 . . . . 0.0 109.686 179.21 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.28 -37.58 94.71 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.338 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 18' ' ' LEU . 76.8 t -62.34 -41.8 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.416 -1.05 . . . . 0.0 109.724 179.415 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.75 -41.44 98.92 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.317 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 51.0 mt -66.59 -37.88 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.389 -1.065 . . . . 0.0 109.71 179.501 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -64.2 -26.19 68.4 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.182 -0.948 . . . . 0.0 109.646 178.988 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.47 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.5 mm? -79.08 -25.25 43.1 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.98 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.571 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 3.5 tp -133.05 55.04 15.1 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.662 -0.649 . . . . 0.0 110.863 179.678 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.571 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.2 Cg_endo . . . . . 0 C--N 1.319 -1.023 0 C-N-CA 120.963 1.109 . . . . 0.0 111.063 -179.932 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.524 ' O ' HG23 ' A' ' 22' ' ' VAL . 7.5 tp . . . . . 0 N--CA 1.493 1.704 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.1 -39.69 95.43 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.865 -0.522 . . . . 0.0 109.652 179.112 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.06 -39.86 90.44 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.626 -0.671 . . . . 0.0 109.729 179.221 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.42 -40.12 98.5 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.417 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 18' ' ' LEU . 98.7 t -63.24 -37.36 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.486 -1.008 . . . . 0.0 109.684 179.336 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.51 -46.94 92.48 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.371 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.7 mt -76.7 -27.68 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.381 -1.07 . . . . 0.0 109.812 179.204 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -60.94 -23.63 65.44 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.035 -1.041 . . . . 0.0 109.696 178.966 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.483 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.9 mm? -79.47 -24.37 42.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.256 -0.903 . . . . 0.0 109.177 178.476 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.59 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.5 tp -132.15 53.73 12.1 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.48 -0.762 . . . . 0.0 110.961 179.718 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.59 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.3 Cg_endo . . . . . 0 C--N 1.318 -1.065 0 C-N-CA 120.947 1.098 . . . . 0.0 111.005 -179.875 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.543 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.6 tt . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 121.342 0.592 . . . . 0.0 109.63 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.36 -37.84 86.23 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.747 -0.595 . . . . 0.0 109.894 179.327 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.89 -42.21 99.69 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.612 -0.68 . . . . 0.0 109.97 179.462 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.31 -38.87 96.95 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.441 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 18' ' ' LEU . 91.2 t -64.2 -40.67 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.49 -1.006 . . . . 0.0 109.757 179.506 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.54 -42.04 99.01 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.51 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.2 mt -65.66 -36.67 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.423 -1.046 . . . . 0.0 109.821 179.527 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -64.93 -26.53 68.35 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.216 -0.927 . . . . 0.0 109.681 178.889 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.499 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.9 mm? -80.0 -24.76 40.64 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.367 -0.833 . . . . 0.0 108.99 178.29 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.596 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 1.2 tp -131.93 53.43 11.38 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.558 -0.714 . . . . 0.0 111.032 179.736 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.596 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 43.4 Cg_endo . . . . . 0 C--N 1.318 -1.035 0 C-N-CA 121.002 1.134 . . . . 0.0 111.144 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.543 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.5 tt . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 121.238 0.542 . . . . 0.0 109.65 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.67 -39.56 93.89 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.799 -0.563 . . . . 0.0 109.807 179.284 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.75 -39.95 95.75 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.635 -0.666 . . . . 0.0 109.897 179.391 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.55 -37.42 94.39 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.398 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 18' ' ' LEU . 90.4 t -63.07 -41.35 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.53 -0.982 . . . . 0.0 109.685 179.471 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.31 -42.66 97.69 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.398 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.4 mt -66.36 -36.27 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.413 -1.051 . . . . 0.0 109.809 179.45 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -63.76 -27.59 69.3 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.32 -0.862 . . . . 0.0 109.8 179.085 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.481 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 3.8 mt -81.25 -21.65 39.3 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.425 -0.797 . . . . 0.0 109.16 178.306 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.628 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.1 OUTLIER -133.18 51.98 7.85 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.524 -0.735 . . . . 0.0 110.896 179.82 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.628 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 45.7 Cg_endo . . . . . 0 C--N 1.32 -0.936 0 C-N-CA 121.101 1.201 . . . . 0.0 111.329 -179.742 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.5 tp . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 121.425 0.631 . . . . 0.0 109.706 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.23 -35.42 77.91 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.819 -0.551 . . . . 0.0 109.943 179.198 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.94 -40.02 87.45 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.55 -0.719 . . . . 0.0 110.283 179.589 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.36 -46.64 90.02 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.577 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 76.5 t -66.06 -40.88 88.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.557 -0.966 . . . . 0.0 109.665 179.363 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.17 -47.14 88.13 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.59 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 35.2 mt -64.48 -33.72 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.435 -1.038 . . . . 0.0 109.885 179.542 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -63.65 -27.22 69.07 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.031 -1.043 . . . . 0.0 109.678 178.87 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.483 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.7 OUTLIER -79.14 -25.25 42.92 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.446 -0.784 . . . . 0.0 108.94 178.229 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.566 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.5 tp -132.95 56.63 23.09 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.539 -0.725 . . . . 0.0 110.714 179.498 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.566 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.5 Cg_endo . . . . . 0 C--N 1.318 -1.048 0 C-N-CA 121.143 1.229 . . . . 0.0 111.496 -179.837 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.522 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.1 tt . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 121.324 0.583 . . . . 0.0 109.5 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.34 -37.92 89.19 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.851 -0.531 . . . . 0.0 109.704 179.207 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.5 -40.04 96.02 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.575 -0.703 . . . . 0.0 109.905 179.249 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.6 -36.98 93.81 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.384 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 18' ' ' LEU . 95.5 t -63.81 -41.41 92.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.55 -0.97 . . . . 0.0 109.751 179.478 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.17 -41.45 98.37 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.372 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 29.8 mm -66.52 -34.86 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.467 -1.019 . . . . 0.0 109.779 179.293 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -63.49 -26.13 68.58 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.277 -0.889 . . . . 0.0 109.654 178.76 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.482 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.9 OUTLIER -79.84 -24.73 41.11 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.356 -0.84 . . . . 0.0 109.037 178.237 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.602 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 14.6 tp -132.13 53.21 10.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.499 -0.751 . . . . 0.0 110.97 179.583 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.602 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.2 Cg_endo . . . . . 0 C--N 1.32 -0.93 0 O-C-N 123.183 1.096 . . . . 0.0 111.005 179.893 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.544 ' O ' HG23 ' A' ' 22' ' ' VAL . 4.6 tp . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.211 0.529 . . . . 0.0 109.903 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.71 -42.63 97.6 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.76 -0.588 . . . . 0.0 109.964 179.511 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.87 -39.83 95.13 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.53 -0.731 . . . . 0.0 109.928 179.235 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.56 -39.35 93.88 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.506 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 18' ' ' LEU . 78.8 t -60.89 -43.37 95.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.503 -0.998 . . . . 0.0 109.996 179.619 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.42 -43.92 98.37 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.496 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.7 mt -66.46 -37.08 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.46 -1.023 . . . . 0.0 109.753 179.446 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -62.45 -26.24 68.41 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.293 -0.879 . . . . 0.0 109.982 179.213 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.482 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 13.4 mt -81.61 -22.43 37.66 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.355 -0.841 . . . . 0.0 109.224 178.349 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.622 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.1 OUTLIER -132.5 51.75 7.73 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.581 -0.699 . . . . 0.0 110.812 179.731 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.622 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.9 Cg_endo . . . . . 0 C--N 1.32 -0.943 0 O-C-N 123.048 1.025 . . . . 0.0 110.822 -179.997 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.517 ' O ' HG23 ' A' ' 22' ' ' VAL . 5.3 tp . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 121.24 0.543 . . . . 0.0 109.61 . . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.47 -41.79 94.92 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.809 -0.557 . . . . 0.0 109.73 179.258 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.78 -40.99 92.53 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.539 -0.726 . . . . 0.0 109.815 179.121 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.409 ' HA2' HD12 ' A' ' 24' ' ' ILE . . . -61.63 -41.09 99.52 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 179.38 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 18' ' ' LEU . 95.5 t -62.76 -40.03 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.568 -0.96 . . . . 0.0 109.801 179.418 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.456 ' HA2' HD12 ' A' ' 26' ' ' LEU . . . -59.69 -42.89 98.1 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.39 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.409 HD12 ' HA2' ' A' ' 21' ' ' GLY . 18.2 mt -68.61 -35.38 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.474 -1.015 . . . . 0.0 109.592 179.26 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -62.97 -27.03 69.12 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.204 -0.935 . . . . 0.0 109.613 178.824 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.456 HD12 ' HA2' ' A' ' 23' ' ' GLY . 13.5 mt -79.18 -18.27 53.36 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.379 -0.826 . . . . 0.0 109.314 178.359 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.588 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.9 tp -140.52 55.09 5.56 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.574 -0.704 . . . . 0.0 110.577 179.643 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.588 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.7 Cg_endo . . . . . 0 C--N 1.319 -1.021 0 C-N-CA 121.106 1.204 . . . . 0.0 111.377 -179.582 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.0 tp . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.263 0.554 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.87 -40.44 97.5 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.734 -0.604 . . . . 0.0 109.834 179.305 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.65 -37.39 87.17 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.629 -0.669 . . . . 0.0 109.884 179.311 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.98 -40.68 93.43 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.453 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.7 t -60.49 -42.24 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.505 -0.997 . . . . 0.0 109.802 179.496 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.21 -44.18 95.98 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.368 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.5 mt -65.22 -34.53 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.447 -1.031 . . . . 0.0 109.775 179.434 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -62.94 -27.23 69.24 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.148 -0.97 . . . . 0.0 109.497 178.754 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.1 mt -79.56 -17.7 53.37 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.428 -0.795 . . . . 0.0 109.353 178.303 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.605 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.7 tp -141.44 54.9 4.6 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.57 -0.706 . . . . 0.0 110.5 179.495 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.605 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.1 Cg_endo . . . . . 0 C--N 1.319 -0.999 0 C-N-CA 121.242 1.294 . . . . 0.0 111.249 -179.836 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.506 ' O ' HG23 ' A' ' 22' ' ' VAL . 9.0 tp . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.347 0.594 . . . . 0.0 109.453 . . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.63 -38.77 92.13 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.841 -0.537 . . . . 0.0 109.796 179.09 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.38 -38.67 91.85 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.587 -0.696 . . . . 0.0 110.054 179.398 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.69 -40.63 94.0 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.595 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 18' ' ' LEU . 99.3 t -61.54 -42.15 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.458 -1.025 . . . . 0.0 109.828 179.577 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.97 -45.53 92.05 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.528 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.2 mt -65.77 -35.14 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.422 -1.046 . . . . 0.0 109.717 179.478 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -63.7 -25.91 68.42 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.315 -0.865 . . . . 0.0 109.498 178.75 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.483 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.3 mm? -79.05 -27.11 43.11 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.203 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.57 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 8.8 tp -131.16 55.46 19.03 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.576 -0.703 . . . . 0.0 110.849 179.518 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.57 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 39.9 Cg_endo . . . . . 0 C--N 1.318 -1.053 0 O-C-N 123.217 1.114 . . . . 0.0 110.561 179.647 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.7 tt . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.497 0.665 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.24 -35.06 78.78 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.849 -0.532 . . . . 0.0 110.376 179.613 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.36 -41.79 97.65 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.417 -0.802 . . . . 0.0 110.223 179.735 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.36 -46.92 66.48 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.632 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 77.9 t -64.61 -37.85 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.546 -0.973 . . . . 0.0 110.036 179.607 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.96 -46.97 92.99 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.704 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.3 mt -65.4 -35.14 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.384 -1.068 . . . . 0.0 109.925 179.605 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -64.99 -27.71 69.01 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.064 -1.022 . . . . 0.0 109.599 178.867 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.501 HD13 ' HA ' ' A' ' 26' ' ' LEU . 1.7 mm? -77.86 -25.34 48.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.321 -0.862 . . . . 0.0 108.689 178.016 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.544 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 5.6 tp -133.59 57.06 23.39 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.617 -0.677 . . . . 0.0 110.468 179.488 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.544 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 39.6 Cg_endo . . . . . 0 C--N 1.318 -1.076 0 C-N-CA 121.111 1.207 . . . . 0.0 111.212 -179.666 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.586 ' O ' HG23 ' A' ' 22' ' ' VAL . 6.9 tp . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.16 0.505 . . . . 0.0 109.956 . . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.37 -46.26 89.16 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.814 -0.554 . . . . 0.0 109.823 179.352 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.93 -37.53 84.49 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.537 -0.727 . . . . 0.0 109.782 179.199 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.9 -39.01 96.96 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.469 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 18' ' ' LEU . 84.1 t -60.35 -44.7 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.491 -1.005 . . . . 0.0 109.668 179.566 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.51 -41.93 99.74 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.411 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 31.1 mt -66.89 -35.35 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.449 -1.03 . . . . 0.0 109.801 179.469 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -62.49 -27.95 69.49 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.161 -0.962 . . . . 0.0 109.663 178.924 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.4 mt -80.6 -17.62 50.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.428 -0.795 . . . . 0.0 109.248 178.293 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.641 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -138.88 51.78 3.77 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.553 -0.717 . . . . 0.0 110.732 179.771 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.641 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 47.3 Cg_endo . . . . . 0 C--N 1.32 -0.936 0 C-N-CA 121.126 1.217 . . . . 0.0 111.145 -179.663 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.545 ' O ' HG23 ' A' ' 22' ' ' VAL . 3.5 tt . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.362 0.601 . . . . 0.0 109.527 . . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.59 -39.56 91.72 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.655 -0.653 . . . . 0.0 109.696 179.061 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.09 -39.55 94.3 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.627 -0.671 . . . . 0.0 109.974 179.304 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.98 -37.91 94.84 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.441 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 18' ' ' LEU . 84.5 t -60.63 -43.29 94.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.512 -0.993 . . . . 0.0 109.76 179.621 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.11 -42.74 97.96 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.215 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 29.2 mm -68.03 -35.46 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.399 -1.06 . . . . 0.0 109.769 179.375 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -62.44 -25.91 68.22 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.259 -0.9 . . . . 0.0 109.571 178.845 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.459 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 8.4 mt -79.4 -24.41 42.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.311 -0.868 . . . . 0.0 108.9 178.27 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.572 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.8 tp -133.65 55.32 15.52 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.609 -0.682 . . . . 0.0 110.716 179.38 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.572 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.6 Cg_endo . . . . . 0 C--N 1.318 -1.032 0 C-N-CA 121.022 1.148 . . . . 0.0 110.994 179.904 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.53 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 121.294 0.569 . . . . 0.0 109.515 . . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.94 -39.04 93.24 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.773 -0.579 . . . . 0.0 109.885 179.153 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.67 -41.75 98.15 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.554 -0.716 . . . . 0.0 109.763 179.255 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.425 ' HA2' HD12 ' A' ' 24' ' ' ILE . . . -62.16 -38.86 96.86 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.32 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 18' ' ' LEU . 90.0 t -62.43 -43.2 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.552 -0.969 . . . . 0.0 109.797 179.433 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.446 ' HA2' HD12 ' A' ' 26' ' ' LEU . . . -62.43 -41.28 99.78 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.584 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.425 HD12 ' HA2' ' A' ' 21' ' ' GLY . 29.2 mt -66.64 -37.31 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.425 -1.044 . . . . 0.0 109.688 179.582 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -62.98 -26.68 68.96 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.216 -0.927 . . . . 0.0 109.666 178.948 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.446 HD12 ' HA2' ' A' ' 23' ' ' GLY . 11.7 mt -80.06 -17.31 53.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.371 -0.83 . . . . 0.0 109.429 178.373 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.612 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -140.26 53.5 4.3 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.539 -0.726 . . . . 0.0 110.648 179.561 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.612 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.7 Cg_endo . . . . . 0 C--N 1.318 -1.072 0 C-N-CA 121.03 1.153 . . . . 0.0 111.11 -179.689 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.8 tp . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 121.375 0.607 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.43 -37.86 89.0 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.808 -0.558 . . . . 0.0 109.945 179.285 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.38 -40.09 96.29 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.621 -0.675 . . . . 0.0 110.1 179.482 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.12 -42.19 94.6 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.624 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 73.2 t -62.32 -40.0 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.45 -1.03 . . . . 0.0 109.972 179.567 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.469 ' HA2' HD12 ' A' ' 26' ' ' LEU . . . -64.12 -44.74 95.3 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.567 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.3 mt -64.8 -35.58 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.358 -1.083 . . . . 0.0 109.784 179.543 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -63.69 -26.54 68.71 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.127 -0.983 . . . . 0.0 109.671 178.775 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.469 HD12 ' HA2' ' A' ' 23' ' ' GLY . 14.9 mt -79.18 -24.2 43.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.401 -0.812 . . . . 0.0 108.862 178.19 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.553 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.3 OUTLIER -133.72 56.31 19.6 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.579 -0.701 . . . . 0.0 110.558 179.411 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.553 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 40.3 Cg_endo . . . . . 0 C--N 1.318 -1.042 0 O-C-N 123.346 1.182 . . . . 0.0 111.143 -179.821 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.504 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 121.283 0.563 . . . . 0.0 109.604 . . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.14 -38.99 92.36 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.747 -0.596 . . . . 0.0 109.98 179.295 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.538 ' O ' HD12 ' A' ' 24' ' ' ILE . . . -64.39 -43.22 95.13 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.587 -0.696 . . . . 0.0 109.758 179.359 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.12 -40.03 96.62 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.231 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 18' ' ' LEU . 94.9 t -63.89 -37.8 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.529 -0.983 . . . . 0.0 109.71 179.244 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.407 ' HA2' HD12 ' A' ' 26' ' ' LEU . . . -60.06 -46.12 94.75 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.415 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.538 HD12 ' O ' ' A' ' 20' ' ' ALA . 1.2 mp -67.18 -34.48 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.447 -1.031 . . . . 0.0 109.561 179.325 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -63.48 -25.99 68.52 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.15 -0.969 . . . . 0.0 109.575 178.842 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.407 HD12 ' HA2' ' A' ' 23' ' ' GLY . 13.6 mt -80.09 -19.43 47.44 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.353 -0.842 . . . . 0.0 109.266 178.273 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.596 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 10.9 tp -138.54 53.95 6.24 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.54 -0.725 . . . . 0.0 110.623 179.438 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.596 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 40.9 Cg_endo . . . . . 0 C--N 1.319 -1.003 0 O-C-N 123.232 1.122 . . . . 0.0 110.967 -179.975 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.524 ' O ' HG23 ' A' ' 22' ' ' VAL . 3.4 tt . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 121.226 0.536 . . . . 0.0 109.688 . . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.16 -38.04 84.79 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.791 -0.568 . . . . 0.0 109.682 179.088 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.65 -39.16 91.1 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.636 -0.665 . . . . 0.0 110.0 179.337 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.1 -39.74 97.46 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.43 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 18' ' ' LEU . 92.3 t -62.22 -43.47 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.497 -1.002 . . . . 0.0 109.608 179.548 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.57 -44.39 92.89 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.411 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.4 mt -65.56 -35.02 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.455 -1.026 . . . . 0.0 109.721 179.411 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -64.1 -27.06 68.84 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.112 -0.992 . . . . 0.0 109.388 178.737 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.465 ' HA ' HD13 ' A' ' 26' ' ' LEU . 1.5 mm? -77.92 -24.88 48.15 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.097 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.549 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 3.4 tp -134.63 57.09 20.23 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.559 -0.713 . . . . 0.0 110.643 179.512 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.549 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.2 Cg_endo . . . . . 0 C--N 1.316 -1.137 0 O-C-N 123.225 1.118 . . . . 0.0 111.121 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 121.012 0.434 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.5 m -110.99 51.25 0.78 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.405 -0.81 . . . . 0.0 110.13 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.453 ' O ' HG12 ' A' ' 3' ' ' VAL . 25.7 t 56.35 49.26 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 CA-C-O 121.471 0.653 . . . . 0.0 110.486 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.4 -36.02 15.71 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.244 -0.91 . . . . 0.0 110.176 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -113.74 31.24 6.66 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.791 -0.568 . . . . 0.0 110.011 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.52 45.91 1.39 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.537 -0.727 . . . . 0.0 110.165 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.2 mmm-85 -97.69 118.49 64.06 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.277 -0.889 . . . . 0.0 109.882 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -72.17 -84.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.238 0 O-C-N 123.908 1.478 . . . . 0.0 110.88 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.419 ' HA ' ' HD1' ' A' ' 12' ' ' TRP . 4.3 mtt180 -140.72 28.71 1.95 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.898 -1.126 . . . . 0.0 110.84 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 49.6 t90 -59.73 -45.31 92.57 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.378 -0.826 . . . . 0.0 109.836 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -86.64 -12.34 48.76 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.568 -0.708 . . . . 0.0 110.543 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.419 ' HD1' ' HA ' ' A' ' 9' ' ' ARG . 82.8 m95 -98.74 13.61 31.64 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.114 -0.991 . . . . 0.0 111.347 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -60.64 -51.35 69.77 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.279 -0.888 . . . . 0.0 109.945 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.8 t -61.16 -33.77 73.96 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.439 0.638 . . . . 0.0 109.469 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.01 -40.98 87.43 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.5 tt -64.44 -40.46 95.78 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.599 -0.688 . . . . 0.0 110.008 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.14 -32.02 72.57 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.481 0.658 . . . . 0.0 109.592 179.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.539 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.8 tp -74.95 -37.01 62.08 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.827 -0.546 . . . . 0.0 109.746 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.7 96.45 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.848 -0.532 . . . . 0.0 109.764 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.98 -39.16 93.89 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.579 -0.701 . . . . 0.0 109.738 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.97 -38.38 95.41 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 18' ' ' LEU . 84.6 t -62.29 -41.29 91.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.498 -1.001 . . . . 0.0 109.827 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.99 -42.01 98.4 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 28.5 mm -66.88 -35.56 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.472 -1.016 . . . . 0.0 109.697 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -64.32 -26.98 68.72 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.275 -0.89 . . . . 0.0 109.513 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.483 ' HA ' HD13 ' A' ' 26' ' ' LEU . 1.9 mm? -78.46 -24.49 45.96 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.373 -0.829 . . . . 0.0 108.878 178.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.573 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 1.4 tp -134.44 56.03 16.78 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.581 -0.699 . . . . 0.0 110.763 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.573 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 43.4 Cg_endo -91.95 -19.75 0.71 Allowed 'Trans proline' 0 C--N 1.319 -1.021 0 C-N-CA 121.096 1.197 . . . . 0.0 111.408 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -103.59 -3.97 24.5 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.26 -0.9 . . . . 0.0 111.203 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.9 0 CA-C-O 117.88 -1.057 . . . . 0.0 110.243 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 72.7 t60 . . . . . 0 N--CA 1.495 1.808 0 CA-C-O 121.117 0.484 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.0 m -136.6 47.52 2.17 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.553 -0.717 . . . . 0.0 110.426 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.6 t -116.9 30.32 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.385 -0.822 . . . . 0.0 110.298 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.1 t -75.89 -20.87 57.69 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.118 -0.989 . . . . 0.0 110.968 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.41 31.32 3.76 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.421 -0.799 . . . . 0.0 110.533 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 51.72 37.38 20.08 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.463 -0.773 . . . . 0.0 110.913 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.2 mtm180 -116.6 86.96 19.57 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.414 -0.804 . . . . 0.0 109.694 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.69 137.91 20.78 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 123.846 1.445 . . . . 0.0 111.075 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.59 ' HA ' ' HB3' ' A' ' 12' ' ' TRP . 2.1 ttt-85 -145.39 -48.5 0.23 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.754 -0.591 . . . . 0.0 110.008 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -46.45 -47.47 19.13 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.701 -0.624 . . . . 0.0 110.443 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -95.71 -29.2 14.41 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.507 -0.745 . . . . 0.0 110.086 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.59 ' HB3' ' HA ' ' A' ' 9' ' ' ARG . 75.3 t-105 -59.28 -30.55 68.39 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.441 -0.787 . . . . 0.0 110.68 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -58.13 -37.39 74.5 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.641 -0.662 . . . . 0.0 109.743 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.4 t -66.2 -36.51 83.25 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.448 HD22 ' CZ3' ' A' ' 12' ' ' TRP . 6.7 tt -66.94 -43.07 84.15 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 tt -64.74 -36.92 85.84 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.487 -0.758 . . . . 0.0 109.684 179.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.22 -32.26 73.78 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.618 0.723 . . . . 0.0 109.509 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.464 HD22 ' HA ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -84.78 -33.9 22.9 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.307 0.575 . . . . 0.0 109.624 179.025 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.8 -37.96 86.32 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.792 -0.567 . . . . 0.0 110.334 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.07 -40.56 96.21 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.455 -0.778 . . . . 0.0 109.965 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.48 -38.65 90.97 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 77.2 t -61.07 -41.23 88.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.474 -1.015 . . . . 0.0 109.939 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.32 -43.51 98.3 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 34.1 mm -67.48 -35.72 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.382 -1.069 . . . . 0.0 109.663 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -63.72 -25.67 68.31 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.217 -0.927 . . . . 0.0 109.645 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.494 ' HA ' HD13 ' A' ' 26' ' ' LEU . 1.6 mm? -80.07 -25.71 39.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.354 -0.841 . . . . 0.0 108.988 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.599 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 4.1 tp -131.28 52.76 10.01 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.467 -0.771 . . . . 0.0 111.126 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.599 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 43.0 Cg_endo -90.14 -20.88 1.02 Allowed 'Trans proline' 0 C--N 1.319 -1.024 0 C-N-CA 120.895 1.064 . . . . 0.0 110.895 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -80.99 -36.54 30.56 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.432 -0.792 . . . . 0.0 110.338 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.19 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.667 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 120.735 0.303 . . . . 0.0 110.27 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.606 ' O ' HG12 ' A' ' 3' ' ' VAL . 1.3 t 62.84 82.59 0.18 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.588 -0.695 . . . . 0.0 109.834 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.606 HG12 ' O ' ' A' ' 2' ' ' SER . 0.4 OUTLIER 60.63 19.45 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 CA-C-O 121.19 0.519 . . . . 0.0 111.008 -179.266 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.6 t -79.45 -38.39 34.74 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.989 -1.07 . . . . 0.0 110.423 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -153.39 26.02 0.52 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.62 -0.675 . . . . 0.0 111.137 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 46.8 48.11 14.97 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.444 -0.785 . . . . 0.0 110.679 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.655 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 6.5 mtt180 -76.32 -54.08 2.0 Allowed Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 121.497 -0.752 . . . . 0.0 110.99 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.655 ' HD3' ' HB2' ' A' ' 7' ' ' ARG . 53.9 Cg_endo -82.91 166.81 14.76 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 O-C-N 123.394 1.208 . . . . 0.0 110.616 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.6 ttm-85 63.48 7.73 3.16 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.826 -0.546 . . . . 0.0 111.924 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.447 ' CE3' ' HA ' ' A' ' 10' ' ' TRP . 6.1 t-105 -101.06 -47.64 4.69 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.973 -1.079 . . . . 0.0 109.73 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -78.06 -20.0 53.17 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.552 -0.717 . . . . 0.0 110.274 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 21.8 m95 -58.26 -28.3 64.81 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.358 -0.839 . . . . 0.0 110.832 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -60.72 -45.24 94.98 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.474 -0.766 . . . . 0.0 109.493 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.9 t -66.56 -36.37 82.48 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.07 -42.81 88.9 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 tt -61.14 -41.49 96.85 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.798 -0.564 . . . . 0.0 109.941 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 tt -60.69 -35.56 76.59 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.382 0.61 . . . . 0.0 109.6 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 tt -73.72 -34.54 64.84 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.21 0.529 . . . . 0.0 109.945 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.8 -35.64 81.26 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.742 -0.599 . . . . 0.0 109.965 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.62 -42.19 64.72 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.504 -0.748 . . . . 0.0 109.979 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.6 -52.26 31.18 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 73.2 t -63.93 -35.25 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.482 -1.011 . . . . 0.0 110.015 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.58 -47.86 89.09 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.6 mt -68.02 -34.79 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.433 -1.04 . . . . 0.0 109.789 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -64.32 -25.08 67.88 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.163 -0.96 . . . . 0.0 109.769 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.511 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.2 mm? -80.81 -26.48 37.07 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.378 -0.826 . . . . 0.0 108.919 178.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.605 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 4.7 tp -130.14 52.0 8.58 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.591 -0.693 . . . . 0.0 111.215 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.605 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.7 Cg_endo -89.03 -33.81 0.1 Allowed 'Trans proline' 0 C--N 1.319 -0.977 0 O-C-N 123.095 1.05 . . . . 0.0 110.787 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -109.14 5.59 24.08 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.398 -0.814 . . . . 0.0 110.691 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.8 mtp85 . . . . . 0 N--CA 1.496 1.838 0 O-C-N 121.218 -0.926 . . . . 0.0 110.436 179.845 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.5 m80 . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 121.031 0.443 . . . . 0.0 110.368 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.3 p -153.92 43.19 0.55 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.552 -0.717 . . . . 0.0 110.69 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.4 t -120.34 46.21 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.209 -0.932 . . . . 0.0 110.064 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.45 -41.29 20.01 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.188 -0.945 . . . . 0.0 110.347 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -140.0 28.93 2.09 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.78 -0.575 . . . . 0.0 110.388 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.411 ' O ' ' CB ' ' A' ' 7' ' ' ARG . . . 51.59 39.83 25.8 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.543 -0.723 . . . . 0.0 110.784 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.411 ' CB ' ' O ' ' A' ' 6' ' ' ALA . 1.6 ttp180 69.45 123.11 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.166 0 O-C-N 121.903 -0.498 . . . . 0.0 110.393 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.67 -28.28 21.06 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 O-C-N 123.64 1.337 . . . . 0.0 110.701 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.6 ttt85 -159.58 -162.26 1.01 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.505 -0.747 . . . . 0.0 109.373 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 52.41 32.97 12.1 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.399 -0.813 . . . . 0.0 110.431 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -174.01 -42.42 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.637 -0.664 . . . . 0.0 109.894 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 27.4 m95 -59.4 -19.72 49.3 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.672 -0.642 . . . . 0.0 111.697 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.04 -37.14 76.28 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.216 -0.928 . . . . 0.0 109.983 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 39.4 m -65.25 -36.7 84.92 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.552 HD13 ' C ' ' A' ' 15' ' ' LEU . 3.4 tm? -65.34 -40.91 94.25 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.489 ' C ' HD13 ' A' ' 16' ' ' LEU . 3.1 tm? -63.84 -39.58 94.55 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.609 -0.682 . . . . 0.0 109.719 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 tp -61.55 -33.42 73.81 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.488 0.661 . . . . 0.0 109.582 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.8 tp -75.03 -31.59 61.38 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.872 -0.517 . . . . 0.0 109.96 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.7 -41.49 95.3 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.725 -0.609 . . . . 0.0 109.999 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.56 -39.25 93.06 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.486 -0.759 . . . . 0.0 109.912 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.88 -39.14 94.87 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.6 t -62.01 -40.34 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.453 -1.027 . . . . 0.0 109.832 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.62 -46.75 91.44 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 37.9 mm -66.56 -33.89 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.54 -0.977 . . . . 0.0 109.578 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -62.5 -25.16 67.86 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.357 -0.839 . . . . 0.0 109.813 178.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.513 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.5 OUTLIER -80.71 -25.62 37.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.51 -0.743 . . . . 0.0 109.095 178.54 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.628 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -130.29 51.08 6.87 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.544 -0.723 . . . . 0.0 111.192 179.544 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.628 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 43.4 Cg_endo -90.17 -19.14 1.25 Allowed 'Trans proline' 0 C--N 1.318 -1.053 0 O-C-N 123.039 1.02 . . . . 0.0 110.651 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -84.96 -36.2 21.53 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.444 -0.785 . . . . 0.0 110.226 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.6 ttp85 . . . . . 0 N--CA 1.501 2.121 0 CA-C-O 118.088 -0.958 . . . . 0.0 110.824 179.854 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' HIS . . . . . 0.56 ' CD2' ' HB2' ' A' ' 5' ' ' HIS . 23.2 t-160 . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 121.12 0.486 . . . . 0.0 110.244 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.6 m -138.28 -96.57 0.18 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.6 -0.687 . . . . 0.0 109.88 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.4 m -125.33 8.57 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.271 -0.893 . . . . 0.0 110.789 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.2 t -95.96 -31.83 12.9 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.315 -0.866 . . . . 0.0 110.006 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.56 ' HB2' ' CD2' ' A' ' 1' ' ' HIS . 70.5 m-70 -103.17 10.03 38.01 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.703 -0.623 . . . . 0.0 110.687 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.41 16.45 19.89 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.268 -0.895 . . . . 0.0 110.729 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.7 tpm_? -154.85 68.19 5.49 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.243 -0.911 . . . . 0.0 109.967 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.503 ' HA ' ' CZ3' ' A' ' 10' ' ' TRP . 44.6 Cg_endo -73.01 -89.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.316 -1.152 0 O-C-N 123.838 1.441 . . . . 0.0 110.925 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.413 ' CG ' ' O ' ' A' ' 8' ' ' PRO . 24.5 ptt85 39.51 30.16 0.05 OUTLIER 'General case' 0 N--CA 1.509 2.521 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.503 ' CZ3' ' HA ' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -68.8 89.05 0.39 Allowed 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 177.139 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 60.56 26.92 16.59 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 -174.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 47.42 43.98 16.04 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.872 0.844 . . . . 0.0 110.138 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -69.35 -45.5 69.24 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.293 0.568 . . . . 0.0 109.524 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.4 t -65.2 -34.39 78.25 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 178.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 tt -66.24 -42.48 88.55 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.1 tt -63.82 -39.94 95.43 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.592 -0.693 . . . . 0.0 110.083 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 tt -62.01 -32.03 72.47 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.516 0.674 . . . . 0.0 109.465 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.552 ' O ' HG23 ' A' ' 22' ' ' VAL . 9.0 tp -74.14 -37.91 63.9 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.322 0.582 . . . . 0.0 109.627 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.41 -39.99 95.99 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.882 -0.511 . . . . 0.0 109.811 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.62 -40.18 96.16 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.563 -0.71 . . . . 0.0 109.875 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.56 -39.22 96.63 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 18' ' ' LEU . 89.7 t -61.5 -42.11 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.452 -1.028 . . . . 0.0 109.813 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.446 ' HA2' HD12 ' A' ' 26' ' ' LEU . . . -63.06 -42.32 99.61 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 31.3 mm -67.18 -36.28 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.497 -1.002 . . . . 0.0 109.691 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -62.54 -26.63 68.66 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.198 -0.939 . . . . 0.0 109.609 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.446 HD12 ' HA2' ' A' ' 23' ' ' GLY . 12.8 mt -79.52 -22.21 44.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.438 -0.789 . . . . 0.0 109.146 178.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.592 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.6 tp -135.8 54.63 10.51 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.565 -0.709 . . . . 0.0 110.756 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.592 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.8 Cg_endo -90.57 -21.63 0.79 Allowed 'Trans proline' 0 C--N 1.319 -1.024 0 O-C-N 123.264 1.139 . . . . 0.0 111.039 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -93.92 -37.29 11.78 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.347 -0.845 . . . . 0.0 110.191 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.123 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' HIS . . . . . 0.603 ' O ' HG23 ' A' ' 3' ' ' VAL . 52.0 m80 . . . . . 0 N--CA 1.496 1.837 0 CA-C-O 120.754 0.311 . . . . 0.0 110.184 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.2 p 53.36 36.9 24.12 Favored 'General case' 0 N--CA 1.504 2.268 0 CA-C-O 121.128 0.489 . . . . 0.0 111.721 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.742 HG22 ' HG3' ' A' ' 8' ' ' PRO . 16.3 t -116.61 29.16 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 120.944 -1.097 . . . . 0.0 110.326 179.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.33 -38.48 90.26 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.059 -1.026 . . . . 0.0 110.136 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -112.85 33.87 4.76 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.856 -0.528 . . . . 0.0 109.985 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 51.72 43.23 30.09 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.635 -0.665 . . . . 0.0 110.932 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.563 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -63.36 -52.91 57.26 Favored Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 121.288 -0.882 . . . . 0.0 110.808 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.742 ' HG3' HG22 ' A' ' 3' ' ' VAL . 48.4 Cg_endo -74.36 -163.99 0.2 Allowed 'Trans proline' 0 N--CA 1.486 1.054 0 O-C-N 123.513 1.27 . . . . 0.0 110.233 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.499 ' HA ' ' HB2' ' A' ' 12' ' ' TRP . 4.7 mmt85 -95.61 19.63 10.83 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.151 -0.968 . . . . 0.0 111.09 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 7.7 t-105 -65.2 -49.02 71.36 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.239 -0.913 . . . . 0.0 109.981 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -91.37 11.35 24.05 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.498 -0.751 . . . . 0.0 110.558 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.499 ' HB2' ' HA ' ' A' ' 9' ' ' ARG . 18.1 m95 -105.43 14.77 28.22 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.163 -0.961 . . . . 0.0 110.752 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -62.17 -53.71 51.46 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.121 -0.987 . . . . 0.0 109.93 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.9 t -60.91 -33.22 72.8 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.393 0.616 . . . . 0.0 109.791 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.65 -40.56 76.4 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.761 -0.587 . . . . 0.0 109.444 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 tt -63.78 -40.02 95.65 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.587 -0.695 . . . . 0.0 109.91 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 tt -63.17 -29.74 71.03 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.406 0.622 . . . . 0.0 109.632 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.0 tp -79.7 -34.44 40.15 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.823 -0.548 . . . . 0.0 109.838 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.06 -39.94 83.62 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.842 -0.536 . . . . 0.0 110.298 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.35 -41.13 98.35 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.485 -0.76 . . . . 0.0 110.006 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.28 -40.39 96.58 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 71.9 t -62.89 -40.58 89.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.503 -0.998 . . . . 0.0 109.943 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.06 -42.17 99.72 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 36.0 mt -67.05 -36.96 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.458 -1.025 . . . . 0.0 109.782 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -64.8 -26.17 68.23 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.166 -0.959 . . . . 0.0 109.6 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.488 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.7 mm? -79.17 -25.69 42.78 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.34 -0.85 . . . . 0.0 108.858 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.573 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -131.49 55.33 17.97 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.602 -0.686 . . . . 0.0 110.962 179.556 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.573 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.2 Cg_endo -90.45 -21.96 0.79 Allowed 'Trans proline' 0 C--N 1.318 -1.065 0 C-N-CA 120.891 1.061 . . . . 0.0 110.993 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -92.35 -10.79 36.95 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.298 -0.876 . . . . 0.0 110.922 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 20.6 mtm-85 . . . . . 0 N--CA 1.502 2.145 0 O-C-N 121.463 -0.773 . . . . 0.0 110.675 -179.865 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 30.2 p80 . . . . . 0 N--CA 1.498 1.974 0 CA-C-O 120.96 0.41 . . . . 0.0 110.556 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 t -155.28 54.87 0.63 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.493 -0.755 . . . . 0.0 110.426 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.476 ' O ' HG12 ' A' ' 3' ' ' VAL . 15.4 t 57.58 23.35 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 121.593 -0.692 . . . . 0.0 111.252 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.89 -37.4 13.59 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.886 -1.134 . . . . 0.0 110.059 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -118.17 13.82 13.85 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.74 -0.6 . . . . 0.0 110.845 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -107.35 46.4 0.94 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.303 -0.873 . . . . 0.0 110.488 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 56.62 83.31 0.23 Allowed Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.515 -0.741 . . . . 0.0 110.656 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -73.05 84.34 1.32 Allowed 'Trans proline' 0 C--N 1.314 -1.24 0 O-C-N 123.612 1.322 . . . . 0.0 110.79 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.477 ' HG3' ' CD1' ' A' ' 10' ' ' TRP . 1.3 ptm180 -154.58 -119.76 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.475 -0.766 . . . . 0.0 110.051 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.512 ' O ' ' CB ' ' A' ' 11' ' ' PHE . 27.6 p-90 32.44 88.89 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.766 0 CA-C-N 119.026 0.83 . . . . 0.0 112.064 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.512 ' CB ' ' O ' ' A' ' 10' ' ' TRP . 6.4 t80 78.89 -43.48 0.33 Allowed 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.656 -0.653 . . . . 0.0 111.14 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.425 ' HB3' ' O ' ' A' ' 9' ' ' ARG . 67.4 t-105 -57.49 -35.48 70.26 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.05 -1.031 . . . . 0.0 110.127 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -55.64 -35.07 65.53 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.757 -0.589 . . . . 0.0 109.707 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.0 m -64.55 -37.45 87.59 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.0 tt -65.01 -42.5 94.37 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 tt -64.93 -35.53 81.47 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.547 -0.721 . . . . 0.0 109.731 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.7 tp -62.92 -37.07 85.55 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.4 tt -65.76 -39.25 90.85 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.378 0.608 . . . . 0.0 109.377 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.56 -35.1 78.38 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.879 -0.513 . . . . 0.0 109.803 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.7 -39.85 94.36 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.587 -0.695 . . . . 0.0 110.018 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.54 -42.28 95.75 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 64.2 t -65.05 -42.26 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.512 -0.993 . . . . 0.0 109.538 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.3 -46.93 89.39 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.0 mt -65.43 -32.14 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.445 -1.032 . . . . 0.0 109.872 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.438 ' O ' ' HG3' ' A' ' 28' ' ' PRO . 44.0 t80 -64.79 -28.09 69.34 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.983 -1.073 . . . . 0.0 109.565 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.46 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.8 OUTLIER -77.37 -25.79 51.28 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.037 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.515 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.1 OUTLIER -133.8 59.13 37.14 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.724 -0.61 . . . . 0.0 109.975 179.35 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.6 Cg_endo -90.99 -19.55 0.91 Allowed 'Trans proline' 0 C--N 1.319 -1.011 0 C-N-CA 121.223 1.282 . . . . 0.0 111.535 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -58.1 -32.54 68.19 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.408 -0.807 . . . . 0.0 110.764 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.199 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.553 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.4 p 39.47 48.4 1.75 Allowed 'General case' 0 N--CA 1.506 2.329 0 CA-C-O 121.225 0.536 . . . . 0.0 111.592 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.443 ' HA ' ' HB3' ' A' ' 6' ' ' ALA . 3.0 p -120.27 19.72 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.28 -0.888 . . . . 0.0 110.729 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 45.4 t -65.97 -26.35 67.52 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.183 -0.948 . . . . 0.0 110.526 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 34.3 p-80 -129.78 15.77 5.85 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.739 -0.601 . . . . 0.0 110.705 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.443 ' HB3' ' HA ' ' A' ' 3' ' ' VAL . . . -111.49 32.61 5.26 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.461 -0.775 . . . . 0.0 110.965 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.0 ptt-85 -151.82 62.36 4.72 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 121.109 -0.994 . . . . 0.0 110.395 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -74.37 -174.79 1.94 Allowed 'Trans proline' 0 C--N 1.315 -1.209 0 O-C-N 123.735 1.387 . . . . 0.0 111.017 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -164.87 61.05 0.13 Allowed 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.809 0.814 . . . . 0.0 110.276 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -138.9 -58.17 0.61 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.76 -0.588 . . . . 0.0 110.079 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -79.47 -16.39 56.17 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.467 -0.771 . . . . 0.0 110.643 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.543 ' CZ3' HD13 ' A' ' 15' ' ' LEU . 13.9 m95 -56.7 -31.26 64.3 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.419 -0.8 . . . . 0.0 111.267 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -63.59 -39.55 94.66 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.413 -0.804 . . . . 0.0 109.66 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.8 t -65.9 -35.78 81.57 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.543 HD13 ' CZ3' ' A' ' 12' ' ' TRP . 3.3 tt -66.07 -41.61 90.51 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 tt -63.61 -37.91 89.12 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.686 -0.634 . . . . 0.0 109.923 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.0 tp -62.66 -33.81 75.8 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.599 0.714 . . . . 0.0 109.44 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.513 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -75.64 -36.57 60.16 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.237 0.542 . . . . 0.0 109.863 179.24 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.15 -41.78 98.61 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.839 -0.538 . . . . 0.0 109.979 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.01 -40.58 98.18 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.636 -0.665 . . . . 0.0 109.958 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.17 -38.87 96.88 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 18' ' ' LEU . 88.5 t -64.73 -41.6 92.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.516 -0.99 . . . . 0.0 109.792 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.82 -41.49 99.18 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 38.4 mt -66.73 -34.9 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.427 -1.043 . . . . 0.0 109.593 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -63.88 -27.04 68.88 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.291 -0.88 . . . . 0.0 109.606 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.41 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.6 OUTLIER -78.97 -21.7 46.72 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.455 -0.778 . . . . 0.0 109.125 178.254 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.588 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 6.5 tp -136.25 54.07 8.91 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.619 -0.675 . . . . 0.0 110.757 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.588 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.4 Cg_endo -89.86 -29.21 0.22 Allowed 'Trans proline' 0 C--N 1.318 -1.033 0 O-C-N 123.263 1.139 . . . . 0.0 111.435 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -84.53 -33.46 23.49 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.234 -0.916 . . . . 0.0 110.545 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.2 ttm180 . . . . . 0 N--CA 1.502 2.148 0 CA-C-O 118.091 -0.957 . . . . 0.0 111.124 179.785 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 12.3 m80 . . . . . 0 N--CA 1.494 1.768 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 86.7 p 39.58 44.26 1.18 Allowed 'General case' 0 N--CA 1.507 2.399 0 O-C-N 122.064 -0.398 . . . . 0.0 111.798 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.439 ' O ' HG12 ' A' ' 3' ' ' VAL . 17.5 t 47.01 39.93 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.611 -0.681 . . . . 0.0 110.668 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.2 m -80.04 -73.09 0.37 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.152 -0.967 . . . . 0.0 110.065 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -151.91 -75.31 0.14 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.69 -0.631 . . . . 0.0 110.623 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 49.62 56.76 7.36 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.835 -0.54 . . . . 0.0 110.513 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.47 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 4.2 ttp180 -173.44 -57.84 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.073 0 O-C-N 121.512 -0.743 . . . . 0.0 110.823 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.47 ' HD3' ' HB3' ' A' ' 7' ' ' ARG . 43.3 Cg_endo -69.74 -169.96 0.36 Allowed 'Trans proline' 0 N--CA 1.492 1.407 0 O-C-N 123.549 1.289 . . . . 0.0 111.277 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.465 ' HA ' ' HB3' ' A' ' 12' ' ' TRP . 0.3 OUTLIER -62.68 -73.75 0.1 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.376 -0.828 . . . . 0.0 111.042 -179.201 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 74.4 t-105 52.53 -94.26 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.62 -0.675 . . . . 0.0 110.214 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -76.83 -32.06 57.32 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.026 -1.046 . . . . 0.0 109.667 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.465 ' HB3' ' HA ' ' A' ' 9' ' ' ARG . 68.5 t-105 -68.91 -17.19 63.93 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.564 -0.71 . . . . 0.0 110.484 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -63.77 -36.41 83.77 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.436 -0.79 . . . . 0.0 109.529 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.23 -40.5 94.15 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.445 HD22 ' CZ2' ' A' ' 12' ' ' TRP . 6.6 tt -62.97 -41.55 99.57 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.9 tt -64.51 -42.08 96.03 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.713 -0.617 . . . . 0.0 109.957 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 tt -61.06 -32.57 72.2 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.545 0.688 . . . . 0.0 109.441 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.547 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -68.79 -39.45 80.15 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.36 0.6 . . . . 0.0 109.611 178.918 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.57 -37.8 85.71 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.632 -0.667 . . . . 0.0 109.774 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.02 -41.02 91.52 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.537 -0.727 . . . . 0.0 109.946 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.84 -37.37 94.21 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 18' ' ' LEU . 94.3 t -61.71 -39.36 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.526 -0.984 . . . . 0.0 109.618 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.57 -49.16 66.2 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -65.08 -32.2 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.434 -1.039 . . . . 0.0 109.971 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -62.94 -27.0 69.08 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.148 -0.97 . . . . 0.0 109.631 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.487 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.8 OUTLIER -78.64 -26.54 45.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.41 -0.806 . . . . 0.0 108.927 178.238 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.554 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.7 OUTLIER -131.6 56.56 24.93 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.504 -0.747 . . . . 0.0 110.738 179.386 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.554 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.9 Cg_endo -91.79 -19.19 0.8 Allowed 'Trans proline' 0 C--N 1.316 -1.14 0 C-N-CA 121.138 1.225 . . . . 0.0 111.129 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -89.54 -0.67 57.67 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.311 -0.868 . . . . 0.0 111.24 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.802 0 O-C-N 121.021 -1.05 . . . . 0.0 110.237 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 29.8 m80 . . . . . 0 N--CA 1.496 1.826 0 CA-C-O 121.066 0.46 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.1 p -104.85 35.02 2.92 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.44 -0.787 . . . . 0.0 110.721 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.455 ' O ' HG12 ' A' ' 3' ' ' VAL . 23.5 t 51.97 47.15 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.507 -0.746 . . . . 0.0 110.349 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 t -98.65 -15.85 19.26 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.256 -0.903 . . . . 0.0 110.773 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -98.22 37.89 1.39 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.384 -0.822 . . . . 0.0 110.342 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -151.24 41.61 0.73 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.454 -0.779 . . . . 0.0 110.19 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.518 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -165.89 -62.47 0.01 OUTLIER Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.363 -0.835 . . . . 0.0 110.515 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 7' ' ' ARG . 46.8 Cg_endo -72.74 110.3 2.98 Favored 'Trans proline' 0 N--CA 1.485 1.02 0 O-C-N 123.445 1.234 . . . . 0.0 110.295 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.2 mmt85 -103.91 16.2 26.86 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.608 -0.682 . . . . 0.0 110.944 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 84.6 t90 -62.04 -45.48 93.37 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.228 -0.92 . . . . 0.0 110.15 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -69.6 -22.72 63.48 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.567 -0.708 . . . . 0.0 110.523 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -105.3 13.69 30.06 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.362 -0.836 . . . . 0.0 111.259 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -70.11 -51.3 32.69 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.178 -0.951 . . . . 0.0 109.683 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.2 p -64.03 -35.09 79.58 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.84 -41.94 86.59 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.1 tt -65.36 -38.04 88.85 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.611 -0.68 . . . . 0.0 109.559 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.0 tp -61.56 -35.43 77.77 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.501 0.667 . . . . 0.0 109.411 178.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.0 tp -71.92 -36.05 69.85 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.394 0.616 . . . . 0.0 109.649 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.78 -33.25 75.21 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.828 -0.545 . . . . 0.0 109.926 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.54 -43.09 67.06 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.481 -0.762 . . . . 0.0 110.135 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.48 -53.06 22.79 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 81.8 t -65.62 -36.83 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.435 -1.038 . . . . 0.0 110.132 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.07 -47.82 87.38 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.6 mm -65.46 -35.07 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.368 -1.078 . . . . 0.0 110.013 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.403 ' O ' ' HG3' ' A' ' 28' ' ' PRO . 16.1 t80 -64.11 -28.48 69.8 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.996 -1.065 . . . . 0.0 109.718 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.503 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.7 OUTLIER -78.9 -25.54 43.81 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.341 -0.849 . . . . 0.0 108.882 178.253 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.573 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.2 OUTLIER -131.31 55.27 17.77 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.594 -0.691 . . . . 0.0 110.854 179.677 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.573 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.9 Cg_endo -91.21 -20.43 0.77 Allowed 'Trans proline' 0 C--N 1.319 -1.007 0 C-N-CA 121.013 1.142 . . . . 0.0 110.95 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -100.94 6.2 43.51 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.366 -0.834 . . . . 0.0 110.896 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.237 0 O-C-N 121.497 -0.752 . . . . 0.0 111.351 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 120.837 0.351 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 60.36 74.15 0.46 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.688 -0.632 . . . . 0.0 109.993 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.561 HG13 ' HB3' ' A' ' 7' ' ' ARG . 36.5 t 57.46 68.25 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 CA-C-O 121.605 0.717 . . . . 0.0 109.867 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.5 t -137.81 -63.58 0.57 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.376 -0.828 . . . . 0.0 110.623 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -115.7 34.27 5.03 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.586 -0.697 . . . . 0.0 110.646 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -176.7 48.7 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.561 -0.712 . . . . 0.0 110.078 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.561 ' HB3' HG13 ' A' ' 3' ' ' VAL . 0.9 OUTLIER -173.5 -57.32 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.097 0 O-C-N 121.269 -0.894 . . . . 0.0 111.429 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.454 ' HD3' ' CB ' ' A' ' 7' ' ' ARG . 44.3 Cg_endo -75.33 -84.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.487 1.099 0 O-C-N 123.37 1.195 . . . . 0.0 111.297 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.418 ' O ' ' C ' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -135.99 -61.88 0.69 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.083 -1.011 . . . . 0.0 110.293 -179.685 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.508 ' O ' ' CB ' ' A' ' 11' ' ' PHE . 6.1 m95 -39.97 136.61 1.09 Allowed 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.162 -0.961 . . . . 0.0 111.021 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.508 ' CB ' ' O ' ' A' ' 10' ' ' TRP . 2.6 t80 81.3 -10.25 1.21 Allowed 'General case' 0 N--CA 1.507 2.387 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.131 -179.038 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.503 ' CE3' ' N ' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -88.88 13.05 13.56 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.962 -1.086 . . . . 0.0 110.935 179.101 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.503 ' N ' ' CE3' ' A' ' 12' ' ' TRP . 2.5 t80 -73.24 -42.01 63.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.582 -0.699 . . . . 0.0 109.454 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.78 -33.19 75.41 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.9 tp -66.37 -40.3 89.64 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.6 tt -64.77 -39.08 93.02 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.688 -0.632 . . . . 0.0 109.342 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.18 -31.63 72.91 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.682 0.753 . . . . 0.0 109.048 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.551 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -71.76 -32.06 67.3 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.881 -0.512 . . . . 0.0 109.823 178.826 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.96 -39.67 82.4 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.765 -0.584 . . . . 0.0 109.995 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.86 -40.64 97.04 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.52 -0.738 . . . . 0.0 109.671 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.34 -37.09 94.29 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 18' ' ' LEU . 76.4 t -61.83 -40.42 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.506 -0.997 . . . . 0.0 109.53 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.21 -45.15 95.92 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.2 mt -68.49 -32.36 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.377 -1.072 . . . . 0.0 109.657 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -61.41 -22.2 64.78 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.458 -0.776 . . . . 0.0 109.901 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.534 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.8 mm? -82.3 -25.05 34.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.399 -0.813 . . . . 0.0 109.487 178.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.629 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.6 OUTLIER -127.58 48.29 3.25 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.411 -0.806 . . . . 0.0 111.589 179.749 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.629 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 45.7 Cg_endo -90.42 -21.08 0.9 Allowed 'Trans proline' 0 C--N 1.319 -0.976 0 O-C-N 122.862 0.928 . . . . 0.0 110.839 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -100.32 -39.09 8.18 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.391 -0.818 . . . . 0.0 110.275 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 117.927 -1.035 . . . . 0.0 110.015 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 31.6 m80 . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 120.991 0.424 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.7 t -111.37 48.12 0.97 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.503 -0.748 . . . . 0.0 110.38 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.404 HG12 ' O ' ' A' ' 3' ' ' VAL . 11.6 t -111.66 36.43 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.294 -0.879 . . . . 0.0 110.141 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.2 t -93.76 -34.36 13.24 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.198 -0.939 . . . . 0.0 110.406 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -96.3 13.4 27.75 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.744 -0.598 . . . . 0.0 111.067 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 52.62 71.92 0.44 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.282 -0.886 . . . . 0.0 110.262 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.417 ' O ' ' HB2' ' A' ' 12' ' ' TRP . 1.3 mmp_? -86.99 118.79 70.55 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.291 -0.88 . . . . 0.0 110.762 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -75.67 -27.61 8.81 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 123.896 1.472 . . . . 0.0 110.637 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.479 ' O ' ' HB2' ' A' ' 10' ' ' TRP . 7.0 mmt180 -141.99 -165.7 2.07 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.434 -0.791 . . . . 0.0 109.839 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.479 ' HB2' ' O ' ' A' ' 9' ' ' ARG . 16.4 m-90 62.49 -82.39 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.825 -0.547 . . . . 0.0 110.175 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.75 16.63 10.36 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.265 -0.897 . . . . 0.0 110.043 178.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.616 ' CZ3' HD22 ' A' ' 15' ' ' LEU . 67.9 t-105 -105.55 -21.09 13.28 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.335 -0.853 . . . . 0.0 111.097 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -61.74 -45.42 94.01 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.347 -0.846 . . . . 0.0 109.888 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.9 p -62.7 -33.36 74.92 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.616 HD22 ' CZ3' ' A' ' 12' ' ' TRP . 0.2 OUTLIER -64.94 -43.77 91.65 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.608 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.9 tt -63.72 -36.62 84.45 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.771 -0.58 . . . . 0.0 109.767 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.3 tp -64.65 -36.98 86.02 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.646 0.736 . . . . 0.0 109.157 178.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.538 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.2 tt -68.45 -37.12 79.93 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.322 0.582 . . . . 0.0 109.434 178.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.49 -38.87 92.51 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.827 -0.546 . . . . 0.0 109.765 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.84 -40.23 96.09 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.6 -0.688 . . . . 0.0 109.724 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.77 -37.65 94.61 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 18' ' ' LEU . 95.5 t -62.97 -41.64 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.45 -1.029 . . . . 0.0 109.805 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.67 -41.84 98.9 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.4 mm -67.17 -34.9 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.409 -1.054 . . . . 0.0 109.692 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -63.44 -26.75 68.88 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.255 -0.903 . . . . 0.0 109.637 178.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.471 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.8 OUTLIER -79.06 -24.9 43.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.412 -0.805 . . . . 0.0 109.022 178.226 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.586 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 5.7 tp -132.65 54.35 13.47 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.518 -0.739 . . . . 0.0 110.946 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.586 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.9 Cg_endo -90.67 -22.43 0.67 Allowed 'Trans proline' 0 C--N 1.319 -1.018 0 C-N-CA 120.936 1.091 . . . . 0.0 111.162 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.75 -28.96 66.22 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.232 -0.917 . . . . 0.0 110.398 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.462 ' NH2' HD23 ' A' ' 27' ' ' LEU . 1.6 mmp_? . . . . . 0 N--CA 1.505 2.307 0 CA-C-O 118.305 -0.855 . . . . 0.0 111.079 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.497 1.902 0 CA-C-O 121.095 0.474 . . . . 0.0 110.431 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.5 m -128.84 37.75 4.04 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.584 -0.698 . . . . 0.0 110.25 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.8 m -115.12 52.44 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.28 -0.887 . . . . 0.0 110.143 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.32 -28.33 47.32 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.44 -0.788 . . . . 0.0 110.749 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -95.9 42.1 1.09 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.483 -0.761 . . . . 0.0 110.386 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.35 31.89 1.52 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.27 -0.894 . . . . 0.0 110.605 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 48.9 mtt180 45.22 59.87 13.88 Favored Pre-proline 0 N--CA 1.503 2.2 0 O-C-N 121.726 -0.609 . . . . 0.0 111.178 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.43 -36.71 4.96 Favored 'Trans proline' 0 N--CA 1.488 1.19 0 O-C-N 123.719 1.379 . . . . 0.0 110.718 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.1 ptp85 -143.87 -150.16 0.3 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.485 -0.759 . . . . 0.0 109.678 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 9.6 t-105 68.19 -67.38 0.2 Allowed 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.755 -0.591 . . . . 0.0 110.39 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -84.23 -19.43 33.94 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.35 -0.844 . . . . 0.0 110.588 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.495 ' HA ' ' CE3' ' A' ' 12' ' ' TRP . 2.3 m95 -85.91 13.32 7.62 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.116 -0.99 . . . . 0.0 111.419 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -66.69 -46.72 74.69 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.986 -1.071 . . . . 0.0 109.711 179.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.0 p -61.35 -34.81 75.92 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.424 0.631 . . . . 0.0 109.437 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.9 tp -64.17 -42.0 96.9 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 tt -63.37 -39.97 95.99 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.692 -0.63 . . . . 0.0 109.749 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.36 -35.34 78.82 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.475 0.655 . . . . 0.0 109.435 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.57 ' O ' HG23 ' A' ' 22' ' ' VAL . 1.3 tt -72.93 -36.1 67.16 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.219 0.533 . . . . 0.0 109.894 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.26 -40.7 95.06 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.72 -0.612 . . . . 0.0 109.773 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.64 -39.92 95.36 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.629 -0.669 . . . . 0.0 109.78 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.42 -37.58 93.96 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 18' ' ' LEU . 87.7 t -61.62 -42.65 94.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.474 -1.016 . . . . 0.0 109.843 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.02 -41.83 99.79 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 30.3 mm -67.23 -36.57 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.455 -1.027 . . . . 0.0 109.761 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -63.08 -25.96 68.61 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.272 -0.893 . . . . 0.0 109.801 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.438 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 13.3 mt -81.44 -20.35 40.52 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.328 -0.858 . . . . 0.0 109.323 178.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.627 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 1.3 tp -135.99 51.86 5.82 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.412 -0.805 . . . . 0.0 110.902 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.627 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 44.7 Cg_endo -91.63 -19.61 0.78 Allowed 'Trans proline' 0 C--N 1.32 -0.946 0 C-N-CA 121.113 1.209 . . . . 0.0 111.223 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -71.57 -38.32 70.97 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.253 -0.905 . . . . 0.0 110.429 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.836 0 CA-C-O 118.353 -0.832 . . . . 0.0 110.562 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 43.0 m80 . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 120.995 0.426 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.5 p -110.49 49.87 0.83 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.574 -0.704 . . . . 0.0 110.018 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.7 t 56.27 57.33 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 121.649 -0.657 . . . . 0.0 110.516 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.1 t -68.62 -34.84 76.43 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.318 -0.864 . . . . 0.0 110.523 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -135.13 26.72 3.54 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.696 -0.627 . . . . 0.0 110.667 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 47.44 49.84 15.39 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.551 -0.718 . . . . 0.0 111.035 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.1 113.52 29.71 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.245 -0.909 . . . . 0.0 110.675 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -79.07 113.32 3.2 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.844 1.444 . . . . 0.0 110.667 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.413 ' HG3' ' CE2' ' A' ' 12' ' ' TRP . 1.3 ttt180 -140.31 -99.57 0.15 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.459 -0.776 . . . . 0.0 110.218 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 53.15 61.6 3.08 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -178.191 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 61.44 26.17 15.99 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 -175.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.512 ' CD1' HD13 ' A' ' 15' ' ' LEU . 6.7 m-90 45.22 44.32 8.73 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.816 0.817 . . . . 0.0 110.148 -178.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -66.42 -47.48 73.09 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.6 t -63.21 -36.47 83.77 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.512 HD13 ' CD1' ' A' ' 12' ' ' TRP . 2.4 tt -68.04 -43.73 78.06 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.3 tt -62.81 -38.17 89.65 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.613 -0.679 . . . . 0.0 109.986 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.0 tt -61.64 -35.84 79.09 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.592 0.711 . . . . 0.0 109.322 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.496 ' O ' HG23 ' A' ' 22' ' ' VAL . 1.3 tt -69.6 -37.22 76.81 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.316 0.579 . . . . 0.0 109.747 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.14 -38.38 85.44 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.861 -0.524 . . . . 0.0 109.922 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.28 -43.11 98.86 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.531 -0.731 . . . . 0.0 109.928 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.57 -39.41 96.43 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 18' ' ' LEU . 98.7 t -64.35 -37.2 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.62 -0.93 . . . . 0.0 109.714 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.421 ' HA2' HD12 ' A' ' 26' ' ' LEU . . . -60.15 -46.97 93.27 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.37 -34.16 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.521 -0.988 . . . . 0.0 109.65 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -63.23 -26.15 68.65 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.084 -1.01 . . . . 0.0 109.64 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.448 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 14.8 mt -78.82 -23.78 44.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.293 -0.88 . . . . 0.0 108.909 178.123 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.56 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -134.59 56.2 17.02 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.553 -0.717 . . . . 0.0 110.681 179.311 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.56 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 40.1 Cg_endo -89.76 -22.52 0.87 Allowed 'Trans proline' 0 C--N 1.318 -1.055 0 O-C-N 123.235 1.124 . . . . 0.0 111.024 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -85.97 -33.83 21.02 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.272 -0.893 . . . . 0.0 110.235 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.106 0 CA-C-O 118.173 -0.918 . . . . 0.0 110.836 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 121.07 0.462 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.446 ' C ' HG22 ' A' ' 3' ' ' VAL . 12.6 p -105.03 40.51 1.5 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.57 -0.706 . . . . 0.0 110.377 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.446 HG22 ' C ' ' A' ' 2' ' ' SER . 34.5 m 34.29 46.64 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.549 0 CA-C-O 121.37 0.605 . . . . 0.0 111.961 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.69 -21.23 17.72 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.536 -0.728 . . . . 0.0 110.775 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.509 ' O ' ' HB3' ' A' ' 6' ' ' ALA . 0.6 OUTLIER -120.36 29.51 7.43 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.401 -0.812 . . . . 0.0 110.74 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 5' ' ' HIS . . . 63.11 86.74 0.11 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.569 -0.707 . . . . 0.0 110.277 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 10.0 ptt-85 -53.59 143.63 37.08 Favored Pre-proline 0 N--CA 1.5 2.073 0 O-C-N 121.689 -0.632 . . . . 0.0 110.582 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.458 ' HG2' ' HB3' ' A' ' 11' ' ' PHE . 48.0 Cg_endo -74.36 171.01 18.93 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 O-C-N 123.768 1.404 . . . . 0.0 110.919 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.7 mtp85 -108.88 -37.23 5.91 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.677 -0.639 . . . . 0.0 110.399 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 45.3 p-90 -61.71 -32.23 72.44 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.401 -0.812 . . . . 0.0 110.415 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.458 ' HB3' ' HG2' ' A' ' 8' ' ' PRO . 11.5 t80 -69.86 -42.75 73.12 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.376 -0.827 . . . . 0.0 109.766 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.614 ' CZ3' HD13 ' A' ' 15' ' ' LEU . 3.9 m95 -67.82 -13.57 62.25 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.453 -0.779 . . . . 0.0 110.969 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -63.91 -34.51 78.13 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.329 -0.857 . . . . 0.0 109.439 178.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.8 t -63.57 -36.76 84.86 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.614 HD13 ' CZ3' ' A' ' 12' ' ' TRP . 0.9 OUTLIER -66.36 -42.95 87.31 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.82 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 tt -62.13 -39.88 94.07 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.656 -0.652 . . . . 0.0 110.042 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.4 tt -61.4 -35.52 77.74 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.492 0.663 . . . . 0.0 109.508 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.57 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.5 tt -70.39 -35.46 73.49 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.174 0.512 . . . . 0.0 109.74 179.019 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.79 -40.51 97.54 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.755 -0.591 . . . . 0.0 109.67 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.51 -38.84 90.88 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.501 -0.75 . . . . 0.0 109.475 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.483 ' HA2' HD12 ' A' ' 24' ' ' ILE . . . -62.42 -36.41 93.09 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 18' ' ' LEU . 87.4 t -62.76 -41.75 93.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.512 -0.993 . . . . 0.0 109.625 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.43 -42.0 99.67 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.483 HD12 ' HA2' ' A' ' 21' ' ' GLY . 22.3 mt -68.98 -32.18 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.545 -0.974 . . . . 0.0 109.555 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -63.46 -25.42 68.26 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.323 -0.86 . . . . 0.0 109.521 178.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.431 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.3 mp -78.61 -22.68 46.63 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.5 -0.75 . . . . 0.0 109.007 178.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.589 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 3.5 tp -135.28 53.98 9.9 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.603 -0.686 . . . . 0.0 110.78 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.589 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.6 Cg_endo -89.39 -42.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.033 0 O-C-N 123.15 1.079 . . . . 0.0 110.86 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -79.89 -32.69 40.32 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.408 -0.807 . . . . 0.0 110.395 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.7 mtp180 . . . . . 0 N--CA 1.501 2.107 0 CA-C-O 118.506 -0.759 . . . . 0.0 110.85 179.907 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 29.4 t60 . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 120.952 0.406 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.3 t 53.61 66.96 1.08 Allowed 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 121.331 0.586 . . . . 0.0 110.679 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.657 HG13 ' H ' ' A' ' 4' ' ' SER . 0.9 OUTLIER -148.62 -83.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.35 -0.844 . . . . 0.0 110.358 179.838 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.657 ' H ' HG13 ' A' ' 3' ' ' VAL . 0.3 OUTLIER 72.3 -14.0 0.58 Allowed 'General case' 0 N--CA 1.511 2.583 0 O-C-N 121.499 -0.751 . . . . 0.0 112.303 179.859 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.427 ' CE1' HG23 ' A' ' 3' ' ' VAL . 17.5 p-80 -105.34 5.85 32.2 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.2 -0.937 . . . . 0.0 110.959 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -101.42 45.44 0.97 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.471 -0.768 . . . . 0.0 110.221 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -114.99 150.46 44.23 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.42 -0.8 . . . . 0.0 109.937 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.572 ' HA ' ' HB3' ' A' ' 14' ' ' SER . 50.9 Cg_endo -76.64 56.09 5.05 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.754 1.397 . . . . 0.0 110.866 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.51 4.1 5.09 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.204 -0.935 . . . . 0.0 111.355 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 73.7 t90 -63.11 93.0 0.06 Allowed 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 177.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 56.38 27.26 11.75 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 -175.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 18.5 m-90 44.66 38.65 2.86 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 122.057 0.932 . . . . 0.0 109.768 -178.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -79.35 -46.92 16.7 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.312 0.577 . . . . 0.0 109.611 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.572 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 6.5 t -63.6 -33.06 74.77 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.454 HD13 ' C ' ' A' ' 15' ' ' LEU . 3.0 tm? -68.4 -41.94 79.76 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.3 tt -62.67 -40.8 98.23 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.665 -0.647 . . . . 0.0 109.941 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.2 tt -61.13 -33.46 73.43 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.402 0.62 . . . . 0.0 109.505 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.557 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -72.56 -34.08 67.24 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.879 -0.513 . . . . 0.0 109.848 178.963 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.42 -45.6 93.03 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.648 -0.657 . . . . 0.0 109.5 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.73 -34.83 78.71 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.623 -0.673 . . . . 0.0 109.801 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.04 -40.12 95.04 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 18' ' ' LEU . 77.3 t -60.04 -42.54 90.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.491 -1.005 . . . . 0.0 109.736 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.61 -45.26 93.45 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.9 mt -66.54 -35.26 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.491 -1.006 . . . . 0.0 109.736 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -63.43 -26.61 68.81 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.152 -0.968 . . . . 0.0 109.585 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.475 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.4 mm? -78.86 -26.51 44.04 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 178.034 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.559 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.0 tp -132.23 56.26 22.28 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.587 -0.696 . . . . 0.0 110.707 179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.559 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.0 Cg_endo -90.1 -20.24 1.12 Allowed 'Trans proline' 0 C--N 1.317 -1.093 0 O-C-N 123.323 1.17 . . . . 0.0 111.015 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -78.68 -32.28 47.01 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.419 -0.801 . . . . 0.0 110.302 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.059 0 CA-C-O 117.716 -1.135 . . . . 0.0 110.758 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' HIS . . . . . 0.492 ' HB3' HG22 ' A' ' 3' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 121.149 0.5 . . . . 0.0 110.335 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.9 p -109.55 48.51 0.88 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.439 -0.788 . . . . 0.0 110.439 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.492 HG22 ' HB3' ' A' ' 1' ' ' HIS . 20.0 m -123.16 30.9 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.347 -0.846 . . . . 0.0 110.623 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.1 m -120.3 -68.65 0.89 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.355 -0.841 . . . . 0.0 110.045 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 51.7 m80 -128.76 19.39 6.12 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.667 -0.646 . . . . 0.0 110.996 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 52.7 32.67 12.38 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.509 -0.744 . . . . 0.0 111.128 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.414 ' HD2' ' HA ' ' A' ' 7' ' ' ARG . 6.1 tpt180 -150.56 94.71 3.6 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.242 -0.911 . . . . 0.0 110.153 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.15 90.09 1.01 Allowed 'Trans proline' 0 C--N 1.313 -1.342 0 O-C-N 123.916 1.482 . . . . 0.0 110.408 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.697 ' HE ' HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -116.35 -81.21 0.61 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.389 -0.819 . . . . 0.0 110.013 -179.854 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 13.8 m95 47.4 -92.88 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.739 -0.6 . . . . 0.0 111.26 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -83.08 -26.82 30.71 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.158 -0.964 . . . . 0.0 110.816 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 17.9 m95 -71.0 -0.72 10.0 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.244 -0.91 . . . . 0.0 111.796 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -61.26 -40.2 93.2 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.043 -1.036 . . . . 0.0 110.142 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.4 p -65.21 -36.28 83.68 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.429 0.633 . . . . 0.0 109.481 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.1 tt -65.02 -41.61 95.16 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 178.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.697 HD13 ' HE ' ' A' ' 9' ' ' ARG . 1.0 OUTLIER -66.75 -35.09 79.28 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.589 -0.694 . . . . 0.0 109.871 179.174 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.0 tp -67.26 -32.82 74.1 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.41 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.9 OUTLIER -72.22 -30.82 65.28 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.109 0.48 . . . . 0.0 109.848 178.933 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.54 -41.53 94.64 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.72 -0.612 . . . . 0.0 110.051 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.41 -38.24 89.36 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.55 -0.719 . . . . 0.0 109.827 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.6 -40.72 96.14 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 18' ' ' LEU . 69.9 t -62.94 -38.14 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.504 -0.997 . . . . 0.0 109.895 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.33 -48.09 87.68 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 28.9 mm -71.48 -35.81 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.486 -1.008 . . . . 0.0 109.587 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -65.01 -26.62 68.36 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.266 -0.896 . . . . 0.0 109.629 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.426 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 10.7 mt -79.32 -21.23 46.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 0.0 109.046 178.201 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.574 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 3.0 tp -135.86 54.3 9.81 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.603 -0.685 . . . . 0.0 110.698 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.574 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 40.7 Cg_endo -89.77 -24.98 0.55 Allowed 'Trans proline' 0 C--N 1.317 -1.092 0 O-C-N 123.103 1.054 . . . . 0.0 111.183 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -92.05 -14.87 28.64 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.276 -0.89 . . . . 0.0 110.696 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.501 2.08 0 CA-C-O 117.92 -1.038 . . . . 0.0 110.791 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 33.9 p80 . . . . . 0 N--CA 1.497 1.906 0 CA-C-O 120.956 0.408 . . . . 0.0 110.477 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.3 m 53.47 44.92 29.28 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.702 -0.624 . . . . 0.0 110.806 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.4 p -119.23 22.85 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.263 -0.898 . . . . 0.0 110.802 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.62 -13.87 16.36 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.263 -0.898 . . . . 0.0 111.276 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 24.2 m80 -100.57 41.29 1.18 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.271 -0.893 . . . . 0.0 110.874 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -128.8 22.04 5.86 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.18 -0.95 . . . . 0.0 110.808 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -144.68 150.45 46.96 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.235 -0.916 . . . . 0.0 110.112 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -72.48 -66.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.269 0 O-C-N 123.807 1.425 . . . . 0.0 111.102 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 19.3 mtp85 55.75 21.51 4.75 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.494 -0.754 . . . . 0.0 111.683 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 31.4 p-90 -99.38 -33.27 10.77 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.12 -0.988 . . . . 0.0 109.743 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -85.36 -13.81 48.34 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.466 -0.771 . . . . 0.0 109.929 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 30.8 m95 -104.27 7.68 35.93 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.211 -0.931 . . . . 0.0 111.306 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -69.27 -48.59 61.33 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.099 -1.0 . . . . 0.0 109.516 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.5 p -63.42 -33.63 75.97 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.58 -42.28 95.71 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.9 tt -63.66 -40.8 97.76 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.716 -0.615 . . . . 0.0 109.735 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 tt -62.31 -36.5 82.35 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.649 0.737 . . . . 0.0 109.336 178.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.562 ' O ' HG23 ' A' ' 22' ' ' VAL . 1.3 tt -69.11 -36.59 77.69 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.264 0.554 . . . . 0.0 109.724 178.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.97 -41.16 99.45 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.69 -0.631 . . . . 0.0 109.688 179.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.64 -39.03 93.31 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.541 -0.724 . . . . 0.0 109.66 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.52 -37.16 93.39 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 18' ' ' LEU . 88.0 t -61.24 -41.02 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.408 -1.054 . . . . 0.0 109.576 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.453 ' HA2' HD12 ' A' ' 26' ' ' LEU . . . -64.71 -45.65 92.16 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.0 mt -68.14 -33.03 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.48 -1.012 . . . . 0.0 109.793 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -60.71 -23.46 64.91 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.304 -0.872 . . . . 0.0 109.821 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.453 HD12 ' HA2' ' A' ' 23' ' ' GLY . 12.3 mt -81.06 -17.4 50.26 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.328 -0.858 . . . . 0.0 109.638 178.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.636 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.4 tp -137.29 51.31 4.31 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.268 -0.895 . . . . 0.0 111.015 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.636 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 43.4 Cg_endo -90.64 -21.0 0.85 Allowed 'Trans proline' 0 C--N 1.318 -1.03 0 O-C-N 123.16 1.084 . . . . 0.0 111.059 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -89.96 -37.75 14.13 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.355 -0.841 . . . . 0.0 110.433 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 . . . . . 0 N--CA 1.495 1.816 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.268 179.955 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 12.7 m80 . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 120.874 0.369 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.1 m 53.82 39.65 30.6 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.763 -0.586 . . . . 0.0 110.934 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.4 p -116.58 22.61 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.253 -0.905 . . . . 0.0 110.804 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.1 t -105.4 -12.28 16.09 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.278 -0.889 . . . . 0.0 111.044 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -90.95 34.06 0.93 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.274 -0.891 . . . . 0.0 110.92 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -128.01 23.34 6.12 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.177 -0.952 . . . . 0.0 110.928 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.559 ' HB3' ' HD2' ' A' ' 9' ' ' ARG . 11.2 mtt-85 -154.23 142.28 14.11 Favored Pre-proline 0 N--CA 1.498 1.949 0 O-C-N 121.28 -0.888 . . . . 0.0 110.371 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -74.17 82.02 1.89 Allowed 'Trans proline' 0 C--N 1.314 -1.262 0 O-C-N 123.7 1.368 . . . . 0.0 110.102 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.559 ' HD2' ' HB3' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -135.73 6.94 3.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.318 -0.864 . . . . 0.0 111.762 -179.188 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 77.3 t-105 -64.9 87.84 0.06 Allowed 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.403 ' N ' ' O ' ' A' ' 9' ' ' ARG . 0.2 OUTLIER 58.33 25.06 12.32 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -175.008 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.408 ' NE1' ' HG3' ' A' ' 9' ' ' ARG . 1.9 m-90 44.99 38.54 3.07 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.905 0.86 . . . . 0.0 109.555 -177.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -66.92 -58.15 5.55 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.828 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.5 m -59.94 -34.09 72.79 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.46 HD22 ' HA ' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -65.03 -44.35 89.41 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.044 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.2 tt -67.17 -38.48 85.51 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.652 -0.655 . . . . 0.0 109.41 178.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.8 -37.31 86.22 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.65 0.738 . . . . 0.0 109.189 178.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.523 ' O ' HG23 ' A' ' 22' ' ' VAL . 1.9 tt -72.96 -35.93 67.02 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.307 0.575 . . . . 0.0 109.658 178.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.86 -39.02 93.22 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.755 -0.59 . . . . 0.0 109.97 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.97 -41.05 97.57 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.603 -0.686 . . . . 0.0 109.813 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.35 -38.09 95.37 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 18' ' ' LEU . 95.5 t -63.2 -40.65 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.471 -1.017 . . . . 0.0 109.777 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.34 -41.41 98.16 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 29.9 mm -66.91 -36.36 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.382 -1.07 . . . . 0.0 109.697 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -64.58 -26.58 68.47 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.14 -0.975 . . . . 0.0 109.48 178.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.451 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.6 mm? -78.13 -24.76 47.26 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.406 -0.809 . . . . 0.0 108.872 177.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.561 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.3 tp -134.41 56.05 16.9 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.71 -0.619 . . . . 0.0 110.752 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.561 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.2 Cg_endo -90.85 -20.49 0.84 Allowed 'Trans proline' 0 C--N 1.317 -1.126 0 C-N-CA 121.081 1.187 . . . . 0.0 111.139 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -105.32 5.61 32.06 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.355 -0.841 . . . . 0.0 110.856 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.83 0 O-C-N 121.276 -0.89 . . . . 0.0 110.501 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 9.4 m80 . . . . . 0 N--CA 1.496 1.834 0 CA-C-O 120.766 0.317 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.2 t 51.74 45.79 27.59 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.684 -0.635 . . . . 0.0 110.965 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.418 ' O ' HG12 ' A' ' 3' ' ' VAL . 11.2 t 54.29 31.53 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 121.56 -0.713 . . . . 0.0 110.771 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.3 t -110.41 -15.42 13.93 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.097 -1.002 . . . . 0.0 111.04 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.4 m80 -135.87 62.22 1.63 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.289 -0.882 . . . . 0.0 109.932 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -131.96 -82.88 0.5 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.507 -0.746 . . . . 0.0 110.425 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.97 88.96 6.2 Favored Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 121.466 -0.771 . . . . 0.0 110.085 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -69.59 -10.66 29.25 Favored 'Trans proline' 0 N--CA 1.491 1.366 0 O-C-N 123.65 1.342 . . . . 0.0 111.723 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.407 ' O ' ' N ' ' A' ' 11' ' ' PHE . 12.7 mtm-85 -72.59 -67.37 0.56 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.2 -0.938 . . . . 0.0 110.519 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER 56.79 -85.12 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.854 -0.528 . . . . 0.0 110.184 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.407 ' N ' ' O ' ' A' ' 9' ' ' ARG . 10.0 t80 -75.52 -18.34 59.83 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.14 -0.975 . . . . 0.0 110.321 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.599 ' CE3' HD13 ' A' ' 15' ' ' LEU . 67.5 m95 -84.8 17.65 2.72 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.307 -0.871 . . . . 0.0 111.118 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -68.46 -41.68 79.83 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.09 -1.006 . . . . 0.0 109.619 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.8 m -62.3 -36.79 83.22 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.463 0.649 . . . . 0.0 109.298 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.599 HD13 ' CE3' ' A' ' 12' ' ' TRP . 1.4 tt -63.65 -41.97 98.17 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.9 tt -62.78 -38.35 90.28 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.609 -0.682 . . . . 0.0 109.9 179.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.6 tt -62.14 -36.13 80.86 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.536 0.684 . . . . 0.0 109.43 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.85 -35.23 72.33 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.313 0.577 . . . . 0.0 109.78 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.94 -36.94 75.71 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.79 -0.569 . . . . 0.0 109.92 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.44 -40.17 95.72 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.62 -0.675 . . . . 0.0 109.991 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.09 -45.21 88.74 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 179.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.3 t -65.52 -40.96 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.515 -0.991 . . . . 0.0 109.747 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.99 -48.83 80.84 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 23.8 mm -65.67 -34.97 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.406 -1.056 . . . . 0.0 109.71 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -62.29 -26.14 68.24 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.221 -0.925 . . . . 0.0 109.66 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.495 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 16.9 mt -79.58 -25.61 41.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.357 -0.84 . . . . 0.0 109.114 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.591 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 3.8 tp -131.52 53.54 11.88 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.453 -0.779 . . . . 0.0 110.921 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.591 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.5 Cg_endo -90.2 -20.75 1.02 Allowed 'Trans proline' 0 C--N 1.319 -1.016 0 C-N-CA 120.96 1.107 . . . . 0.0 110.749 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.04 -38.43 8.17 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.377 -0.827 . . . . 0.0 110.03 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.4 mtt85 . . . . . 0 N--CA 1.497 1.878 0 CA-C-O 117.916 -1.04 . . . . 0.0 110.218 179.76 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 . . . . . 0 N--CA 1.497 1.9 0 CA-C-O 121.306 0.575 . . . . 0.0 110.377 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.3 52.65 0.91 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.315 -0.865 . . . . 0.0 110.274 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.486 HG13 ' HB3' ' A' ' 6' ' ' ALA . 9.6 t 53.19 55.05 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.585 -0.697 . . . . 0.0 110.625 179.759 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.7 t -86.72 -19.39 29.23 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.245 -0.91 . . . . 0.0 110.929 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -144.89 40.14 1.25 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.519 -0.738 . . . . 0.0 110.269 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.486 ' HB3' HG13 ' A' ' 3' ' ' VAL . . . -97.31 31.84 2.38 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.249 -0.907 . . . . 0.0 111.013 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.57 84.92 0.2 Allowed Pre-proline 0 N--CA 1.502 2.146 0 O-C-N 121.506 -0.746 . . . . 0.0 110.887 179.691 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.64 98.87 0.9 Allowed 'Trans proline' 0 C--N 1.314 -1.255 0 O-C-N 123.627 1.33 . . . . 0.0 110.542 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.414 ' HA ' ' HB3' ' A' ' 12' ' ' TRP . 4.0 mpt_? -62.17 -31.69 72.22 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.539 -0.726 . . . . 0.0 110.704 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 27.6 m-90 -55.11 -40.15 70.17 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.664 -0.648 . . . . 0.0 110.416 179.91 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -98.82 -33.42 10.9 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.545 -0.722 . . . . 0.0 110.111 179.635 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.538 ' CZ3' HD22 ' A' ' 15' ' ' LEU . 68.3 t-105 -64.57 -25.76 68.11 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.406 -0.809 . . . . 0.0 110.839 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -60.0 -43.25 95.32 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.506 -0.746 . . . . 0.0 109.625 179.391 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.1 t -63.15 -34.24 77.19 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.307 0.575 . . . . 0.0 109.539 179.052 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.538 HD22 ' CZ3' ' A' ' 12' ' ' TRP . 6.2 tt -67.09 -42.27 84.9 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.798 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 tt -61.25 -40.31 93.59 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.65 -0.656 . . . . 0.0 109.885 179.276 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 tt -63.82 -32.0 73.37 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.609 0.719 . . . . 0.0 109.399 178.703 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.474 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -76.46 -32.81 58.63 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.285 0.564 . . . . 0.0 109.811 178.915 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.68 -40.54 92.5 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.668 -0.645 . . . . 0.0 110.178 179.537 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.19 -42.05 99.28 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.522 -0.736 . . . . 0.0 109.695 179.374 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.38 -38.5 96.38 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.288 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 18' ' ' LEU . 89.9 t -62.95 -41.41 92.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.535 -0.979 . . . . 0.0 109.841 179.5 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.96 -42.24 99.67 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.338 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.9 mt -67.67 -35.26 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.576 -0.955 . . . . 0.0 109.53 179.06 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 92.7 t80 -63.9 -22.46 66.93 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.354 -0.841 . . . . 0.0 110.006 178.916 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.538 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -83.77 -25.05 30.8 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.426 -0.796 . . . . 0.0 109.505 178.75 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.68 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.9 tp -125.65 44.75 1.22 Allowed Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.39 -0.819 . . . . 0.0 111.92 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.68 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 44.3 Cg_endo -88.99 -46.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.322 -0.831 0 O-C-N 122.868 0.931 . . . . 0.0 110.077 179.437 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -109.11 7.69 25.72 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.622 -0.674 . . . . 0.0 110.524 179.152 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.7 mmt85 . . . . . 0 N--CA 1.502 2.14 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.697 -179.764 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 . . . . . 0 N--CA 1.495 1.783 0 CA-C-O 121.374 0.607 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.8 p -106.18 27.44 8.65 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.445 -0.784 . . . . 0.0 110.643 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.2 t 49.54 47.38 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 O-C-N 121.593 -0.692 . . . . 0.0 110.474 -179.951 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.7 t -85.33 -17.64 36.21 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.272 -0.893 . . . . 0.0 110.963 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -107.85 33.13 4.25 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.461 -0.775 . . . . 0.0 110.181 179.553 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -159.44 42.37 0.22 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.504 -0.748 . . . . 0.0 110.191 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.492 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -165.09 -61.47 0.01 OUTLIER Pre-proline 0 N--CA 1.498 1.949 0 O-C-N 121.465 -0.772 . . . . 0.0 110.369 -179.985 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.492 ' HD3' ' CB ' ' A' ' 7' ' ' ARG . 47.7 Cg_endo -74.17 144.17 33.13 Favored 'Trans proline' 0 N--CA 1.484 0.94 0 O-C-N 123.436 1.23 . . . . 0.0 110.502 179.698 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.56 -142.46 0.37 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.618 -0.676 . . . . 0.0 110.242 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 1.4 m95 64.71 -82.82 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.422 -0.798 . . . . 0.0 110.422 -179.654 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -65.09 -33.18 75.41 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.119 -0.988 . . . . 0.0 109.836 179.39 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.512 ' CZ3' HD22 ' A' ' 15' ' ' LEU . 49.3 t-105 -83.76 -21.51 32.18 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.384 -0.822 . . . . 0.0 110.089 179.129 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -62.26 -41.61 98.6 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.618 -0.676 . . . . 0.0 109.776 179.352 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.62 -35.62 81.59 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.78 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.512 HD22 ' CZ3' ' A' ' 12' ' ' TRP . 6.9 tt -63.93 -40.91 97.53 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.743 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 tt -63.39 -41.91 98.77 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.372 0.606 . . . . 0.0 109.853 179.136 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 tt -63.12 -36.42 83.53 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.669 0.747 . . . . 0.0 109.008 178.559 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -67.82 -35.71 79.1 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.258 0.551 . . . . 0.0 109.56 178.709 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.09 -39.88 95.03 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.679 -0.638 . . . . 0.0 109.732 179.17 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.55 -38.66 91.97 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.519 -0.738 . . . . 0.0 109.712 179.151 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.38 -37.48 90.43 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 179.292 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 18' ' ' LEU . 71.7 t -61.06 -39.21 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.307 -1.114 . . . . 0.0 109.534 179.242 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.439 ' HA2' HD12 ' A' ' 26' ' ' LEU . . . -66.0 -47.28 75.26 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.399 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 tp -68.0 -29.01 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.406 -1.055 . . . . 0.0 110.008 179.514 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -64.23 -21.63 66.65 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.288 -0.883 . . . . 0.0 109.81 178.703 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.469 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 12.6 mt -83.98 -21.3 31.78 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.323 -0.86 . . . . 0.0 109.685 178.891 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.674 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 5.5 tp -130.38 45.59 1.83 Allowed Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.322 -0.861 . . . . 0.0 111.668 179.772 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.674 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 47.1 Cg_endo -89.46 -45.84 0.03 OUTLIER 'Trans proline' 0 C--N 1.322 -0.828 0 O-C-N 122.946 0.972 . . . . 0.0 110.239 179.434 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -108.06 -37.05 6.16 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.659 -0.65 . . . . 0.0 109.936 179.551 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? . . . . . 0 N--CA 1.496 1.863 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.21 179.679 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.829 0 CA-C-O 120.924 0.392 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 t 67.42 89.59 0.1 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.606 -0.684 . . . . 0.0 110.224 -179.787 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.599 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 46.4 t -95.8 16.38 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.645 -0.659 . . . . 0.0 110.473 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.38 -26.58 66.53 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.182 -0.949 . . . . 0.0 110.282 179.304 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -105.5 35.55 2.82 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.692 -0.63 . . . . 0.0 110.028 179.444 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.996 ' HB1' ' HB2' ' A' ' 9' ' ' ARG . . . 56.74 66.54 1.16 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.713 -0.617 . . . . 0.0 110.335 -179.751 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.599 ' HB2' ' HA ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER -53.51 -52.04 70.47 Favored Pre-proline 0 N--CA 1.502 2.139 0 O-C-N 121.596 -0.69 . . . . 0.0 111.35 -179.779 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 7' ' ' ARG . 45.0 Cg_endo -70.83 -21.74 28.13 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 O-C-N 123.369 1.194 . . . . 0.0 111.006 179.884 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.996 ' HB2' ' HB1' ' A' ' 6' ' ' ALA . 18.3 mtt180 -91.73 -100.04 0.12 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.318 -0.864 . . . . 0.0 110.127 179.871 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 11.1 t90 51.38 63.71 2.13 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 -177.973 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 63.86 28.54 14.64 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 -175.371 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 3.0 m-90 47.01 45.39 15.59 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.805 0.812 . . . . 0.0 110.433 -178.51 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -79.72 -49.05 12.65 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.139 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.414 ' HB2' ' HA ' ' A' ' 8' ' ' PRO . 50.1 m -63.89 -35.36 80.41 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.459 0.647 . . . . 0.0 109.376 178.906 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.487 ' O ' HD13 ' A' ' 15' ' ' LEU . 2.6 tm? -67.26 -41.34 85.74 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.668 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.6 tt -63.97 -39.34 93.92 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.53 -0.731 . . . . 0.0 109.881 179.092 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.4 tt -60.65 -36.82 79.63 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.536 0.684 . . . . 0.0 109.393 178.924 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.7 tt -70.52 -35.56 73.25 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.385 0.612 . . . . 0.0 109.632 178.881 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.73 -35.43 72.68 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.733 -0.605 . . . . 0.0 109.956 179.275 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.77 -39.19 87.76 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.524 -0.735 . . . . 0.0 110.231 179.696 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.4 -47.59 82.78 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.566 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 88.2 t -65.72 -39.76 85.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.586 -0.95 . . . . 0.0 109.7 179.324 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.78 -44.7 94.4 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.615 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 26.3 mt -65.17 -36.82 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.361 -1.082 . . . . 0.0 109.955 179.582 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -64.54 -26.27 68.35 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.137 -0.977 . . . . 0.0 109.599 178.898 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.488 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.4 mm? -78.32 -26.64 46.94 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.002 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.565 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 5.9 tp -131.74 55.81 20.46 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.549 -0.719 . . . . 0.0 110.874 179.579 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.565 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.9 Cg_endo -90.24 -21.72 0.87 Allowed 'Trans proline' 0 C--N 1.318 -1.044 0 C-N-CA 121.038 1.158 . . . . 0.0 111.049 -179.948 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 -68.11 -36.36 79.63 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.388 -0.82 . . . . 0.0 110.207 179.595 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.147 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.207 179.791 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 . . . . . 0 N--CA 1.496 1.828 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.73 27.32 6.46 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.444 -0.785 . . . . 0.0 110.894 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.4 t -117.93 50.85 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.153 -0.967 . . . . 0.0 109.93 179.539 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.2 t -83.94 -41.19 17.62 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.173 -0.954 . . . . 0.0 109.973 179.7 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -139.63 29.02 2.16 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.868 -0.52 . . . . 0.0 110.305 179.533 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 52.65 51.37 16.19 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.477 -0.764 . . . . 0.0 110.72 -179.921 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 38.8 mtt85 53.95 75.62 0.6 Allowed Pre-proline 0 N--CA 1.501 2.107 0 O-C-N 121.81 -0.556 . . . . 0.0 110.766 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.481 ' HG2' ' CE2' ' A' ' 10' ' ' TRP . 43.8 Cg_endo -71.0 148.27 56.7 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.753 1.396 . . . . 0.0 110.582 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 62.8 mtt85 -104.65 20.51 18.5 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.648 -0.657 . . . . 0.0 111.0 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.59 ' N ' ' CD1' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -40.8 -84.69 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.506 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.594 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -83.34 22.28 1.04 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.675 -1.265 . . . . 0.0 111.209 -179.547 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.56 ' NE1' HD12 ' A' ' 16' ' ' LEU . 26.0 t-105 -103.51 -23.02 13.54 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.126 -0.984 . . . . 0.0 110.36 179.527 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -56.27 -46.96 79.47 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.401 -0.812 . . . . 0.0 109.92 179.649 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.5 p -63.95 -37.98 89.4 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.369 0.605 . . . . 0.0 109.753 179.156 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.454 ' HB3' ' CE3' ' A' ' 12' ' ' TRP . 1.6 tp -67.25 -41.42 85.64 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.801 -0.562 . . . . 0.0 109.527 179.115 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.56 HD12 ' NE1' ' A' ' 12' ' ' TRP . 3.9 tt -63.47 -39.1 93.55 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.577 -0.702 . . . . 0.0 109.669 178.992 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.0 tt -62.11 -37.3 84.58 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.571 0.701 . . . . 0.0 109.435 178.768 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.543 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.8 tt -68.29 -36.55 79.53 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.249 0.547 . . . . 0.0 109.58 178.876 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.6 -38.75 90.36 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.792 -0.568 . . . . 0.0 109.797 179.118 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.8 -38.44 91.09 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.528 -0.733 . . . . 0.0 109.851 179.224 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.42 -38.15 93.3 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.299 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 18' ' ' LEU . 94.2 t -60.99 -44.17 97.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.473 -1.016 . . . . 0.0 109.677 179.403 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.91 -44.48 95.99 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.347 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 67.5 mt -65.93 -35.06 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.461 -1.023 . . . . 0.0 109.735 179.41 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -62.61 -26.76 68.78 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.215 -0.928 . . . . 0.0 109.524 178.744 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.438 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 6.1 mt -78.81 -23.6 45.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.385 -0.822 . . . . 0.0 108.98 178.206 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.571 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.5 tp -134.85 56.54 17.43 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.444 -0.785 . . . . 0.0 110.633 179.34 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.571 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.9 Cg_endo -91.09 -21.33 0.69 Allowed 'Trans proline' 0 C--N 1.316 -1.133 0 C-N-CA 121.084 1.189 . . . . 0.0 111.202 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -97.92 6.15 48.07 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.292 -0.88 . . . . 0.0 110.658 179.594 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 118.142 -0.932 . . . . 0.0 110.196 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 . . . . . 0 N--CA 1.498 1.969 0 CA-C-O 120.966 0.413 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.5 p -130.3 32.43 4.47 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.254 -0.904 . . . . 0.0 110.726 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.448 ' O ' HG12 ' A' ' 3' ' ' VAL . 22.6 t 50.59 48.01 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.463 -0.773 . . . . 0.0 110.347 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 t -90.08 -28.39 19.04 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.245 -0.909 . . . . 0.0 110.521 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -128.25 33.95 4.64 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.71 -0.619 . . . . 0.0 110.418 179.777 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -124.01 37.51 4.39 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.363 -0.836 . . . . 0.0 110.286 179.59 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.63 84.65 8.23 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.358 -0.839 . . . . 0.0 110.131 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.71 -23.04 26.91 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.58 1.305 . . . . 0.0 111.658 -179.552 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.542 ' HG2' ' HB2' ' A' ' 12' ' ' TRP . 4.0 ttt85 -100.6 18.67 18.61 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.242 -0.911 . . . . 0.0 111.396 -179.7 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 4.9 p-90 -73.37 -28.92 62.29 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.157 -0.964 . . . . 0.0 111.053 -179.856 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.92 19.39 19.49 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.253 -0.905 . . . . 0.0 110.475 179.556 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.542 ' HB2' ' HG2' ' A' ' 9' ' ' ARG . 57.0 m95 -105.02 10.86 33.93 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.218 -0.926 . . . . 0.0 110.652 179.615 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -73.43 -42.59 61.83 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.332 -0.855 . . . . 0.0 109.357 179.223 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.1 m -64.74 -35.1 79.96 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.691 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.478 HD13 ' C ' ' A' ' 15' ' ' LEU . 2.9 tm? -63.73 -40.57 97.08 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.614 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.66 -40.12 96.04 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.369 0.604 . . . . 0.0 109.752 178.801 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.54 -34.84 76.24 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.469 0.652 . . . . 0.0 109.576 178.88 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.602 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.9 OUTLIER -74.37 -32.62 62.82 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.119 0.485 . . . . 0.0 109.999 178.987 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.84 -41.73 96.41 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.703 -0.623 . . . . 0.0 110.015 179.392 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.29 95.07 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.532 -0.73 . . . . 0.0 109.686 179.21 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.28 -37.58 94.71 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.338 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 18' ' ' LEU . 76.8 t -62.34 -41.8 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.416 -1.05 . . . . 0.0 109.724 179.415 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.75 -41.44 98.92 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.317 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 51.0 mt -66.59 -37.88 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.389 -1.065 . . . . 0.0 109.71 179.501 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -64.2 -26.19 68.4 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.182 -0.948 . . . . 0.0 109.646 178.988 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.47 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.5 mm? -79.08 -25.25 43.1 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.98 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.571 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 3.5 tp -133.05 55.04 15.1 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.662 -0.649 . . . . 0.0 110.863 179.678 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.571 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.2 Cg_endo -90.82 -20.8 0.82 Allowed 'Trans proline' 0 C--N 1.319 -1.023 0 C-N-CA 120.963 1.109 . . . . 0.0 111.063 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -76.45 -23.58 53.91 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.316 -0.865 . . . . 0.0 110.761 179.894 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 45.0 mtt-85 . . . . . 0 N--CA 1.496 1.864 0 CA-C-O 117.884 -1.055 . . . . 0.0 110.255 -179.912 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 5.0 m80 . . . . . 0 N--CA 1.495 1.793 0 CA-C-O 120.747 0.308 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.4 p 40.39 56.72 2.64 Favored 'General case' 0 N--CA 1.505 2.28 0 CA-C-O 121.314 0.578 . . . . 0.0 111.408 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.449 ' O ' ' CB ' ' A' ' 4' ' ' SER . 29.1 m -96.64 29.95 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 O-C-N 121.427 -0.796 . . . . 0.0 110.821 179.832 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.449 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 2.0 t 76.57 -49.21 0.57 Allowed 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.898 -0.502 . . . . 0.0 110.727 -179.697 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -95.29 30.17 2.29 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.764 -0.585 . . . . 0.0 110.493 179.48 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.42 ' HB2' HG22 ' A' ' 3' ' ' VAL . . . -100.8 26.09 7.23 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.385 -0.822 . . . . 0.0 110.686 179.775 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.523 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -75.45 -49.53 3.8 Favored Pre-proline 0 N--CA 1.498 1.931 0 O-C-N 121.126 -0.984 . . . . 0.0 110.66 179.53 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 7' ' ' ARG . 46.3 Cg_endo -73.63 -167.47 0.38 Allowed 'Trans proline' 0 N--CA 1.488 1.148 0 O-C-N 123.499 1.263 . . . . 0.0 110.438 179.788 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 64.71 31.68 11.74 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.507 -0.745 . . . . 0.0 110.54 -179.513 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -47.63 26.04 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.388 -0.82 . . . . 0.0 110.431 179.778 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -75.03 -28.36 60.42 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.479 -0.763 . . . . 0.0 110.708 -179.993 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.418 ' CZ3' HD13 ' A' ' 15' ' ' LEU . 88.8 m95 -84.28 -0.03 50.83 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.198 -0.939 . . . . 0.0 111.422 -179.6 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -65.06 -40.31 94.53 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.177 -0.952 . . . . 0.0 110.036 179.374 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.7 m -64.16 -36.78 85.18 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.38 0.61 . . . . 0.0 109.403 178.978 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.418 HD13 ' CZ3' ' A' ' 12' ' ' TRP . 2.3 tt -64.23 -42.37 96.57 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.858 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.9 tt -65.68 -37.44 86.5 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.637 -0.665 . . . . 0.0 109.838 179.136 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.8 tp -63.08 -36.06 82.32 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.573 0.702 . . . . 0.0 109.284 178.633 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.524 ' O ' HG23 ' A' ' 22' ' ' VAL . 7.5 tp -69.04 -36.87 78.19 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.883 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.1 -39.69 95.43 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.865 -0.522 . . . . 0.0 109.652 179.112 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.06 -39.86 90.44 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.626 -0.671 . . . . 0.0 109.729 179.221 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.42 -40.12 98.5 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.417 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 18' ' ' LEU . 98.7 t -63.24 -37.36 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.486 -1.008 . . . . 0.0 109.684 179.336 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.51 -46.94 92.48 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.371 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.7 mt -76.7 -27.68 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.381 -1.07 . . . . 0.0 109.812 179.204 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -60.94 -23.63 65.44 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.035 -1.041 . . . . 0.0 109.696 178.966 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.483 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.9 mm? -79.47 -24.37 42.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.256 -0.903 . . . . 0.0 109.177 178.476 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.59 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.5 tp -132.15 53.73 12.1 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.48 -0.762 . . . . 0.0 110.961 179.718 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.59 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.3 Cg_endo -89.67 -21.2 1.11 Allowed 'Trans proline' 0 C--N 1.318 -1.065 0 C-N-CA 120.947 1.098 . . . . 0.0 111.005 -179.875 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -75.13 -30.77 60.9 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.398 -0.814 . . . . 0.0 110.439 179.634 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 . . . . . 0 N--CA 1.503 2.192 0 CA-C-O 118.348 -0.834 . . . . 0.0 111.094 179.799 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 121.133 0.492 . . . . 0.0 110.416 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.2 m -125.02 27.97 6.55 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.484 -0.76 . . . . 0.0 110.821 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.9 p -126.05 19.3 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.241 -0.912 . . . . 0.0 110.75 179.675 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.9 t -82.65 -25.49 33.04 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.222 -0.924 . . . . 0.0 110.631 179.783 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 33.4 p80 -66.67 -20.86 66.08 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.656 -0.652 . . . . 0.0 110.951 179.672 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -96.42 45.74 1.06 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.348 -0.845 . . . . 0.0 109.884 179.699 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -121.78 81.04 41.14 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.383 -0.823 . . . . 0.0 110.238 -179.9 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.46 93.07 0.75 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.837 1.44 . . . . 0.0 110.008 179.772 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.4 mtm105 56.61 33.61 23.03 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 121.353 0.596 . . . . 0.0 110.474 -179.019 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 28.7 t-105 -66.29 140.43 58.12 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.515 -0.74 . . . . 0.0 110.332 179.861 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.7 t80 66.87 8.76 6.28 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.849 -0.532 . . . . 0.0 111.347 -179.695 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 22.1 m95 -120.69 2.24 10.61 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.017 -1.052 . . . . 0.0 110.848 179.681 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -69.77 -43.29 72.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.309 -0.869 . . . . 0.0 109.707 179.399 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.2 p -64.02 -34.77 78.77 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 178.658 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.9 tt -64.35 -42.99 95.95 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.468 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 tt -62.63 -38.76 91.52 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.664 -0.648 . . . . 0.0 109.886 179.114 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 tt -61.4 -37.48 83.57 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.553 0.692 . . . . 0.0 109.319 178.838 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.543 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.6 tt -70.13 -38.08 75.45 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.342 0.592 . . . . 0.0 109.63 178.917 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.36 -37.84 86.23 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.747 -0.595 . . . . 0.0 109.894 179.327 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.89 -42.21 99.69 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.612 -0.68 . . . . 0.0 109.97 179.462 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.31 -38.87 96.95 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.441 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 18' ' ' LEU . 91.2 t -64.2 -40.67 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.49 -1.006 . . . . 0.0 109.757 179.506 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.54 -42.04 99.01 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.51 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.2 mt -65.66 -36.67 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.423 -1.046 . . . . 0.0 109.821 179.527 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -64.93 -26.53 68.35 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.216 -0.927 . . . . 0.0 109.681 178.889 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.499 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.9 mm? -80.0 -24.76 40.64 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.367 -0.833 . . . . 0.0 108.99 178.29 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.596 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 1.2 tp -131.93 53.43 11.38 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.558 -0.714 . . . . 0.0 111.032 179.736 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.596 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 43.4 Cg_endo -91.53 -18.93 0.88 Allowed 'Trans proline' 0 C--N 1.318 -1.035 0 C-N-CA 121.002 1.134 . . . . 0.0 111.144 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.33 7.05 46.0 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.322 -0.861 . . . . 0.0 111.234 -179.77 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 117.808 -1.091 . . . . 0.0 110.289 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 10.5 m80 . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 121.04 0.448 . . . . 0.0 110.412 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.502 ' HB2' ' HB3' ' A' ' 6' ' ' ALA . 10.9 p -150.92 50.2 0.85 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.503 -0.748 . . . . 0.0 110.334 -179.829 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.467 HG22 ' HB2' ' A' ' 6' ' ' ALA . 32.2 m 35.51 42.31 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.588 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.977 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 1.4 t 73.89 -30.51 0.21 Allowed 'General case' 0 N--CA 1.509 2.523 0 O-C-N 121.837 -0.539 . . . . 0.0 112.445 179.512 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -166.69 82.2 0.25 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.156 -0.965 . . . . 0.0 110.271 -179.747 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.502 ' HB3' ' HB2' ' A' ' 2' ' ' SER . . . -104.02 37.23 2.11 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.656 -0.653 . . . . 0.0 110.508 179.886 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.9 ttp180 68.1 132.43 0.04 OUTLIER Pre-proline 0 N--CA 1.504 2.245 0 O-C-N 121.793 -0.567 . . . . 0.0 111.177 179.732 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.99 102.66 1.48 Allowed 'Trans proline' 0 C--N 1.314 -1.244 0 O-C-N 123.632 1.333 . . . . 0.0 110.798 -179.945 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.6 mtp85 -65.91 -24.07 66.76 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.478 -0.764 . . . . 0.0 110.82 179.91 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.472 ' O ' ' CB ' ' A' ' 11' ' ' PHE . 1.1 m-90 -53.36 152.01 5.01 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.599 -0.688 . . . . 0.0 110.176 179.768 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.472 ' CB ' ' O ' ' A' ' 10' ' ' TRP . 16.0 t80 77.58 -42.54 0.38 Allowed 'General case' 0 N--CA 1.508 2.475 0 O-C-N 122.069 -0.395 . . . . 0.0 110.554 -179.086 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.428 ' CZ3' HD13 ' A' ' 15' ' ' LEU . 20.7 m95 -76.62 6.02 6.57 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.134 -0.979 . . . . 0.0 111.468 179.651 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -62.21 -39.44 92.77 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.018 -1.051 . . . . 0.0 110.08 179.626 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.5 t -62.98 -35.26 79.59 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.516 0.674 . . . . 0.0 109.425 178.882 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.428 HD13 ' CZ3' ' A' ' 12' ' ' TRP . 1.2 tt -68.25 -41.9 80.48 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.907 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 tt -63.78 -38.72 92.15 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.675 -0.641 . . . . 0.0 110.019 179.43 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 tt -62.03 -34.13 75.64 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.488 0.661 . . . . 0.0 109.474 178.846 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.543 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.5 tt -70.91 -38.16 72.95 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.238 0.542 . . . . 0.0 109.65 178.983 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.67 -39.56 93.89 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.799 -0.563 . . . . 0.0 109.807 179.284 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.75 -39.95 95.75 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.635 -0.666 . . . . 0.0 109.897 179.391 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.55 -37.42 94.39 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.398 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 18' ' ' LEU . 90.4 t -63.07 -41.35 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.53 -0.982 . . . . 0.0 109.685 179.471 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.31 -42.66 97.69 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.398 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.4 mt -66.36 -36.27 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.413 -1.051 . . . . 0.0 109.809 179.45 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -63.76 -27.59 69.3 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.32 -0.862 . . . . 0.0 109.8 179.085 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.481 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 3.8 mt -81.25 -21.65 39.3 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.425 -0.797 . . . . 0.0 109.16 178.306 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.628 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.1 OUTLIER -133.18 51.98 7.85 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.524 -0.735 . . . . 0.0 110.896 179.82 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.628 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 45.7 Cg_endo -92.89 -17.64 0.72 Allowed 'Trans proline' 0 C--N 1.32 -0.936 0 C-N-CA 121.101 1.201 . . . . 0.0 111.329 -179.742 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -68.54 -37.11 79.7 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.307 -0.87 . . . . 0.0 110.706 -179.493 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.7 mmt85 . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 117.851 -1.071 . . . . 0.0 110.281 -179.974 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.4 t60 . . . . . 0 N--CA 1.499 1.983 0 CA-C-O 120.737 0.303 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.7 p -113.2 45.68 1.35 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.06 -1.025 . . . . 0.0 110.15 179.903 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.482 ' O ' HG12 ' A' ' 3' ' ' VAL . 17.9 t 58.74 17.87 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.688 -0.633 . . . . 0.0 111.114 -179.535 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.15 -16.65 14.22 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.005 -1.06 . . . . 0.0 110.613 179.438 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -102.83 39.68 1.5 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.518 -0.739 . . . . 0.0 109.993 179.568 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -105.02 1.7 28.85 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.4 -0.813 . . . . 0.0 111.244 -179.961 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.515 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -61.9 -50.03 82.99 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 121.29 -0.881 . . . . 0.0 110.321 179.504 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 7' ' ' ARG . 48.9 Cg_endo -75.26 -174.61 2.03 Favored 'Trans proline' 0 N--CA 1.485 0.975 0 O-C-N 123.503 1.265 . . . . 0.0 110.131 179.359 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 23.1 mtt180 -88.19 21.99 2.6 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.344 -0.848 . . . . 0.0 111.01 179.656 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -71.98 -67.42 0.54 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.065 -1.022 . . . . 0.0 109.948 179.838 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.48 -26.82 58.51 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.478 -0.764 . . . . 0.0 110.132 179.293 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 65.5 t-105 -79.69 -6.35 57.01 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.564 -0.71 . . . . 0.0 111.315 -179.911 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -53.63 -51.75 62.1 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.104 -0.997 . . . . 0.0 110.406 179.772 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.3 p -58.74 -36.16 73.88 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.296 0.569 . . . . 0.0 109.992 179.515 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.472 HD22 ' HA ' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -69.3 -45.56 69.27 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.834 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.52 -36.52 84.07 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.565 -0.709 . . . . 0.0 109.665 178.98 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.4 tt -62.74 -37.26 85.88 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.589 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.5 tp -68.61 -37.68 79.96 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.425 0.631 . . . . 0.0 109.706 178.86 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.23 -35.42 77.91 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.819 -0.551 . . . . 0.0 109.943 179.198 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.94 -40.02 87.45 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.55 -0.719 . . . . 0.0 110.283 179.589 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.36 -46.64 90.02 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.577 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 76.5 t -66.06 -40.88 88.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.557 -0.966 . . . . 0.0 109.665 179.363 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.17 -47.14 88.13 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.59 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 35.2 mt -64.48 -33.72 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.435 -1.038 . . . . 0.0 109.885 179.542 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -63.65 -27.22 69.07 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.031 -1.043 . . . . 0.0 109.678 178.87 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.483 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.7 OUTLIER -79.14 -25.25 42.92 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.446 -0.784 . . . . 0.0 108.94 178.229 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.566 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.5 tp -132.95 56.63 23.09 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.539 -0.725 . . . . 0.0 110.714 179.498 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.566 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.5 Cg_endo -91.92 -20.39 0.65 Allowed 'Trans proline' 0 C--N 1.318 -1.048 0 C-N-CA 121.143 1.229 . . . . 0.0 111.496 -179.837 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -78.05 -37.48 46.66 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.109 -0.994 . . . . 0.0 110.612 -179.979 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.914 0 O-C-N 121.336 -0.853 . . . . 0.0 110.747 179.959 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 . . . . . 0 N--CA 1.496 1.833 0 CA-C-O 120.934 0.397 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.23 53.53 1.55 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.463 -0.773 . . . . 0.0 110.496 -179.821 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.7 t 52.42 57.47 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.625 -0.672 . . . . 0.0 110.772 179.618 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.5 t -81.58 -15.62 54.18 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.13 -0.981 . . . . 0.0 111.166 179.771 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -104.04 18.8 21.29 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.24 -0.912 . . . . 0.0 110.65 179.734 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -163.79 60.56 0.16 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.179 -0.951 . . . . 0.0 109.883 179.826 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.47 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -58.69 -53.36 67.1 Favored Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 121.509 -0.744 . . . . 0.0 111.582 -179.604 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 7' ' ' ARG . 43.2 Cg_endo -70.46 -92.03 0.01 OUTLIER 'Trans proline' 0 N--CA 1.487 1.116 0 O-C-N 123.56 1.295 . . . . 0.0 110.453 -179.717 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.448 ' C ' ' O ' ' A' ' 8' ' ' PRO . 10.6 ttt-85 31.38 -105.84 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.641 -0.662 . . . . 0.0 111.84 179.775 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.477 ' O ' ' HB2' ' A' ' 11' ' ' PHE . 3.3 m95 49.55 66.31 1.16 Allowed 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 -177.969 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.477 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 94.8 m-85 62.51 31.25 17.1 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -175.618 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER 46.64 35.55 3.09 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.563 0.697 . . . . 0.0 110.463 -178.337 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -79.76 -52.02 8.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.606 -0.684 . . . . 0.0 109.3 179.205 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.9 m -60.65 -32.92 72.08 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.757 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.504 HD22 ' HA ' ' A' ' 15' ' ' LEU . 0.3 OUTLIER -67.84 -41.02 83.6 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.8 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.1 tt -65.26 -39.45 92.65 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.566 -0.709 . . . . 0.0 109.953 179.225 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 tt -62.18 -35.33 78.49 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.511 0.672 . . . . 0.0 109.369 178.845 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.522 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.1 tt -69.2 -39.09 78.86 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.324 0.583 . . . . 0.0 109.5 178.778 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.34 -37.92 89.19 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.851 -0.531 . . . . 0.0 109.704 179.207 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.5 -40.04 96.02 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.575 -0.703 . . . . 0.0 109.905 179.249 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.6 -36.98 93.81 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.384 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 18' ' ' LEU . 95.5 t -63.81 -41.41 92.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.55 -0.97 . . . . 0.0 109.751 179.478 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.17 -41.45 98.37 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.372 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 29.8 mm -66.52 -34.86 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.467 -1.019 . . . . 0.0 109.779 179.293 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -63.49 -26.13 68.58 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.277 -0.889 . . . . 0.0 109.654 178.76 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.482 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.9 OUTLIER -79.84 -24.73 41.11 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.356 -0.84 . . . . 0.0 109.037 178.237 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.602 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 14.6 tp -132.13 53.21 10.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.499 -0.751 . . . . 0.0 110.97 179.583 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.602 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.2 Cg_endo -90.23 -21.31 0.93 Allowed 'Trans proline' 0 C--N 1.32 -0.93 0 O-C-N 123.183 1.096 . . . . 0.0 111.005 179.893 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -82.85 -37.17 24.75 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.381 -0.824 . . . . 0.0 110.216 179.664 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.501 2.079 0 CA-C-O 118.069 -0.967 . . . . 0.0 111.024 179.93 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 . . . . . 0 N--CA 1.495 1.803 0 CA-C-O 121.028 0.442 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.7 39.7 3.57 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.507 -0.746 . . . . 0.0 110.451 179.862 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.4 t 52.6 52.82 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.628 -0.67 . . . . 0.0 110.609 179.852 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.8 t -90.04 -39.69 12.77 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.183 -0.948 . . . . 0.0 110.283 179.682 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 48.7 t60 -98.45 2.15 47.45 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.789 -0.569 . . . . 0.0 110.656 179.579 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 48.59 49.78 18.01 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.547 -0.721 . . . . 0.0 110.746 179.819 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpt85 68.38 121.81 0.03 OUTLIER Pre-proline 0 N--CA 1.503 2.177 0 O-C-N 121.945 -0.472 . . . . 0.0 110.644 -179.773 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -74.0 -105.3 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.182 0 O-C-N 123.708 1.372 . . . . 0.0 110.863 -179.764 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.8 ptp85 -173.83 -163.67 0.18 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.813 -1.179 . . . . 0.0 109.829 -179.798 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER 66.26 125.34 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 CA-C-O 121.263 0.554 . . . . 0.0 110.547 -179.912 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 58.79 17.09 4.93 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.597 -0.689 . . . . 0.0 110.848 -179.298 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.576 ' CZ3' HD13 ' A' ' 15' ' ' LEU . 58.3 t-105 -123.46 -21.22 5.35 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.087 -1.008 . . . . 0.0 110.936 -179.944 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -61.5 -40.46 94.68 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.305 -0.872 . . . . 0.0 109.89 179.482 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.9 m -61.42 -36.08 79.34 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.378 0.609 . . . . 0.0 109.397 178.952 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.576 HD13 ' CZ3' ' A' ' 12' ' ' TRP . 5.7 tt -67.01 -42.94 84.12 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.757 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.501 ' C ' HD13 ' A' ' 16' ' ' LEU . 3.1 tm? -62.91 -40.48 97.72 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.693 -0.629 . . . . 0.0 109.937 179.216 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.8 tt -60.99 -36.59 79.86 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.637 0.732 . . . . 0.0 109.426 178.889 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.544 ' O ' HG23 ' A' ' 22' ' ' VAL . 4.6 tp -72.6 -34.17 67.21 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.211 0.529 . . . . 0.0 109.903 178.984 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.71 -42.63 97.6 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.76 -0.588 . . . . 0.0 109.964 179.511 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.87 -39.83 95.13 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.53 -0.731 . . . . 0.0 109.928 179.235 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.56 -39.35 93.88 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.506 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 18' ' ' LEU . 78.8 t -60.89 -43.37 95.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.503 -0.998 . . . . 0.0 109.996 179.619 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.42 -43.92 98.37 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.496 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.7 mt -66.46 -37.08 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.46 -1.023 . . . . 0.0 109.753 179.446 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -62.45 -26.24 68.41 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.293 -0.879 . . . . 0.0 109.982 179.213 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.482 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 13.4 mt -81.61 -22.43 37.66 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.355 -0.841 . . . . 0.0 109.224 178.349 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.622 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.1 OUTLIER -132.5 51.75 7.73 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.581 -0.699 . . . . 0.0 110.812 179.731 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.622 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.9 Cg_endo -91.11 -45.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.32 -0.943 0 O-C-N 123.048 1.025 . . . . 0.0 110.822 -179.997 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -107.74 -37.15 6.22 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.492 -0.755 . . . . 0.0 110.148 179.796 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.137 179.756 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.07 0.462 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.7 p -111.2 37.73 2.76 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.543 -0.723 . . . . 0.0 110.668 -179.837 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.401 HG12 ' O ' ' A' ' 3' ' ' VAL . 11.3 t 52.84 39.68 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 O-C-N 121.539 -0.726 . . . . 0.0 110.899 179.833 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.7 t -104.03 -15.06 15.71 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.139 -0.976 . . . . 0.0 111.045 179.799 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -111.5 38.7 2.52 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.407 -0.808 . . . . 0.0 110.381 179.971 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -108.15 42.42 1.37 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.25 -0.906 . . . . 0.0 110.0 179.671 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.36 84.44 0.2 Allowed Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 121.733 -0.604 . . . . 0.0 110.566 -179.786 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.03 -170.26 0.68 Allowed 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.732 1.385 . . . . 0.0 110.498 179.849 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.623 ' HB3' ' HB2' ' A' ' 12' ' ' TRP . 12.7 ttt180 -140.9 167.4 22.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.143 -0.973 . . . . 0.0 110.433 179.712 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 40.6 m0 -61.73 -59.36 5.28 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.379 -0.825 . . . . 0.0 109.879 179.779 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -69.13 -18.07 63.91 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.445 -0.784 . . . . 0.0 109.981 178.828 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.623 ' HB2' ' HB3' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -54.82 -44.57 73.98 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.466 -0.772 . . . . 0.0 110.109 179.323 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -64.97 -35.8 82.36 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.67 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.7 m -66.75 -34.15 77.19 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.507 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.531 HD22 ' HZ3' ' A' ' 12' ' ' TRP . 4.2 tt -65.63 -41.62 92.45 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.707 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 tt -66.87 -39.4 87.51 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.719 -0.613 . . . . 0.0 109.83 179.071 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.3 -33.61 75.9 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.496 0.665 . . . . 0.0 109.385 178.885 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.517 ' O ' HG23 ' A' ' 22' ' ' VAL . 5.3 tp -72.42 -36.91 68.72 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.24 0.543 . . . . 0.0 109.61 178.902 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.47 -41.79 94.92 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.809 -0.557 . . . . 0.0 109.73 179.258 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.78 -40.99 92.53 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.539 -0.726 . . . . 0.0 109.815 179.121 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.409 ' HA2' HD12 ' A' ' 24' ' ' ILE . . . -61.63 -41.09 99.52 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 179.38 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 18' ' ' LEU . 95.5 t -62.76 -40.03 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.568 -0.96 . . . . 0.0 109.801 179.418 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.456 ' HA2' HD12 ' A' ' 26' ' ' LEU . . . -59.69 -42.89 98.1 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.39 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.409 HD12 ' HA2' ' A' ' 21' ' ' GLY . 18.2 mt -68.61 -35.38 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.474 -1.015 . . . . 0.0 109.592 179.26 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -62.97 -27.03 69.12 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.204 -0.935 . . . . 0.0 109.613 178.824 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.456 HD12 ' HA2' ' A' ' 23' ' ' GLY . 13.5 mt -79.18 -18.27 53.36 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.379 -0.826 . . . . 0.0 109.314 178.359 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.588 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.9 tp -140.52 55.09 5.56 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.574 -0.704 . . . . 0.0 110.577 179.643 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.588 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.7 Cg_endo -91.18 -21.22 0.69 Allowed 'Trans proline' 0 C--N 1.319 -1.021 0 C-N-CA 121.106 1.204 . . . . 0.0 111.377 -179.582 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -98.71 -33.86 10.76 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.251 -0.906 . . . . 0.0 110.299 179.815 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.1 mtt180 . . . . . 0 N--CA 1.496 1.861 0 CA-C-O 117.916 -1.04 . . . . 0.0 110.284 179.842 . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 30.1 p80 . . . . . 0 N--CA 1.497 1.894 0 CA-C-O 121.11 0.481 . . . . 0.0 110.528 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.4 p -166.93 78.42 0.2 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.495 -0.753 . . . . 0.0 110.359 -179.977 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.434 ' O ' HG12 ' A' ' 3' ' ' VAL . 21.7 t -100.12 45.03 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.264 -0.897 . . . . 0.0 109.707 179.695 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.4 t -82.75 -34.22 27.21 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.265 -0.897 . . . . 0.0 110.377 179.959 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -128.86 40.3 3.66 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.659 -0.651 . . . . 0.0 109.963 179.807 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -129.51 61.02 1.56 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.431 -0.793 . . . . 0.0 110.236 -179.953 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.28 72.67 19.51 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.361 -0.837 . . . . 0.0 110.079 179.735 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -76.37 78.89 3.12 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 O-C-N 123.715 1.376 . . . . 0.0 110.632 -179.768 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.5 ttp-105 60.37 28.88 18.53 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.621 -0.674 . . . . 0.0 110.659 -179.821 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -77.49 -40.09 44.13 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.256 -0.902 . . . . 0.0 110.116 179.816 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -77.86 -28.87 50.15 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.484 -0.76 . . . . 0.0 110.325 179.576 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 46.9 m95 -80.27 9.45 5.72 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.37 -0.831 . . . . 0.0 111.515 -179.654 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -61.1 -44.82 96.76 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.169 -0.957 . . . . 0.0 109.511 179.193 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 56.8 p -63.57 -36.34 83.49 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.679 0.752 . . . . 0.0 109.315 178.651 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.423 HD22 ' HA ' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -66.34 -41.59 89.37 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.943 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.2 tt -64.72 -37.69 88.45 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.533 -0.73 . . . . 0.0 109.85 179.081 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.01 -35.11 79.13 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.609 0.718 . . . . 0.0 109.291 178.74 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.0 tp -71.83 -37.78 70.26 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.263 0.554 . . . . 0.0 109.753 179.025 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.87 -40.44 97.5 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.734 -0.604 . . . . 0.0 109.834 179.305 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.65 -37.39 87.17 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.629 -0.669 . . . . 0.0 109.884 179.311 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.98 -40.68 93.43 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.453 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.7 t -60.49 -42.24 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.505 -0.997 . . . . 0.0 109.802 179.496 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.21 -44.18 95.98 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.368 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.5 mt -65.22 -34.53 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.447 -1.031 . . . . 0.0 109.775 179.434 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -62.94 -27.23 69.24 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.148 -0.97 . . . . 0.0 109.497 178.754 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.1 mt -79.56 -17.7 53.37 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.428 -0.795 . . . . 0.0 109.353 178.303 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.605 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.7 tp -141.44 54.9 4.6 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.57 -0.706 . . . . 0.0 110.5 179.495 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.605 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.1 Cg_endo -91.08 -20.8 0.75 Allowed 'Trans proline' 0 C--N 1.319 -0.999 0 C-N-CA 121.242 1.294 . . . . 0.0 111.249 -179.836 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -104.45 5.37 34.11 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.253 -0.905 . . . . 0.0 110.893 179.722 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.833 0 O-C-N 121.163 -0.961 . . . . 0.0 110.628 179.885 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 120.765 0.317 . . . . 0.0 110.223 . . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.0 m 55.99 41.25 30.02 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.554 -0.716 . . . . 0.0 110.81 -179.897 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.5 t 52.29 45.79 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.68 -0.638 . . . . 0.0 110.674 179.664 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.0 t -82.83 -21.13 34.55 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.238 -0.914 . . . . 0.0 110.908 179.961 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.7 m80 -126.11 57.12 1.4 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.402 -0.811 . . . . 0.0 110.136 -179.803 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -99.18 22.04 11.02 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.38 -0.825 . . . . 0.0 110.959 179.894 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.496 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -59.48 -51.54 80.53 Favored Pre-proline 0 N--CA 1.501 2.097 0 O-C-N 121.204 -0.935 . . . . 0.0 110.723 179.652 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 7' ' ' ARG . 48.8 Cg_endo -74.62 -14.39 22.13 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.528 1.278 . . . . 0.0 110.88 179.495 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.538 ' HB3' ' HB2' ' A' ' 13' ' ' PHE . 46.2 mmt-85 -89.7 -103.41 0.09 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.301 -0.874 . . . . 0.0 109.688 -179.928 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER 56.99 -82.09 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.501 -0.749 . . . . 0.0 111.283 179.519 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.401 ' N ' ' O ' ' A' ' 9' ' ' ARG . 90.7 m-85 -97.73 -34.17 11.01 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.122 -0.987 . . . . 0.0 109.496 179.535 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 72.7 t-105 -74.51 -11.71 60.29 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.585 -0.697 . . . . 0.0 110.511 179.267 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.538 ' HB2' ' HB3' ' A' ' 9' ' ' ARG . 56.1 t80 -59.38 -51.71 68.76 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.356 -0.84 . . . . 0.0 110.105 179.753 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.7 p -62.87 -37.54 87.28 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.022 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.13 -41.27 86.42 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.332 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 16' ' ' LEU . 2.9 tm? -65.38 -39.03 91.75 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.025 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.5 tp -61.16 -38.54 86.81 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.596 0.712 . . . . 0.0 109.09 178.606 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.506 ' O ' HG23 ' A' ' 22' ' ' VAL . 9.0 tp -67.83 -37.71 82.29 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.347 0.594 . . . . 0.0 109.453 178.779 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.63 -38.77 92.13 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.841 -0.537 . . . . 0.0 109.796 179.09 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.38 -38.67 91.85 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.587 -0.696 . . . . 0.0 110.054 179.398 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.69 -40.63 94.0 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.595 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 18' ' ' LEU . 99.3 t -61.54 -42.15 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.458 -1.025 . . . . 0.0 109.828 179.577 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.97 -45.53 92.05 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.528 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.2 mt -65.77 -35.14 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.422 -1.046 . . . . 0.0 109.717 179.478 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -63.7 -25.91 68.42 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.315 -0.865 . . . . 0.0 109.498 178.75 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.483 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.3 mm? -79.05 -27.11 43.11 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.203 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.57 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 8.8 tp -131.16 55.46 19.03 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.576 -0.703 . . . . 0.0 110.849 179.518 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.57 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 39.9 Cg_endo -88.88 -22.45 1.1 Allowed 'Trans proline' 0 C--N 1.318 -1.053 0 O-C-N 123.217 1.114 . . . . 0.0 110.561 179.647 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -103.38 -14.07 16.41 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.37 -0.831 . . . . 0.0 110.188 178.997 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.049 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.964 -179.99 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 . . . . . 0 N--CA 1.497 1.911 0 CA-C-O 120.97 0.414 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.2 m -105.26 27.38 8.32 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.487 -0.758 . . . . 0.0 110.922 -179.871 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.558 HG13 ' HG3' ' A' ' 7' ' ' ARG . 24.2 t 53.09 58.51 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.358 -0.839 . . . . 0.0 110.515 179.701 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.86 -24.45 55.73 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.22 -0.925 . . . . 0.0 110.581 179.705 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.467 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 6.0 t-80 -119.17 32.41 6.13 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.646 -0.659 . . . . 0.0 109.977 179.615 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 5' ' ' HIS . . . 58.84 32.54 22.32 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.71 -0.619 . . . . 0.0 110.961 -179.908 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.558 ' HG3' HG13 ' A' ' 3' ' ' VAL . 10.9 mtm180 51.62 72.14 1.3 Allowed Pre-proline 0 N--CA 1.502 2.138 0 O-C-N 121.538 -0.726 . . . . 0.0 110.884 179.695 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' A' ' 5' ' ' HIS . 51.6 Cg_endo -77.94 177.38 8.87 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.723 1.38 . . . . 0.0 110.593 179.853 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER 61.21 -78.1 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.216 0 O-C-N 122.029 -0.419 . . . . 0.0 111.347 179.662 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER 68.42 -68.09 0.18 Allowed 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.708 -0.62 . . . . 0.0 110.3 -179.529 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -97.09 -18.59 19.25 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.369 -0.832 . . . . 0.0 110.199 179.484 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.468 ' CE3' HD13 ' A' ' 15' ' ' LEU . 90.9 m95 -95.46 16.24 17.51 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.315 -0.866 . . . . 0.0 111.089 -179.934 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -64.61 -45.4 87.06 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.128 -0.982 . . . . 0.0 110.06 179.76 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.8 m -62.16 -37.43 85.19 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.435 0.636 . . . . 0.0 109.635 179.236 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.468 HD13 ' CE3' ' A' ' 12' ' ' TRP . 1.3 tt -65.88 -42.34 90.42 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.017 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.9 tt -63.53 -35.44 80.48 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.655 -0.653 . . . . 0.0 109.675 179.122 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.3 tp -63.55 -34.05 76.95 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.586 0.708 . . . . 0.0 109.304 178.525 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.7 tt -80.51 -38.63 29.41 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.497 0.665 . . . . 0.0 109.525 178.878 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.24 -35.06 78.78 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.849 -0.532 . . . . 0.0 110.376 179.613 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.36 -41.79 97.65 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.417 -0.802 . . . . 0.0 110.223 179.735 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.36 -46.92 66.48 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.632 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 77.9 t -64.61 -37.85 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.546 -0.973 . . . . 0.0 110.036 179.607 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.96 -46.97 92.99 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.704 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.3 mt -65.4 -35.14 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.384 -1.068 . . . . 0.0 109.925 179.605 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -64.99 -27.71 69.01 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.064 -1.022 . . . . 0.0 109.599 178.867 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.501 HD13 ' HA ' ' A' ' 26' ' ' LEU . 1.7 mm? -77.86 -25.34 48.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.321 -0.862 . . . . 0.0 108.689 178.016 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.544 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 5.6 tp -133.59 57.06 23.39 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.617 -0.677 . . . . 0.0 110.468 179.488 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.544 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 39.6 Cg_endo -89.89 -22.39 0.86 Allowed 'Trans proline' 0 C--N 1.318 -1.076 0 C-N-CA 121.111 1.207 . . . . 0.0 111.212 -179.666 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -67.23 -34.07 76.7 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.327 -0.858 . . . . 0.0 110.171 179.461 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.5 mtt180 . . . . . 0 N--CA 1.499 1.985 0 CA-C-O 118.743 -0.646 . . . . 0.0 110.563 179.966 . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 35.1 t60 . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 121.099 0.476 . . . . 0.0 110.351 . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.3 p -159.56 58.81 0.39 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.52 -0.737 . . . . 0.0 110.457 179.955 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.0 m -131.31 42.66 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.293 -0.88 . . . . 0.0 110.349 179.82 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.4 m -121.26 -85.79 0.66 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.421 -0.799 . . . . 0.0 110.282 179.957 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -132.12 42.36 3.14 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.364 -0.835 . . . . 0.0 110.193 179.804 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -118.09 56.86 0.85 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.474 -0.766 . . . . 0.0 109.934 179.88 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.432 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 6.1 ptp180 -73.67 132.13 81.25 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 121.425 -0.797 . . . . 0.0 110.437 -179.933 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 7' ' ' ARG . 51.6 Cg_endo -87.32 31.67 0.44 Allowed 'Trans proline' 0 C--N 1.315 -1.196 0 O-C-N 123.676 1.356 . . . . 0.0 111.37 179.907 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.8 mtt85 60.53 -177.45 0.1 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.486 -0.759 . . . . 0.0 110.789 -179.915 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 2.1 t90 69.44 134.33 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 121.226 0.536 . . . . 0.0 110.306 -179.419 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.8 t80 64.0 12.12 6.65 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.558 -0.714 . . . . 0.0 110.853 -179.232 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 41.2 m95 -126.5 13.49 7.58 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.269 -0.894 . . . . 0.0 110.433 179.646 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -69.12 -41.47 77.35 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.245 -0.91 . . . . 0.0 109.541 179.486 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.1 t -63.95 -34.09 77.19 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.427 0.632 . . . . 0.0 109.527 178.83 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 tt -69.38 -41.47 76.46 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.106 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 tt -66.81 -38.24 86.09 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.582 -0.698 . . . . 0.0 109.878 179.386 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.5 tp -62.78 -31.32 72.26 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.534 0.683 . . . . 0.0 109.518 178.814 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.586 ' O ' HG23 ' A' ' 22' ' ' VAL . 6.9 tp -75.61 -35.2 60.59 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.16 0.505 . . . . 0.0 109.956 179.167 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.37 -46.26 89.16 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.814 -0.554 . . . . 0.0 109.823 179.352 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.93 -37.53 84.49 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.537 -0.727 . . . . 0.0 109.782 179.199 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.9 -39.01 96.96 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.469 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 18' ' ' LEU . 84.1 t -60.35 -44.7 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.491 -1.005 . . . . 0.0 109.668 179.566 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.51 -41.93 99.74 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.411 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 31.1 mt -66.89 -35.35 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.449 -1.03 . . . . 0.0 109.801 179.469 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -62.49 -27.95 69.49 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.161 -0.962 . . . . 0.0 109.663 178.924 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.4 mt -80.6 -17.62 50.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.428 -0.795 . . . . 0.0 109.248 178.293 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.641 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -138.88 51.78 3.77 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.553 -0.717 . . . . 0.0 110.732 179.771 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.641 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 47.3 Cg_endo -92.86 -16.82 0.81 Allowed 'Trans proline' 0 C--N 1.32 -0.936 0 C-N-CA 121.126 1.217 . . . . 0.0 111.145 -179.663 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -69.02 -38.1 79.01 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.494 -0.754 . . . . 0.0 110.644 -179.47 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.6 mtt180 . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 117.866 -1.064 . . . . 0.0 110.201 179.956 . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 27.2 m80 . . . . . 0 N--CA 1.496 1.871 0 CA-C-O 121.062 0.458 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.9 m -116.66 52.86 0.91 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.478 -0.764 . . . . 0.0 110.157 179.905 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.1 t -110.49 50.1 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.409 -0.807 . . . . 0.0 110.021 -179.908 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.88 -29.02 19.96 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.253 -0.905 . . . . 0.0 110.559 179.651 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -127.68 44.16 2.98 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.541 -0.724 . . . . 0.0 110.19 179.779 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -95.8 42.24 1.09 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.371 -0.83 . . . . 0.0 110.412 179.781 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -83.35 154.47 66.25 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.328 -0.857 . . . . 0.0 110.372 179.92 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.0 92.21 0.72 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.999 1.526 . . . . 0.0 110.572 179.98 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 10' ' ' TRP . 8.3 ptt180 -148.26 158.57 44.16 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.51 -0.743 . . . . 0.0 110.226 179.951 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.41 ' HB2' ' O ' ' A' ' 9' ' ' ARG . 1.8 m-90 61.77 -78.48 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.322 0 O-C-N 122.006 -0.434 . . . . 0.0 110.89 -179.833 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -72.97 -8.37 55.36 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.294 -0.879 . . . . 0.0 111.19 179.911 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -74.6 -7.81 54.35 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.2 -0.937 . . . . 0.0 111.69 -179.883 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.92 -38.7 89.4 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.245 -0.909 . . . . 0.0 110.068 179.721 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.1 m -63.38 -38.72 92.23 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.44 0.638 . . . . 0.0 109.439 178.879 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 tt -63.26 -42.58 99.18 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.983 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 tt -65.27 -36.37 83.9 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.529 -0.732 . . . . 0.0 109.985 179.33 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.1 tp -64.28 -34.53 78.32 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.631 -0.668 . . . . 0.0 109.365 178.606 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.545 ' O ' HG23 ' A' ' 22' ' ' VAL . 3.5 tt -67.79 -38.68 83.65 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.362 0.601 . . . . 0.0 109.527 178.866 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.59 -39.56 91.72 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.655 -0.653 . . . . 0.0 109.696 179.061 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.09 -39.55 94.3 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.627 -0.671 . . . . 0.0 109.974 179.304 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.98 -37.91 94.84 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.441 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 18' ' ' LEU . 84.5 t -60.63 -43.29 94.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.512 -0.993 . . . . 0.0 109.76 179.621 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.11 -42.74 97.96 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.215 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 29.2 mm -68.03 -35.46 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.399 -1.06 . . . . 0.0 109.769 179.375 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -62.44 -25.91 68.22 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.259 -0.9 . . . . 0.0 109.571 178.845 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.459 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 8.4 mt -79.4 -24.41 42.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.311 -0.868 . . . . 0.0 108.9 178.27 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.572 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.8 tp -133.65 55.32 15.52 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.609 -0.682 . . . . 0.0 110.716 179.38 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.572 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.6 Cg_endo -90.54 -21.12 0.86 Allowed 'Trans proline' 0 C--N 1.318 -1.032 0 C-N-CA 121.022 1.148 . . . . 0.0 110.994 179.904 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -89.52 -36.8 15.17 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.304 -0.873 . . . . 0.0 110.07 179.608 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.211 179.758 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 121.038 0.447 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 57.3 m -113.99 46.61 1.3 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.548 -0.72 . . . . 0.0 110.344 179.883 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.401 ' O ' HG12 ' A' ' 3' ' ' VAL . 20.4 t -105.38 47.42 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.378 -0.826 . . . . 0.0 109.814 179.824 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.89 -31.92 21.94 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.367 -0.833 . . . . 0.0 110.66 -179.928 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -123.99 24.81 8.14 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.747 -0.596 . . . . 0.0 110.585 179.897 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.4 50.38 0.87 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.203 -0.936 . . . . 0.0 109.896 179.525 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -143.78 129.16 9.79 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.429 -0.795 . . . . 0.0 110.264 -179.934 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.29 -45.03 0.67 Allowed 'Trans proline' 0 C--N 1.315 -1.203 0 O-C-N 123.876 1.461 . . . . 0.0 110.937 -179.893 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 57.73 24.71 10.98 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.555 -0.716 . . . . 0.0 111.34 -179.899 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.412 ' O ' ' HB2' ' A' ' 11' ' ' PHE . 71.7 t-105 -67.93 89.62 0.29 Allowed 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 177.229 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.412 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 96.6 m-85 57.77 29.0 16.74 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 -174.63 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.567 ' CD1' HD13 ' A' ' 15' ' ' LEU . 0.4 OUTLIER 48.44 37.59 9.16 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.505 0.669 . . . . 0.0 109.963 -178.133 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -67.09 -49.23 65.69 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.697 -0.627 . . . . 0.0 109.733 179.5 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 t -61.85 -34.38 75.88 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.316 0.579 . . . . 0.0 109.523 179.189 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.567 HD13 ' CD1' ' A' ' 12' ' ' TRP . 1.6 tt -67.07 -41.51 86.27 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.901 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.3 tt -63.53 -42.11 98.44 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.629 -0.669 . . . . 0.0 109.919 179.353 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 tt -61.41 -33.13 73.17 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.572 0.701 . . . . 0.0 109.372 178.724 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.53 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -71.05 -38.45 72.52 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.294 0.569 . . . . 0.0 109.515 178.898 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.94 -39.04 93.24 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.773 -0.579 . . . . 0.0 109.885 179.153 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.67 -41.75 98.15 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.554 -0.716 . . . . 0.0 109.763 179.255 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.425 ' HA2' HD12 ' A' ' 24' ' ' ILE . . . -62.16 -38.86 96.86 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.32 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 18' ' ' LEU . 90.0 t -62.43 -43.2 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.552 -0.969 . . . . 0.0 109.797 179.433 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.446 ' HA2' HD12 ' A' ' 26' ' ' LEU . . . -62.43 -41.28 99.78 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.584 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.425 HD12 ' HA2' ' A' ' 21' ' ' GLY . 29.2 mt -66.64 -37.31 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.425 -1.044 . . . . 0.0 109.688 179.582 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -62.98 -26.68 68.96 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.216 -0.927 . . . . 0.0 109.666 178.948 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.446 HD12 ' HA2' ' A' ' 23' ' ' GLY . 11.7 mt -80.06 -17.31 53.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.371 -0.83 . . . . 0.0 109.429 178.373 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.612 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -140.26 53.5 4.3 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.539 -0.726 . . . . 0.0 110.648 179.561 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.612 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.7 Cg_endo -90.39 -21.77 0.83 Allowed 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 121.03 1.153 . . . . 0.0 111.11 -179.689 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.51 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 6.1 p-10 -89.39 -18.13 27.44 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.375 -0.828 . . . . 0.0 111.001 179.78 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.51 ' HG3' ' O ' ' A' ' 29' ' ' ASN . 2.5 ptm180 . . . . . 0 N--CA 1.509 2.489 0 CA-C-O 117.813 -1.089 . . . . 0.0 111.857 -179.76 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 121.086 0.47 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 t -109.6 50.01 0.81 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.504 -0.747 . . . . 0.0 110.223 179.785 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.8 t -114.49 29.68 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.389 -0.82 . . . . 0.0 109.929 179.618 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.0 m -112.11 -80.16 0.59 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.192 -0.942 . . . . 0.0 110.225 179.917 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -112.6 37.26 3.12 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.66 -0.65 . . . . 0.0 110.675 179.979 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -115.16 46.12 1.51 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.387 -0.821 . . . . 0.0 109.982 179.559 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.73 115.1 47.22 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 121.538 -0.726 . . . . 0.0 110.243 -179.801 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.66 84.12 1.65 Allowed 'Trans proline' 0 C--N 1.315 -1.209 0 O-C-N 123.822 1.433 . . . . 0.0 110.286 179.776 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.478 ' O ' ' HB2' ' A' ' 10' ' ' TRP . 1.0 OUTLIER -134.13 -161.45 1.15 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.398 -0.814 . . . . 0.0 110.095 -179.843 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.478 ' HB2' ' O ' ' A' ' 9' ' ' ARG . 14.4 m-90 64.27 -73.2 0.05 Allowed 'General case' 0 N--CA 1.506 2.346 0 O-C-N 122.003 -0.436 . . . . 0.0 110.417 -179.777 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -70.15 -22.82 62.94 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.28 -0.888 . . . . 0.0 110.203 178.959 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -98.07 17.66 17.91 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.279 -0.888 . . . . 0.0 111.169 -179.961 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.439 ' O ' HD23 ' A' ' 17' ' ' LEU . 8.3 t80 -61.89 -45.9 91.72 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.145 -0.972 . . . . 0.0 109.933 179.586 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.3 t -59.91 -35.67 75.38 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.008 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.6 tt -66.17 -47.64 73.32 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.532 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.5 tt -65.76 -37.02 85.2 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.52 0.676 . . . . 0.0 109.211 178.566 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.439 HD23 ' O ' ' A' ' 13' ' ' PHE . 2.1 mm? -61.52 -33.01 73.08 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.518 0.675 . . . . 0.0 109.407 178.611 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.8 tp -74.09 -39.53 63.36 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.375 0.607 . . . . 0.0 109.688 178.915 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.43 -37.86 89.0 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.808 -0.558 . . . . 0.0 109.945 179.285 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.38 -40.09 96.29 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.621 -0.675 . . . . 0.0 110.1 179.482 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.12 -42.19 94.6 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.624 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 73.2 t -62.32 -40.0 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.45 -1.03 . . . . 0.0 109.972 179.567 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.469 ' HA2' HD12 ' A' ' 26' ' ' LEU . . . -64.12 -44.74 95.3 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.567 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.3 mt -64.8 -35.58 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.358 -1.083 . . . . 0.0 109.784 179.543 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -63.69 -26.54 68.71 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.127 -0.983 . . . . 0.0 109.671 178.775 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.469 HD12 ' HA2' ' A' ' 23' ' ' GLY . 14.9 mt -79.18 -24.2 43.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.401 -0.812 . . . . 0.0 108.862 178.19 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.553 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.3 OUTLIER -133.72 56.31 19.6 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.579 -0.701 . . . . 0.0 110.558 179.411 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.553 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 40.3 Cg_endo -90.29 -21.49 0.89 Allowed 'Trans proline' 0 C--N 1.318 -1.042 0 O-C-N 123.346 1.182 . . . . 0.0 111.143 -179.821 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -79.68 -37.13 36.52 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.254 -0.904 . . . . 0.0 110.298 179.514 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.15 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.889 179.962 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 27.5 p80 . . . . . 0 N--CA 1.499 1.988 0 CA-C-O 120.728 0.299 . . . . 0.0 111.575 . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.3 p -117.21 22.91 12.19 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.276 -0.89 . . . . 0.0 110.706 179.971 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.2 m -129.45 59.22 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.175 -0.953 . . . . 0.0 109.99 -179.982 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.7 p -135.33 -90.55 0.31 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.458 -0.777 . . . . 0.0 110.427 -179.646 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -108.79 34.0 3.92 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.695 -0.628 . . . . 0.0 110.188 179.838 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -159.83 76.98 0.66 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.456 -0.777 . . . . 0.0 109.596 179.978 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.7 mpp_? -115.93 76.62 6.28 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.5 -0.75 . . . . 0.0 110.242 -179.577 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.2 -41.24 1.34 Allowed 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.65 1.342 . . . . 0.0 110.785 179.931 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.604 ' HA ' ' HB3' ' A' ' 12' ' ' TRP . 0.2 OUTLIER -116.46 -19.63 10.0 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.411 -0.806 . . . . 0.0 111.118 -179.744 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 5.7 t-105 -54.6 -56.3 20.43 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.274 -0.891 . . . . 0.0 110.474 -179.883 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -71.35 -35.21 71.08 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.323 -0.86 . . . . 0.0 109.605 179.161 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.604 ' HB3' ' HA ' ' A' ' 9' ' ' ARG . 35.3 t-105 -61.65 -23.45 66.08 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.699 -0.625 . . . . 0.0 110.633 179.358 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -59.76 -37.54 79.3 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.511 -0.743 . . . . 0.0 110.203 179.384 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 81.3 p -66.78 -33.15 74.98 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.581 -0.699 . . . . 0.0 109.492 179.047 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.5 tt -67.66 -41.48 83.72 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.49 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 tt -61.32 -41.06 96.38 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.656 -0.653 . . . . 0.0 109.781 179.078 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 tt -62.21 -37.33 84.91 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.543 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.504 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -68.79 -36.34 78.15 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.283 0.563 . . . . 0.0 109.604 178.843 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.14 -38.99 92.36 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.747 -0.596 . . . . 0.0 109.98 179.295 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.538 ' O ' HD12 ' A' ' 24' ' ' ILE . . . -64.39 -43.22 95.13 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.587 -0.696 . . . . 0.0 109.758 179.359 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.12 -40.03 96.62 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.231 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 18' ' ' LEU . 94.9 t -63.89 -37.8 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.529 -0.983 . . . . 0.0 109.71 179.244 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.407 ' HA2' HD12 ' A' ' 26' ' ' LEU . . . -60.06 -46.12 94.75 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.415 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.538 HD12 ' O ' ' A' ' 20' ' ' ALA . 1.2 mp -67.18 -34.48 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.447 -1.031 . . . . 0.0 109.561 179.325 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -63.48 -25.99 68.52 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.15 -0.969 . . . . 0.0 109.575 178.842 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.407 HD12 ' HA2' ' A' ' 23' ' ' GLY . 13.6 mt -80.09 -19.43 47.44 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.353 -0.842 . . . . 0.0 109.266 178.273 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.596 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 10.9 tp -138.54 53.95 6.24 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.54 -0.725 . . . . 0.0 110.623 179.438 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.596 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 40.9 Cg_endo -89.6 -30.15 0.19 Allowed 'Trans proline' 0 C--N 1.319 -1.003 0 O-C-N 123.232 1.122 . . . . 0.0 110.967 -179.975 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -86.85 -14.86 40.87 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.271 -0.893 . . . . 0.0 110.745 179.468 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 26.2 mtt180 . . . . . 0 N--CA 1.5 2.06 0 O-C-N 121.646 -0.659 . . . . 0.0 110.285 -179.624 . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 4.9 m170 . . . . . 0 N--CA 1.497 1.882 0 CA-C-O 121.034 0.445 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.9 p -142.26 35.67 1.51 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.486 -0.759 . . . . 0.0 110.673 -179.955 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.5 t 49.82 43.16 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 121.497 -0.752 . . . . 0.0 110.196 -179.842 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.0 t -70.98 -32.85 69.81 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.276 -0.89 . . . . 0.0 110.656 -179.861 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.524 ' HB3' ' HG3' ' A' ' 8' ' ' PRO . 64.4 m170 -108.19 31.8 5.27 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.604 -0.685 . . . . 0.0 110.336 179.857 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 7' ' ' ARG . . . 55.48 56.89 5.82 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.608 -0.682 . . . . 0.0 110.653 -179.913 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER 30.11 69.56 0.64 Allowed Pre-proline 0 N--CA 1.509 2.507 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 179.796 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.524 ' HG3' ' HB3' ' A' ' 5' ' ' HIS . 52.4 Cg_endo -82.02 170.66 13.56 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.652 1.343 . . . . 0.0 110.926 -179.987 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.9 ptt-85 -110.1 -29.86 8.02 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.535 -0.728 . . . . 0.0 110.427 179.314 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 73.8 t-105 -63.18 -32.61 74.05 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.356 -0.84 . . . . 0.0 110.236 179.506 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -74.25 -23.43 59.14 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.456 -0.777 . . . . 0.0 110.637 179.609 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -78.0 9.16 3.86 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.303 -0.873 . . . . 0.0 111.319 179.991 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -62.49 -32.18 73.04 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.038 -1.039 . . . . 0.0 109.919 179.532 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.31 -38.87 82.03 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.588 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 tt -63.27 -39.51 94.78 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.388 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.3 tt -64.42 -39.0 92.99 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.346 0.594 . . . . 0.0 109.791 178.984 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.2 tp -63.22 -34.99 78.84 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.51 0.671 . . . . 0.0 109.444 178.795 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.524 ' O ' HG23 ' A' ' 22' ' ' VAL . 3.4 tt -68.81 -37.34 79.15 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.226 0.536 . . . . 0.0 109.688 178.89 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.16 -38.04 84.79 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.791 -0.568 . . . . 0.0 109.682 179.088 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.65 -39.16 91.1 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.636 -0.665 . . . . 0.0 110.0 179.337 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.1 -39.74 97.46 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.43 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 18' ' ' LEU . 92.3 t -62.22 -43.47 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.497 -1.002 . . . . 0.0 109.608 179.548 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.57 -44.39 92.89 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.411 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.4 mt -65.56 -35.02 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.455 -1.026 . . . . 0.0 109.721 179.411 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -64.1 -27.06 68.84 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.112 -0.992 . . . . 0.0 109.388 178.737 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.465 ' HA ' HD13 ' A' ' 26' ' ' LEU . 1.5 mm? -77.92 -24.88 48.15 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.097 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.549 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 3.4 tp -134.63 57.09 20.23 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.559 -0.713 . . . . 0.0 110.643 179.512 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.549 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.2 Cg_endo -90.86 -20.61 0.83 Allowed 'Trans proline' 0 C--N 1.316 -1.137 0 O-C-N 123.225 1.118 . . . . 0.0 111.121 -179.927 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -93.31 -23.93 18.31 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.296 -0.878 . . . . 0.0 110.723 179.925 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 . . . . . 0 N--CA 1.497 1.918 0 CA-C-O 118.121 -0.942 . . . . 0.0 110.567 -179.8 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.539 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.8 tp . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.185 0.517 . . . . 0.0 109.746 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.7 96.45 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.848 -0.532 . . . . 0.0 109.764 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.98 -39.16 93.89 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.579 -0.701 . . . . 0.0 109.738 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.97 -38.38 95.41 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 18' ' ' LEU . 84.6 t -62.29 -41.29 91.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.498 -1.001 . . . . 0.0 109.827 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.99 -42.01 98.4 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 28.5 mm -66.88 -35.56 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.472 -1.016 . . . . 0.0 109.697 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -64.32 -26.98 68.72 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.275 -0.89 . . . . 0.0 109.513 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.483 HD13 ' HA ' ' A' ' 26' ' ' LEU . 1.9 mm? -78.46 -24.49 45.96 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.373 -0.829 . . . . 0.0 108.878 178.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.573 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 1.4 tp -134.44 56.03 16.78 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.581 -0.699 . . . . 0.0 110.763 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.573 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 43.4 Cg_endo . . . . . 0 C--N 1.319 -1.021 0 C-N-CA 121.096 1.197 . . . . 0.0 111.408 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.464 HD22 ' HA ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.803 0 CA-C-O 121.307 0.575 . . . . 0.0 109.624 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.8 -37.96 86.32 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.792 -0.567 . . . . 0.0 110.334 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.07 -40.56 96.21 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.455 -0.778 . . . . 0.0 109.965 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.48 -38.65 90.97 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 77.2 t -61.07 -41.23 88.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.474 -1.015 . . . . 0.0 109.939 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.32 -43.51 98.3 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 34.1 mm -67.48 -35.72 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.382 -1.069 . . . . 0.0 109.663 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -63.72 -25.67 68.31 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.217 -0.927 . . . . 0.0 109.645 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.494 HD13 ' HA ' ' A' ' 26' ' ' LEU . 1.6 mm? -80.07 -25.71 39.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.354 -0.841 . . . . 0.0 108.988 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.599 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 4.1 tp -131.28 52.76 10.01 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.467 -0.771 . . . . 0.0 111.126 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.599 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 43.0 Cg_endo . . . . . 0 C--N 1.319 -1.024 0 C-N-CA 120.895 1.064 . . . . 0.0 110.895 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 tt . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 121.21 0.529 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.8 -35.64 81.26 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.742 -0.599 . . . . 0.0 109.965 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.62 -42.19 64.72 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.504 -0.748 . . . . 0.0 109.979 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.6 -52.26 31.18 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 73.2 t -63.93 -35.25 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.482 -1.011 . . . . 0.0 110.015 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.58 -47.86 89.09 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.6 mt -68.02 -34.79 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.433 -1.04 . . . . 0.0 109.789 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -64.32 -25.08 67.88 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.163 -0.96 . . . . 0.0 109.769 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.511 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.2 mm? -80.81 -26.48 37.07 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.378 -0.826 . . . . 0.0 108.919 178.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.605 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 4.7 tp -130.14 52.0 8.58 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.591 -0.693 . . . . 0.0 111.215 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.605 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.7 Cg_endo . . . . . 0 C--N 1.319 -0.977 0 O-C-N 123.095 1.05 . . . . 0.0 110.787 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.8 tp . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.174 0.511 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.7 -41.49 95.3 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.725 -0.609 . . . . 0.0 109.999 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.56 -39.25 93.06 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.486 -0.759 . . . . 0.0 109.912 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.88 -39.14 94.87 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.6 t -62.01 -40.34 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.453 -1.027 . . . . 0.0 109.832 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.62 -46.75 91.44 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 37.9 mm -66.56 -33.89 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.54 -0.977 . . . . 0.0 109.578 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -62.5 -25.16 67.86 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.357 -0.839 . . . . 0.0 109.813 178.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.513 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.5 OUTLIER -80.71 -25.62 37.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.51 -0.743 . . . . 0.0 109.095 178.54 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.628 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -130.29 51.08 6.87 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.544 -0.723 . . . . 0.0 111.192 179.544 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.628 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 43.4 Cg_endo . . . . . 0 C--N 1.318 -1.053 0 O-C-N 123.039 1.02 . . . . 0.0 110.651 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.552 ' O ' HG23 ' A' ' 22' ' ' VAL . 9.0 tp . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.322 0.582 . . . . 0.0 109.627 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.41 -39.99 95.99 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.882 -0.511 . . . . 0.0 109.811 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.62 -40.18 96.16 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.563 -0.71 . . . . 0.0 109.875 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.56 -39.22 96.63 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 18' ' ' LEU . 89.7 t -61.5 -42.11 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.452 -1.028 . . . . 0.0 109.813 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.446 ' HA2' HD12 ' A' ' 26' ' ' LEU . . . -63.06 -42.32 99.61 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 31.3 mm -67.18 -36.28 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.497 -1.002 . . . . 0.0 109.691 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -62.54 -26.63 68.66 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.198 -0.939 . . . . 0.0 109.609 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.446 HD12 ' HA2' ' A' ' 23' ' ' GLY . 12.8 mt -79.52 -22.21 44.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.438 -0.789 . . . . 0.0 109.146 178.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.592 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.6 tp -135.8 54.63 10.51 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.565 -0.709 . . . . 0.0 110.756 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.592 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.8 Cg_endo . . . . . 0 C--N 1.319 -1.024 0 O-C-N 123.264 1.139 . . . . 0.0 111.039 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.0 tp . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 121.224 0.535 . . . . 0.0 109.838 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.06 -39.94 83.62 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.842 -0.536 . . . . 0.0 110.298 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.35 -41.13 98.35 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.485 -0.76 . . . . 0.0 110.006 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.28 -40.39 96.58 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 71.9 t -62.89 -40.58 89.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.503 -0.998 . . . . 0.0 109.943 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.06 -42.17 99.72 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 36.0 mt -67.05 -36.96 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.458 -1.025 . . . . 0.0 109.782 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -64.8 -26.17 68.23 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.166 -0.959 . . . . 0.0 109.6 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.488 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.7 mm? -79.17 -25.69 42.78 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.34 -0.85 . . . . 0.0 108.858 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.573 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -131.49 55.33 17.97 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.602 -0.686 . . . . 0.0 110.962 179.556 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.573 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.2 Cg_endo . . . . . 0 C--N 1.318 -1.065 0 C-N-CA 120.891 1.061 . . . . 0.0 110.993 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.4 tt . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.378 0.608 . . . . 0.0 109.377 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.56 -35.1 78.38 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.879 -0.513 . . . . 0.0 109.803 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.7 -39.85 94.36 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.587 -0.695 . . . . 0.0 110.018 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.54 -42.28 95.75 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 64.2 t -65.05 -42.26 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.512 -0.993 . . . . 0.0 109.538 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.3 -46.93 89.39 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.0 mt -65.43 -32.14 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.445 -1.032 . . . . 0.0 109.872 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.438 ' O ' ' HG3' ' A' ' 28' ' ' PRO . 44.0 t80 -64.79 -28.09 69.34 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.983 -1.073 . . . . 0.0 109.565 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.46 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.8 OUTLIER -77.37 -25.79 51.28 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.037 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.515 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.1 OUTLIER -133.8 59.13 37.14 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.724 -0.61 . . . . 0.0 109.975 179.35 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.6 Cg_endo . . . . . 0 C--N 1.319 -1.011 0 C-N-CA 121.223 1.282 . . . . 0.0 111.535 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.513 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 121.237 0.542 . . . . 0.0 109.863 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.15 -41.78 98.61 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.839 -0.538 . . . . 0.0 109.979 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.01 -40.58 98.18 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.636 -0.665 . . . . 0.0 109.958 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.17 -38.87 96.88 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 18' ' ' LEU . 88.5 t -64.73 -41.6 92.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.516 -0.99 . . . . 0.0 109.792 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.82 -41.49 99.18 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 38.4 mt -66.73 -34.9 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.427 -1.043 . . . . 0.0 109.593 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -63.88 -27.04 68.88 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.291 -0.88 . . . . 0.0 109.606 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.41 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.6 OUTLIER -78.97 -21.7 46.72 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.455 -0.778 . . . . 0.0 109.125 178.254 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.588 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 6.5 tp -136.25 54.07 8.91 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.619 -0.675 . . . . 0.0 110.757 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.588 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.4 Cg_endo . . . . . 0 C--N 1.318 -1.033 0 O-C-N 123.263 1.139 . . . . 0.0 111.435 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.547 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.36 0.6 . . . . 0.0 109.611 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.57 -37.8 85.71 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.632 -0.667 . . . . 0.0 109.774 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.02 -41.02 91.52 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.537 -0.727 . . . . 0.0 109.946 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.84 -37.37 94.21 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 18' ' ' LEU . 94.3 t -61.71 -39.36 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.526 -0.984 . . . . 0.0 109.618 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.57 -49.16 66.2 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -65.08 -32.2 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.434 -1.039 . . . . 0.0 109.971 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -62.94 -27.0 69.08 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.148 -0.97 . . . . 0.0 109.631 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.487 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.8 OUTLIER -78.64 -26.54 45.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.41 -0.806 . . . . 0.0 108.927 178.238 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.554 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.7 OUTLIER -131.6 56.56 24.93 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.504 -0.747 . . . . 0.0 110.738 179.386 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.554 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.9 Cg_endo . . . . . 0 C--N 1.316 -1.14 0 C-N-CA 121.138 1.225 . . . . 0.0 111.129 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.0 tp . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.394 0.616 . . . . 0.0 109.649 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.78 -33.25 75.21 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.828 -0.545 . . . . 0.0 109.926 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.54 -43.09 67.06 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.481 -0.762 . . . . 0.0 110.135 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.48 -53.06 22.79 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 81.8 t -65.62 -36.83 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.435 -1.038 . . . . 0.0 110.132 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.07 -47.82 87.38 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.6 mm -65.46 -35.07 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.368 -1.078 . . . . 0.0 110.013 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.403 ' O ' ' HG3' ' A' ' 28' ' ' PRO . 16.1 t80 -64.11 -28.48 69.8 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.996 -1.065 . . . . 0.0 109.718 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.503 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.7 OUTLIER -78.9 -25.54 43.81 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.341 -0.849 . . . . 0.0 108.882 178.253 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.573 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.2 OUTLIER -131.31 55.27 17.77 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.594 -0.691 . . . . 0.0 110.854 179.677 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.573 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.9 Cg_endo . . . . . 0 C--N 1.319 -1.007 0 C-N-CA 121.013 1.142 . . . . 0.0 110.95 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.551 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.15 0.5 . . . . 0.0 109.823 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.96 -39.67 82.4 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.765 -0.584 . . . . 0.0 109.995 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.86 -40.64 97.04 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.52 -0.738 . . . . 0.0 109.671 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.34 -37.09 94.29 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 18' ' ' LEU . 76.4 t -61.83 -40.42 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.506 -0.997 . . . . 0.0 109.53 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.21 -45.15 95.92 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.2 mt -68.49 -32.36 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.377 -1.072 . . . . 0.0 109.657 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -61.41 -22.2 64.78 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.458 -0.776 . . . . 0.0 109.901 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.534 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.8 mm? -82.3 -25.05 34.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.399 -0.813 . . . . 0.0 109.487 178.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.629 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.6 OUTLIER -127.58 48.29 3.25 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.411 -0.806 . . . . 0.0 111.589 179.749 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.629 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 45.7 Cg_endo . . . . . 0 C--N 1.319 -0.976 0 O-C-N 122.862 0.928 . . . . 0.0 110.839 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.538 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.2 tt . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.322 0.582 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.49 -38.87 92.51 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.827 -0.546 . . . . 0.0 109.765 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.84 -40.23 96.09 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.6 -0.688 . . . . 0.0 109.724 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.77 -37.65 94.61 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 18' ' ' LEU . 95.5 t -62.97 -41.64 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.45 -1.029 . . . . 0.0 109.805 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.67 -41.84 98.9 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.4 mm -67.17 -34.9 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.409 -1.054 . . . . 0.0 109.692 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -63.44 -26.75 68.88 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.255 -0.903 . . . . 0.0 109.637 178.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.471 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.8 OUTLIER -79.06 -24.9 43.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.412 -0.805 . . . . 0.0 109.022 178.226 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.586 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 5.7 tp -132.65 54.35 13.47 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.518 -0.739 . . . . 0.0 110.946 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.586 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.9 Cg_endo . . . . . 0 C--N 1.319 -1.018 0 C-N-CA 120.936 1.091 . . . . 0.0 111.162 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.57 ' O ' HG23 ' A' ' 22' ' ' VAL . 1.3 tt . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.219 0.533 . . . . 0.0 109.894 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.26 -40.7 95.06 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.72 -0.612 . . . . 0.0 109.773 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.64 -39.92 95.36 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.629 -0.669 . . . . 0.0 109.78 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.42 -37.58 93.96 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 18' ' ' LEU . 87.7 t -61.62 -42.65 94.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.474 -1.016 . . . . 0.0 109.843 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.02 -41.83 99.79 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 30.3 mm -67.23 -36.57 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.455 -1.027 . . . . 0.0 109.761 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -63.08 -25.96 68.61 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.272 -0.893 . . . . 0.0 109.801 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.438 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 13.3 mt -81.44 -20.35 40.52 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.328 -0.858 . . . . 0.0 109.323 178.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.627 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 1.3 tp -135.99 51.86 5.82 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.412 -0.805 . . . . 0.0 110.902 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.627 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 44.7 Cg_endo . . . . . 0 C--N 1.32 -0.946 0 C-N-CA 121.113 1.209 . . . . 0.0 111.223 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.496 ' O ' HG23 ' A' ' 22' ' ' VAL . 1.3 tt . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.316 0.579 . . . . 0.0 109.747 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.14 -38.38 85.44 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.861 -0.524 . . . . 0.0 109.922 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.28 -43.11 98.86 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.531 -0.731 . . . . 0.0 109.928 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.57 -39.41 96.43 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 18' ' ' LEU . 98.7 t -64.35 -37.2 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.62 -0.93 . . . . 0.0 109.714 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.421 ' HA2' HD12 ' A' ' 26' ' ' LEU . . . -60.15 -46.97 93.27 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.37 -34.16 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.521 -0.988 . . . . 0.0 109.65 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -63.23 -26.15 68.65 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.084 -1.01 . . . . 0.0 109.64 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.448 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 14.8 mt -78.82 -23.78 44.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.293 -0.88 . . . . 0.0 108.909 178.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.56 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -134.59 56.2 17.02 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.553 -0.717 . . . . 0.0 110.681 179.311 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.56 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 40.1 Cg_endo . . . . . 0 C--N 1.318 -1.055 0 O-C-N 123.235 1.124 . . . . 0.0 111.024 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.57 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.5 tt . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 121.174 0.512 . . . . 0.0 109.74 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.79 -40.51 97.54 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.755 -0.591 . . . . 0.0 109.67 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.51 -38.84 90.88 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.501 -0.75 . . . . 0.0 109.475 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.483 ' HA2' HD12 ' A' ' 24' ' ' ILE . . . -62.42 -36.41 93.09 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 18' ' ' LEU . 87.4 t -62.76 -41.75 93.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.512 -0.993 . . . . 0.0 109.625 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.43 -42.0 99.67 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.483 HD12 ' HA2' ' A' ' 21' ' ' GLY . 22.3 mt -68.98 -32.18 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.545 -0.974 . . . . 0.0 109.555 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -63.46 -25.42 68.26 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.323 -0.86 . . . . 0.0 109.521 178.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.431 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.3 mp -78.61 -22.68 46.63 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.5 -0.75 . . . . 0.0 109.007 178.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.589 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 3.5 tp -135.28 53.98 9.9 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.603 -0.686 . . . . 0.0 110.78 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.589 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.6 Cg_endo . . . . . 0 C--N 1.318 -1.033 0 O-C-N 123.15 1.079 . . . . 0.0 110.86 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.557 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.065 0.459 . . . . 0.0 109.848 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.42 -45.6 93.03 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.648 -0.657 . . . . 0.0 109.5 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.73 -34.83 78.71 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.623 -0.673 . . . . 0.0 109.801 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.04 -40.12 95.04 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 18' ' ' LEU . 77.3 t -60.04 -42.54 90.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.491 -1.005 . . . . 0.0 109.736 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.61 -45.26 93.45 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.9 mt -66.54 -35.26 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.491 -1.006 . . . . 0.0 109.736 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -63.43 -26.61 68.81 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.152 -0.968 . . . . 0.0 109.585 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.475 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.4 mm? -78.86 -26.51 44.04 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 178.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.559 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.0 tp -132.23 56.26 22.28 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.587 -0.696 . . . . 0.0 110.707 179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.559 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.0 Cg_endo . . . . . 0 C--N 1.317 -1.093 0 O-C-N 123.323 1.17 . . . . 0.0 111.015 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.41 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 121.109 0.48 . . . . 0.0 109.848 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.54 -41.53 94.64 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.72 -0.612 . . . . 0.0 110.051 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.41 -38.24 89.36 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.55 -0.719 . . . . 0.0 109.827 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.6 -40.72 96.14 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 18' ' ' LEU . 69.9 t -62.94 -38.14 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.504 -0.997 . . . . 0.0 109.895 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.33 -48.09 87.68 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 28.9 mm -71.48 -35.81 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.486 -1.008 . . . . 0.0 109.587 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -65.01 -26.62 68.36 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.266 -0.896 . . . . 0.0 109.629 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.426 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 10.7 mt -79.32 -21.23 46.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 0.0 109.046 178.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.574 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 3.0 tp -135.86 54.3 9.81 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.603 -0.685 . . . . 0.0 110.698 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.574 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 40.7 Cg_endo . . . . . 0 C--N 1.317 -1.092 0 O-C-N 123.103 1.054 . . . . 0.0 111.183 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.562 ' O ' HG23 ' A' ' 22' ' ' VAL . 1.3 tt . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.264 0.554 . . . . 0.0 109.724 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.97 -41.16 99.45 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.69 -0.631 . . . . 0.0 109.688 179.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.64 -39.03 93.31 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.541 -0.724 . . . . 0.0 109.66 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.52 -37.16 93.39 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 18' ' ' LEU . 88.0 t -61.24 -41.02 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.408 -1.054 . . . . 0.0 109.576 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.453 ' HA2' HD12 ' A' ' 26' ' ' LEU . . . -64.71 -45.65 92.16 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.0 mt -68.14 -33.03 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.48 -1.012 . . . . 0.0 109.793 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -60.71 -23.46 64.91 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.304 -0.872 . . . . 0.0 109.821 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.453 HD12 ' HA2' ' A' ' 23' ' ' GLY . 12.3 mt -81.06 -17.4 50.26 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.328 -0.858 . . . . 0.0 109.638 178.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.636 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.4 tp -137.29 51.31 4.31 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.268 -0.895 . . . . 0.0 111.015 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.636 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 43.4 Cg_endo . . . . . 0 C--N 1.318 -1.03 0 O-C-N 123.16 1.084 . . . . 0.0 111.059 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.523 ' O ' HG23 ' A' ' 22' ' ' VAL . 1.9 tt . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.307 0.575 . . . . 0.0 109.658 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.86 -39.02 93.22 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.755 -0.59 . . . . 0.0 109.97 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.97 -41.05 97.57 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.603 -0.686 . . . . 0.0 109.813 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.35 -38.09 95.37 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 18' ' ' LEU . 95.5 t -63.2 -40.65 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.471 -1.017 . . . . 0.0 109.777 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.34 -41.41 98.16 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 29.9 mm -66.91 -36.36 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.382 -1.07 . . . . 0.0 109.697 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -64.58 -26.58 68.47 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.14 -0.975 . . . . 0.0 109.48 178.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.451 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.6 mm? -78.13 -24.76 47.26 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.406 -0.809 . . . . 0.0 108.872 177.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.561 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.3 tp -134.41 56.05 16.9 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.71 -0.619 . . . . 0.0 110.752 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.561 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.2 Cg_endo . . . . . 0 C--N 1.317 -1.126 0 C-N-CA 121.081 1.187 . . . . 0.0 111.139 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 121.313 0.577 . . . . 0.0 109.78 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.94 -36.94 75.71 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.79 -0.569 . . . . 0.0 109.92 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.44 -40.17 95.72 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.62 -0.675 . . . . 0.0 109.991 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.09 -45.21 88.74 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 179.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.3 t -65.52 -40.96 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.515 -0.991 . . . . 0.0 109.747 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.99 -48.83 80.84 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 23.8 mm -65.67 -34.97 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.406 -1.056 . . . . 0.0 109.71 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -62.29 -26.14 68.24 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.221 -0.925 . . . . 0.0 109.66 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.495 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 16.9 mt -79.58 -25.61 41.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.357 -0.84 . . . . 0.0 109.114 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.591 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 3.8 tp -131.52 53.54 11.88 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.453 -0.779 . . . . 0.0 110.921 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.591 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.5 Cg_endo . . . . . 0 C--N 1.319 -1.016 0 C-N-CA 120.96 1.107 . . . . 0.0 110.749 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.474 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.285 0.564 . . . . 0.0 109.811 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.68 -40.54 92.5 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.668 -0.645 . . . . 0.0 110.178 179.537 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.19 -42.05 99.28 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.522 -0.736 . . . . 0.0 109.695 179.374 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.38 -38.5 96.38 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.288 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 18' ' ' LEU . 89.9 t -62.95 -41.41 92.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.535 -0.979 . . . . 0.0 109.841 179.5 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.96 -42.24 99.67 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.338 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.9 mt -67.67 -35.26 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.576 -0.955 . . . . 0.0 109.53 179.06 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 92.7 t80 -63.9 -22.46 66.93 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.354 -0.841 . . . . 0.0 110.006 178.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.538 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -83.77 -25.05 30.8 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.426 -0.796 . . . . 0.0 109.505 178.75 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.68 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.9 tp -125.65 44.75 1.22 Allowed Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.39 -0.819 . . . . 0.0 111.92 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.68 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 44.3 Cg_endo . . . . . 0 C--N 1.322 -0.831 0 O-C-N 122.868 0.931 . . . . 0.0 110.077 179.437 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.258 0.551 . . . . 0.0 109.56 . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.09 -39.88 95.03 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.679 -0.638 . . . . 0.0 109.732 179.17 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.55 -38.66 91.97 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.519 -0.738 . . . . 0.0 109.712 179.151 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.38 -37.48 90.43 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 179.292 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 18' ' ' LEU . 71.7 t -61.06 -39.21 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.307 -1.114 . . . . 0.0 109.534 179.242 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.439 ' HA2' HD12 ' A' ' 26' ' ' LEU . . . -66.0 -47.28 75.26 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.399 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 tp -68.0 -29.01 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.406 -1.055 . . . . 0.0 110.008 179.514 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -64.23 -21.63 66.65 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.288 -0.883 . . . . 0.0 109.81 178.703 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.469 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 12.6 mt -83.98 -21.3 31.78 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.323 -0.86 . . . . 0.0 109.685 178.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.674 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 5.5 tp -130.38 45.59 1.83 Allowed Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.322 -0.861 . . . . 0.0 111.668 179.772 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.674 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 47.1 Cg_endo . . . . . 0 C--N 1.322 -0.828 0 O-C-N 122.946 0.972 . . . . 0.0 110.239 179.434 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.7 tt . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 121.385 0.612 . . . . 0.0 109.632 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.73 -35.43 72.68 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.733 -0.605 . . . . 0.0 109.956 179.275 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.77 -39.19 87.76 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.524 -0.735 . . . . 0.0 110.231 179.696 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.4 -47.59 82.78 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.566 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 88.2 t -65.72 -39.76 85.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.586 -0.95 . . . . 0.0 109.7 179.324 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.78 -44.7 94.4 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.615 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 26.3 mt -65.17 -36.82 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.361 -1.082 . . . . 0.0 109.955 179.582 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -64.54 -26.27 68.35 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.137 -0.977 . . . . 0.0 109.599 178.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.488 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.4 mm? -78.32 -26.64 46.94 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.002 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.565 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 5.9 tp -131.74 55.81 20.46 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.549 -0.719 . . . . 0.0 110.874 179.579 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.565 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.9 Cg_endo . . . . . 0 C--N 1.318 -1.044 0 C-N-CA 121.038 1.158 . . . . 0.0 111.049 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.543 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.8 tt . . . . . 0 N--CA 1.494 1.766 0 CA-C-O 121.249 0.547 . . . . 0.0 109.58 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.6 -38.75 90.36 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.792 -0.568 . . . . 0.0 109.797 179.118 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.8 -38.44 91.09 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.528 -0.733 . . . . 0.0 109.851 179.224 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.42 -38.15 93.3 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.299 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 18' ' ' LEU . 94.2 t -60.99 -44.17 97.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.473 -1.016 . . . . 0.0 109.677 179.403 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.91 -44.48 95.99 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.347 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 67.5 mt -65.93 -35.06 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.461 -1.023 . . . . 0.0 109.735 179.41 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -62.61 -26.76 68.78 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.215 -0.928 . . . . 0.0 109.524 178.744 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.438 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 6.1 mt -78.81 -23.6 45.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.385 -0.822 . . . . 0.0 108.98 178.206 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.571 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.5 tp -134.85 56.54 17.43 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.444 -0.785 . . . . 0.0 110.633 179.34 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.571 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.9 Cg_endo . . . . . 0 C--N 1.316 -1.133 0 C-N-CA 121.084 1.189 . . . . 0.0 111.202 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.602 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 121.119 0.485 . . . . 0.0 109.999 . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.84 -41.73 96.41 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.703 -0.623 . . . . 0.0 110.015 179.392 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.29 95.07 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.532 -0.73 . . . . 0.0 109.686 179.21 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.28 -37.58 94.71 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.338 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 18' ' ' LEU . 76.8 t -62.34 -41.8 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.416 -1.05 . . . . 0.0 109.724 179.415 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.75 -41.44 98.92 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.317 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 51.0 mt -66.59 -37.88 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.389 -1.065 . . . . 0.0 109.71 179.501 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -64.2 -26.19 68.4 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.182 -0.948 . . . . 0.0 109.646 178.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.47 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.5 mm? -79.08 -25.25 43.1 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.571 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 3.5 tp -133.05 55.04 15.1 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.662 -0.649 . . . . 0.0 110.863 179.678 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.571 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.2 Cg_endo . . . . . 0 C--N 1.319 -1.023 0 C-N-CA 120.963 1.109 . . . . 0.0 111.063 -179.932 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.524 ' O ' HG23 ' A' ' 22' ' ' VAL . 7.5 tp . . . . . 0 N--CA 1.493 1.704 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.1 -39.69 95.43 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.865 -0.522 . . . . 0.0 109.652 179.112 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.06 -39.86 90.44 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.626 -0.671 . . . . 0.0 109.729 179.221 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.42 -40.12 98.5 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.417 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 18' ' ' LEU . 98.7 t -63.24 -37.36 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.486 -1.008 . . . . 0.0 109.684 179.336 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.51 -46.94 92.48 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.371 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.7 mt -76.7 -27.68 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.381 -1.07 . . . . 0.0 109.812 179.204 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -60.94 -23.63 65.44 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.035 -1.041 . . . . 0.0 109.696 178.966 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.483 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.9 mm? -79.47 -24.37 42.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.256 -0.903 . . . . 0.0 109.177 178.476 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.59 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.5 tp -132.15 53.73 12.1 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.48 -0.762 . . . . 0.0 110.961 179.718 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.59 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.3 Cg_endo . . . . . 0 C--N 1.318 -1.065 0 C-N-CA 120.947 1.098 . . . . 0.0 111.005 -179.875 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.543 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.6 tt . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 121.342 0.592 . . . . 0.0 109.63 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.36 -37.84 86.23 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.747 -0.595 . . . . 0.0 109.894 179.327 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.89 -42.21 99.69 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.612 -0.68 . . . . 0.0 109.97 179.462 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.31 -38.87 96.95 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.441 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 18' ' ' LEU . 91.2 t -64.2 -40.67 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.49 -1.006 . . . . 0.0 109.757 179.506 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.54 -42.04 99.01 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.51 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.2 mt -65.66 -36.67 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.423 -1.046 . . . . 0.0 109.821 179.527 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -64.93 -26.53 68.35 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.216 -0.927 . . . . 0.0 109.681 178.889 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.499 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.9 mm? -80.0 -24.76 40.64 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.367 -0.833 . . . . 0.0 108.99 178.29 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.596 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 1.2 tp -131.93 53.43 11.38 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.558 -0.714 . . . . 0.0 111.032 179.736 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.596 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 43.4 Cg_endo . . . . . 0 C--N 1.318 -1.035 0 C-N-CA 121.002 1.134 . . . . 0.0 111.144 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.543 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.5 tt . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 121.238 0.542 . . . . 0.0 109.65 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.67 -39.56 93.89 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.799 -0.563 . . . . 0.0 109.807 179.284 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.75 -39.95 95.75 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.635 -0.666 . . . . 0.0 109.897 179.391 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.55 -37.42 94.39 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.398 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 18' ' ' LEU . 90.4 t -63.07 -41.35 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.53 -0.982 . . . . 0.0 109.685 179.471 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.31 -42.66 97.69 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.398 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.4 mt -66.36 -36.27 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.413 -1.051 . . . . 0.0 109.809 179.45 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -63.76 -27.59 69.3 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.32 -0.862 . . . . 0.0 109.8 179.085 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.481 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 3.8 mt -81.25 -21.65 39.3 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.425 -0.797 . . . . 0.0 109.16 178.306 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.628 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.1 OUTLIER -133.18 51.98 7.85 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.524 -0.735 . . . . 0.0 110.896 179.82 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.628 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 45.7 Cg_endo . . . . . 0 C--N 1.32 -0.936 0 C-N-CA 121.101 1.201 . . . . 0.0 111.329 -179.742 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.5 tp . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 121.425 0.631 . . . . 0.0 109.706 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.23 -35.42 77.91 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.819 -0.551 . . . . 0.0 109.943 179.198 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.94 -40.02 87.45 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.55 -0.719 . . . . 0.0 110.283 179.589 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.36 -46.64 90.02 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.577 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 76.5 t -66.06 -40.88 88.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.557 -0.966 . . . . 0.0 109.665 179.363 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.17 -47.14 88.13 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.59 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 35.2 mt -64.48 -33.72 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.435 -1.038 . . . . 0.0 109.885 179.542 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -63.65 -27.22 69.07 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.031 -1.043 . . . . 0.0 109.678 178.87 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.483 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.7 OUTLIER -79.14 -25.25 42.92 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.446 -0.784 . . . . 0.0 108.94 178.229 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.566 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.5 tp -132.95 56.63 23.09 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.539 -0.725 . . . . 0.0 110.714 179.498 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.566 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.5 Cg_endo . . . . . 0 C--N 1.318 -1.048 0 C-N-CA 121.143 1.229 . . . . 0.0 111.496 -179.837 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.522 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.1 tt . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 121.324 0.583 . . . . 0.0 109.5 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.34 -37.92 89.19 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.851 -0.531 . . . . 0.0 109.704 179.207 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.5 -40.04 96.02 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.575 -0.703 . . . . 0.0 109.905 179.249 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.6 -36.98 93.81 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.384 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 18' ' ' LEU . 95.5 t -63.81 -41.41 92.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.55 -0.97 . . . . 0.0 109.751 179.478 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.17 -41.45 98.37 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.372 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 29.8 mm -66.52 -34.86 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.467 -1.019 . . . . 0.0 109.779 179.293 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -63.49 -26.13 68.58 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.277 -0.889 . . . . 0.0 109.654 178.76 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.482 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.9 OUTLIER -79.84 -24.73 41.11 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.356 -0.84 . . . . 0.0 109.037 178.237 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.602 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 14.6 tp -132.13 53.21 10.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.499 -0.751 . . . . 0.0 110.97 179.583 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.602 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.2 Cg_endo . . . . . 0 C--N 1.32 -0.93 0 O-C-N 123.183 1.096 . . . . 0.0 111.005 179.893 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.544 ' O ' HG23 ' A' ' 22' ' ' VAL . 4.6 tp . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.211 0.529 . . . . 0.0 109.903 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.71 -42.63 97.6 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.76 -0.588 . . . . 0.0 109.964 179.511 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.87 -39.83 95.13 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.53 -0.731 . . . . 0.0 109.928 179.235 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.56 -39.35 93.88 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.506 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 18' ' ' LEU . 78.8 t -60.89 -43.37 95.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.503 -0.998 . . . . 0.0 109.996 179.619 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.42 -43.92 98.37 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.496 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.7 mt -66.46 -37.08 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.46 -1.023 . . . . 0.0 109.753 179.446 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -62.45 -26.24 68.41 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.293 -0.879 . . . . 0.0 109.982 179.213 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.482 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 13.4 mt -81.61 -22.43 37.66 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.355 -0.841 . . . . 0.0 109.224 178.349 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.622 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.1 OUTLIER -132.5 51.75 7.73 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.581 -0.699 . . . . 0.0 110.812 179.731 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.622 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.9 Cg_endo . . . . . 0 C--N 1.32 -0.943 0 O-C-N 123.048 1.025 . . . . 0.0 110.822 -179.997 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.517 ' O ' HG23 ' A' ' 22' ' ' VAL . 5.3 tp . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 121.24 0.543 . . . . 0.0 109.61 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.47 -41.79 94.92 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.809 -0.557 . . . . 0.0 109.73 179.258 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.78 -40.99 92.53 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.539 -0.726 . . . . 0.0 109.815 179.121 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.409 ' HA2' HD12 ' A' ' 24' ' ' ILE . . . -61.63 -41.09 99.52 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 179.38 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 18' ' ' LEU . 95.5 t -62.76 -40.03 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.568 -0.96 . . . . 0.0 109.801 179.418 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.456 ' HA2' HD12 ' A' ' 26' ' ' LEU . . . -59.69 -42.89 98.1 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.39 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.409 HD12 ' HA2' ' A' ' 21' ' ' GLY . 18.2 mt -68.61 -35.38 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.474 -1.015 . . . . 0.0 109.592 179.26 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -62.97 -27.03 69.12 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.204 -0.935 . . . . 0.0 109.613 178.824 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.456 HD12 ' HA2' ' A' ' 23' ' ' GLY . 13.5 mt -79.18 -18.27 53.36 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.379 -0.826 . . . . 0.0 109.314 178.359 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.588 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.9 tp -140.52 55.09 5.56 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.574 -0.704 . . . . 0.0 110.577 179.643 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.588 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.7 Cg_endo . . . . . 0 C--N 1.319 -1.021 0 C-N-CA 121.106 1.204 . . . . 0.0 111.377 -179.582 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.0 tp . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.263 0.554 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.87 -40.44 97.5 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.734 -0.604 . . . . 0.0 109.834 179.305 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.65 -37.39 87.17 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.629 -0.669 . . . . 0.0 109.884 179.311 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.98 -40.68 93.43 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.453 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.7 t -60.49 -42.24 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.505 -0.997 . . . . 0.0 109.802 179.496 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.21 -44.18 95.98 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.368 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.5 mt -65.22 -34.53 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.447 -1.031 . . . . 0.0 109.775 179.434 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -62.94 -27.23 69.24 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.148 -0.97 . . . . 0.0 109.497 178.754 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.1 mt -79.56 -17.7 53.37 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.428 -0.795 . . . . 0.0 109.353 178.303 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.605 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.7 tp -141.44 54.9 4.6 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.57 -0.706 . . . . 0.0 110.5 179.495 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.605 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.1 Cg_endo . . . . . 0 C--N 1.319 -0.999 0 C-N-CA 121.242 1.294 . . . . 0.0 111.249 -179.836 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.506 ' O ' HG23 ' A' ' 22' ' ' VAL . 9.0 tp . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.347 0.594 . . . . 0.0 109.453 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.63 -38.77 92.13 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.841 -0.537 . . . . 0.0 109.796 179.09 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.38 -38.67 91.85 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.587 -0.696 . . . . 0.0 110.054 179.398 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.69 -40.63 94.0 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.595 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 18' ' ' LEU . 99.3 t -61.54 -42.15 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.458 -1.025 . . . . 0.0 109.828 179.577 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.97 -45.53 92.05 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.528 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.2 mt -65.77 -35.14 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.422 -1.046 . . . . 0.0 109.717 179.478 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -63.7 -25.91 68.42 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.315 -0.865 . . . . 0.0 109.498 178.75 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.483 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.3 mm? -79.05 -27.11 43.11 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.203 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.57 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 8.8 tp -131.16 55.46 19.03 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.576 -0.703 . . . . 0.0 110.849 179.518 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.57 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 39.9 Cg_endo . . . . . 0 C--N 1.318 -1.053 0 O-C-N 123.217 1.114 . . . . 0.0 110.561 179.647 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.7 tt . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.497 0.665 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.24 -35.06 78.78 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.849 -0.532 . . . . 0.0 110.376 179.613 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.36 -41.79 97.65 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.417 -0.802 . . . . 0.0 110.223 179.735 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.36 -46.92 66.48 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.632 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 77.9 t -64.61 -37.85 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.546 -0.973 . . . . 0.0 110.036 179.607 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.96 -46.97 92.99 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.704 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.3 mt -65.4 -35.14 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.384 -1.068 . . . . 0.0 109.925 179.605 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -64.99 -27.71 69.01 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.064 -1.022 . . . . 0.0 109.599 178.867 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.501 HD13 ' HA ' ' A' ' 26' ' ' LEU . 1.7 mm? -77.86 -25.34 48.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.321 -0.862 . . . . 0.0 108.689 178.016 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.544 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 5.6 tp -133.59 57.06 23.39 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.617 -0.677 . . . . 0.0 110.468 179.488 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.544 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 39.6 Cg_endo . . . . . 0 C--N 1.318 -1.076 0 C-N-CA 121.111 1.207 . . . . 0.0 111.212 -179.666 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.586 ' O ' HG23 ' A' ' 22' ' ' VAL . 6.9 tp . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.16 0.505 . . . . 0.0 109.956 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.37 -46.26 89.16 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.814 -0.554 . . . . 0.0 109.823 179.352 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.93 -37.53 84.49 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.537 -0.727 . . . . 0.0 109.782 179.199 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.9 -39.01 96.96 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.469 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 18' ' ' LEU . 84.1 t -60.35 -44.7 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.491 -1.005 . . . . 0.0 109.668 179.566 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.51 -41.93 99.74 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.411 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 31.1 mt -66.89 -35.35 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.449 -1.03 . . . . 0.0 109.801 179.469 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -62.49 -27.95 69.49 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.161 -0.962 . . . . 0.0 109.663 178.924 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.4 mt -80.6 -17.62 50.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.428 -0.795 . . . . 0.0 109.248 178.293 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.641 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -138.88 51.78 3.77 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.553 -0.717 . . . . 0.0 110.732 179.771 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.641 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 47.3 Cg_endo . . . . . 0 C--N 1.32 -0.936 0 C-N-CA 121.126 1.217 . . . . 0.0 111.145 -179.663 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.545 ' O ' HG23 ' A' ' 22' ' ' VAL . 3.5 tt . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.362 0.601 . . . . 0.0 109.527 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.59 -39.56 91.72 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.655 -0.653 . . . . 0.0 109.696 179.061 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.09 -39.55 94.3 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.627 -0.671 . . . . 0.0 109.974 179.304 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.98 -37.91 94.84 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.441 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 18' ' ' LEU . 84.5 t -60.63 -43.29 94.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.512 -0.993 . . . . 0.0 109.76 179.621 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.11 -42.74 97.96 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.215 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 29.2 mm -68.03 -35.46 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.399 -1.06 . . . . 0.0 109.769 179.375 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -62.44 -25.91 68.22 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.259 -0.9 . . . . 0.0 109.571 178.845 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.459 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 8.4 mt -79.4 -24.41 42.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.311 -0.868 . . . . 0.0 108.9 178.27 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.572 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.8 tp -133.65 55.32 15.52 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.609 -0.682 . . . . 0.0 110.716 179.38 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.572 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.6 Cg_endo . . . . . 0 C--N 1.318 -1.032 0 C-N-CA 121.022 1.148 . . . . 0.0 110.994 179.904 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.53 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 121.294 0.569 . . . . 0.0 109.515 . . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.94 -39.04 93.24 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.773 -0.579 . . . . 0.0 109.885 179.153 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.67 -41.75 98.15 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.554 -0.716 . . . . 0.0 109.763 179.255 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.425 ' HA2' HD12 ' A' ' 24' ' ' ILE . . . -62.16 -38.86 96.86 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.32 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 18' ' ' LEU . 90.0 t -62.43 -43.2 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.552 -0.969 . . . . 0.0 109.797 179.433 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.446 ' HA2' HD12 ' A' ' 26' ' ' LEU . . . -62.43 -41.28 99.78 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.584 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.425 HD12 ' HA2' ' A' ' 21' ' ' GLY . 29.2 mt -66.64 -37.31 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.425 -1.044 . . . . 0.0 109.688 179.582 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -62.98 -26.68 68.96 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.216 -0.927 . . . . 0.0 109.666 178.948 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.446 HD12 ' HA2' ' A' ' 23' ' ' GLY . 11.7 mt -80.06 -17.31 53.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.371 -0.83 . . . . 0.0 109.429 178.373 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.612 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -140.26 53.5 4.3 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.539 -0.726 . . . . 0.0 110.648 179.561 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.612 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.7 Cg_endo . . . . . 0 C--N 1.318 -1.072 0 C-N-CA 121.03 1.153 . . . . 0.0 111.11 -179.689 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.8 tp . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 121.375 0.607 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.43 -37.86 89.0 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.808 -0.558 . . . . 0.0 109.945 179.285 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.38 -40.09 96.29 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.621 -0.675 . . . . 0.0 110.1 179.482 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.12 -42.19 94.6 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.624 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 73.2 t -62.32 -40.0 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.45 -1.03 . . . . 0.0 109.972 179.567 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.469 ' HA2' HD12 ' A' ' 26' ' ' LEU . . . -64.12 -44.74 95.3 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.567 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.3 mt -64.8 -35.58 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.358 -1.083 . . . . 0.0 109.784 179.543 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -63.69 -26.54 68.71 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.127 -0.983 . . . . 0.0 109.671 178.775 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.469 HD12 ' HA2' ' A' ' 23' ' ' GLY . 14.9 mt -79.18 -24.2 43.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.401 -0.812 . . . . 0.0 108.862 178.19 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.553 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.3 OUTLIER -133.72 56.31 19.6 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.579 -0.701 . . . . 0.0 110.558 179.411 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.553 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 40.3 Cg_endo . . . . . 0 C--N 1.318 -1.042 0 O-C-N 123.346 1.182 . . . . 0.0 111.143 -179.821 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.504 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 121.283 0.563 . . . . 0.0 109.604 . . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.14 -38.99 92.36 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.747 -0.596 . . . . 0.0 109.98 179.295 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.538 ' O ' HD12 ' A' ' 24' ' ' ILE . . . -64.39 -43.22 95.13 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.587 -0.696 . . . . 0.0 109.758 179.359 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.12 -40.03 96.62 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.231 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 18' ' ' LEU . 94.9 t -63.89 -37.8 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.529 -0.983 . . . . 0.0 109.71 179.244 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.407 ' HA2' HD12 ' A' ' 26' ' ' LEU . . . -60.06 -46.12 94.75 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.415 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.538 HD12 ' O ' ' A' ' 20' ' ' ALA . 1.2 mp -67.18 -34.48 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.447 -1.031 . . . . 0.0 109.561 179.325 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -63.48 -25.99 68.52 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.15 -0.969 . . . . 0.0 109.575 178.842 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.407 HD12 ' HA2' ' A' ' 23' ' ' GLY . 13.6 mt -80.09 -19.43 47.44 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.353 -0.842 . . . . 0.0 109.266 178.273 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.596 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 10.9 tp -138.54 53.95 6.24 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.54 -0.725 . . . . 0.0 110.623 179.438 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.596 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 40.9 Cg_endo . . . . . 0 C--N 1.319 -1.003 0 O-C-N 123.232 1.122 . . . . 0.0 110.967 -179.975 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.524 ' O ' HG23 ' A' ' 22' ' ' VAL . 3.4 tt . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 121.226 0.536 . . . . 0.0 109.688 . . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.16 -38.04 84.79 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.791 -0.568 . . . . 0.0 109.682 179.088 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.65 -39.16 91.1 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.636 -0.665 . . . . 0.0 110.0 179.337 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.1 -39.74 97.46 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.43 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 18' ' ' LEU . 92.3 t -62.22 -43.47 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.497 -1.002 . . . . 0.0 109.608 179.548 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.57 -44.39 92.89 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.411 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.4 mt -65.56 -35.02 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.455 -1.026 . . . . 0.0 109.721 179.411 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -64.1 -27.06 68.84 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.112 -0.992 . . . . 0.0 109.388 178.737 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.465 HD13 ' HA ' ' A' ' 26' ' ' LEU . 1.5 mm? -77.92 -24.88 48.15 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.097 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.549 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 3.4 tp -134.63 57.09 20.23 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.559 -0.713 . . . . 0.0 110.643 179.512 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.549 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.2 Cg_endo . . . . . 0 C--N 1.316 -1.137 0 O-C-N 123.225 1.118 . . . . 0.0 111.121 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 121.012 0.434 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.5 m -110.99 51.25 0.78 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.405 -0.81 . . . . 0.0 110.13 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.453 ' O ' HG12 ' A' ' 3' ' ' VAL . 25.7 t 56.35 49.26 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 CA-C-O 121.471 0.653 . . . . 0.0 110.486 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.4 -36.02 15.71 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.244 -0.91 . . . . 0.0 110.176 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -113.74 31.24 6.66 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.791 -0.568 . . . . 0.0 110.011 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.52 45.91 1.39 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.537 -0.727 . . . . 0.0 110.165 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.2 mmm-85 -97.69 118.49 64.06 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.277 -0.889 . . . . 0.0 109.882 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -72.17 -84.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.238 0 O-C-N 123.908 1.478 . . . . 0.0 110.88 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.419 ' HA ' ' HD1' ' A' ' 12' ' ' TRP . 4.3 mtt180 -140.72 28.71 1.95 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.898 -1.126 . . . . 0.0 110.84 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 49.6 t90 -59.73 -45.31 92.57 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.378 -0.826 . . . . 0.0 109.836 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -86.64 -12.34 48.76 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.568 -0.708 . . . . 0.0 110.543 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.419 ' HD1' ' HA ' ' A' ' 9' ' ' ARG . 82.8 m95 -98.74 13.61 31.64 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.114 -0.991 . . . . 0.0 111.347 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -60.64 -51.35 69.77 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.279 -0.888 . . . . 0.0 109.945 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.8 t -61.16 -33.77 73.96 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.439 0.638 . . . . 0.0 109.469 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.01 -40.98 87.43 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.5 tt -64.44 -40.46 95.78 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.599 -0.688 . . . . 0.0 110.008 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.14 -32.02 72.57 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.481 0.658 . . . . 0.0 109.592 179.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.539 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.8 tp -74.95 -37.01 62.08 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.827 -0.546 . . . . 0.0 109.746 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.7 96.45 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.848 -0.532 . . . . 0.0 109.764 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.98 -39.16 93.89 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.579 -0.701 . . . . 0.0 109.738 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.97 -38.38 95.41 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 18' ' ' LEU . 84.6 t -62.29 -41.29 91.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.498 -1.001 . . . . 0.0 109.827 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.99 -42.01 98.4 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 28.5 mm -66.88 -35.56 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.472 -1.016 . . . . 0.0 109.697 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -64.32 -26.98 68.72 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.275 -0.89 . . . . 0.0 109.513 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.483 HD13 ' HA ' ' A' ' 26' ' ' LEU . 1.9 mm? -78.46 -24.49 45.96 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.373 -0.829 . . . . 0.0 108.878 178.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.573 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 1.4 tp -134.44 56.03 16.78 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.581 -0.699 . . . . 0.0 110.763 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.573 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 43.4 Cg_endo -91.95 -19.75 0.71 Allowed 'Trans proline' 0 C--N 1.319 -1.021 0 C-N-CA 121.096 1.197 . . . . 0.0 111.408 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -103.59 -3.97 24.5 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.26 -0.9 . . . . 0.0 111.203 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.9 0 CA-C-O 117.88 -1.057 . . . . 0.0 110.243 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 72.7 t60 . . . . . 0 N--CA 1.495 1.808 0 CA-C-O 121.117 0.484 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.0 m -136.6 47.52 2.17 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.553 -0.717 . . . . 0.0 110.426 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.6 t -116.9 30.32 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.385 -0.822 . . . . 0.0 110.298 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.1 t -75.89 -20.87 57.69 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.118 -0.989 . . . . 0.0 110.968 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.41 31.32 3.76 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.421 -0.799 . . . . 0.0 110.533 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 51.72 37.38 20.08 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.463 -0.773 . . . . 0.0 110.913 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.2 mtm180 -116.6 86.96 19.57 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.414 -0.804 . . . . 0.0 109.694 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.69 137.91 20.78 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 123.846 1.445 . . . . 0.0 111.075 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.59 ' HA ' ' HB3' ' A' ' 12' ' ' TRP . 2.1 ttt-85 -145.39 -48.5 0.23 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.754 -0.591 . . . . 0.0 110.008 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -46.45 -47.47 19.13 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.701 -0.624 . . . . 0.0 110.443 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -95.71 -29.2 14.41 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.507 -0.745 . . . . 0.0 110.086 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.59 ' HB3' ' HA ' ' A' ' 9' ' ' ARG . 75.3 t-105 -59.28 -30.55 68.39 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.441 -0.787 . . . . 0.0 110.68 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -58.13 -37.39 74.5 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.641 -0.662 . . . . 0.0 109.743 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.4 t -66.2 -36.51 83.25 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.448 HD22 ' CZ3' ' A' ' 12' ' ' TRP . 6.7 tt -66.94 -43.07 84.15 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 tt -64.74 -36.92 85.84 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.487 -0.758 . . . . 0.0 109.684 179.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.22 -32.26 73.78 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.618 0.723 . . . . 0.0 109.509 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.464 HD22 ' HA ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -84.78 -33.9 22.9 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.307 0.575 . . . . 0.0 109.624 179.025 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.8 -37.96 86.32 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.792 -0.567 . . . . 0.0 110.334 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.07 -40.56 96.21 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.455 -0.778 . . . . 0.0 109.965 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.48 -38.65 90.97 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 77.2 t -61.07 -41.23 88.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.474 -1.015 . . . . 0.0 109.939 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.32 -43.51 98.3 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 34.1 mm -67.48 -35.72 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.382 -1.069 . . . . 0.0 109.663 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -63.72 -25.67 68.31 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.217 -0.927 . . . . 0.0 109.645 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.494 HD13 ' HA ' ' A' ' 26' ' ' LEU . 1.6 mm? -80.07 -25.71 39.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.354 -0.841 . . . . 0.0 108.988 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.599 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 4.1 tp -131.28 52.76 10.01 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.467 -0.771 . . . . 0.0 111.126 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.599 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 43.0 Cg_endo -90.14 -20.88 1.02 Allowed 'Trans proline' 0 C--N 1.319 -1.024 0 C-N-CA 120.895 1.064 . . . . 0.0 110.895 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -80.99 -36.54 30.56 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.432 -0.792 . . . . 0.0 110.338 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.19 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.667 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 120.735 0.303 . . . . 0.0 110.27 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.606 ' O ' HG12 ' A' ' 3' ' ' VAL . 1.3 t 62.84 82.59 0.18 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.588 -0.695 . . . . 0.0 109.834 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.606 HG12 ' O ' ' A' ' 2' ' ' SER . 0.4 OUTLIER 60.63 19.45 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 CA-C-O 121.19 0.519 . . . . 0.0 111.008 -179.266 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.6 t -79.45 -38.39 34.74 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.989 -1.07 . . . . 0.0 110.423 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -153.39 26.02 0.52 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.62 -0.675 . . . . 0.0 111.137 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 46.8 48.11 14.97 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.444 -0.785 . . . . 0.0 110.679 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.655 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 6.5 mtt180 -76.32 -54.08 2.0 Allowed Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 121.497 -0.752 . . . . 0.0 110.99 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.655 ' HD3' ' HB2' ' A' ' 7' ' ' ARG . 53.9 Cg_endo -82.91 166.81 14.76 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 O-C-N 123.394 1.208 . . . . 0.0 110.616 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.6 ttm-85 63.48 7.73 3.16 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.826 -0.546 . . . . 0.0 111.924 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.447 ' HA ' ' CE3' ' A' ' 10' ' ' TRP . 6.1 t-105 -101.06 -47.64 4.69 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.973 -1.079 . . . . 0.0 109.73 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -78.06 -20.0 53.17 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.552 -0.717 . . . . 0.0 110.274 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 21.8 m95 -58.26 -28.3 64.81 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.358 -0.839 . . . . 0.0 110.832 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -60.72 -45.24 94.98 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.474 -0.766 . . . . 0.0 109.493 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.9 t -66.56 -36.37 82.48 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.07 -42.81 88.9 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 tt -61.14 -41.49 96.85 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.798 -0.564 . . . . 0.0 109.941 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 tt -60.69 -35.56 76.59 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.382 0.61 . . . . 0.0 109.6 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 tt -73.72 -34.54 64.84 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.21 0.529 . . . . 0.0 109.945 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.8 -35.64 81.26 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.742 -0.599 . . . . 0.0 109.965 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.62 -42.19 64.72 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.504 -0.748 . . . . 0.0 109.979 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.6 -52.26 31.18 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 73.2 t -63.93 -35.25 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.482 -1.011 . . . . 0.0 110.015 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.58 -47.86 89.09 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.6 mt -68.02 -34.79 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.433 -1.04 . . . . 0.0 109.789 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -64.32 -25.08 67.88 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.163 -0.96 . . . . 0.0 109.769 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.511 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.2 mm? -80.81 -26.48 37.07 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.378 -0.826 . . . . 0.0 108.919 178.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.605 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 4.7 tp -130.14 52.0 8.58 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.591 -0.693 . . . . 0.0 111.215 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.605 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.7 Cg_endo -89.03 -33.81 0.1 Allowed 'Trans proline' 0 C--N 1.319 -0.977 0 O-C-N 123.095 1.05 . . . . 0.0 110.787 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -109.14 5.59 24.08 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.398 -0.814 . . . . 0.0 110.691 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.8 mtp85 . . . . . 0 N--CA 1.496 1.838 0 O-C-N 121.218 -0.926 . . . . 0.0 110.436 179.845 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.5 m80 . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 121.031 0.443 . . . . 0.0 110.368 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.3 p -153.92 43.19 0.55 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.552 -0.717 . . . . 0.0 110.69 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.4 t -120.34 46.21 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.209 -0.932 . . . . 0.0 110.064 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.45 -41.29 20.01 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.188 -0.945 . . . . 0.0 110.347 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -140.0 28.93 2.09 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.78 -0.575 . . . . 0.0 110.388 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.411 ' O ' ' CB ' ' A' ' 7' ' ' ARG . . . 51.59 39.83 25.8 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.543 -0.723 . . . . 0.0 110.784 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.411 ' CB ' ' O ' ' A' ' 6' ' ' ALA . 1.6 ttp180 69.45 123.11 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.166 0 O-C-N 121.903 -0.498 . . . . 0.0 110.393 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.67 -28.28 21.06 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 O-C-N 123.64 1.337 . . . . 0.0 110.701 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.6 ttt85 -159.58 -162.26 1.01 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.505 -0.747 . . . . 0.0 109.373 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 52.41 32.97 12.1 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.399 -0.813 . . . . 0.0 110.431 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -174.01 -42.42 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.637 -0.664 . . . . 0.0 109.894 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 27.4 m95 -59.4 -19.72 49.3 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.672 -0.642 . . . . 0.0 111.697 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.04 -37.14 76.28 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.216 -0.928 . . . . 0.0 109.983 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 39.4 m -65.25 -36.7 84.92 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.552 ' C ' HD13 ' A' ' 15' ' ' LEU . 3.4 tm? -65.34 -40.91 94.25 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.489 HD13 ' C ' ' A' ' 16' ' ' LEU . 3.1 tm? -63.84 -39.58 94.55 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.609 -0.682 . . . . 0.0 109.719 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 tp -61.55 -33.42 73.81 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.488 0.661 . . . . 0.0 109.582 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.8 tp -75.03 -31.59 61.38 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.872 -0.517 . . . . 0.0 109.96 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.7 -41.49 95.3 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.725 -0.609 . . . . 0.0 109.999 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.56 -39.25 93.06 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.486 -0.759 . . . . 0.0 109.912 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.88 -39.14 94.87 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.6 t -62.01 -40.34 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.453 -1.027 . . . . 0.0 109.832 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.62 -46.75 91.44 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 37.9 mm -66.56 -33.89 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.54 -0.977 . . . . 0.0 109.578 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -62.5 -25.16 67.86 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.357 -0.839 . . . . 0.0 109.813 178.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.513 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.5 OUTLIER -80.71 -25.62 37.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.51 -0.743 . . . . 0.0 109.095 178.54 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.628 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -130.29 51.08 6.87 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.544 -0.723 . . . . 0.0 111.192 179.544 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.628 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 43.4 Cg_endo -90.17 -19.14 1.25 Allowed 'Trans proline' 0 C--N 1.318 -1.053 0 O-C-N 123.039 1.02 . . . . 0.0 110.651 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -84.96 -36.2 21.53 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.444 -0.785 . . . . 0.0 110.226 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.6 ttp85 . . . . . 0 N--CA 1.501 2.121 0 CA-C-O 118.088 -0.958 . . . . 0.0 110.824 179.854 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . 0.56 ' CD2' ' HB2' ' A' ' 5' ' ' HIS . 23.2 t-160 . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 121.12 0.486 . . . . 0.0 110.244 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.6 m -138.28 -96.57 0.18 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.6 -0.687 . . . . 0.0 109.88 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.4 m -125.33 8.57 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.271 -0.893 . . . . 0.0 110.789 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.2 t -95.96 -31.83 12.9 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.315 -0.866 . . . . 0.0 110.006 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.56 ' HB2' ' CD2' ' A' ' 1' ' ' HIS . 70.5 m-70 -103.17 10.03 38.01 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.703 -0.623 . . . . 0.0 110.687 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.41 16.45 19.89 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.268 -0.895 . . . . 0.0 110.729 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.7 tpm_? -154.85 68.19 5.49 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.243 -0.911 . . . . 0.0 109.967 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.503 ' HA ' ' CZ3' ' A' ' 10' ' ' TRP . 44.6 Cg_endo -73.01 -89.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.316 -1.152 0 O-C-N 123.838 1.441 . . . . 0.0 110.925 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.413 ' CG ' ' O ' ' A' ' 8' ' ' PRO . 24.5 ptt85 39.51 30.16 0.05 OUTLIER 'General case' 0 N--CA 1.509 2.521 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.503 ' CZ3' ' HA ' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -68.8 89.05 0.39 Allowed 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 177.139 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 60.56 26.92 16.59 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 -174.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 47.42 43.98 16.04 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.872 0.844 . . . . 0.0 110.138 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -69.35 -45.5 69.24 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.293 0.568 . . . . 0.0 109.524 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.4 t -65.2 -34.39 78.25 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 178.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 tt -66.24 -42.48 88.55 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.1 tt -63.82 -39.94 95.43 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.592 -0.693 . . . . 0.0 110.083 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 tt -62.01 -32.03 72.47 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.516 0.674 . . . . 0.0 109.465 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.552 ' O ' HG23 ' A' ' 22' ' ' VAL . 9.0 tp -74.14 -37.91 63.9 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.322 0.582 . . . . 0.0 109.627 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.41 -39.99 95.99 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.882 -0.511 . . . . 0.0 109.811 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.62 -40.18 96.16 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.563 -0.71 . . . . 0.0 109.875 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.56 -39.22 96.63 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 18' ' ' LEU . 89.7 t -61.5 -42.11 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.452 -1.028 . . . . 0.0 109.813 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.446 ' HA2' HD12 ' A' ' 26' ' ' LEU . . . -63.06 -42.32 99.61 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 31.3 mm -67.18 -36.28 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.497 -1.002 . . . . 0.0 109.691 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -62.54 -26.63 68.66 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.198 -0.939 . . . . 0.0 109.609 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.446 HD12 ' HA2' ' A' ' 23' ' ' GLY . 12.8 mt -79.52 -22.21 44.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.438 -0.789 . . . . 0.0 109.146 178.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.592 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.6 tp -135.8 54.63 10.51 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.565 -0.709 . . . . 0.0 110.756 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.592 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.8 Cg_endo -90.57 -21.63 0.79 Allowed 'Trans proline' 0 C--N 1.319 -1.024 0 O-C-N 123.264 1.139 . . . . 0.0 111.039 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -93.92 -37.29 11.78 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.347 -0.845 . . . . 0.0 110.191 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.123 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . 0.603 ' O ' HG23 ' A' ' 3' ' ' VAL . 52.0 m80 . . . . . 0 N--CA 1.496 1.837 0 CA-C-O 120.754 0.311 . . . . 0.0 110.184 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.2 p 53.36 36.9 24.12 Favored 'General case' 0 N--CA 1.504 2.268 0 CA-C-O 121.128 0.489 . . . . 0.0 111.721 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.742 HG22 ' HG3' ' A' ' 8' ' ' PRO . 16.3 t -116.61 29.16 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 120.944 -1.097 . . . . 0.0 110.326 179.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.33 -38.48 90.26 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.059 -1.026 . . . . 0.0 110.136 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -112.85 33.87 4.76 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.856 -0.528 . . . . 0.0 109.985 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 51.72 43.23 30.09 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.635 -0.665 . . . . 0.0 110.932 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.563 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -63.36 -52.91 57.26 Favored Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 121.288 -0.882 . . . . 0.0 110.808 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.742 ' HG3' HG22 ' A' ' 3' ' ' VAL . 48.4 Cg_endo -74.36 -163.99 0.2 Allowed 'Trans proline' 0 N--CA 1.486 1.054 0 O-C-N 123.513 1.27 . . . . 0.0 110.233 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.499 ' HA ' ' HB2' ' A' ' 12' ' ' TRP . 4.7 mmt85 -95.61 19.63 10.83 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.151 -0.968 . . . . 0.0 111.09 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 7.7 t-105 -65.2 -49.02 71.36 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.239 -0.913 . . . . 0.0 109.981 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -91.37 11.35 24.05 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.498 -0.751 . . . . 0.0 110.558 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.499 ' HB2' ' HA ' ' A' ' 9' ' ' ARG . 18.1 m95 -105.43 14.77 28.22 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.163 -0.961 . . . . 0.0 110.752 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -62.17 -53.71 51.46 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.121 -0.987 . . . . 0.0 109.93 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.9 t -60.91 -33.22 72.8 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.393 0.616 . . . . 0.0 109.791 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.65 -40.56 76.4 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.761 -0.587 . . . . 0.0 109.444 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 tt -63.78 -40.02 95.65 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.587 -0.695 . . . . 0.0 109.91 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 tt -63.17 -29.74 71.03 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.406 0.622 . . . . 0.0 109.632 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.0 tp -79.7 -34.44 40.15 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.823 -0.548 . . . . 0.0 109.838 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.06 -39.94 83.62 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.842 -0.536 . . . . 0.0 110.298 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.35 -41.13 98.35 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.485 -0.76 . . . . 0.0 110.006 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.28 -40.39 96.58 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 71.9 t -62.89 -40.58 89.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.503 -0.998 . . . . 0.0 109.943 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.06 -42.17 99.72 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 36.0 mt -67.05 -36.96 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.458 -1.025 . . . . 0.0 109.782 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -64.8 -26.17 68.23 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.166 -0.959 . . . . 0.0 109.6 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.488 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.7 mm? -79.17 -25.69 42.78 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.34 -0.85 . . . . 0.0 108.858 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.573 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -131.49 55.33 17.97 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.602 -0.686 . . . . 0.0 110.962 179.556 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.573 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.2 Cg_endo -90.45 -21.96 0.79 Allowed 'Trans proline' 0 C--N 1.318 -1.065 0 C-N-CA 120.891 1.061 . . . . 0.0 110.993 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -92.35 -10.79 36.95 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.298 -0.876 . . . . 0.0 110.922 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 20.6 mtm-85 . . . . . 0 N--CA 1.502 2.145 0 O-C-N 121.463 -0.773 . . . . 0.0 110.675 -179.865 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 30.2 p80 . . . . . 0 N--CA 1.498 1.974 0 CA-C-O 120.96 0.41 . . . . 0.0 110.556 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 t -155.28 54.87 0.63 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.493 -0.755 . . . . 0.0 110.426 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.476 ' O ' HG12 ' A' ' 3' ' ' VAL . 15.4 t 57.58 23.35 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 121.593 -0.692 . . . . 0.0 111.252 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.89 -37.4 13.59 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.886 -1.134 . . . . 0.0 110.059 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -118.17 13.82 13.85 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.74 -0.6 . . . . 0.0 110.845 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -107.35 46.4 0.94 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.303 -0.873 . . . . 0.0 110.488 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 56.62 83.31 0.23 Allowed Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.515 -0.741 . . . . 0.0 110.656 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -73.05 84.34 1.32 Allowed 'Trans proline' 0 C--N 1.314 -1.24 0 O-C-N 123.612 1.322 . . . . 0.0 110.79 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.477 ' HG3' ' CD1' ' A' ' 10' ' ' TRP . 1.3 ptm180 -154.58 -119.76 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.475 -0.766 . . . . 0.0 110.051 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.512 ' O ' ' CB ' ' A' ' 11' ' ' PHE . 27.6 p-90 32.44 88.89 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.766 0 CA-C-N 119.026 0.83 . . . . 0.0 112.064 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.512 ' CB ' ' O ' ' A' ' 10' ' ' TRP . 6.4 t80 78.89 -43.48 0.33 Allowed 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.656 -0.653 . . . . 0.0 111.14 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.425 ' HB3' ' O ' ' A' ' 9' ' ' ARG . 67.4 t-105 -57.49 -35.48 70.26 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.05 -1.031 . . . . 0.0 110.127 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -55.64 -35.07 65.53 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.757 -0.589 . . . . 0.0 109.707 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.0 m -64.55 -37.45 87.59 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.0 tt -65.01 -42.5 94.37 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 tt -64.93 -35.53 81.47 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.547 -0.721 . . . . 0.0 109.731 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.7 tp -62.92 -37.07 85.55 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.4 tt -65.76 -39.25 90.85 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.378 0.608 . . . . 0.0 109.377 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.56 -35.1 78.38 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.879 -0.513 . . . . 0.0 109.803 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.7 -39.85 94.36 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.587 -0.695 . . . . 0.0 110.018 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.54 -42.28 95.75 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 64.2 t -65.05 -42.26 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.512 -0.993 . . . . 0.0 109.538 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.3 -46.93 89.39 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.0 mt -65.43 -32.14 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.445 -1.032 . . . . 0.0 109.872 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.438 ' O ' ' HG3' ' A' ' 28' ' ' PRO . 44.0 t80 -64.79 -28.09 69.34 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.983 -1.073 . . . . 0.0 109.565 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.46 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.8 OUTLIER -77.37 -25.79 51.28 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.037 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.515 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.1 OUTLIER -133.8 59.13 37.14 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.724 -0.61 . . . . 0.0 109.975 179.35 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.6 Cg_endo -90.99 -19.55 0.91 Allowed 'Trans proline' 0 C--N 1.319 -1.011 0 C-N-CA 121.223 1.282 . . . . 0.0 111.535 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -58.1 -32.54 68.19 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.408 -0.807 . . . . 0.0 110.764 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.199 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.553 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.4 p 39.47 48.4 1.75 Allowed 'General case' 0 N--CA 1.506 2.329 0 CA-C-O 121.225 0.536 . . . . 0.0 111.592 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.443 ' HA ' ' HB3' ' A' ' 6' ' ' ALA . 3.0 p -120.27 19.72 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.28 -0.888 . . . . 0.0 110.729 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 45.4 t -65.97 -26.35 67.52 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.183 -0.948 . . . . 0.0 110.526 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 34.3 p-80 -129.78 15.77 5.85 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.739 -0.601 . . . . 0.0 110.705 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.443 ' HB3' ' HA ' ' A' ' 3' ' ' VAL . . . -111.49 32.61 5.26 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.461 -0.775 . . . . 0.0 110.965 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.0 ptt-85 -151.82 62.36 4.72 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 121.109 -0.994 . . . . 0.0 110.395 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -74.37 -174.79 1.94 Allowed 'Trans proline' 0 C--N 1.315 -1.209 0 O-C-N 123.735 1.387 . . . . 0.0 111.017 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -164.87 61.05 0.13 Allowed 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.809 0.814 . . . . 0.0 110.276 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -138.9 -58.17 0.61 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.76 -0.588 . . . . 0.0 110.079 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -79.47 -16.39 56.17 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.467 -0.771 . . . . 0.0 110.643 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.543 ' CZ3' HD13 ' A' ' 15' ' ' LEU . 13.9 m95 -56.7 -31.26 64.3 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.419 -0.8 . . . . 0.0 111.267 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -63.59 -39.55 94.66 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.413 -0.804 . . . . 0.0 109.66 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.8 t -65.9 -35.78 81.57 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.543 HD13 ' CZ3' ' A' ' 12' ' ' TRP . 3.3 tt -66.07 -41.61 90.51 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 tt -63.61 -37.91 89.12 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.686 -0.634 . . . . 0.0 109.923 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.0 tp -62.66 -33.81 75.8 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.599 0.714 . . . . 0.0 109.44 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.513 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -75.64 -36.57 60.16 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.237 0.542 . . . . 0.0 109.863 179.24 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.15 -41.78 98.61 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.839 -0.538 . . . . 0.0 109.979 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.01 -40.58 98.18 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.636 -0.665 . . . . 0.0 109.958 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.17 -38.87 96.88 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 18' ' ' LEU . 88.5 t -64.73 -41.6 92.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.516 -0.99 . . . . 0.0 109.792 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.82 -41.49 99.18 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 38.4 mt -66.73 -34.9 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.427 -1.043 . . . . 0.0 109.593 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -63.88 -27.04 68.88 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.291 -0.88 . . . . 0.0 109.606 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.41 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.6 OUTLIER -78.97 -21.7 46.72 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.455 -0.778 . . . . 0.0 109.125 178.254 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.588 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 6.5 tp -136.25 54.07 8.91 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.619 -0.675 . . . . 0.0 110.757 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.588 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.4 Cg_endo -89.86 -29.21 0.22 Allowed 'Trans proline' 0 C--N 1.318 -1.033 0 O-C-N 123.263 1.139 . . . . 0.0 111.435 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -84.53 -33.46 23.49 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.234 -0.916 . . . . 0.0 110.545 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.2 ttm180 . . . . . 0 N--CA 1.502 2.148 0 CA-C-O 118.091 -0.957 . . . . 0.0 111.124 179.785 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 12.3 m80 . . . . . 0 N--CA 1.494 1.768 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 86.7 p 39.58 44.26 1.18 Allowed 'General case' 0 N--CA 1.507 2.399 0 O-C-N 122.064 -0.398 . . . . 0.0 111.798 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.439 ' O ' HG12 ' A' ' 3' ' ' VAL . 17.5 t 47.01 39.93 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.611 -0.681 . . . . 0.0 110.668 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.2 m -80.04 -73.09 0.37 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.152 -0.967 . . . . 0.0 110.065 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.428 ' CD2' ' HG3' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -151.91 -75.31 0.14 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.69 -0.631 . . . . 0.0 110.623 179.787 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 49.62 56.76 7.36 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.835 -0.54 . . . . 0.0 110.513 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.47 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 4.2 ttp180 -173.44 -57.84 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.073 0 O-C-N 121.512 -0.743 . . . . 0.0 110.823 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.47 ' HD3' ' HB3' ' A' ' 7' ' ' ARG . 43.3 Cg_endo -69.74 -169.96 0.36 Allowed 'Trans proline' 0 N--CA 1.492 1.407 0 O-C-N 123.549 1.289 . . . . 0.0 111.277 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.465 ' HA ' ' HB3' ' A' ' 12' ' ' TRP . 0.3 OUTLIER -62.68 -73.75 0.1 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.376 -0.828 . . . . 0.0 111.042 -179.201 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 74.4 t-105 52.53 -94.26 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.62 -0.675 . . . . 0.0 110.214 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -76.83 -32.06 57.32 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.026 -1.046 . . . . 0.0 109.667 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.465 ' HB3' ' HA ' ' A' ' 9' ' ' ARG . 68.5 t-105 -68.91 -17.19 63.93 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.564 -0.71 . . . . 0.0 110.484 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -63.77 -36.41 83.77 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.436 -0.79 . . . . 0.0 109.529 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.23 -40.5 94.15 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.445 HD22 ' CZ2' ' A' ' 12' ' ' TRP . 6.6 tt -62.97 -41.55 99.57 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.9 tt -64.51 -42.08 96.03 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.713 -0.617 . . . . 0.0 109.957 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 tt -61.06 -32.57 72.2 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.545 0.688 . . . . 0.0 109.441 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.547 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -68.79 -39.45 80.15 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.36 0.6 . . . . 0.0 109.611 178.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.57 -37.8 85.71 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.632 -0.667 . . . . 0.0 109.774 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.02 -41.02 91.52 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.537 -0.727 . . . . 0.0 109.946 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.84 -37.37 94.21 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 18' ' ' LEU . 94.3 t -61.71 -39.36 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.526 -0.984 . . . . 0.0 109.618 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.57 -49.16 66.2 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -65.08 -32.2 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.434 -1.039 . . . . 0.0 109.971 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -62.94 -27.0 69.08 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.148 -0.97 . . . . 0.0 109.631 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.487 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.8 OUTLIER -78.64 -26.54 45.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.41 -0.806 . . . . 0.0 108.927 178.238 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.554 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.7 OUTLIER -131.6 56.56 24.93 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.504 -0.747 . . . . 0.0 110.738 179.386 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.554 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.9 Cg_endo -91.79 -19.19 0.8 Allowed 'Trans proline' 0 C--N 1.316 -1.14 0 C-N-CA 121.138 1.225 . . . . 0.0 111.129 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -89.54 -0.67 57.67 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.311 -0.868 . . . . 0.0 111.24 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.802 0 O-C-N 121.021 -1.05 . . . . 0.0 110.237 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 29.8 m80 . . . . . 0 N--CA 1.496 1.826 0 CA-C-O 121.066 0.46 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.1 p -104.85 35.02 2.92 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.44 -0.787 . . . . 0.0 110.721 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.455 ' O ' HG12 ' A' ' 3' ' ' VAL . 23.5 t 51.97 47.15 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.507 -0.746 . . . . 0.0 110.349 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 t -98.65 -15.85 19.26 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.256 -0.903 . . . . 0.0 110.773 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -98.22 37.89 1.39 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.384 -0.822 . . . . 0.0 110.342 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -151.24 41.61 0.73 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.454 -0.779 . . . . 0.0 110.19 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.518 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -165.89 -62.47 0.01 OUTLIER Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.363 -0.835 . . . . 0.0 110.515 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 7' ' ' ARG . 46.8 Cg_endo -72.74 110.3 2.98 Favored 'Trans proline' 0 N--CA 1.485 1.02 0 O-C-N 123.445 1.234 . . . . 0.0 110.295 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.2 mmt85 -103.91 16.2 26.86 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.608 -0.682 . . . . 0.0 110.944 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 84.6 t90 -62.04 -45.48 93.37 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.228 -0.92 . . . . 0.0 110.15 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -69.6 -22.72 63.48 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.567 -0.708 . . . . 0.0 110.523 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -105.3 13.69 30.06 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.362 -0.836 . . . . 0.0 111.259 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -70.11 -51.3 32.69 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.178 -0.951 . . . . 0.0 109.683 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.2 p -64.03 -35.09 79.58 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.84 -41.94 86.59 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.1 tt -65.36 -38.04 88.85 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.611 -0.68 . . . . 0.0 109.559 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.0 tp -61.56 -35.43 77.77 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.501 0.667 . . . . 0.0 109.411 178.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.0 tp -71.92 -36.05 69.85 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.394 0.616 . . . . 0.0 109.649 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.78 -33.25 75.21 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.828 -0.545 . . . . 0.0 109.926 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.54 -43.09 67.06 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.481 -0.762 . . . . 0.0 110.135 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.48 -53.06 22.79 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 81.8 t -65.62 -36.83 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.435 -1.038 . . . . 0.0 110.132 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.07 -47.82 87.38 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.6 mm -65.46 -35.07 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.368 -1.078 . . . . 0.0 110.013 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.403 ' O ' ' HG3' ' A' ' 28' ' ' PRO . 16.1 t80 -64.11 -28.48 69.8 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.996 -1.065 . . . . 0.0 109.718 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.503 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.7 OUTLIER -78.9 -25.54 43.81 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.341 -0.849 . . . . 0.0 108.882 178.253 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.573 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.2 OUTLIER -131.31 55.27 17.77 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.594 -0.691 . . . . 0.0 110.854 179.677 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.573 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.9 Cg_endo -91.21 -20.43 0.77 Allowed 'Trans proline' 0 C--N 1.319 -1.007 0 C-N-CA 121.013 1.142 . . . . 0.0 110.95 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -100.94 6.2 43.51 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.366 -0.834 . . . . 0.0 110.896 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.237 0 O-C-N 121.497 -0.752 . . . . 0.0 111.351 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 120.837 0.351 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 60.36 74.15 0.46 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.688 -0.632 . . . . 0.0 109.993 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.561 HG13 ' HB3' ' A' ' 7' ' ' ARG . 36.5 t 57.46 68.25 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 CA-C-O 121.605 0.717 . . . . 0.0 109.867 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.5 t -137.81 -63.58 0.57 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.376 -0.828 . . . . 0.0 110.623 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -115.7 34.27 5.03 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.586 -0.697 . . . . 0.0 110.646 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -176.7 48.7 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.561 -0.712 . . . . 0.0 110.078 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.561 ' HB3' HG13 ' A' ' 3' ' ' VAL . 0.9 OUTLIER -173.5 -57.32 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.097 0 O-C-N 121.269 -0.894 . . . . 0.0 111.429 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.454 ' HD3' ' CB ' ' A' ' 7' ' ' ARG . 44.3 Cg_endo -75.33 -84.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.487 1.099 0 O-C-N 123.37 1.195 . . . . 0.0 111.297 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.418 ' O ' ' C ' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -135.99 -61.88 0.69 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.083 -1.011 . . . . 0.0 110.293 -179.685 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.508 ' O ' ' CB ' ' A' ' 11' ' ' PHE . 6.1 m95 -39.97 136.61 1.09 Allowed 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.162 -0.961 . . . . 0.0 111.021 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.508 ' CB ' ' O ' ' A' ' 10' ' ' TRP . 2.6 t80 81.3 -10.25 1.21 Allowed 'General case' 0 N--CA 1.507 2.387 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.131 -179.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.503 ' CE3' ' N ' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -88.88 13.05 13.56 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.962 -1.086 . . . . 0.0 110.935 179.101 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.503 ' N ' ' CE3' ' A' ' 12' ' ' TRP . 2.5 t80 -73.24 -42.01 63.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.582 -0.699 . . . . 0.0 109.454 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.78 -33.19 75.41 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.9 tp -66.37 -40.3 89.64 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.6 tt -64.77 -39.08 93.02 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.688 -0.632 . . . . 0.0 109.342 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.18 -31.63 72.91 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.682 0.753 . . . . 0.0 109.048 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.551 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -71.76 -32.06 67.3 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.881 -0.512 . . . . 0.0 109.823 178.826 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.96 -39.67 82.4 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.765 -0.584 . . . . 0.0 109.995 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.86 -40.64 97.04 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.52 -0.738 . . . . 0.0 109.671 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.34 -37.09 94.29 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 18' ' ' LEU . 76.4 t -61.83 -40.42 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.506 -0.997 . . . . 0.0 109.53 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.21 -45.15 95.92 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.2 mt -68.49 -32.36 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.377 -1.072 . . . . 0.0 109.657 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -61.41 -22.2 64.78 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.458 -0.776 . . . . 0.0 109.901 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.534 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.8 mm? -82.3 -25.05 34.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.399 -0.813 . . . . 0.0 109.487 178.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.629 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.6 OUTLIER -127.58 48.29 3.25 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.411 -0.806 . . . . 0.0 111.589 179.749 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.629 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 45.7 Cg_endo -90.42 -21.08 0.9 Allowed 'Trans proline' 0 C--N 1.319 -0.976 0 O-C-N 122.862 0.928 . . . . 0.0 110.839 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -100.32 -39.09 8.18 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.391 -0.818 . . . . 0.0 110.275 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 117.927 -1.035 . . . . 0.0 110.015 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 31.6 m80 . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 120.991 0.424 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.7 t -111.37 48.12 0.97 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.503 -0.748 . . . . 0.0 110.38 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.404 HG12 ' O ' ' A' ' 3' ' ' VAL . 11.6 t -111.66 36.43 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.294 -0.879 . . . . 0.0 110.141 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.2 t -93.76 -34.36 13.24 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.198 -0.939 . . . . 0.0 110.406 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -96.3 13.4 27.75 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.744 -0.598 . . . . 0.0 111.067 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 52.62 71.92 0.44 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.282 -0.886 . . . . 0.0 110.262 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.417 ' O ' ' HB2' ' A' ' 12' ' ' TRP . 1.3 mmp_? -86.99 118.79 70.55 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.291 -0.88 . . . . 0.0 110.762 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -75.67 -27.61 8.81 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 123.896 1.472 . . . . 0.0 110.637 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.479 ' O ' ' HB2' ' A' ' 10' ' ' TRP . 7.0 mmt180 -141.99 -165.7 2.07 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.434 -0.791 . . . . 0.0 109.839 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.479 ' HB2' ' O ' ' A' ' 9' ' ' ARG . 16.4 m-90 62.49 -82.39 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.825 -0.547 . . . . 0.0 110.175 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.75 16.63 10.36 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.265 -0.897 . . . . 0.0 110.043 178.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.616 ' CZ3' HD22 ' A' ' 15' ' ' LEU . 67.9 t-105 -105.55 -21.09 13.28 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.335 -0.853 . . . . 0.0 111.097 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -61.74 -45.42 94.01 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.347 -0.846 . . . . 0.0 109.888 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.9 p -62.7 -33.36 74.92 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.616 HD22 ' CZ3' ' A' ' 12' ' ' TRP . 0.2 OUTLIER -64.94 -43.77 91.65 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.608 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.9 tt -63.72 -36.62 84.45 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.771 -0.58 . . . . 0.0 109.767 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.3 tp -64.65 -36.98 86.02 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.646 0.736 . . . . 0.0 109.157 178.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.538 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.2 tt -68.45 -37.12 79.93 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.322 0.582 . . . . 0.0 109.434 178.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.49 -38.87 92.51 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.827 -0.546 . . . . 0.0 109.765 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.84 -40.23 96.09 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.6 -0.688 . . . . 0.0 109.724 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.77 -37.65 94.61 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 18' ' ' LEU . 95.5 t -62.97 -41.64 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.45 -1.029 . . . . 0.0 109.805 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.67 -41.84 98.9 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.4 mm -67.17 -34.9 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.409 -1.054 . . . . 0.0 109.692 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -63.44 -26.75 68.88 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.255 -0.903 . . . . 0.0 109.637 178.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.471 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.8 OUTLIER -79.06 -24.9 43.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.412 -0.805 . . . . 0.0 109.022 178.226 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.586 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 5.7 tp -132.65 54.35 13.47 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.518 -0.739 . . . . 0.0 110.946 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.586 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.9 Cg_endo -90.67 -22.43 0.67 Allowed 'Trans proline' 0 C--N 1.319 -1.018 0 C-N-CA 120.936 1.091 . . . . 0.0 111.162 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.75 -28.96 66.22 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.232 -0.917 . . . . 0.0 110.398 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.462 ' NH2' HD23 ' A' ' 27' ' ' LEU . 1.6 mmp_? . . . . . 0 N--CA 1.505 2.307 0 CA-C-O 118.305 -0.855 . . . . 0.0 111.079 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.497 1.902 0 CA-C-O 121.095 0.474 . . . . 0.0 110.431 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.5 m -128.84 37.75 4.04 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.584 -0.698 . . . . 0.0 110.25 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.8 m -115.12 52.44 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.28 -0.887 . . . . 0.0 110.143 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.32 -28.33 47.32 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.44 -0.788 . . . . 0.0 110.749 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -95.9 42.1 1.09 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.483 -0.761 . . . . 0.0 110.386 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.35 31.89 1.52 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.27 -0.894 . . . . 0.0 110.605 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 48.9 mtt180 45.22 59.87 13.88 Favored Pre-proline 0 N--CA 1.503 2.2 0 O-C-N 121.726 -0.609 . . . . 0.0 111.178 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.43 -36.71 4.96 Favored 'Trans proline' 0 N--CA 1.488 1.19 0 O-C-N 123.719 1.379 . . . . 0.0 110.718 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.1 ptp85 -143.87 -150.16 0.3 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.485 -0.759 . . . . 0.0 109.678 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 9.6 t-105 68.19 -67.38 0.2 Allowed 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.755 -0.591 . . . . 0.0 110.39 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -84.23 -19.43 33.94 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.35 -0.844 . . . . 0.0 110.588 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.495 ' HA ' ' CE3' ' A' ' 12' ' ' TRP . 2.3 m95 -85.91 13.32 7.62 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.116 -0.99 . . . . 0.0 111.419 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -66.69 -46.72 74.69 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.986 -1.071 . . . . 0.0 109.711 179.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.0 p -61.35 -34.81 75.92 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.424 0.631 . . . . 0.0 109.437 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.9 tp -64.17 -42.0 96.9 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 tt -63.37 -39.97 95.99 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.692 -0.63 . . . . 0.0 109.749 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.36 -35.34 78.82 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.475 0.655 . . . . 0.0 109.435 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.57 ' O ' HG23 ' A' ' 22' ' ' VAL . 1.3 tt -72.93 -36.1 67.16 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.219 0.533 . . . . 0.0 109.894 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.26 -40.7 95.06 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.72 -0.612 . . . . 0.0 109.773 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.64 -39.92 95.36 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.629 -0.669 . . . . 0.0 109.78 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.42 -37.58 93.96 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 18' ' ' LEU . 87.7 t -61.62 -42.65 94.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.474 -1.016 . . . . 0.0 109.843 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.02 -41.83 99.79 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 30.3 mm -67.23 -36.57 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.455 -1.027 . . . . 0.0 109.761 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -63.08 -25.96 68.61 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.272 -0.893 . . . . 0.0 109.801 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.438 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 13.3 mt -81.44 -20.35 40.52 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.328 -0.858 . . . . 0.0 109.323 178.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.627 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 1.3 tp -135.99 51.86 5.82 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.412 -0.805 . . . . 0.0 110.902 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.627 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 44.7 Cg_endo -91.63 -19.61 0.78 Allowed 'Trans proline' 0 C--N 1.32 -0.946 0 C-N-CA 121.113 1.209 . . . . 0.0 111.223 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -71.57 -38.32 70.97 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.253 -0.905 . . . . 0.0 110.429 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.836 0 CA-C-O 118.353 -0.832 . . . . 0.0 110.562 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 43.0 m80 . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 120.995 0.426 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.5 p -110.49 49.87 0.83 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.574 -0.704 . . . . 0.0 110.018 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.7 t 56.27 57.33 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 121.649 -0.657 . . . . 0.0 110.516 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.1 t -68.62 -34.84 76.43 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.318 -0.864 . . . . 0.0 110.523 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -135.13 26.72 3.54 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.696 -0.627 . . . . 0.0 110.667 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 47.44 49.84 15.39 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.551 -0.718 . . . . 0.0 111.035 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.1 113.52 29.71 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.245 -0.909 . . . . 0.0 110.675 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -79.07 113.32 3.2 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.844 1.444 . . . . 0.0 110.667 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.413 ' HG3' ' CE2' ' A' ' 12' ' ' TRP . 1.3 ttt180 -140.31 -99.57 0.15 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.459 -0.776 . . . . 0.0 110.218 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 53.15 61.6 3.08 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -178.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 61.44 26.17 15.99 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 -175.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.512 ' CD1' HD13 ' A' ' 15' ' ' LEU . 6.7 m-90 45.22 44.32 8.73 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.816 0.817 . . . . 0.0 110.148 -178.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -66.42 -47.48 73.09 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.6 t -63.21 -36.47 83.77 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.512 HD13 ' CD1' ' A' ' 12' ' ' TRP . 2.4 tt -68.04 -43.73 78.06 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.3 tt -62.81 -38.17 89.65 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.613 -0.679 . . . . 0.0 109.986 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.0 tt -61.64 -35.84 79.09 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.592 0.711 . . . . 0.0 109.322 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.496 ' O ' HG23 ' A' ' 22' ' ' VAL . 1.3 tt -69.6 -37.22 76.81 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.316 0.579 . . . . 0.0 109.747 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.14 -38.38 85.44 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.861 -0.524 . . . . 0.0 109.922 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.28 -43.11 98.86 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.531 -0.731 . . . . 0.0 109.928 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.57 -39.41 96.43 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 18' ' ' LEU . 98.7 t -64.35 -37.2 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.62 -0.93 . . . . 0.0 109.714 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.421 ' HA2' HD12 ' A' ' 26' ' ' LEU . . . -60.15 -46.97 93.27 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.37 -34.16 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.521 -0.988 . . . . 0.0 109.65 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -63.23 -26.15 68.65 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.084 -1.01 . . . . 0.0 109.64 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.448 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 14.8 mt -78.82 -23.78 44.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.293 -0.88 . . . . 0.0 108.909 178.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.56 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -134.59 56.2 17.02 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.553 -0.717 . . . . 0.0 110.681 179.311 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.56 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 40.1 Cg_endo -89.76 -22.52 0.87 Allowed 'Trans proline' 0 C--N 1.318 -1.055 0 O-C-N 123.235 1.124 . . . . 0.0 111.024 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -85.97 -33.83 21.02 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.272 -0.893 . . . . 0.0 110.235 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.106 0 CA-C-O 118.173 -0.918 . . . . 0.0 110.836 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 121.07 0.462 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.446 ' C ' HG22 ' A' ' 3' ' ' VAL . 12.6 p -105.03 40.51 1.5 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.57 -0.706 . . . . 0.0 110.377 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.446 HG22 ' C ' ' A' ' 2' ' ' SER . 34.5 m 34.29 46.64 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.549 0 CA-C-O 121.37 0.605 . . . . 0.0 111.961 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.69 -21.23 17.72 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.536 -0.728 . . . . 0.0 110.775 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.509 ' O ' ' HB3' ' A' ' 6' ' ' ALA . 0.6 OUTLIER -120.36 29.51 7.43 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.401 -0.812 . . . . 0.0 110.74 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 5' ' ' HIS . . . 63.11 86.74 0.11 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.569 -0.707 . . . . 0.0 110.277 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 10.0 ptt-85 -53.59 143.63 37.08 Favored Pre-proline 0 N--CA 1.5 2.073 0 O-C-N 121.689 -0.632 . . . . 0.0 110.582 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.458 ' HG2' ' HB3' ' A' ' 11' ' ' PHE . 48.0 Cg_endo -74.36 171.01 18.93 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 O-C-N 123.768 1.404 . . . . 0.0 110.919 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.7 mtp85 -108.88 -37.23 5.91 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.677 -0.639 . . . . 0.0 110.399 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 45.3 p-90 -61.71 -32.23 72.44 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.401 -0.812 . . . . 0.0 110.415 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.458 ' HB3' ' HG2' ' A' ' 8' ' ' PRO . 11.5 t80 -69.86 -42.75 73.12 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.376 -0.827 . . . . 0.0 109.766 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.614 ' CZ3' HD13 ' A' ' 15' ' ' LEU . 3.9 m95 -67.82 -13.57 62.25 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.453 -0.779 . . . . 0.0 110.969 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -63.91 -34.51 78.13 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.329 -0.857 . . . . 0.0 109.439 178.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.8 t -63.57 -36.76 84.86 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.614 HD13 ' CZ3' ' A' ' 12' ' ' TRP . 0.9 OUTLIER -66.36 -42.95 87.31 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.82 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 tt -62.13 -39.88 94.07 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.656 -0.652 . . . . 0.0 110.042 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.4 tt -61.4 -35.52 77.74 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.492 0.663 . . . . 0.0 109.508 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.57 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.5 tt -70.39 -35.46 73.49 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.174 0.512 . . . . 0.0 109.74 179.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.79 -40.51 97.54 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.755 -0.591 . . . . 0.0 109.67 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.51 -38.84 90.88 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.501 -0.75 . . . . 0.0 109.475 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.483 ' HA2' HD12 ' A' ' 24' ' ' ILE . . . -62.42 -36.41 93.09 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 18' ' ' LEU . 87.4 t -62.76 -41.75 93.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.512 -0.993 . . . . 0.0 109.625 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.43 -42.0 99.67 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.483 HD12 ' HA2' ' A' ' 21' ' ' GLY . 22.3 mt -68.98 -32.18 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.545 -0.974 . . . . 0.0 109.555 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -63.46 -25.42 68.26 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.323 -0.86 . . . . 0.0 109.521 178.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.431 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.3 mp -78.61 -22.68 46.63 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.5 -0.75 . . . . 0.0 109.007 178.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.589 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 3.5 tp -135.28 53.98 9.9 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.603 -0.686 . . . . 0.0 110.78 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.589 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.6 Cg_endo -89.39 -42.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.033 0 O-C-N 123.15 1.079 . . . . 0.0 110.86 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -79.89 -32.69 40.32 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.408 -0.807 . . . . 0.0 110.395 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.7 mtp180 . . . . . 0 N--CA 1.501 2.107 0 CA-C-O 118.506 -0.759 . . . . 0.0 110.85 179.907 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 29.4 t60 . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 120.952 0.406 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.3 t 53.61 66.96 1.08 Allowed 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 121.331 0.586 . . . . 0.0 110.679 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.657 HG13 ' H ' ' A' ' 4' ' ' SER . 0.9 OUTLIER -148.62 -83.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.35 -0.844 . . . . 0.0 110.358 179.838 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.657 ' H ' HG13 ' A' ' 3' ' ' VAL . 0.3 OUTLIER 72.3 -14.0 0.58 Allowed 'General case' 0 N--CA 1.511 2.583 0 O-C-N 121.499 -0.751 . . . . 0.0 112.303 179.859 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.427 ' CE1' HG23 ' A' ' 3' ' ' VAL . 17.5 p-80 -105.34 5.85 32.2 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.2 -0.937 . . . . 0.0 110.959 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -101.42 45.44 0.97 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.471 -0.768 . . . . 0.0 110.221 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -114.99 150.46 44.23 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.42 -0.8 . . . . 0.0 109.937 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.572 ' HA ' ' HB3' ' A' ' 14' ' ' SER . 50.9 Cg_endo -76.64 56.09 5.05 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.754 1.397 . . . . 0.0 110.866 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.51 4.1 5.09 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.204 -0.935 . . . . 0.0 111.355 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 73.7 t90 -63.11 93.0 0.06 Allowed 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 177.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 56.38 27.26 11.75 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 -175.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 18.5 m-90 44.66 38.65 2.86 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 122.057 0.932 . . . . 0.0 109.768 -178.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -79.35 -46.92 16.7 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.312 0.577 . . . . 0.0 109.611 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.572 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 6.5 t -63.6 -33.06 74.77 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.454 ' C ' HD13 ' A' ' 15' ' ' LEU . 3.0 tm? -68.4 -41.94 79.76 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.3 tt -62.67 -40.8 98.23 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.665 -0.647 . . . . 0.0 109.941 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.2 tt -61.13 -33.46 73.43 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.402 0.62 . . . . 0.0 109.505 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.557 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -72.56 -34.08 67.24 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.879 -0.513 . . . . 0.0 109.848 178.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.42 -45.6 93.03 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.648 -0.657 . . . . 0.0 109.5 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.73 -34.83 78.71 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.623 -0.673 . . . . 0.0 109.801 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.04 -40.12 95.04 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 18' ' ' LEU . 77.3 t -60.04 -42.54 90.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.491 -1.005 . . . . 0.0 109.736 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.61 -45.26 93.45 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.9 mt -66.54 -35.26 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.491 -1.006 . . . . 0.0 109.736 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -63.43 -26.61 68.81 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.152 -0.968 . . . . 0.0 109.585 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.475 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.4 mm? -78.86 -26.51 44.04 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 178.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.559 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.0 tp -132.23 56.26 22.28 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.587 -0.696 . . . . 0.0 110.707 179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.559 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.0 Cg_endo -90.1 -20.24 1.12 Allowed 'Trans proline' 0 C--N 1.317 -1.093 0 O-C-N 123.323 1.17 . . . . 0.0 111.015 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -78.68 -32.28 47.01 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.419 -0.801 . . . . 0.0 110.302 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.059 0 CA-C-O 117.716 -1.135 . . . . 0.0 110.758 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . 0.492 ' HB3' HG22 ' A' ' 3' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 121.149 0.5 . . . . 0.0 110.335 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.9 p -109.55 48.51 0.88 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.439 -0.788 . . . . 0.0 110.439 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.492 HG22 ' HB3' ' A' ' 1' ' ' HIS . 20.0 m -123.16 30.9 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.347 -0.846 . . . . 0.0 110.623 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.1 m -120.3 -68.65 0.89 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.355 -0.841 . . . . 0.0 110.045 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 51.7 m80 -128.76 19.39 6.12 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.667 -0.646 . . . . 0.0 110.996 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 52.7 32.67 12.38 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.509 -0.744 . . . . 0.0 111.128 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.414 ' HD2' ' HA ' ' A' ' 7' ' ' ARG . 6.1 tpt180 -150.56 94.71 3.6 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.242 -0.911 . . . . 0.0 110.153 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.15 90.09 1.01 Allowed 'Trans proline' 0 C--N 1.313 -1.342 0 O-C-N 123.916 1.482 . . . . 0.0 110.408 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.697 ' HE ' HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -116.35 -81.21 0.61 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.389 -0.819 . . . . 0.0 110.013 -179.854 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 13.8 m95 47.4 -92.88 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.739 -0.6 . . . . 0.0 111.26 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -83.08 -26.82 30.71 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.158 -0.964 . . . . 0.0 110.816 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 17.9 m95 -71.0 -0.72 10.0 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.244 -0.91 . . . . 0.0 111.796 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -61.26 -40.2 93.2 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.043 -1.036 . . . . 0.0 110.142 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.4 p -65.21 -36.28 83.68 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.429 0.633 . . . . 0.0 109.481 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.1 tt -65.02 -41.61 95.16 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 178.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.697 HD13 ' HE ' ' A' ' 9' ' ' ARG . 1.0 OUTLIER -66.75 -35.09 79.28 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.589 -0.694 . . . . 0.0 109.871 179.174 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.0 tp -67.26 -32.82 74.1 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.41 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.9 OUTLIER -72.22 -30.82 65.28 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.109 0.48 . . . . 0.0 109.848 178.933 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.54 -41.53 94.64 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.72 -0.612 . . . . 0.0 110.051 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.41 -38.24 89.36 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.55 -0.719 . . . . 0.0 109.827 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.6 -40.72 96.14 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 18' ' ' LEU . 69.9 t -62.94 -38.14 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.504 -0.997 . . . . 0.0 109.895 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.33 -48.09 87.68 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 28.9 mm -71.48 -35.81 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.486 -1.008 . . . . 0.0 109.587 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -65.01 -26.62 68.36 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.266 -0.896 . . . . 0.0 109.629 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.426 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 10.7 mt -79.32 -21.23 46.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 0.0 109.046 178.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.574 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 3.0 tp -135.86 54.3 9.81 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.603 -0.685 . . . . 0.0 110.698 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.574 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 40.7 Cg_endo -89.77 -24.98 0.55 Allowed 'Trans proline' 0 C--N 1.317 -1.092 0 O-C-N 123.103 1.054 . . . . 0.0 111.183 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -92.05 -14.87 28.64 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.276 -0.89 . . . . 0.0 110.696 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.501 2.08 0 CA-C-O 117.92 -1.038 . . . . 0.0 110.791 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 33.9 p80 . . . . . 0 N--CA 1.497 1.906 0 CA-C-O 120.956 0.408 . . . . 0.0 110.477 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.3 m 53.47 44.92 29.28 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.702 -0.624 . . . . 0.0 110.806 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.4 p -119.23 22.85 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.263 -0.898 . . . . 0.0 110.802 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.62 -13.87 16.36 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.263 -0.898 . . . . 0.0 111.276 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 24.2 m80 -100.57 41.29 1.18 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.271 -0.893 . . . . 0.0 110.874 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -128.8 22.04 5.86 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.18 -0.95 . . . . 0.0 110.808 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -144.68 150.45 46.96 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.235 -0.916 . . . . 0.0 110.112 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -72.48 -66.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.269 0 O-C-N 123.807 1.425 . . . . 0.0 111.102 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 19.3 mtp85 55.75 21.51 4.75 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.494 -0.754 . . . . 0.0 111.683 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 31.4 p-90 -99.38 -33.27 10.77 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.12 -0.988 . . . . 0.0 109.743 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -85.36 -13.81 48.34 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.466 -0.771 . . . . 0.0 109.929 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 30.8 m95 -104.27 7.68 35.93 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.211 -0.931 . . . . 0.0 111.306 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -69.27 -48.59 61.33 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.099 -1.0 . . . . 0.0 109.516 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.5 p -63.42 -33.63 75.97 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.58 -42.28 95.71 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.9 tt -63.66 -40.8 97.76 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.716 -0.615 . . . . 0.0 109.735 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 tt -62.31 -36.5 82.35 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.649 0.737 . . . . 0.0 109.336 178.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.562 ' O ' HG23 ' A' ' 22' ' ' VAL . 1.3 tt -69.11 -36.59 77.69 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.264 0.554 . . . . 0.0 109.724 178.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.97 -41.16 99.45 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.69 -0.631 . . . . 0.0 109.688 179.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.64 -39.03 93.31 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.541 -0.724 . . . . 0.0 109.66 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.52 -37.16 93.39 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 18' ' ' LEU . 88.0 t -61.24 -41.02 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.408 -1.054 . . . . 0.0 109.576 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.453 ' HA2' HD12 ' A' ' 26' ' ' LEU . . . -64.71 -45.65 92.16 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.0 mt -68.14 -33.03 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.48 -1.012 . . . . 0.0 109.793 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -60.71 -23.46 64.91 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.304 -0.872 . . . . 0.0 109.821 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.453 HD12 ' HA2' ' A' ' 23' ' ' GLY . 12.3 mt -81.06 -17.4 50.26 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.328 -0.858 . . . . 0.0 109.638 178.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.636 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.4 tp -137.29 51.31 4.31 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.268 -0.895 . . . . 0.0 111.015 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.636 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 43.4 Cg_endo -90.64 -21.0 0.85 Allowed 'Trans proline' 0 C--N 1.318 -1.03 0 O-C-N 123.16 1.084 . . . . 0.0 111.059 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -89.96 -37.75 14.13 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.355 -0.841 . . . . 0.0 110.433 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 . . . . . 0 N--CA 1.495 1.816 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.268 179.955 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 12.7 m80 . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 120.874 0.369 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.1 m 53.82 39.65 30.6 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.763 -0.586 . . . . 0.0 110.934 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.4 p -116.58 22.61 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.253 -0.905 . . . . 0.0 110.804 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.1 t -105.4 -12.28 16.09 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.278 -0.889 . . . . 0.0 111.044 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -90.95 34.06 0.93 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.274 -0.891 . . . . 0.0 110.92 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -128.01 23.34 6.12 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.177 -0.952 . . . . 0.0 110.928 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.559 ' HB3' ' HD2' ' A' ' 9' ' ' ARG . 11.2 mtt-85 -154.23 142.28 14.11 Favored Pre-proline 0 N--CA 1.498 1.949 0 O-C-N 121.28 -0.888 . . . . 0.0 110.371 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -74.17 82.02 1.89 Allowed 'Trans proline' 0 C--N 1.314 -1.262 0 O-C-N 123.7 1.368 . . . . 0.0 110.102 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.559 ' HD2' ' HB3' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -135.73 6.94 3.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.318 -0.864 . . . . 0.0 111.762 -179.188 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 77.3 t-105 -64.9 87.84 0.06 Allowed 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.403 ' N ' ' O ' ' A' ' 9' ' ' ARG . 0.2 OUTLIER 58.33 25.06 12.32 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -175.008 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.408 ' NE1' ' HG3' ' A' ' 9' ' ' ARG . 1.9 m-90 44.99 38.54 3.07 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.905 0.86 . . . . 0.0 109.555 -177.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -66.92 -58.15 5.55 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.828 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.5 m -59.94 -34.09 72.79 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.46 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.5 OUTLIER -65.03 -44.35 89.41 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.044 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.2 tt -67.17 -38.48 85.51 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.652 -0.655 . . . . 0.0 109.41 178.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.8 -37.31 86.22 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.65 0.738 . . . . 0.0 109.189 178.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.523 ' O ' HG23 ' A' ' 22' ' ' VAL . 1.9 tt -72.96 -35.93 67.02 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.307 0.575 . . . . 0.0 109.658 178.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.86 -39.02 93.22 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.755 -0.59 . . . . 0.0 109.97 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.97 -41.05 97.57 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.603 -0.686 . . . . 0.0 109.813 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.35 -38.09 95.37 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 18' ' ' LEU . 95.5 t -63.2 -40.65 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.471 -1.017 . . . . 0.0 109.777 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.34 -41.41 98.16 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 29.9 mm -66.91 -36.36 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.382 -1.07 . . . . 0.0 109.697 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -64.58 -26.58 68.47 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.14 -0.975 . . . . 0.0 109.48 178.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.451 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.6 mm? -78.13 -24.76 47.26 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.406 -0.809 . . . . 0.0 108.872 177.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.561 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.3 tp -134.41 56.05 16.9 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.71 -0.619 . . . . 0.0 110.752 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.561 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.2 Cg_endo -90.85 -20.49 0.84 Allowed 'Trans proline' 0 C--N 1.317 -1.126 0 C-N-CA 121.081 1.187 . . . . 0.0 111.139 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -105.32 5.61 32.06 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.355 -0.841 . . . . 0.0 110.856 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.83 0 O-C-N 121.276 -0.89 . . . . 0.0 110.501 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 9.4 m80 . . . . . 0 N--CA 1.496 1.834 0 CA-C-O 120.766 0.317 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.2 t 51.74 45.79 27.59 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.684 -0.635 . . . . 0.0 110.965 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.418 ' O ' HG12 ' A' ' 3' ' ' VAL . 11.2 t 54.29 31.53 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 121.56 -0.713 . . . . 0.0 110.771 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.3 t -110.41 -15.42 13.93 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.097 -1.002 . . . . 0.0 111.04 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.4 m80 -135.87 62.22 1.63 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.289 -0.882 . . . . 0.0 109.932 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -131.96 -82.88 0.5 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.507 -0.746 . . . . 0.0 110.425 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.97 88.96 6.2 Favored Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 121.466 -0.771 . . . . 0.0 110.085 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -69.59 -10.66 29.25 Favored 'Trans proline' 0 N--CA 1.491 1.366 0 O-C-N 123.65 1.342 . . . . 0.0 111.723 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.407 ' O ' ' N ' ' A' ' 11' ' ' PHE . 12.7 mtm-85 -72.59 -67.37 0.56 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.2 -0.938 . . . . 0.0 110.519 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER 56.79 -85.12 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.854 -0.528 . . . . 0.0 110.184 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.407 ' N ' ' O ' ' A' ' 9' ' ' ARG . 10.0 t80 -75.52 -18.34 59.83 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.14 -0.975 . . . . 0.0 110.321 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.599 ' CE3' HD13 ' A' ' 15' ' ' LEU . 67.5 m95 -84.8 17.65 2.72 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.307 -0.871 . . . . 0.0 111.118 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -68.46 -41.68 79.83 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.09 -1.006 . . . . 0.0 109.619 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.8 m -62.3 -36.79 83.22 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.463 0.649 . . . . 0.0 109.298 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.599 HD13 ' CE3' ' A' ' 12' ' ' TRP . 1.4 tt -63.65 -41.97 98.17 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.9 tt -62.78 -38.35 90.28 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.609 -0.682 . . . . 0.0 109.9 179.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.6 tt -62.14 -36.13 80.86 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.536 0.684 . . . . 0.0 109.43 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.85 -35.23 72.33 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.313 0.577 . . . . 0.0 109.78 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.94 -36.94 75.71 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.79 -0.569 . . . . 0.0 109.92 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.44 -40.17 95.72 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.62 -0.675 . . . . 0.0 109.991 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.09 -45.21 88.74 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 179.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.3 t -65.52 -40.96 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.515 -0.991 . . . . 0.0 109.747 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.99 -48.83 80.84 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 23.8 mm -65.67 -34.97 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.406 -1.056 . . . . 0.0 109.71 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -62.29 -26.14 68.24 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.221 -0.925 . . . . 0.0 109.66 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.495 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 16.9 mt -79.58 -25.61 41.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.357 -0.84 . . . . 0.0 109.114 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.591 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 3.8 tp -131.52 53.54 11.88 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.453 -0.779 . . . . 0.0 110.921 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.591 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.5 Cg_endo -90.2 -20.75 1.02 Allowed 'Trans proline' 0 C--N 1.319 -1.016 0 C-N-CA 120.96 1.107 . . . . 0.0 110.749 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.04 -38.43 8.17 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.377 -0.827 . . . . 0.0 110.03 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.4 mtt85 . . . . . 0 N--CA 1.497 1.878 0 CA-C-O 117.916 -1.04 . . . . 0.0 110.218 179.76 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 . . . . . 0 N--CA 1.497 1.9 0 CA-C-O 121.306 0.575 . . . . 0.0 110.377 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.3 52.65 0.91 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.315 -0.865 . . . . 0.0 110.274 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.486 HG13 ' HB3' ' A' ' 6' ' ' ALA . 9.6 t 53.19 55.05 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.585 -0.697 . . . . 0.0 110.625 179.759 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.7 t -86.72 -19.39 29.23 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.245 -0.91 . . . . 0.0 110.929 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -144.89 40.14 1.25 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.519 -0.738 . . . . 0.0 110.269 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.486 ' HB3' HG13 ' A' ' 3' ' ' VAL . . . -97.31 31.84 2.38 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.249 -0.907 . . . . 0.0 111.013 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.57 84.92 0.2 Allowed Pre-proline 0 N--CA 1.502 2.146 0 O-C-N 121.506 -0.746 . . . . 0.0 110.887 179.691 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.64 98.87 0.9 Allowed 'Trans proline' 0 C--N 1.314 -1.255 0 O-C-N 123.627 1.33 . . . . 0.0 110.542 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.414 ' HA ' ' HB3' ' A' ' 12' ' ' TRP . 4.0 mpt_? -62.17 -31.69 72.22 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.539 -0.726 . . . . 0.0 110.704 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 27.6 m-90 -55.11 -40.15 70.17 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.664 -0.648 . . . . 0.0 110.416 179.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -98.82 -33.42 10.9 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.545 -0.722 . . . . 0.0 110.111 179.635 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.538 ' CZ3' HD22 ' A' ' 15' ' ' LEU . 68.3 t-105 -64.57 -25.76 68.11 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.406 -0.809 . . . . 0.0 110.839 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -60.0 -43.25 95.32 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.506 -0.746 . . . . 0.0 109.625 179.391 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.1 t -63.15 -34.24 77.19 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.307 0.575 . . . . 0.0 109.539 179.052 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.538 HD22 ' CZ3' ' A' ' 12' ' ' TRP . 6.2 tt -67.09 -42.27 84.9 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.798 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 tt -61.25 -40.31 93.59 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.65 -0.656 . . . . 0.0 109.885 179.276 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 tt -63.82 -32.0 73.37 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.609 0.719 . . . . 0.0 109.399 178.703 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.474 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -76.46 -32.81 58.63 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.285 0.564 . . . . 0.0 109.811 178.915 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.68 -40.54 92.5 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.668 -0.645 . . . . 0.0 110.178 179.537 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.19 -42.05 99.28 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.522 -0.736 . . . . 0.0 109.695 179.374 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.38 -38.5 96.38 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.288 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 18' ' ' LEU . 89.9 t -62.95 -41.41 92.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.535 -0.979 . . . . 0.0 109.841 179.5 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.96 -42.24 99.67 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.338 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.9 mt -67.67 -35.26 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.576 -0.955 . . . . 0.0 109.53 179.06 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 92.7 t80 -63.9 -22.46 66.93 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.354 -0.841 . . . . 0.0 110.006 178.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.538 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -83.77 -25.05 30.8 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.426 -0.796 . . . . 0.0 109.505 178.75 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.68 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.9 tp -125.65 44.75 1.22 Allowed Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.39 -0.819 . . . . 0.0 111.92 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.68 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 44.3 Cg_endo -88.99 -46.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.322 -0.831 0 O-C-N 122.868 0.931 . . . . 0.0 110.077 179.437 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -109.11 7.69 25.72 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.622 -0.674 . . . . 0.0 110.524 179.152 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.7 mmt85 . . . . . 0 N--CA 1.502 2.14 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.697 -179.764 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 . . . . . 0 N--CA 1.495 1.783 0 CA-C-O 121.374 0.607 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.8 p -106.18 27.44 8.65 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.445 -0.784 . . . . 0.0 110.643 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.2 t 49.54 47.38 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 O-C-N 121.593 -0.692 . . . . 0.0 110.474 -179.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.7 t -85.33 -17.64 36.21 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.272 -0.893 . . . . 0.0 110.963 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -107.85 33.13 4.25 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.461 -0.775 . . . . 0.0 110.181 179.553 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -159.44 42.37 0.22 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.504 -0.748 . . . . 0.0 110.191 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.492 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -165.09 -61.47 0.01 OUTLIER Pre-proline 0 N--CA 1.498 1.949 0 O-C-N 121.465 -0.772 . . . . 0.0 110.369 -179.985 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.492 ' HD3' ' CB ' ' A' ' 7' ' ' ARG . 47.7 Cg_endo -74.17 144.17 33.13 Favored 'Trans proline' 0 N--CA 1.484 0.94 0 O-C-N 123.436 1.23 . . . . 0.0 110.502 179.698 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.56 -142.46 0.37 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.618 -0.676 . . . . 0.0 110.242 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 1.4 m95 64.71 -82.82 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.422 -0.798 . . . . 0.0 110.422 -179.654 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -65.09 -33.18 75.41 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.119 -0.988 . . . . 0.0 109.836 179.39 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.512 ' CZ3' HD22 ' A' ' 15' ' ' LEU . 49.3 t-105 -83.76 -21.51 32.18 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.384 -0.822 . . . . 0.0 110.089 179.129 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -62.26 -41.61 98.6 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.618 -0.676 . . . . 0.0 109.776 179.352 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.62 -35.62 81.59 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.78 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.512 HD22 ' CZ3' ' A' ' 12' ' ' TRP . 6.9 tt -63.93 -40.91 97.53 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.743 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 tt -63.39 -41.91 98.77 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.372 0.606 . . . . 0.0 109.853 179.136 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 tt -63.12 -36.42 83.53 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.669 0.747 . . . . 0.0 109.008 178.559 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -67.82 -35.71 79.1 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.258 0.551 . . . . 0.0 109.56 178.709 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.09 -39.88 95.03 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.679 -0.638 . . . . 0.0 109.732 179.17 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.55 -38.66 91.97 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.519 -0.738 . . . . 0.0 109.712 179.151 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.38 -37.48 90.43 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 179.292 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 18' ' ' LEU . 71.7 t -61.06 -39.21 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.307 -1.114 . . . . 0.0 109.534 179.242 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.439 ' HA2' HD12 ' A' ' 26' ' ' LEU . . . -66.0 -47.28 75.26 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.399 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 tp -68.0 -29.01 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.406 -1.055 . . . . 0.0 110.008 179.514 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -64.23 -21.63 66.65 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.288 -0.883 . . . . 0.0 109.81 178.703 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.469 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 12.6 mt -83.98 -21.3 31.78 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.323 -0.86 . . . . 0.0 109.685 178.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.674 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 5.5 tp -130.38 45.59 1.83 Allowed Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.322 -0.861 . . . . 0.0 111.668 179.772 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.674 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 47.1 Cg_endo -89.46 -45.84 0.03 OUTLIER 'Trans proline' 0 C--N 1.322 -0.828 0 O-C-N 122.946 0.972 . . . . 0.0 110.239 179.434 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -108.06 -37.05 6.16 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.659 -0.65 . . . . 0.0 109.936 179.551 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? . . . . . 0 N--CA 1.496 1.863 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.21 179.679 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.829 0 CA-C-O 120.924 0.392 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 t 67.42 89.59 0.1 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.606 -0.684 . . . . 0.0 110.224 -179.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.599 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 46.4 t -95.8 16.38 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.645 -0.659 . . . . 0.0 110.473 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.38 -26.58 66.53 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.182 -0.949 . . . . 0.0 110.282 179.304 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -105.5 35.55 2.82 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.692 -0.63 . . . . 0.0 110.028 179.444 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.996 ' HB1' ' HB2' ' A' ' 9' ' ' ARG . . . 56.74 66.54 1.16 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.713 -0.617 . . . . 0.0 110.335 -179.751 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.599 ' HB2' ' HA ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER -53.51 -52.04 70.47 Favored Pre-proline 0 N--CA 1.502 2.139 0 O-C-N 121.596 -0.69 . . . . 0.0 111.35 -179.779 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 7' ' ' ARG . 45.0 Cg_endo -70.83 -21.74 28.13 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 O-C-N 123.369 1.194 . . . . 0.0 111.006 179.884 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.996 ' HB2' ' HB1' ' A' ' 6' ' ' ALA . 18.3 mtt180 -91.73 -100.04 0.12 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.318 -0.864 . . . . 0.0 110.127 179.871 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 11.1 t90 51.38 63.71 2.13 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 -177.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 63.86 28.54 14.64 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 -175.371 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 3.0 m-90 47.01 45.39 15.59 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.805 0.812 . . . . 0.0 110.433 -178.51 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -79.72 -49.05 12.65 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.139 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.414 ' HB2' ' HA ' ' A' ' 8' ' ' PRO . 50.1 m -63.89 -35.36 80.41 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.459 0.647 . . . . 0.0 109.376 178.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.487 HD13 ' O ' ' A' ' 15' ' ' LEU . 2.6 tm? -67.26 -41.34 85.74 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.668 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.6 tt -63.97 -39.34 93.92 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.53 -0.731 . . . . 0.0 109.881 179.092 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.4 tt -60.65 -36.82 79.63 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.536 0.684 . . . . 0.0 109.393 178.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.7 tt -70.52 -35.56 73.25 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.385 0.612 . . . . 0.0 109.632 178.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.73 -35.43 72.68 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.733 -0.605 . . . . 0.0 109.956 179.275 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.77 -39.19 87.76 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.524 -0.735 . . . . 0.0 110.231 179.696 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.4 -47.59 82.78 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.566 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 88.2 t -65.72 -39.76 85.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.586 -0.95 . . . . 0.0 109.7 179.324 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.78 -44.7 94.4 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.615 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 26.3 mt -65.17 -36.82 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.361 -1.082 . . . . 0.0 109.955 179.582 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -64.54 -26.27 68.35 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.137 -0.977 . . . . 0.0 109.599 178.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.488 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.4 mm? -78.32 -26.64 46.94 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.002 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.565 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 5.9 tp -131.74 55.81 20.46 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.549 -0.719 . . . . 0.0 110.874 179.579 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.565 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.9 Cg_endo -90.24 -21.72 0.87 Allowed 'Trans proline' 0 C--N 1.318 -1.044 0 C-N-CA 121.038 1.158 . . . . 0.0 111.049 -179.948 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 -68.11 -36.36 79.63 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.388 -0.82 . . . . 0.0 110.207 179.595 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.147 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.207 179.791 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 . . . . . 0 N--CA 1.496 1.828 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.73 27.32 6.46 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.444 -0.785 . . . . 0.0 110.894 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.4 t -117.93 50.85 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.153 -0.967 . . . . 0.0 109.93 179.539 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.2 t -83.94 -41.19 17.62 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.173 -0.954 . . . . 0.0 109.973 179.7 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -139.63 29.02 2.16 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.868 -0.52 . . . . 0.0 110.305 179.533 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 52.65 51.37 16.19 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.477 -0.764 . . . . 0.0 110.72 -179.921 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 38.8 mtt85 53.95 75.62 0.6 Allowed Pre-proline 0 N--CA 1.501 2.107 0 O-C-N 121.81 -0.556 . . . . 0.0 110.766 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.481 ' HG2' ' CE2' ' A' ' 10' ' ' TRP . 43.8 Cg_endo -71.0 148.27 56.7 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.753 1.396 . . . . 0.0 110.582 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 62.8 mtt85 -104.65 20.51 18.5 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.648 -0.657 . . . . 0.0 111.0 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.59 ' N ' ' CD1' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -40.8 -84.69 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.506 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.594 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -83.34 22.28 1.04 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.675 -1.265 . . . . 0.0 111.209 -179.547 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.56 ' NE1' HD12 ' A' ' 16' ' ' LEU . 26.0 t-105 -103.51 -23.02 13.54 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.126 -0.984 . . . . 0.0 110.36 179.527 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -56.27 -46.96 79.47 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.401 -0.812 . . . . 0.0 109.92 179.649 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.5 p -63.95 -37.98 89.4 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.369 0.605 . . . . 0.0 109.753 179.156 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.454 ' HB3' ' CE3' ' A' ' 12' ' ' TRP . 1.6 tp -67.25 -41.42 85.64 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.801 -0.562 . . . . 0.0 109.527 179.115 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.56 HD12 ' NE1' ' A' ' 12' ' ' TRP . 3.9 tt -63.47 -39.1 93.55 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.577 -0.702 . . . . 0.0 109.669 178.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.0 tt -62.11 -37.3 84.58 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.571 0.701 . . . . 0.0 109.435 178.768 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.543 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.8 tt -68.29 -36.55 79.53 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.249 0.547 . . . . 0.0 109.58 178.876 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.6 -38.75 90.36 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.792 -0.568 . . . . 0.0 109.797 179.118 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.8 -38.44 91.09 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.528 -0.733 . . . . 0.0 109.851 179.224 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.42 -38.15 93.3 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.299 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 18' ' ' LEU . 94.2 t -60.99 -44.17 97.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.473 -1.016 . . . . 0.0 109.677 179.403 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.91 -44.48 95.99 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.347 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 67.5 mt -65.93 -35.06 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.461 -1.023 . . . . 0.0 109.735 179.41 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -62.61 -26.76 68.78 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.215 -0.928 . . . . 0.0 109.524 178.744 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.438 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 6.1 mt -78.81 -23.6 45.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.385 -0.822 . . . . 0.0 108.98 178.206 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.571 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.5 tp -134.85 56.54 17.43 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.444 -0.785 . . . . 0.0 110.633 179.34 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.571 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.9 Cg_endo -91.09 -21.33 0.69 Allowed 'Trans proline' 0 C--N 1.316 -1.133 0 C-N-CA 121.084 1.189 . . . . 0.0 111.202 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -97.92 6.15 48.07 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.292 -0.88 . . . . 0.0 110.658 179.594 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 118.142 -0.932 . . . . 0.0 110.196 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 . . . . . 0 N--CA 1.498 1.969 0 CA-C-O 120.966 0.413 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.5 p -130.3 32.43 4.47 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.254 -0.904 . . . . 0.0 110.726 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.448 ' O ' HG12 ' A' ' 3' ' ' VAL . 22.6 t 50.59 48.01 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.463 -0.773 . . . . 0.0 110.347 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 t -90.08 -28.39 19.04 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.245 -0.909 . . . . 0.0 110.521 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -128.25 33.95 4.64 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.71 -0.619 . . . . 0.0 110.418 179.777 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -124.01 37.51 4.39 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.363 -0.836 . . . . 0.0 110.286 179.59 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.63 84.65 8.23 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.358 -0.839 . . . . 0.0 110.131 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.71 -23.04 26.91 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.58 1.305 . . . . 0.0 111.658 -179.552 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.542 ' HG2' ' HB2' ' A' ' 12' ' ' TRP . 4.0 ttt85 -100.6 18.67 18.61 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.242 -0.911 . . . . 0.0 111.396 -179.7 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 4.9 p-90 -73.37 -28.92 62.29 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.157 -0.964 . . . . 0.0 111.053 -179.856 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.92 19.39 19.49 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.253 -0.905 . . . . 0.0 110.475 179.556 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.542 ' HB2' ' HG2' ' A' ' 9' ' ' ARG . 57.0 m95 -105.02 10.86 33.93 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.218 -0.926 . . . . 0.0 110.652 179.615 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -73.43 -42.59 61.83 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.332 -0.855 . . . . 0.0 109.357 179.223 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.1 m -64.74 -35.1 79.96 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.691 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.478 ' C ' HD13 ' A' ' 15' ' ' LEU . 2.9 tm? -63.73 -40.57 97.08 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.614 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.66 -40.12 96.04 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.369 0.604 . . . . 0.0 109.752 178.801 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.54 -34.84 76.24 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.469 0.652 . . . . 0.0 109.576 178.88 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.602 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.9 OUTLIER -74.37 -32.62 62.82 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.119 0.485 . . . . 0.0 109.999 178.987 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.84 -41.73 96.41 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.703 -0.623 . . . . 0.0 110.015 179.392 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.29 95.07 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.532 -0.73 . . . . 0.0 109.686 179.21 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.28 -37.58 94.71 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.338 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 18' ' ' LEU . 76.8 t -62.34 -41.8 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.416 -1.05 . . . . 0.0 109.724 179.415 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.75 -41.44 98.92 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.317 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 51.0 mt -66.59 -37.88 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.389 -1.065 . . . . 0.0 109.71 179.501 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -64.2 -26.19 68.4 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.182 -0.948 . . . . 0.0 109.646 178.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.47 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.5 mm? -79.08 -25.25 43.1 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.571 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 3.5 tp -133.05 55.04 15.1 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.662 -0.649 . . . . 0.0 110.863 179.678 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.571 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.2 Cg_endo -90.82 -20.8 0.82 Allowed 'Trans proline' 0 C--N 1.319 -1.023 0 C-N-CA 120.963 1.109 . . . . 0.0 111.063 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -76.45 -23.58 53.91 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.316 -0.865 . . . . 0.0 110.761 179.894 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 45.0 mtt-85 . . . . . 0 N--CA 1.496 1.864 0 CA-C-O 117.884 -1.055 . . . . 0.0 110.255 -179.912 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 5.0 m80 . . . . . 0 N--CA 1.495 1.793 0 CA-C-O 120.747 0.308 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.4 p 40.39 56.72 2.64 Favored 'General case' 0 N--CA 1.505 2.28 0 CA-C-O 121.314 0.578 . . . . 0.0 111.408 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.449 ' O ' ' CB ' ' A' ' 4' ' ' SER . 29.1 m -96.64 29.95 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 O-C-N 121.427 -0.796 . . . . 0.0 110.821 179.832 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.449 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 2.0 t 76.57 -49.21 0.57 Allowed 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.898 -0.502 . . . . 0.0 110.727 -179.697 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -95.29 30.17 2.29 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.764 -0.585 . . . . 0.0 110.493 179.48 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.42 ' HB2' HG22 ' A' ' 3' ' ' VAL . . . -100.8 26.09 7.23 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.385 -0.822 . . . . 0.0 110.686 179.775 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.523 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -75.45 -49.53 3.8 Favored Pre-proline 0 N--CA 1.498 1.931 0 O-C-N 121.126 -0.984 . . . . 0.0 110.66 179.53 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 7' ' ' ARG . 46.3 Cg_endo -73.63 -167.47 0.38 Allowed 'Trans proline' 0 N--CA 1.488 1.148 0 O-C-N 123.499 1.263 . . . . 0.0 110.438 179.788 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 64.71 31.68 11.74 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.507 -0.745 . . . . 0.0 110.54 -179.513 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -47.63 26.04 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.388 -0.82 . . . . 0.0 110.431 179.778 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -75.03 -28.36 60.42 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.479 -0.763 . . . . 0.0 110.708 -179.993 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.418 ' CZ3' HD13 ' A' ' 15' ' ' LEU . 88.8 m95 -84.28 -0.03 50.83 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.198 -0.939 . . . . 0.0 111.422 -179.6 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -65.06 -40.31 94.53 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.177 -0.952 . . . . 0.0 110.036 179.374 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.7 m -64.16 -36.78 85.18 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.38 0.61 . . . . 0.0 109.403 178.978 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.418 HD13 ' CZ3' ' A' ' 12' ' ' TRP . 2.3 tt -64.23 -42.37 96.57 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.858 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.9 tt -65.68 -37.44 86.5 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.637 -0.665 . . . . 0.0 109.838 179.136 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.8 tp -63.08 -36.06 82.32 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.573 0.702 . . . . 0.0 109.284 178.633 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.524 ' O ' HG23 ' A' ' 22' ' ' VAL . 7.5 tp -69.04 -36.87 78.19 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.883 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.1 -39.69 95.43 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.865 -0.522 . . . . 0.0 109.652 179.112 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.06 -39.86 90.44 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.626 -0.671 . . . . 0.0 109.729 179.221 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.42 -40.12 98.5 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.417 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 18' ' ' LEU . 98.7 t -63.24 -37.36 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.486 -1.008 . . . . 0.0 109.684 179.336 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.51 -46.94 92.48 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.371 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.7 mt -76.7 -27.68 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.381 -1.07 . . . . 0.0 109.812 179.204 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -60.94 -23.63 65.44 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.035 -1.041 . . . . 0.0 109.696 178.966 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.483 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.9 mm? -79.47 -24.37 42.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.256 -0.903 . . . . 0.0 109.177 178.476 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.59 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.5 tp -132.15 53.73 12.1 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.48 -0.762 . . . . 0.0 110.961 179.718 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.59 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.3 Cg_endo -89.67 -21.2 1.11 Allowed 'Trans proline' 0 C--N 1.318 -1.065 0 C-N-CA 120.947 1.098 . . . . 0.0 111.005 -179.875 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -75.13 -30.77 60.9 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.398 -0.814 . . . . 0.0 110.439 179.634 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 . . . . . 0 N--CA 1.503 2.192 0 CA-C-O 118.348 -0.834 . . . . 0.0 111.094 179.799 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 121.133 0.492 . . . . 0.0 110.416 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.2 m -125.02 27.97 6.55 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.484 -0.76 . . . . 0.0 110.821 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.9 p -126.05 19.3 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.241 -0.912 . . . . 0.0 110.75 179.675 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.9 t -82.65 -25.49 33.04 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.222 -0.924 . . . . 0.0 110.631 179.783 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 33.4 p80 -66.67 -20.86 66.08 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.656 -0.652 . . . . 0.0 110.951 179.672 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -96.42 45.74 1.06 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.348 -0.845 . . . . 0.0 109.884 179.699 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -121.78 81.04 41.14 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.383 -0.823 . . . . 0.0 110.238 -179.9 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.46 93.07 0.75 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.837 1.44 . . . . 0.0 110.008 179.772 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.4 mtm105 56.61 33.61 23.03 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 121.353 0.596 . . . . 0.0 110.474 -179.019 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 28.7 t-105 -66.29 140.43 58.12 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.515 -0.74 . . . . 0.0 110.332 179.861 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.7 t80 66.87 8.76 6.28 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.849 -0.532 . . . . 0.0 111.347 -179.695 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 22.1 m95 -120.69 2.24 10.61 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.017 -1.052 . . . . 0.0 110.848 179.681 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -69.77 -43.29 72.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.309 -0.869 . . . . 0.0 109.707 179.399 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.2 p -64.02 -34.77 78.77 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 178.658 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.9 tt -64.35 -42.99 95.95 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.468 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 tt -62.63 -38.76 91.52 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.664 -0.648 . . . . 0.0 109.886 179.114 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 tt -61.4 -37.48 83.57 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.553 0.692 . . . . 0.0 109.319 178.838 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.543 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.6 tt -70.13 -38.08 75.45 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.342 0.592 . . . . 0.0 109.63 178.917 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.36 -37.84 86.23 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.747 -0.595 . . . . 0.0 109.894 179.327 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.89 -42.21 99.69 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.612 -0.68 . . . . 0.0 109.97 179.462 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.31 -38.87 96.95 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.441 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 18' ' ' LEU . 91.2 t -64.2 -40.67 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.49 -1.006 . . . . 0.0 109.757 179.506 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.54 -42.04 99.01 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.51 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.2 mt -65.66 -36.67 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.423 -1.046 . . . . 0.0 109.821 179.527 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -64.93 -26.53 68.35 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.216 -0.927 . . . . 0.0 109.681 178.889 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.499 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.9 mm? -80.0 -24.76 40.64 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.367 -0.833 . . . . 0.0 108.99 178.29 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.596 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 1.2 tp -131.93 53.43 11.38 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.558 -0.714 . . . . 0.0 111.032 179.736 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.596 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 43.4 Cg_endo -91.53 -18.93 0.88 Allowed 'Trans proline' 0 C--N 1.318 -1.035 0 C-N-CA 121.002 1.134 . . . . 0.0 111.144 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.33 7.05 46.0 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.322 -0.861 . . . . 0.0 111.234 -179.77 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 117.808 -1.091 . . . . 0.0 110.289 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 10.5 m80 . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 121.04 0.448 . . . . 0.0 110.412 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.502 ' HB2' ' HB3' ' A' ' 6' ' ' ALA . 10.9 p -150.92 50.2 0.85 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.503 -0.748 . . . . 0.0 110.334 -179.829 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.467 HG22 ' HB2' ' A' ' 6' ' ' ALA . 32.2 m 35.51 42.31 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.588 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.977 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 1.4 t 73.89 -30.51 0.21 Allowed 'General case' 0 N--CA 1.509 2.523 0 O-C-N 121.837 -0.539 . . . . 0.0 112.445 179.512 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -166.69 82.2 0.25 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.156 -0.965 . . . . 0.0 110.271 -179.747 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.502 ' HB3' ' HB2' ' A' ' 2' ' ' SER . . . -104.02 37.23 2.11 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.656 -0.653 . . . . 0.0 110.508 179.886 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.9 ttp180 68.1 132.43 0.04 OUTLIER Pre-proline 0 N--CA 1.504 2.245 0 O-C-N 121.793 -0.567 . . . . 0.0 111.177 179.732 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.99 102.66 1.48 Allowed 'Trans proline' 0 C--N 1.314 -1.244 0 O-C-N 123.632 1.333 . . . . 0.0 110.798 -179.945 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.6 mtp85 -65.91 -24.07 66.76 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.478 -0.764 . . . . 0.0 110.82 179.91 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.472 ' O ' ' CB ' ' A' ' 11' ' ' PHE . 1.1 m-90 -53.36 152.01 5.01 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.599 -0.688 . . . . 0.0 110.176 179.768 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.472 ' CB ' ' O ' ' A' ' 10' ' ' TRP . 16.0 t80 77.58 -42.54 0.38 Allowed 'General case' 0 N--CA 1.508 2.475 0 O-C-N 122.069 -0.395 . . . . 0.0 110.554 -179.086 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.428 ' CZ3' HD13 ' A' ' 15' ' ' LEU . 20.7 m95 -76.62 6.02 6.57 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.134 -0.979 . . . . 0.0 111.468 179.651 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -62.21 -39.44 92.77 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.018 -1.051 . . . . 0.0 110.08 179.626 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.5 t -62.98 -35.26 79.59 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.516 0.674 . . . . 0.0 109.425 178.882 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.428 HD13 ' CZ3' ' A' ' 12' ' ' TRP . 1.2 tt -68.25 -41.9 80.48 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.907 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 tt -63.78 -38.72 92.15 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.675 -0.641 . . . . 0.0 110.019 179.43 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 tt -62.03 -34.13 75.64 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.488 0.661 . . . . 0.0 109.474 178.846 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.543 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.5 tt -70.91 -38.16 72.95 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.238 0.542 . . . . 0.0 109.65 178.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.67 -39.56 93.89 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.799 -0.563 . . . . 0.0 109.807 179.284 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.75 -39.95 95.75 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.635 -0.666 . . . . 0.0 109.897 179.391 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.55 -37.42 94.39 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.398 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 18' ' ' LEU . 90.4 t -63.07 -41.35 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.53 -0.982 . . . . 0.0 109.685 179.471 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.31 -42.66 97.69 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.398 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.4 mt -66.36 -36.27 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.413 -1.051 . . . . 0.0 109.809 179.45 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -63.76 -27.59 69.3 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.32 -0.862 . . . . 0.0 109.8 179.085 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.481 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 3.8 mt -81.25 -21.65 39.3 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.425 -0.797 . . . . 0.0 109.16 178.306 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.628 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.1 OUTLIER -133.18 51.98 7.85 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.524 -0.735 . . . . 0.0 110.896 179.82 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.628 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 45.7 Cg_endo -92.89 -17.64 0.72 Allowed 'Trans proline' 0 C--N 1.32 -0.936 0 C-N-CA 121.101 1.201 . . . . 0.0 111.329 -179.742 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -68.54 -37.11 79.7 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.307 -0.87 . . . . 0.0 110.706 -179.493 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.7 mmt85 . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 117.851 -1.071 . . . . 0.0 110.281 -179.974 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.4 t60 . . . . . 0 N--CA 1.499 1.983 0 CA-C-O 120.737 0.303 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.7 p -113.2 45.68 1.35 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.06 -1.025 . . . . 0.0 110.15 179.903 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.482 ' O ' HG12 ' A' ' 3' ' ' VAL . 17.9 t 58.74 17.87 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.688 -0.633 . . . . 0.0 111.114 -179.535 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.15 -16.65 14.22 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.005 -1.06 . . . . 0.0 110.613 179.438 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -102.83 39.68 1.5 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.518 -0.739 . . . . 0.0 109.993 179.568 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -105.02 1.7 28.85 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.4 -0.813 . . . . 0.0 111.244 -179.961 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.515 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -61.9 -50.03 82.99 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 121.29 -0.881 . . . . 0.0 110.321 179.504 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 7' ' ' ARG . 48.9 Cg_endo -75.26 -174.61 2.03 Favored 'Trans proline' 0 N--CA 1.485 0.975 0 O-C-N 123.503 1.265 . . . . 0.0 110.131 179.359 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 23.1 mtt180 -88.19 21.99 2.6 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.344 -0.848 . . . . 0.0 111.01 179.656 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -71.98 -67.42 0.54 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.065 -1.022 . . . . 0.0 109.948 179.838 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.48 -26.82 58.51 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.478 -0.764 . . . . 0.0 110.132 179.293 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 65.5 t-105 -79.69 -6.35 57.01 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.564 -0.71 . . . . 0.0 111.315 -179.911 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -53.63 -51.75 62.1 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.104 -0.997 . . . . 0.0 110.406 179.772 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.3 p -58.74 -36.16 73.88 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.296 0.569 . . . . 0.0 109.992 179.515 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.472 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -69.3 -45.56 69.27 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.834 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.52 -36.52 84.07 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.565 -0.709 . . . . 0.0 109.665 178.98 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.4 tt -62.74 -37.26 85.88 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.589 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.5 tp -68.61 -37.68 79.96 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.425 0.631 . . . . 0.0 109.706 178.86 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.23 -35.42 77.91 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.819 -0.551 . . . . 0.0 109.943 179.198 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.94 -40.02 87.45 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.55 -0.719 . . . . 0.0 110.283 179.589 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.36 -46.64 90.02 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.577 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 76.5 t -66.06 -40.88 88.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.557 -0.966 . . . . 0.0 109.665 179.363 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.17 -47.14 88.13 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.59 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 35.2 mt -64.48 -33.72 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.435 -1.038 . . . . 0.0 109.885 179.542 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -63.65 -27.22 69.07 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.031 -1.043 . . . . 0.0 109.678 178.87 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.483 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.7 OUTLIER -79.14 -25.25 42.92 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.446 -0.784 . . . . 0.0 108.94 178.229 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.566 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.5 tp -132.95 56.63 23.09 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.539 -0.725 . . . . 0.0 110.714 179.498 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.566 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.5 Cg_endo -91.92 -20.39 0.65 Allowed 'Trans proline' 0 C--N 1.318 -1.048 0 C-N-CA 121.143 1.229 . . . . 0.0 111.496 -179.837 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -78.05 -37.48 46.66 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.109 -0.994 . . . . 0.0 110.612 -179.979 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.914 0 O-C-N 121.336 -0.853 . . . . 0.0 110.747 179.959 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 . . . . . 0 N--CA 1.496 1.833 0 CA-C-O 120.934 0.397 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.23 53.53 1.55 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.463 -0.773 . . . . 0.0 110.496 -179.821 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.7 t 52.42 57.47 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.625 -0.672 . . . . 0.0 110.772 179.618 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.5 t -81.58 -15.62 54.18 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.13 -0.981 . . . . 0.0 111.166 179.771 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -104.04 18.8 21.29 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.24 -0.912 . . . . 0.0 110.65 179.734 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -163.79 60.56 0.16 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.179 -0.951 . . . . 0.0 109.883 179.826 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.47 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -58.69 -53.36 67.1 Favored Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 121.509 -0.744 . . . . 0.0 111.582 -179.604 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 7' ' ' ARG . 43.2 Cg_endo -70.46 -92.03 0.01 OUTLIER 'Trans proline' 0 N--CA 1.487 1.116 0 O-C-N 123.56 1.295 . . . . 0.0 110.453 -179.717 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.448 ' C ' ' O ' ' A' ' 8' ' ' PRO . 10.6 ttt-85 31.38 -105.84 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.641 -0.662 . . . . 0.0 111.84 179.775 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.477 ' O ' ' HB2' ' A' ' 11' ' ' PHE . 3.3 m95 49.55 66.31 1.16 Allowed 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 -177.969 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.477 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 94.8 m-85 62.51 31.25 17.1 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -175.618 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER 46.64 35.55 3.09 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.563 0.697 . . . . 0.0 110.463 -178.337 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -79.76 -52.02 8.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.606 -0.684 . . . . 0.0 109.3 179.205 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.9 m -60.65 -32.92 72.08 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.757 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.504 HD22 ' HA ' ' A' ' 15' ' ' LEU . 0.3 OUTLIER -67.84 -41.02 83.6 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.8 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.1 tt -65.26 -39.45 92.65 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.566 -0.709 . . . . 0.0 109.953 179.225 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 tt -62.18 -35.33 78.49 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.511 0.672 . . . . 0.0 109.369 178.845 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.522 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.1 tt -69.2 -39.09 78.86 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.324 0.583 . . . . 0.0 109.5 178.778 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.34 -37.92 89.19 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.851 -0.531 . . . . 0.0 109.704 179.207 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.5 -40.04 96.02 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.575 -0.703 . . . . 0.0 109.905 179.249 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.6 -36.98 93.81 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.384 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 18' ' ' LEU . 95.5 t -63.81 -41.41 92.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.55 -0.97 . . . . 0.0 109.751 179.478 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.17 -41.45 98.37 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.372 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 29.8 mm -66.52 -34.86 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.467 -1.019 . . . . 0.0 109.779 179.293 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -63.49 -26.13 68.58 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.277 -0.889 . . . . 0.0 109.654 178.76 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.482 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 0.9 OUTLIER -79.84 -24.73 41.11 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.356 -0.84 . . . . 0.0 109.037 178.237 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.602 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 14.6 tp -132.13 53.21 10.68 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.499 -0.751 . . . . 0.0 110.97 179.583 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.602 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.2 Cg_endo -90.23 -21.31 0.93 Allowed 'Trans proline' 0 C--N 1.32 -0.93 0 O-C-N 123.183 1.096 . . . . 0.0 111.005 179.893 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -82.85 -37.17 24.75 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.381 -0.824 . . . . 0.0 110.216 179.664 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.501 2.079 0 CA-C-O 118.069 -0.967 . . . . 0.0 111.024 179.93 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 . . . . . 0 N--CA 1.495 1.803 0 CA-C-O 121.028 0.442 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.7 39.7 3.57 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.507 -0.746 . . . . 0.0 110.451 179.862 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.4 t 52.6 52.82 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.628 -0.67 . . . . 0.0 110.609 179.852 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.8 t -90.04 -39.69 12.77 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.183 -0.948 . . . . 0.0 110.283 179.682 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 48.7 t60 -98.45 2.15 47.45 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.789 -0.569 . . . . 0.0 110.656 179.579 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 48.59 49.78 18.01 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.547 -0.721 . . . . 0.0 110.746 179.819 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpt85 68.38 121.81 0.03 OUTLIER Pre-proline 0 N--CA 1.503 2.177 0 O-C-N 121.945 -0.472 . . . . 0.0 110.644 -179.773 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -74.0 -105.3 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.182 0 O-C-N 123.708 1.372 . . . . 0.0 110.863 -179.764 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.8 ptp85 -173.83 -163.67 0.18 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.813 -1.179 . . . . 0.0 109.829 -179.798 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER 66.26 125.34 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 CA-C-O 121.263 0.554 . . . . 0.0 110.547 -179.912 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 58.79 17.09 4.93 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.597 -0.689 . . . . 0.0 110.848 -179.298 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.576 ' CZ3' HD13 ' A' ' 15' ' ' LEU . 58.3 t-105 -123.46 -21.22 5.35 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.087 -1.008 . . . . 0.0 110.936 -179.944 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -61.5 -40.46 94.68 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.305 -0.872 . . . . 0.0 109.89 179.482 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.9 m -61.42 -36.08 79.34 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.378 0.609 . . . . 0.0 109.397 178.952 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.576 HD13 ' CZ3' ' A' ' 12' ' ' TRP . 5.7 tt -67.01 -42.94 84.12 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.757 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.501 HD13 ' C ' ' A' ' 16' ' ' LEU . 3.1 tm? -62.91 -40.48 97.72 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.693 -0.629 . . . . 0.0 109.937 179.216 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.8 tt -60.99 -36.59 79.86 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.637 0.732 . . . . 0.0 109.426 178.889 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.544 ' O ' HG23 ' A' ' 22' ' ' VAL . 4.6 tp -72.6 -34.17 67.21 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.211 0.529 . . . . 0.0 109.903 178.984 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.71 -42.63 97.6 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.76 -0.588 . . . . 0.0 109.964 179.511 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.87 -39.83 95.13 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.53 -0.731 . . . . 0.0 109.928 179.235 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.56 -39.35 93.88 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.506 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 18' ' ' LEU . 78.8 t -60.89 -43.37 95.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.503 -0.998 . . . . 0.0 109.996 179.619 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.42 -43.92 98.37 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.496 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.7 mt -66.46 -37.08 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.46 -1.023 . . . . 0.0 109.753 179.446 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -62.45 -26.24 68.41 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.293 -0.879 . . . . 0.0 109.982 179.213 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.482 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 13.4 mt -81.61 -22.43 37.66 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.355 -0.841 . . . . 0.0 109.224 178.349 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.622 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.1 OUTLIER -132.5 51.75 7.73 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.581 -0.699 . . . . 0.0 110.812 179.731 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.622 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.9 Cg_endo -91.11 -45.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.32 -0.943 0 O-C-N 123.048 1.025 . . . . 0.0 110.822 -179.997 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -107.74 -37.15 6.22 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.492 -0.755 . . . . 0.0 110.148 179.796 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.137 179.756 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.07 0.462 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.7 p -111.2 37.73 2.76 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.543 -0.723 . . . . 0.0 110.668 -179.837 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.401 HG12 ' O ' ' A' ' 3' ' ' VAL . 11.3 t 52.84 39.68 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 O-C-N 121.539 -0.726 . . . . 0.0 110.899 179.833 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.7 t -104.03 -15.06 15.71 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.139 -0.976 . . . . 0.0 111.045 179.799 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -111.5 38.7 2.52 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.407 -0.808 . . . . 0.0 110.381 179.971 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -108.15 42.42 1.37 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.25 -0.906 . . . . 0.0 110.0 179.671 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.36 84.44 0.2 Allowed Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 121.733 -0.604 . . . . 0.0 110.566 -179.786 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.03 -170.26 0.68 Allowed 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.732 1.385 . . . . 0.0 110.498 179.849 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.623 ' HB3' ' HB2' ' A' ' 12' ' ' TRP . 12.7 ttt180 -140.9 167.4 22.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.143 -0.973 . . . . 0.0 110.433 179.712 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 40.6 m0 -61.73 -59.36 5.28 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.379 -0.825 . . . . 0.0 109.879 179.779 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -69.13 -18.07 63.91 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.445 -0.784 . . . . 0.0 109.981 178.828 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.623 ' HB2' ' HB3' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -54.82 -44.57 73.98 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.466 -0.772 . . . . 0.0 110.109 179.323 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -64.97 -35.8 82.36 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.67 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.7 m -66.75 -34.15 77.19 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.507 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.531 HD22 ' HZ3' ' A' ' 12' ' ' TRP . 4.2 tt -65.63 -41.62 92.45 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.707 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 tt -66.87 -39.4 87.51 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.719 -0.613 . . . . 0.0 109.83 179.071 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.3 -33.61 75.9 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.496 0.665 . . . . 0.0 109.385 178.885 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.517 ' O ' HG23 ' A' ' 22' ' ' VAL . 5.3 tp -72.42 -36.91 68.72 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.24 0.543 . . . . 0.0 109.61 178.902 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.47 -41.79 94.92 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.809 -0.557 . . . . 0.0 109.73 179.258 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.78 -40.99 92.53 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.539 -0.726 . . . . 0.0 109.815 179.121 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.409 ' HA2' HD12 ' A' ' 24' ' ' ILE . . . -61.63 -41.09 99.52 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 179.38 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 18' ' ' LEU . 95.5 t -62.76 -40.03 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.568 -0.96 . . . . 0.0 109.801 179.418 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.456 ' HA2' HD12 ' A' ' 26' ' ' LEU . . . -59.69 -42.89 98.1 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.39 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.409 HD12 ' HA2' ' A' ' 21' ' ' GLY . 18.2 mt -68.61 -35.38 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.474 -1.015 . . . . 0.0 109.592 179.26 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -62.97 -27.03 69.12 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.204 -0.935 . . . . 0.0 109.613 178.824 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.456 HD12 ' HA2' ' A' ' 23' ' ' GLY . 13.5 mt -79.18 -18.27 53.36 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.379 -0.826 . . . . 0.0 109.314 178.359 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.588 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.9 tp -140.52 55.09 5.56 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.574 -0.704 . . . . 0.0 110.577 179.643 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.588 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.7 Cg_endo -91.18 -21.22 0.69 Allowed 'Trans proline' 0 C--N 1.319 -1.021 0 C-N-CA 121.106 1.204 . . . . 0.0 111.377 -179.582 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -98.71 -33.86 10.76 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.251 -0.906 . . . . 0.0 110.299 179.815 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.1 mtt180 . . . . . 0 N--CA 1.496 1.861 0 CA-C-O 117.916 -1.04 . . . . 0.0 110.284 179.842 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 30.1 p80 . . . . . 0 N--CA 1.497 1.894 0 CA-C-O 121.11 0.481 . . . . 0.0 110.528 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.4 p -166.93 78.42 0.2 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.495 -0.753 . . . . 0.0 110.359 -179.977 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.434 ' O ' HG12 ' A' ' 3' ' ' VAL . 21.7 t -100.12 45.03 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.264 -0.897 . . . . 0.0 109.707 179.695 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.4 t -82.75 -34.22 27.21 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.265 -0.897 . . . . 0.0 110.377 179.959 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 47.7 m-70 -128.86 40.3 3.66 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.659 -0.651 . . . . 0.0 109.963 179.807 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -129.51 61.02 1.56 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.431 -0.793 . . . . 0.0 110.236 -179.953 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.28 72.67 19.51 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.361 -0.837 . . . . 0.0 110.079 179.735 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -76.37 78.89 3.12 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 O-C-N 123.715 1.376 . . . . 0.0 110.632 -179.768 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.5 ttp-105 60.37 28.88 18.53 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.621 -0.674 . . . . 0.0 110.659 -179.821 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -77.49 -40.09 44.13 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.256 -0.902 . . . . 0.0 110.116 179.816 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -77.86 -28.87 50.15 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.484 -0.76 . . . . 0.0 110.325 179.576 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 46.9 m95 -80.27 9.45 5.72 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.37 -0.831 . . . . 0.0 111.515 -179.654 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -61.1 -44.82 96.76 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.169 -0.957 . . . . 0.0 109.511 179.193 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 56.8 p -63.57 -36.34 83.49 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.679 0.752 . . . . 0.0 109.315 178.651 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.423 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -66.34 -41.59 89.37 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.943 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.2 tt -64.72 -37.69 88.45 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.533 -0.73 . . . . 0.0 109.85 179.081 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.01 -35.11 79.13 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.609 0.718 . . . . 0.0 109.291 178.74 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.0 tp -71.83 -37.78 70.26 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.263 0.554 . . . . 0.0 109.753 179.025 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.87 -40.44 97.5 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.734 -0.604 . . . . 0.0 109.834 179.305 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.65 -37.39 87.17 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.629 -0.669 . . . . 0.0 109.884 179.311 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.98 -40.68 93.43 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.453 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.7 t -60.49 -42.24 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.505 -0.997 . . . . 0.0 109.802 179.496 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.21 -44.18 95.98 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.368 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.5 mt -65.22 -34.53 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.447 -1.031 . . . . 0.0 109.775 179.434 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -62.94 -27.23 69.24 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.148 -0.97 . . . . 0.0 109.497 178.754 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.1 mt -79.56 -17.7 53.37 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.428 -0.795 . . . . 0.0 109.353 178.303 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.605 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.7 tp -141.44 54.9 4.6 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.57 -0.706 . . . . 0.0 110.5 179.495 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.605 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.1 Cg_endo -91.08 -20.8 0.75 Allowed 'Trans proline' 0 C--N 1.319 -0.999 0 C-N-CA 121.242 1.294 . . . . 0.0 111.249 -179.836 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -104.45 5.37 34.11 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.253 -0.905 . . . . 0.0 110.893 179.722 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.833 0 O-C-N 121.163 -0.961 . . . . 0.0 110.628 179.885 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 120.765 0.317 . . . . 0.0 110.223 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.0 m 55.99 41.25 30.02 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.554 -0.716 . . . . 0.0 110.81 -179.897 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.5 t 52.29 45.79 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.68 -0.638 . . . . 0.0 110.674 179.664 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.0 t -82.83 -21.13 34.55 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.238 -0.914 . . . . 0.0 110.908 179.961 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.7 m80 -126.11 57.12 1.4 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.402 -0.811 . . . . 0.0 110.136 -179.803 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -99.18 22.04 11.02 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.38 -0.825 . . . . 0.0 110.959 179.894 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.496 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -59.48 -51.54 80.53 Favored Pre-proline 0 N--CA 1.501 2.097 0 O-C-N 121.204 -0.935 . . . . 0.0 110.723 179.652 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 7' ' ' ARG . 48.8 Cg_endo -74.62 -14.39 22.13 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.528 1.278 . . . . 0.0 110.88 179.495 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.538 ' HB3' ' HB2' ' A' ' 13' ' ' PHE . 46.2 mmt-85 -89.7 -103.41 0.09 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.301 -0.874 . . . . 0.0 109.688 -179.928 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER 56.99 -82.09 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.501 -0.749 . . . . 0.0 111.283 179.519 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.401 ' N ' ' O ' ' A' ' 9' ' ' ARG . 90.7 m-85 -97.73 -34.17 11.01 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.122 -0.987 . . . . 0.0 109.496 179.535 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 72.7 t-105 -74.51 -11.71 60.29 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.585 -0.697 . . . . 0.0 110.511 179.267 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.538 ' HB2' ' HB3' ' A' ' 9' ' ' ARG . 56.1 t80 -59.38 -51.71 68.76 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.356 -0.84 . . . . 0.0 110.105 179.753 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.7 p -62.87 -37.54 87.28 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.022 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.13 -41.27 86.42 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.332 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 16' ' ' LEU . 2.9 tm? -65.38 -39.03 91.75 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.025 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.5 tp -61.16 -38.54 86.81 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.596 0.712 . . . . 0.0 109.09 178.606 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.506 ' O ' HG23 ' A' ' 22' ' ' VAL . 9.0 tp -67.83 -37.71 82.29 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.347 0.594 . . . . 0.0 109.453 178.779 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.63 -38.77 92.13 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.841 -0.537 . . . . 0.0 109.796 179.09 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.38 -38.67 91.85 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.587 -0.696 . . . . 0.0 110.054 179.398 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.69 -40.63 94.0 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.595 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 18' ' ' LEU . 99.3 t -61.54 -42.15 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.458 -1.025 . . . . 0.0 109.828 179.577 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.97 -45.53 92.05 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.528 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.2 mt -65.77 -35.14 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.422 -1.046 . . . . 0.0 109.717 179.478 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -63.7 -25.91 68.42 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.315 -0.865 . . . . 0.0 109.498 178.75 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.483 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 1.3 mm? -79.05 -27.11 43.11 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.203 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.57 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 8.8 tp -131.16 55.46 19.03 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.576 -0.703 . . . . 0.0 110.849 179.518 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.57 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 39.9 Cg_endo -88.88 -22.45 1.1 Allowed 'Trans proline' 0 C--N 1.318 -1.053 0 O-C-N 123.217 1.114 . . . . 0.0 110.561 179.647 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -103.38 -14.07 16.41 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.37 -0.831 . . . . 0.0 110.188 178.997 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.049 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.964 -179.99 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 . . . . . 0 N--CA 1.497 1.911 0 CA-C-O 120.97 0.414 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.2 m -105.26 27.38 8.32 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.487 -0.758 . . . . 0.0 110.922 -179.871 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.558 HG13 ' HG3' ' A' ' 7' ' ' ARG . 24.2 t 53.09 58.51 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.358 -0.839 . . . . 0.0 110.515 179.701 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.86 -24.45 55.73 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.22 -0.925 . . . . 0.0 110.581 179.705 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.467 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 6.0 t-80 -119.17 32.41 6.13 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.646 -0.659 . . . . 0.0 109.977 179.615 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 5' ' ' HIS . . . 58.84 32.54 22.32 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.71 -0.619 . . . . 0.0 110.961 -179.908 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.558 ' HG3' HG13 ' A' ' 3' ' ' VAL . 10.9 mtm180 51.62 72.14 1.3 Allowed Pre-proline 0 N--CA 1.502 2.138 0 O-C-N 121.538 -0.726 . . . . 0.0 110.884 179.695 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' A' ' 5' ' ' HIS . 51.6 Cg_endo -77.94 177.38 8.87 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.723 1.38 . . . . 0.0 110.593 179.853 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER 61.21 -78.1 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.216 0 O-C-N 122.029 -0.419 . . . . 0.0 111.347 179.662 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER 68.42 -68.09 0.18 Allowed 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.708 -0.62 . . . . 0.0 110.3 -179.529 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -97.09 -18.59 19.25 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.369 -0.832 . . . . 0.0 110.199 179.484 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.468 ' CE3' HD13 ' A' ' 15' ' ' LEU . 90.9 m95 -95.46 16.24 17.51 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.315 -0.866 . . . . 0.0 111.089 -179.934 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -64.61 -45.4 87.06 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.128 -0.982 . . . . 0.0 110.06 179.76 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.8 m -62.16 -37.43 85.19 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.435 0.636 . . . . 0.0 109.635 179.236 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.468 HD13 ' CE3' ' A' ' 12' ' ' TRP . 1.3 tt -65.88 -42.34 90.42 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.017 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.9 tt -63.53 -35.44 80.48 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.655 -0.653 . . . . 0.0 109.675 179.122 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.3 tp -63.55 -34.05 76.95 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.586 0.708 . . . . 0.0 109.304 178.525 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.7 tt -80.51 -38.63 29.41 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.497 0.665 . . . . 0.0 109.525 178.878 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.24 -35.06 78.78 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.849 -0.532 . . . . 0.0 110.376 179.613 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.36 -41.79 97.65 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.417 -0.802 . . . . 0.0 110.223 179.735 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.36 -46.92 66.48 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.632 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 77.9 t -64.61 -37.85 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.546 -0.973 . . . . 0.0 110.036 179.607 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.96 -46.97 92.99 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.704 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.3 mt -65.4 -35.14 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.384 -1.068 . . . . 0.0 109.925 179.605 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -64.99 -27.71 69.01 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.064 -1.022 . . . . 0.0 109.599 178.867 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.501 HD13 ' HA ' ' A' ' 26' ' ' LEU . 1.7 mm? -77.86 -25.34 48.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.321 -0.862 . . . . 0.0 108.689 178.016 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.544 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 5.6 tp -133.59 57.06 23.39 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.617 -0.677 . . . . 0.0 110.468 179.488 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.544 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 39.6 Cg_endo -89.89 -22.39 0.86 Allowed 'Trans proline' 0 C--N 1.318 -1.076 0 C-N-CA 121.111 1.207 . . . . 0.0 111.212 -179.666 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -67.23 -34.07 76.7 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.327 -0.858 . . . . 0.0 110.171 179.461 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.5 mtt180 . . . . . 0 N--CA 1.499 1.985 0 CA-C-O 118.743 -0.646 . . . . 0.0 110.563 179.966 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 35.1 t60 . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 121.099 0.476 . . . . 0.0 110.351 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.3 p -159.56 58.81 0.39 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.52 -0.737 . . . . 0.0 110.457 179.955 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.0 m -131.31 42.66 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.293 -0.88 . . . . 0.0 110.349 179.82 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.4 m -121.26 -85.79 0.66 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.421 -0.799 . . . . 0.0 110.282 179.957 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -132.12 42.36 3.14 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.364 -0.835 . . . . 0.0 110.193 179.804 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -118.09 56.86 0.85 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.474 -0.766 . . . . 0.0 109.934 179.88 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.432 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 6.1 ptp180 -73.67 132.13 81.25 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 121.425 -0.797 . . . . 0.0 110.437 -179.933 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 7' ' ' ARG . 51.6 Cg_endo -87.32 31.67 0.44 Allowed 'Trans proline' 0 C--N 1.315 -1.196 0 O-C-N 123.676 1.356 . . . . 0.0 111.37 179.907 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.8 mtt85 60.53 -177.45 0.1 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.486 -0.759 . . . . 0.0 110.789 -179.915 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 2.1 t90 69.44 134.33 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 121.226 0.536 . . . . 0.0 110.306 -179.419 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.8 t80 64.0 12.12 6.65 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.558 -0.714 . . . . 0.0 110.853 -179.232 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 41.2 m95 -126.5 13.49 7.58 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.269 -0.894 . . . . 0.0 110.433 179.646 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -69.12 -41.47 77.35 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.245 -0.91 . . . . 0.0 109.541 179.486 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.1 t -63.95 -34.09 77.19 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.427 0.632 . . . . 0.0 109.527 178.83 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 tt -69.38 -41.47 76.46 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.106 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 tt -66.81 -38.24 86.09 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.582 -0.698 . . . . 0.0 109.878 179.386 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.5 tp -62.78 -31.32 72.26 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.534 0.683 . . . . 0.0 109.518 178.814 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.586 ' O ' HG23 ' A' ' 22' ' ' VAL . 6.9 tp -75.61 -35.2 60.59 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.16 0.505 . . . . 0.0 109.956 179.167 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.37 -46.26 89.16 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.814 -0.554 . . . . 0.0 109.823 179.352 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.93 -37.53 84.49 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.537 -0.727 . . . . 0.0 109.782 179.199 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.9 -39.01 96.96 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.469 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 18' ' ' LEU . 84.1 t -60.35 -44.7 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.491 -1.005 . . . . 0.0 109.668 179.566 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.51 -41.93 99.74 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.411 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 31.1 mt -66.89 -35.35 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.449 -1.03 . . . . 0.0 109.801 179.469 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -62.49 -27.95 69.49 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.161 -0.962 . . . . 0.0 109.663 178.924 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.4 mt -80.6 -17.62 50.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.428 -0.795 . . . . 0.0 109.248 178.293 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.641 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -138.88 51.78 3.77 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.553 -0.717 . . . . 0.0 110.732 179.771 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.641 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 47.3 Cg_endo -92.86 -16.82 0.81 Allowed 'Trans proline' 0 C--N 1.32 -0.936 0 C-N-CA 121.126 1.217 . . . . 0.0 111.145 -179.663 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -69.02 -38.1 79.01 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.494 -0.754 . . . . 0.0 110.644 -179.47 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.6 mtt180 . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 117.866 -1.064 . . . . 0.0 110.201 179.956 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 27.2 m80 . . . . . 0 N--CA 1.496 1.871 0 CA-C-O 121.062 0.458 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.9 m -116.66 52.86 0.91 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.478 -0.764 . . . . 0.0 110.157 179.905 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.1 t -110.49 50.1 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.409 -0.807 . . . . 0.0 110.021 -179.908 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.88 -29.02 19.96 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.253 -0.905 . . . . 0.0 110.559 179.651 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -127.68 44.16 2.98 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.541 -0.724 . . . . 0.0 110.19 179.779 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -95.8 42.24 1.09 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.371 -0.83 . . . . 0.0 110.412 179.781 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -83.35 154.47 66.25 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.328 -0.857 . . . . 0.0 110.372 179.92 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.0 92.21 0.72 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.999 1.526 . . . . 0.0 110.572 179.98 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 10' ' ' TRP . 8.3 ptt180 -148.26 158.57 44.16 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.51 -0.743 . . . . 0.0 110.226 179.951 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.41 ' HB2' ' O ' ' A' ' 9' ' ' ARG . 1.8 m-90 61.77 -78.48 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.322 0 O-C-N 122.006 -0.434 . . . . 0.0 110.89 -179.833 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -72.97 -8.37 55.36 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.294 -0.879 . . . . 0.0 111.19 179.911 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -74.6 -7.81 54.35 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.2 -0.937 . . . . 0.0 111.69 -179.883 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.92 -38.7 89.4 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.245 -0.909 . . . . 0.0 110.068 179.721 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.1 m -63.38 -38.72 92.23 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.44 0.638 . . . . 0.0 109.439 178.879 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 tt -63.26 -42.58 99.18 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.983 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 tt -65.27 -36.37 83.9 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.529 -0.732 . . . . 0.0 109.985 179.33 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.1 tp -64.28 -34.53 78.32 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.631 -0.668 . . . . 0.0 109.365 178.606 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.545 ' O ' HG23 ' A' ' 22' ' ' VAL . 3.5 tt -67.79 -38.68 83.65 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.362 0.601 . . . . 0.0 109.527 178.866 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.59 -39.56 91.72 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.655 -0.653 . . . . 0.0 109.696 179.061 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.09 -39.55 94.3 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.627 -0.671 . . . . 0.0 109.974 179.304 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.98 -37.91 94.84 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.441 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 18' ' ' LEU . 84.5 t -60.63 -43.29 94.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.512 -0.993 . . . . 0.0 109.76 179.621 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.11 -42.74 97.96 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.215 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 29.2 mm -68.03 -35.46 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.399 -1.06 . . . . 0.0 109.769 179.375 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -62.44 -25.91 68.22 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.259 -0.9 . . . . 0.0 109.571 178.845 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.459 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 8.4 mt -79.4 -24.41 42.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.311 -0.868 . . . . 0.0 108.9 178.27 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.572 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 2.8 tp -133.65 55.32 15.52 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.609 -0.682 . . . . 0.0 110.716 179.38 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.572 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 42.6 Cg_endo -90.54 -21.12 0.86 Allowed 'Trans proline' 0 C--N 1.318 -1.032 0 C-N-CA 121.022 1.148 . . . . 0.0 110.994 179.904 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -89.52 -36.8 15.17 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.304 -0.873 . . . . 0.0 110.07 179.608 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.211 179.758 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 121.038 0.447 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 57.3 m -113.99 46.61 1.3 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.548 -0.72 . . . . 0.0 110.344 179.883 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.401 ' O ' HG12 ' A' ' 3' ' ' VAL . 20.4 t -105.38 47.42 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.378 -0.826 . . . . 0.0 109.814 179.824 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.89 -31.92 21.94 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.367 -0.833 . . . . 0.0 110.66 -179.928 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -123.99 24.81 8.14 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.747 -0.596 . . . . 0.0 110.585 179.897 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.4 50.38 0.87 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.203 -0.936 . . . . 0.0 109.896 179.525 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -143.78 129.16 9.79 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.429 -0.795 . . . . 0.0 110.264 -179.934 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.29 -45.03 0.67 Allowed 'Trans proline' 0 C--N 1.315 -1.203 0 O-C-N 123.876 1.461 . . . . 0.0 110.937 -179.893 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 57.73 24.71 10.98 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.555 -0.716 . . . . 0.0 111.34 -179.899 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.412 ' O ' ' HB2' ' A' ' 11' ' ' PHE . 71.7 t-105 -67.93 89.62 0.29 Allowed 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 177.229 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.412 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 96.6 m-85 57.77 29.0 16.74 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 -174.63 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.567 ' CD1' HD13 ' A' ' 15' ' ' LEU . 0.4 OUTLIER 48.44 37.59 9.16 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.505 0.669 . . . . 0.0 109.963 -178.133 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -67.09 -49.23 65.69 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.697 -0.627 . . . . 0.0 109.733 179.5 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 t -61.85 -34.38 75.88 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.316 0.579 . . . . 0.0 109.523 179.189 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.567 HD13 ' CD1' ' A' ' 12' ' ' TRP . 1.6 tt -67.07 -41.51 86.27 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.901 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.3 tt -63.53 -42.11 98.44 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.629 -0.669 . . . . 0.0 109.919 179.353 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 tt -61.41 -33.13 73.17 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.572 0.701 . . . . 0.0 109.372 178.724 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.53 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -71.05 -38.45 72.52 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.294 0.569 . . . . 0.0 109.515 178.898 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.94 -39.04 93.24 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.773 -0.579 . . . . 0.0 109.885 179.153 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.67 -41.75 98.15 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.554 -0.716 . . . . 0.0 109.763 179.255 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.425 ' HA2' HD12 ' A' ' 24' ' ' ILE . . . -62.16 -38.86 96.86 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.32 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 18' ' ' LEU . 90.0 t -62.43 -43.2 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.552 -0.969 . . . . 0.0 109.797 179.433 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.446 ' HA2' HD12 ' A' ' 26' ' ' LEU . . . -62.43 -41.28 99.78 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.584 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.425 HD12 ' HA2' ' A' ' 21' ' ' GLY . 29.2 mt -66.64 -37.31 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.425 -1.044 . . . . 0.0 109.688 179.582 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -62.98 -26.68 68.96 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.216 -0.927 . . . . 0.0 109.666 178.948 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.446 HD12 ' HA2' ' A' ' 23' ' ' GLY . 11.7 mt -80.06 -17.31 53.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.371 -0.83 . . . . 0.0 109.429 178.373 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.612 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.4 OUTLIER -140.26 53.5 4.3 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.539 -0.726 . . . . 0.0 110.648 179.561 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.612 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.7 Cg_endo -90.39 -21.77 0.83 Allowed 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 121.03 1.153 . . . . 0.0 111.11 -179.689 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.51 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 6.1 p-10 -89.39 -18.13 27.44 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.375 -0.828 . . . . 0.0 111.001 179.78 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.51 ' HG3' ' O ' ' A' ' 29' ' ' ASN . 2.5 ptm180 . . . . . 0 N--CA 1.509 2.489 0 CA-C-O 117.813 -1.089 . . . . 0.0 111.857 -179.76 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 121.086 0.47 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 t -109.6 50.01 0.81 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.504 -0.747 . . . . 0.0 110.223 179.785 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.8 t -114.49 29.68 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.389 -0.82 . . . . 0.0 109.929 179.618 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.0 m -112.11 -80.16 0.59 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.192 -0.942 . . . . 0.0 110.225 179.917 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -112.6 37.26 3.12 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.66 -0.65 . . . . 0.0 110.675 179.979 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -115.16 46.12 1.51 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.387 -0.821 . . . . 0.0 109.982 179.559 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.73 115.1 47.22 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 121.538 -0.726 . . . . 0.0 110.243 -179.801 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.66 84.12 1.65 Allowed 'Trans proline' 0 C--N 1.315 -1.209 0 O-C-N 123.822 1.433 . . . . 0.0 110.286 179.776 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.478 ' O ' ' HB2' ' A' ' 10' ' ' TRP . 1.0 OUTLIER -134.13 -161.45 1.15 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.398 -0.814 . . . . 0.0 110.095 -179.843 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.478 ' HB2' ' O ' ' A' ' 9' ' ' ARG . 14.4 m-90 64.27 -73.2 0.05 Allowed 'General case' 0 N--CA 1.506 2.346 0 O-C-N 122.003 -0.436 . . . . 0.0 110.417 -179.777 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -70.15 -22.82 62.94 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.28 -0.888 . . . . 0.0 110.203 178.959 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -98.07 17.66 17.91 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.279 -0.888 . . . . 0.0 111.169 -179.961 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.439 ' O ' HD23 ' A' ' 17' ' ' LEU . 8.3 t80 -61.89 -45.9 91.72 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.145 -0.972 . . . . 0.0 109.933 179.586 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.3 t -59.91 -35.67 75.38 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.008 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.6 tt -66.17 -47.64 73.32 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.532 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.5 tt -65.76 -37.02 85.2 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.52 0.676 . . . . 0.0 109.211 178.566 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.439 HD23 ' O ' ' A' ' 13' ' ' PHE . 2.1 mm? -61.52 -33.01 73.08 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.518 0.675 . . . . 0.0 109.407 178.611 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.8 tp -74.09 -39.53 63.36 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.375 0.607 . . . . 0.0 109.688 178.915 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.43 -37.86 89.0 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.808 -0.558 . . . . 0.0 109.945 179.285 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.38 -40.09 96.29 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.621 -0.675 . . . . 0.0 110.1 179.482 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.12 -42.19 94.6 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.624 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 73.2 t -62.32 -40.0 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.45 -1.03 . . . . 0.0 109.972 179.567 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.469 ' HA2' HD12 ' A' ' 26' ' ' LEU . . . -64.12 -44.74 95.3 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.567 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.3 mt -64.8 -35.58 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.358 -1.083 . . . . 0.0 109.784 179.543 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -63.69 -26.54 68.71 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.127 -0.983 . . . . 0.0 109.671 178.775 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.469 HD12 ' HA2' ' A' ' 23' ' ' GLY . 14.9 mt -79.18 -24.2 43.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.401 -0.812 . . . . 0.0 108.862 178.19 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.553 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 0.3 OUTLIER -133.72 56.31 19.6 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.579 -0.701 . . . . 0.0 110.558 179.411 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.553 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 40.3 Cg_endo -90.29 -21.49 0.89 Allowed 'Trans proline' 0 C--N 1.318 -1.042 0 O-C-N 123.346 1.182 . . . . 0.0 111.143 -179.821 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -79.68 -37.13 36.52 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.254 -0.904 . . . . 0.0 110.298 179.514 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.15 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.889 179.962 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 27.5 p80 . . . . . 0 N--CA 1.499 1.988 0 CA-C-O 120.728 0.299 . . . . 0.0 111.575 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.3 p -117.21 22.91 12.19 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.276 -0.89 . . . . 0.0 110.706 179.971 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.2 m -129.45 59.22 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.175 -0.953 . . . . 0.0 109.99 -179.982 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.7 p -135.33 -90.55 0.31 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.458 -0.777 . . . . 0.0 110.427 -179.646 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -108.79 34.0 3.92 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.695 -0.628 . . . . 0.0 110.188 179.838 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -159.83 76.98 0.66 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.456 -0.777 . . . . 0.0 109.596 179.978 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.7 mpp_? -115.93 76.62 6.28 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.5 -0.75 . . . . 0.0 110.242 -179.577 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.2 -41.24 1.34 Allowed 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.65 1.342 . . . . 0.0 110.785 179.931 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.604 ' HA ' ' HB3' ' A' ' 12' ' ' TRP . 0.2 OUTLIER -116.46 -19.63 10.0 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.411 -0.806 . . . . 0.0 111.118 -179.744 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 5.7 t-105 -54.6 -56.3 20.43 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.274 -0.891 . . . . 0.0 110.474 -179.883 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -71.35 -35.21 71.08 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.323 -0.86 . . . . 0.0 109.605 179.161 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.604 ' HB3' ' HA ' ' A' ' 9' ' ' ARG . 35.3 t-105 -61.65 -23.45 66.08 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.699 -0.625 . . . . 0.0 110.633 179.358 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -59.76 -37.54 79.3 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.511 -0.743 . . . . 0.0 110.203 179.384 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 81.3 p -66.78 -33.15 74.98 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.581 -0.699 . . . . 0.0 109.492 179.047 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.5 tt -67.66 -41.48 83.72 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.49 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 tt -61.32 -41.06 96.38 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.656 -0.653 . . . . 0.0 109.781 179.078 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 tt -62.21 -37.33 84.91 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.543 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.504 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -68.79 -36.34 78.15 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.283 0.563 . . . . 0.0 109.604 178.843 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.14 -38.99 92.36 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.747 -0.596 . . . . 0.0 109.98 179.295 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.538 ' O ' HD12 ' A' ' 24' ' ' ILE . . . -64.39 -43.22 95.13 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.587 -0.696 . . . . 0.0 109.758 179.359 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.12 -40.03 96.62 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.231 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 18' ' ' LEU . 94.9 t -63.89 -37.8 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.529 -0.983 . . . . 0.0 109.71 179.244 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.407 ' HA2' HD12 ' A' ' 26' ' ' LEU . . . -60.06 -46.12 94.75 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.415 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.538 HD12 ' O ' ' A' ' 20' ' ' ALA . 1.2 mp -67.18 -34.48 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.447 -1.031 . . . . 0.0 109.561 179.325 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -63.48 -25.99 68.52 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.15 -0.969 . . . . 0.0 109.575 178.842 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.407 HD12 ' HA2' ' A' ' 23' ' ' GLY . 13.6 mt -80.09 -19.43 47.44 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.353 -0.842 . . . . 0.0 109.266 178.273 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.596 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 10.9 tp -138.54 53.95 6.24 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.54 -0.725 . . . . 0.0 110.623 179.438 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.596 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 40.9 Cg_endo -89.6 -30.15 0.19 Allowed 'Trans proline' 0 C--N 1.319 -1.003 0 O-C-N 123.232 1.122 . . . . 0.0 110.967 -179.975 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -86.85 -14.86 40.87 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.271 -0.893 . . . . 0.0 110.745 179.468 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 26.2 mtt180 . . . . . 0 N--CA 1.5 2.06 0 O-C-N 121.646 -0.659 . . . . 0.0 110.285 -179.624 . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 4.9 m170 . . . . . 0 N--CA 1.497 1.882 0 CA-C-O 121.034 0.445 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.9 p -142.26 35.67 1.51 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.486 -0.759 . . . . 0.0 110.673 -179.955 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.5 t 49.82 43.16 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 121.497 -0.752 . . . . 0.0 110.196 -179.842 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.0 t -70.98 -32.85 69.81 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.276 -0.89 . . . . 0.0 110.656 -179.861 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.524 ' HB3' ' HG3' ' A' ' 8' ' ' PRO . 64.4 m170 -108.19 31.8 5.27 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.604 -0.685 . . . . 0.0 110.336 179.857 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 7' ' ' ARG . . . 55.48 56.89 5.82 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.608 -0.682 . . . . 0.0 110.653 -179.913 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER 30.11 69.56 0.64 Allowed Pre-proline 0 N--CA 1.509 2.507 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 179.796 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.524 ' HG3' ' HB3' ' A' ' 5' ' ' HIS . 52.4 Cg_endo -82.02 170.66 13.56 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.652 1.343 . . . . 0.0 110.926 -179.987 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.9 ptt-85 -110.1 -29.86 8.02 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.535 -0.728 . . . . 0.0 110.427 179.314 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 73.8 t-105 -63.18 -32.61 74.05 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.356 -0.84 . . . . 0.0 110.236 179.506 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -74.25 -23.43 59.14 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.456 -0.777 . . . . 0.0 110.637 179.609 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -78.0 9.16 3.86 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.303 -0.873 . . . . 0.0 111.319 179.991 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -62.49 -32.18 73.04 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.038 -1.039 . . . . 0.0 109.919 179.532 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.31 -38.87 82.03 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.588 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 tt -63.27 -39.51 94.78 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.388 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.3 tt -64.42 -39.0 92.99 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.346 0.594 . . . . 0.0 109.791 178.984 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.2 tp -63.22 -34.99 78.84 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.51 0.671 . . . . 0.0 109.444 178.795 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.524 ' O ' HG23 ' A' ' 22' ' ' VAL . 3.4 tt -68.81 -37.34 79.15 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.226 0.536 . . . . 0.0 109.688 178.89 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.16 -38.04 84.79 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.791 -0.568 . . . . 0.0 109.682 179.088 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.65 -39.16 91.1 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.636 -0.665 . . . . 0.0 110.0 179.337 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.1 -39.74 97.46 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.43 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 18' ' ' LEU . 92.3 t -62.22 -43.47 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.497 -1.002 . . . . 0.0 109.608 179.548 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.57 -44.39 92.89 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.411 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.4 mt -65.56 -35.02 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.455 -1.026 . . . . 0.0 109.721 179.411 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -64.1 -27.06 68.84 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.112 -0.992 . . . . 0.0 109.388 178.737 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.465 HD13 ' HA ' ' A' ' 26' ' ' LEU . 1.5 mm? -77.92 -24.88 48.15 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.097 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.549 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 3.4 tp -134.63 57.09 20.23 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.559 -0.713 . . . . 0.0 110.643 179.512 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.549 ' HD3' ' N ' ' A' ' 27' ' ' LEU . 41.2 Cg_endo -90.86 -20.61 0.83 Allowed 'Trans proline' 0 C--N 1.316 -1.137 0 O-C-N 123.225 1.118 . . . . 0.0 111.121 -179.927 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -93.31 -23.93 18.31 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.296 -0.878 . . . . 0.0 110.723 179.925 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 . . . . . 0 N--CA 1.497 1.918 0 CA-C-O 118.121 -0.942 . . . . 0.0 110.567 -179.8 . . . . . . . . 0 0 . 1 stop_ save_